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Summary
Despite its medical significance relatively little is known about pancreatic 
growth, particularly in postnatal life. The existence of a pancreatic stem cell population 
and the limitation on the division potential of the differentiated cells, are matters of 
contention. In this work, a number of studies were conducted to investigate the growth 
and differentiation of the mammalian (mouse) pancreas.
A characterisation was made of a sub-population of migratory epithelial cells in 
cultures of recombinant pancreatic buds combining the epithelium from a P-gal- 
expressing ROSA-26 embryo and an intact bud from a wild-type embryo. The 
migratory characteristics of these cells were studied and a proportion was found to 
express insulin or glucagon.
Extending a previous study (Shen et al., 2000), showing that the synthetic 
glucocorticoid dexamethasone (Dex) induces hepatocytes in intact pancreatic cultures, 
an investigation was made into the relationship between two Dex-induced pancreatic 
hepatocyte populations expressing either of two hepatic enzymes. By depriving the 
pancreatic epithelium of mesenchyme it was demonstrated that induction of the two 
populations occurs independently of the other.
The postnatal clonal development of the pancreatic islets and ducts was followed 
in p-gal-expressing X-inactivation mosaic mice. The consistent heterogeneous ductal P- 
gal+/p-gal' cell composition showed that pancreatic ducts arise from multiple progenitor 
cells and retain this polyclonal state postnatally. Although at birth islets were mixed, 
confirming their formation from multiple progenitor cells, by three weeks after birth 
almost 95 % of islets were homogeneous indicating a shift towards monoclonality. This 
“clonal purification” might be assisted by an unreported process of islet fission for 
which morphological and cell composition evidence is presented.
A morphometric analysis was made of histological sections from transgenic 
mice specifically overexpressing IGF-II either in the pancreatic acini or islet P-cells. 
Both lines demonstrated a similar phenotype of islet hyperplasia with disorganised islet 
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The pancreas (pi. pancreata) is an especially important organ from a medical 
perspective because it is affected by two significant diseases: diabetes mellitus and 
pancreatic cancer. A total of 150 million people worldwide currently suffer from type 1 
or type 2 diabetes mellitus and this figure is predicted to rise to 300 million over the 
course of the next 20 years (Zimmet et al., 2001). Despite the availability of insulin, 
diabetes mellitus is still problematic, causing premature death and prolonged ill health. 
Approximately 6700 people are diagnosed with pancreatic cancer each year in the UK, 
accounting for about 3 % of all cases of cancer in this country (Cancer Research UK, 
2002). Despite being the 11th most common cancer in the UK, it is the fifth most 
common cause of cancer mortality owing to the disease being virtually incurable. The 
five-year survival rate for patients suffering from cancer of the pancreas is only about 2 
% (Cancer Research UK, 2002). It follows that a better understanding of the 
development of the organ as a whole is likely to lead to the development of novel 
therapies for the treatment of these diseases, diabetes in particular. However, despite the 
obvious significance of this organ, the pancreas was largely overlooked in the field of 
developmental biology until relatively recently.
1.2. Anatomy and Histolosv o f  the Pancreas
1.2.1. Gross Morphology and Function
The pancreas is a flattened and elongated compound racemose gland, that is a 
gland bearing branching ducts that terminate in sacs of secreting cells. The human 
pancreas comprises an organ of 70-150 grams in weight and 15-25 cm in length, lying 
laterally to the upper right hand side of the abdominal cavity. It is connected to the 
duodenum by the ampulla of Vater, where the main pancreatic duct joins with the 
common bile duct from the liver and gallbladder (Figs. 1.1. and 1.2.). Regions of the 
human pancreas are usually designated as the head, body and tail, from proximal to 
distal and some textbooks also include a neck and an uncinate (or “hook-like”) process, 
which is the posterior part of the head. The form of the pancreas in rodents however, is 
less well defined although the terms head and tail are also typically applied.
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Figure 1.1. Anatomy of the Adult Human Pancreas. (Reproduced from Gray’s 
Anatomy, 38th Edition, Williams, P. L., Copyright [1995], with Permission from 
Elsevier)
Portal Vein
Hepatic ArteryCommon Bile Duct
Ampulla 
of









Figure 1.2. Location of the Dorsal 
and Ventral Pancreatic Buds in a 
Human Embryo of About 36 Days 
(After Slack, 1995)
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The pancreas is an organ with two distinct functions: the secretion of enzymes 
and salts into the digestive tract and secretion of hormones into the bloodstream which 
regulate blood glucose levels. These functions are performed by two quite distinct types 
of glandular tissue: the exocrine and endocrine tissue respectively. However, the 
pancreas is a single integrated organ from a biological perspective, despite the frequent 
segregation of its endocrine and exocrine functions in many medical texts.
1.2.2. The Exocrine Pancreas
The exocrine pancreas is a lobulated, branched, acinar gland. The secretory 
exocrine cells form a system of terminal or intercalary acini of small lumens, connected 
by ducts (Fig. 1.3.). The acinar cells are pyramidal in shape and are specialised for 
protein synthesis, characterised especially by a prominent Golgi complex and numerous 
secretory (zymogen) granules containing digestive enzymes including proteases, 
amylases, lipases and nucleases. The majority of these enzymes are secreted as inactive 
precursors, only becoming activated upon entering the duodenum. Low cuboidal 
centroacinar cells, located at the junction of acini and ducts secrete non-enzymic 
components of the pancreatic juice, including bicarbonate. The ducts themselves are 
lined with columnar epithelial cells, and small numbers of goblet and brush cells are 
present in the larger ducts, much like those of the intestine. Secretion of the pancreatic 
juice is modulated by hormonal stimulation, principally by secretin, cholecystokinin and 
gastrin, and also by neural stimuli. The acini and smaller ducts are encapsulated by a 
delicate, loose connective tissue or septa, which becomes more extensive around the 
larger ducts.
1.2.3. The Endocrine Pancreas
The endocrine cells are predominantly aggregated into the islets of Langerhans. 
The islets are compact spheroidal clusters embedded in the exocrine tissue and form the 
functional endocrine units of the pancreas (Figs. 1.3. and 1.4.). The human pancreas 
contains approximately one million of these structures and although distributed 
throughout the organ, they are more abundant in the tail. The islets vary considerably in 
size, ranging from tens of cells to several thousand though all are richly vascularised by 
a network of fenestrated capillaries.
3
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Figure 1.3. Schematic of Histological Architecture in the Mammalian Pancreas 
(Reproduced from Color Textbook o f Histology, Gartner, L. P. and Hiatt, J. L., 
















(Exocrine) Pancreatic Acinar Cell
Figure 1.4. Histology of the Adult Mouse Pancreas
(a) An islet adjacent to a duct (arrowhead), surrounded by secretory acini (H & E stain).
(b) Immunostaining for insulin showing p-cells in centre (core) of islet, (c) Immuno- 
staining for glucagon, revealing less numerous a-cells in the periphery (mantle) of the 
islet. Bar = 100 pm
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There are four principal endocrine cell types within the islet. The p (or B) cells 
secrete the hormone insulin and the insulin antagonist amylin or islet amyloid 
polypeptide (IAPP). They constitute the majority (approximately 60-80 %) of the islet 
cells and form the core of the islet, around which cells of the other three endocrine cell 
types are arranged. The a  (or A or A2) cells represent approximately 20 % of the islet 
cells and are generally located around the periphery or mantle of the islet. They 
synthesise and secrete the hormone glucagon. They respond to gastrointestinal 
hormones, neural inputs and paracrine agents such as the insulin secretion inhibitor 
somatostatin (SS), secreted by the 8 (or D or Al) cells which form about 5 % of the islet 
cells. Finally, the PP (or F or y) cells can constitute up to 1 % of the islet cells. They 
release pancreatic polypeptide (PP), a paracrine inhibitor of acinar cell secretion. A 
fraction of the adult islet cells synthesise peptide YY in addition to their principal 
product (Ali-Rachedi et al., 1984). Activin A, a member of the TGF-p superfamily, is 
abundant in the A and D cells (Yasuda et al., 1993). In rodents, there is a marked 
delineation within the islets between the central p-cells and the peripheral cells of other 
types. Although present, such segregation in humans is less pronounced. Despite their 
obvious functional significance, the proportion of endocrine cells is a small fraction of 
the total, accounting for only about 4 % of total cells in the adult rat (Githens, 1988). 
Small numbers of endocrine cells also occur outside the islets: so-called extra-insular P- 
cell clusters or single cells, some of them duct-associated, represent less than 1 % of all 
beta cells in the rat pancreas (Wang et al., 1994, 1995). Endocrine cells which 
synthesise glucagon, somatostatin, amylin and peptide YY are present elsewhere in the 
gut in addition to the pancreas. All islet cell types, further to their specific hormones, 
also express a number of gene products characteristic of neuroendocrine cells, such as 
neuron-specific enolase, tetanus toxin receptor, A2B5 antigen (Le Douarin, 1988) and 
the homeodomain-LIM protein Islet-1 or Isll (Thor et al., 1991). The whole of the early 
pancreatic rudiment also expresses the enzyme L-amino acid decarboxylase (AADC), 
which becomes confined to islet cells postnatally (Teitelman et al., 1987). The enzyme 
tyrosine hydroxylase is also expressed by some cells in the early pancreas, although this 
is not an invariable characteristic (Teitelman and Lee, 1987).
1.2.3.1. Insulin and Diabetes
Insulin is a dimeric disulphide-linked protein. It is synthesised as a single chain 
precursor which initially loses its signal peptide, before losing its so-called “C-peptide”
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segment during conversion to the mature hormone molecule. Mature insulin is stored in 
secretory granules and its release is modulated by the level of glucose in the perfusing 
blood. The effects of insulin on the target tissues are both metabolic, especially in 
promoting glucose uptake, and mitogenic. The hormone acts via a tyrosine kinase type 
receptor, the major intracellular target of which is insulin receptor substrate 1 (IRS-1; 
Siddle, 1992).
P-Cell function and insulin synthesis is of great consequence to the well-being of 
the animal. Decreased insulin secretion or impaired insulin action leads to diabetes 
mellitus, of which there are two principal forms. Type 1 or insulin-dependent diabetes, 
found most often in children and young people, manifests itself as p-cell destruction as 
a result of an autoimmune reaction. Severe permanent insulin deficiency consequently 
ensues. Type 2 or non-insulin-dependent diabetes is the most common form of diabetes, 
accounting for more than 90 % of diagnosed cases and affecting about 4 % of the 
population worldwide. It is more frequently an affliction of mature individuals and is a 
more complex and heterogeneous range of conditions. Type 2 diabetes usually involves 
a degree of insulin non-responsiveness in the target tissues, p-cell dysfunction, or a 
combination of both. It may involve a contribution from pancreatic pathology since the 
islets of patients are frequently invested with a deposit of amyloid, the major component 
of which is a precipitated form of the amylin produced by the P-cells. The 
manifestations of the illness are widespread. Diabetes mellitus causes premature death 
and prolonged ill health from severe complications including kidney, cardiovascular, 
and eye disease (reviewed by Sander and German, 1997). A more comprehensive 
understanding of P-cell biology and islet and pancreas development in general would be 
beneficial to the development of improved therapy for type 1 diabetes, either by 
stimulating p-cell regeneration or by being able to culture and graft p-cells between 
individuals.
1.2.4. Blood and Nervous Supply
In addition to its glandular components, the pancreas possesses an extensive 
blood supply; arterial blood passes in each lobule first to the islets and then to the 
surrounding acini. There is also an extensive lymphatic drainage, and a rich sympathetic 
and parasympathetic nerve supply. Smooth muscle occurs around the larger ducts and in 
the sphincter muscles of the two ampullae. The fibroblastic, lymphatic and smooth
6
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muscle components of the pancreas are presumed to arise from the abundant 
mesenchyme enveloping the embryonic pancreatic buds.
1.3. Pancreatic Morphogenesis
1.3.1. Orisin from Two Buds
Much of today’s knowledge of the morphological development of the early 
mammalian pancreas stems from the detailed descriptions of Wessels and Cohen 
(1967), Pictet et al. (1972) and Pictet and Rutter (1972). Relatively little has been 
contributed to the understanding of the morphological basis of pancreas development in 
the intervening years. Many aspects of pancreatic development are homologous 
between species, especially during the early phases. A distinctive feature of pancreatic 
development in mammals, birds and amphibians is that the pancreas originates 
embryologically as separate dorsal and ventral rudiments which initially develop 
independently before meeting and fusing to form a single organ (Slack, 1995) (Figs.
1.2. and 1.5.). In the mouse at around embryonic day 9.5 (E9.5), the dorsal pancreatic 
bud first appears as an evagination in the primitive gut endoderm, near the junction of 
the foregut and midgut in the area that is destined to give rise to the duodenum 
(Wessells and Cohen, 1967). Approximately one day later, the ventral pancreatic bud 
arises on the opposite side of the gut tube, immediately adjacent to the hepatic 
diverticulum, its developmental progression mirroring that of the dorsal bud albeit with 
a small time delay (Spooner et al., 1970). It remains unclear how the initially separate 
programs of dorsal and ventral pancreatic bud development are coordinated to produce a 
convergent developmental program.
Owing to differential growth of the foregut wall, the stomach and duodenum 
rotate to the left. The ventral pancreatic rudiment and hepatopancreatic orifice (hepatic 
duct) migrate round the foregut until they come into apposition with the dorsal bud and 
at around E l6-17 fusion of the two buds occurs (Pictet and Rutter, 1972). The dorsal 
bud gives rise to the majority of the pancreas whilst the ventral bud forms only the 
posterior portion of the head, or uncinate process which remains visible postnatally in 
humans. Although the dorsal pancreatic rudiment is the larger of the two, it is the 
ventral duct which persists as the main pancreatic duct (duct of Wirsung) by fusing with 
the distal part of the dorsal duct. The remnant, proximal part of the dorsal duct 















Figure 1.5. Schematic Diagram Showing the Development and Fusion of the 
Pancreatic Buds to Form the Pancreas in the Mouse. (After Dubois, 1989)
The two pancreatic primordia are shown in ventral view, prior to fusion in (a)-(c). 
Owing to differential growth of the foregut wall, the stomach and duodenum rotate 
to the left (b). The ventral bud and hepatopancreatic orifice (hepatic duct) migrate 
round the foregut until they come into apposition with the dorsal bud and fusion of 
the two buds occurs at around E16-17 (Pictet and Rutter, 1972).
The dorsal pancreatic bud gives rise to the main mass of the adult pancreas whilst 
the ventral bud forms the uncinate process, the posterior part of the head of the 
organ, highlighted in (d)
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small accessory pancreatic duct (duct of Santorini), typically with its own opening into 
the duodenum.
1.3.2. Appearance of Endocrine Cells
The pancreatic buds grow into their surrounding mesoderm and rapidly form 
new protmsions, leading to a highly branched structure. In vitro studies suggest that this 
budding of the epithelium may be driven by a local increase in cell division (Horb and 
Slack, 2000). The tubules subsequently terminate in distinct aggregates of cells, the 
presumptive acini. Murine acini and ducts become clearly visible as histologically 
differentiated structures by E l4.5. Low levels of the various terminal differentiation 
products can be detected throughout pancreatic development (the “protodifferentiated 
state”; Pictet and Rutter, 1972, further extended to the reverse transcriptase-polymerase 
chain reaction [RT-PCR] level in Gittes and Rutter, 1992). Somatostatin mRNA can be 
detected prior to formation of the pancreatic anlage as early as E8.5; insulin and 
glucagon mRNA expression can be observed from E9.5, PP from E l0.5, and amylase 
mRNA from E l2.5 (Gittes and Rutter, 1992; Herrera et al., 1991). Amylase becomes 
detectable by immunostaining from about E l4.5. Endocrine cells can be detected in the 
forming pancreas from the earliest stages. As a consequence of the temporal divergence 
in development between the two pancreatic buds, the first endocrine cells appear in the 
dorsal bud at least 36 h prior to the overt differentiation of endocrine cells in the ventral 
bud (Pictet and Rutter, 1972; Spooner et al., 1970). Three immunostaining studies on 
the formation of the endocrine cells (Herrera et al., 1991; Teitelman et al., 1993; 
Upchurch et al., 1994) have generated conflicting results. Certain common conclusions 
can, however, be extrapolated: the first cells containing insulin or glucagon appear at 
about E9.5 in the dorsal pancreatic bud. These early endocrine cells frequently reside in 
the region lining the ductules (Wessells and Evans, 1968). As insulin-containing cells 
have been reported to be much less prevalent at E9.5 than glucagon-containing cells, 
many of which lack insulin reactivity, this has prompted the idea that glucagon- 
expressing cells appear initially in endocrine development (Herrera et al., 1991; Pictet 
and Rutter, 1972; Teitelman and Lee, 1987; Upchurch et al., 1994). It has recently been 
shown that blocking the early expression and function of glucagon prevents insulin- 
positive differentiation in E ll mouse pancreas, leading to speculation that glucagon 
plays a key role in the paracrine induction of differentiation of other pancreatic 
components in the early embryonic pancreas (Prasadan et al., 2002). At E10.5-11.5,
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cells are frequently observed expressing insulin and glucagon simultaneously. 
Somatostatin- or PP-expressing cells only arise later in development; somatostatin 
appears in the primordial pancreas at around E l5 and then PP is first detected 
perinatally (Teitelman and Lee, 1987; Teitelman et al., 1993; Upchurch et al., 1994). 
During development, the majority if not all of the immature endocrine cells coexpress 
PYY, but only a fraction of the mature islet cells continue to coexpress PYY in addition 
to their principal product (Upchurch et al., 1994). As mentioned, it has been frequently 
observed that between E l0.5 and E l4.5, many of the early endocrine cells stain 
simultaneously with antibodies to multiple hormones (both insulin and glucagon for 
example). This is in contrast to the '''‘one cell, one hormone” rule which applies to the 
postnatal pancreas, so there is a distinction to be made between such early 
multihormone-expressing cells and the later mature endocrine cells (Slack, 1999). 
Indeed it has been proposed that the multihormone-expressing population represent 
endocrine cell precursors (Alpert et al., 1988). Also expressed in early endocrine cells 
are the enzyme tyrosine hydroxylase (Teitelman, 1990), and the signalling molecule 
activin (Yasuda et al., 1993), implicated in a wide variety of developmental processes.
13.2.1. PP-Fold Peptides
There has been much debate over expression of the “PP-fold” peptides in the 
developing pancreas. The three peptides, pancreatic polypeptide (PP), neuropeptide Y 
(NPY) and peptide YY (PYY), exhibit very similar primary sequences. Antibodies 
specific to one frequently cross-react with the others. PP is one of the products of a 
subset of the mature endocrine cells and is postulated to play a physiological role in the 
antagonism of insulin secretion. Some evidence suggests the expression of PP in the 
early multihormone cell population (Herrera et al., 1991), although this has also been 
claimed to be NPY (Teitelman et al., 1993). The most widely supported view however 
is that it is PYY which is expressed in many or all of the early endocrine cells 
(Upchurch et al., 1994). It has not been resolved whether such cells are actually the 
precursors of the mature endocrine cells.
1.3.3. Islet Development
The pancreas grows very rapidly during the midgestation period with 
vascularisation occurring from about E l4 in mouse. By E l5.5, endocrine cells
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constitute about 10 % of the total cells although they are still predominantly individual 
and associated with the ducts. Islets, with the characteristic distribution of insulin- 
expressing cells in the centre and non-insulin-producing cells in the periphery, do not 
form until the end of gestation, at about El 8.5 in the mouse (Herrera et al., 1991). The 
presumptive islets form as aggregates or “clumps” of cells, distinct from those of the 
terminal structures, which bud off from the walls of the smaller branches. These early 
endocrine cells separate from the cell layer of the developing exocrine gland, probably 
by a change in the axis of cell division allowing the escape from the ductule lumen of 
one of the daughter cells (Pictet and Rutter, 1972). Expression of the cell adhesion 
molecule R-cadherin in the intraductal primitive endocrine cells disappears prior to islet 
formation; this downregulation is associated with and presumably facilitates, migration 
out of the duct epithelium to form islets (Hutton et al., 1993; Sjodin et al., 1995). 
Migration of endocrine cells into the extracellular matrix and islet morphogenesis are 
probably dependent on matrix degradation by activated matrix metalloproteinases 
(MMPs). MMP overactivation in vitro has been shown to result in a perturbation of 
normal islet architecture (Miralles et al., 1998a). As the presumptive islet cell groups 
migrate away from the tubules into the stroma of the developing gland, new aggregates 
continue to form and bud off. It is not yet known to what extent islet formation occurs 
by aggregation of pre-existing cells or by monoclonal growth from individual 
precursors. The islets may expand by merging or recruiting cell clusters in close 
proximity or through proliferation of the islet cell precursors or through a combination 
of the two. In an aggregation chimera study using human C-peptide/proinsulin product 
as a cell marker, islets were seen that contained cells from both aggregated embryos, 
suggesting that at least some islets are formed by cell aggregation (Deltour et al., 1991). 
Conclusions were, however, drawn from only two informative cases. In a more recent 
study (Percival and Slack, 1999), it was demonstrated that when pancreatic epithelium 
from transgenic ROSA-26 mouse embryos which ubiquitously express Escherichia coli 
P-galactosidase is recombined with mesenchyme from unlabelled embryos, both 
individual acini and individual islets in the resulting culture are frequently of mixed 
cellular composition. This study also suggests that the islets are initially formed by cell 
aggregation although it must be assumed that events in vitro accurately reflect those in 
situ. The rate of increase of endocrine cell numbers could be accounted for by 
multiplication of the precursors present early in development, but a cell kinetic study in 
the rat by Kaung (1994) suggested recruitment into the endocrine population both 
preceding and following birth. The integrity of the islets is apparently reliant on cell
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adhesion. Transgenic mice in which a dominant negative E-cadherin gene is driven by 
the insulin promoter exhibit a failure of p-cells to aggregate, though a-cells are 
unaffected and selectively aggregate into clusters lacking p-cells (Dahl et al., 1996). 
Neural cell adhesion molecule (N-CAM) has been shown to play a role in the 
segregation of islet cells in vitro and it is presumed that owing to its expression being 
mostly confined to peripheral non-P-cells, it is principally responsible for maintaining 
this peripheral arrangement in vivo (Cirruli et al., 1994; Rouiller et al., 1990).
1.4. Pancreatic Determination and Transcription Factor 
Expression
1.4.1. Timing of Pancreatic Determination
It is not known precisely when the pancreatic anlage is specified in relation to 
the surrounding endoderm. However, Wessells and Cohen (1967) showed that by E8.5 
in the mouse the region of the embryonic foregut from which the pancreas develops has 
acquired the ability to give rise to a differentiated pancreas when explanted and cultured 
in vitro. Dorsal gut endodermal cells are committed towards a pancreatic fate prior to 
the appearance of the first terminal differentiation products. Using RT-PCR, Gittes and 
Rutter (1992) were able to detect somatostatin mRNA at E8.5, preceding the first 
morphological evidence of pancreas development by one day. It cannot be excluded that 
the future pancreatic endodermal cells are subdivided into an endocrine and an exocrine 
compartment prior to bud formation (Sander and German, 1997). It is presumed that the 
fate of the individual endodermal cells is determined by an intrinsic “epigenetic code” 
established by the expression of a distinct set of transcription factors in the cells of the 
future pancreatic anlage (Sander and German, 1997). Transcription factor expression 
permits cells in this region to respond to the signals from the pancreatic mesenchyme or 
other surrounding tissues that induce pancreatic growth and cell differentiation.
1.4.2. Endoderm Formation and Extrinsic Signals Initiatins Pancreatic 
Bud Outsrowth
1.4.2.1. Sienals from the Notochord
In the mouse, the three germ layers, endoderm, ectoderm and mesoderm, are 
established by the close of gastrulation at E7.5. Little is known regarding the nature of
12
Chapter 1: Introduction
signals instructing the pluripotent embryonic cells to form endoderm. However, 
numerous soluble growth factors are produced in the adjacent germ layers and are 
presumed to influence endoderm patterning. Recently, the mesodermal Fibroblast 
Growth Factor (FGF)4 has been implicated in early endoderm specification (Wells and 
Melton, 2000). FGF4 is able to induce the expression of specific pancreatic genes in the 
endoderm in vitro. Further data from Wells and coworkers also suggests that these 
soluble factors render the endoderm competent to respond to subsequent inductive 
signals from the adjacent notochord. Two members of the hedgehog family of signalling 
molecules, Sonic hedgehog (Shh) and Indian hedgehog (Ihh), are together expressed 
uniformly, although in a partially overlapping manner, in regions of the gut endoderm 
anterior and posterior to the position at which the pancreas develops (Apelqvist et al., 
1997; Bitgood and McMahon, 1995). In the pancreatic endoderm, the expression of 
both Shh and Ihh is restricted to the lateral prospective intestinal part of the epithelium 
and is excluded from both the dorsal and ventral pancreatic epithelium (Apelqvist et al., 
1997; Bitgood and McMahon, 1995). Repression of Shh in the pancreatic endoderm has 
been shown to be critical for proper pancreas development since ectopic expression of 
Shh in the prospective pancreatic epithelium of the posterior foregut results in disrupted 
pancreatic morphogenesis (Apelqvist et al., 1997) and a compensatory enhancement of 
intestinal development with inhibition of spleen development.
The region of the gut epithelium fated to form the dorsal pancreatic bud is 
initially in direct contact with the notochord (Slack, 1995; Wessells and Cohen, 1967) 
(Fig. 1.6.). It has been demonstrated that activin-pB, a member of the transforming 
growth factor p (TGF-P) family, and FGF2 which are both expressed by the notochord, 
are able to repress Shh and Ihh expression in the presumptive dorsal pancreatic 
endoderm (Hebrok et al., 1998; Kim et al., 1997; Kim and Melton, 1998). Abrogation 
of Shh function invokes a relative increase in endocrine cell number and pancreas size 
(Hebrok et al., 2000) and mutations of activin receptor ActRILA and ActRBII lead to a 
disruption in pancreas development (Kim et al., 2000). Under such conditions, islets are 
formed, but insulin expression is markedly reduced, showing that type II activin 
receptors are required for endocrine differentiation in pancreas. In contrast, the ventral 
gut epithelium fated to form the ventral pancreatic bud is never contacted by the 
notochord, implying that the exclusion of Shh and Ihh gene expression from the ventral 
pancreatic epithelium is achieved by a distinct notochord-independent mechanism.
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Figure 1.6. Signals Initiating Outgrowth of the Dorsal and Ventral Pancreatic Buds
(a). Before the formation of the pancreatic buds, a pre-patterning of the gut 
endoderm renders the dorsal endoderm competent to respond to specific signals 
from the notochord (dark blue arrows) and cardiac mesoderm (red arrows):
- Notochord factors such as activin-f3B, FGF2 and probably other unidentified 
factors repress endodermal Shh and Ihh expression (dark blue arrows), permitting 
the expression of Pdxl and other pancreatic developmental genes (blue region) - 
outgrowth of the dorsal pancreatic bud (DB) is initiated
- FGF signalling from the cardiac mesoderm is sufficient (uniformly red arrow) to 
direct proximal endoderm from the default pancreatic fate to a hepatic fate (green 
region). Endoderm that is not proximal to the cardiac mesoderm, for example at 
the lip that extends the foregut to the midgut, does not receive sufficient FGF from 
the cardiac mesoderm (red fading arrow) to activate the hepatic developmental 
program. Therefore, the intrinsic developmental program for pancreas is followed 
without perturbation (blue region), allowing the ventral pancreatic bud (VB) to 
form. While the cardiac mesoderm has a net positive effect on hepatic induction, 
mechanistically it appears to block the intrinsic program for pancreas and thereby 
promote liver development within the ventral foregut endoderm
(b). As the pancreatic buds form and proliferate, factors produced by the 
mesenchyme surrounding the pancreatic epithelium promote the development of 
the exocrine tissue while inhibiting endocrine differentiation (pale blue arrows). 
Follistatin and additional unknown factors probably participate in this process. 
Proximal endoderm meanwhile, continues to follow a program of hepatic 
development (green arrows), giving rise to the liver
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I.4.2.2. Sisnals from the Cardiac Mesoderm
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A more recent study has offered insight into the mechanisms responsible for 
patterning of the ventral endoderm and so generation of the ventral pancreas. The 
ventral endoderm from which the ventral pancreatic bud derives, lies in close proximity 
to the developing heart and can also give rise to liver cells or hepatocytes (Gualdi et al., 
1996), suggesting that development of the pancreas and liver is related. Deutsch and 
colleagues (Deutsch et al., 2001) showed that E8.5 ventral endoderm lying adjacent to 
the cardiac mesoderm gives rise to cells expressing the liver marker albumin whilst cells 
expressing the pancreatic marker, Pdxl, originate from a region of endoderm extending 
beyond the cardiac anlage. This indicates that both tissues derive from non-overlapping 
domains of ventral endoderm. Hepatic development has been shown to be induced by 
FGFs secreted from the cardiac mesoderm which act on the underlying ventral 
endoderm (Jung et al., 1999); ventral endoderm cultured in the absence of FGF or 
cardiac tissue fails to activate an hepatic developmental program. Deutsch and 
coworkers (Deutsch et al., 2001) demonstrated that if isolated endoderm from 2-6 
somite-stage embryos prior to its interaction with the cardiac mesoderm, is cultured in 
isolation, all ventral endoderm cells initiate expression of both exocrine and endocrine 
pancreatic markers. If cultured with cardiac mesoderm or FGF2 however, pancreatic 
development is inhibited and the endoderm cells progress towards a hepatic fate. These 
findings can be explained by a model in which ventral endoderm cells are bipotential, 
competent to follow either a pancreatic or hepatic developmental program and are 
actively driven towards a hepatic fate by the action of cardiac-secreted FGFs (Fig. 1.6.). 
Therefore, ventral endoderm lying beyond the immediate vicinity of the cardiac 
mesoderm gives rise to the ventral pancreas by a default program of pancreatic 
differentiation followed in the absence of cardiac-secreted FGFs. So, in the 
development of the ventral pancreas, FGFs inhibit the pancreatic program, whereas they 
function to promote development of the dorsal bud.
I.4.2.3. Sisnals from the Mesenchyme
In addition to the cardiac mesoderm, the pancreatic mesenchyme may provide an 
extrinsic signal for induction of pancreatic anlage formation. At the same stage that the 
notochord is in apposition to the dorsal gut endoderm the lateral sides of the gut are 
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Figure 1.7. Orientation of the Mesenchyme and Notochord with Respect to the 
Gut Endoderm in the Early Development of the Mouse Pancreas. Views are 
from the Dorsal Aspect. (After Slack, 1995 and Yamaoka and Itakura, 1999)
At the 15-somite stage the notochord lies in apposition to the neural tube and gut; 
by the 20-somite stage the dorsal aorta separates the gut and notochord. By the 




at E9 the mesenchyme begins to accumulate on the dorsal side of the gut. The exact 
timing of mesenchyme accumulation in the region of the dorsal pancreatic bud is 
contentious: either prior to or simultaneous with bud formation (Gittes and Rutter, 1992; 
Pictet and Rutter, 1972; Wessells and Cohen, 1967) or immediately subsequent to bud 
formation (Ahlgren et al., 1996). Resolving the exact timing is significant. Mesenchyme 
induces pancreatic growth and differentiation in culture and so could be the inducer of 
bud formation if it is present at the appropriate time.
It has been known for some time that the Hox gene cluster specifies anterior- 
posterior positional value in the central nervous system and axial mesoderm (McGinnis 
and Krumlauf, 1992; Slack et al., 1993). Although not expressed in the endodermal 
epithelium, these genes are expressed in the early developing gut mesenchyme (Roberts 
et al., 1995; Yokouchi et al., 1995). It has been suggested that the mesenchyme dictates 
the positional character of the epithelium through mesenchymal-epithelial inductive 
interactions (Wessells, 1977). Hence, the Hox gene state might be transmitted via 
extracellular factors that induce regionally-specific non-Hox factors in the epithelium 
(Roberts et al., 1998).
So in summary, activin-pB and FGF2 from the notochord repress Shh and Ihh 
expression in the adjacent presumptive dorsal pancreatic endoderm, allowing formation 
of the dorsal pancreas. The ventral pancreas is formed by a default developmental 
program from bipotential ventral endoderm cells lying beyond the “sphere of influence” 
of FGFs secreted from the cardiac mesoderm which otherwise actively drive the same 
cells towards a hepatic fate. Therefore FGFs function to promote development of the 
dorsal pancreas, whereas in the development of the ventral pancreas they act to inhibit 
the pancreatic program.
1.5. Role o f  Transcription Factors in Pancreas Development
Following gut closure, transcription factors are expressed in a nested manner in 
the definitive endoderm. Those involved in pancreas development belong to three 
distinct families: the homeodomain family, the basic helix-loop-helix (bHLH) family 
and the winged helix family of proteins. Within the last decade, a large number of gene 
disruption studies in mice have contributed massively to our understanding of the 
function and hierarchy of transcription factors in pancreas development.
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Hepatocyte Nuclear Factor (HNF)-3{PForkhead Box (Fox) a2
HNF-3P or Foxa2 is a winged helix transcription factor. It is a member of the 
HNF3 family of forkhead-related genes, expressed in the gut epithelium and initially 
identified as transcriptional regulators of hepatocyte-specific genes (Lai et al., 1991; Liu 
et al., 1991). HNF-3p is first expressed at E5.5-6.5 in the anterior part of the early 
primitive streak and then later in the definitive endoderm (Ang et al., 1993; Monaghan 
et al., 1993; Ruiz i Altaba et al., 1993; Sasaki and Hogan, 1993). Homozygous 
inactivation of HNF-3p in mice results in defects in foregut morphogenesis. The null 
mutants die around E ll however (Ang and Rossant, 1994; Weinstein et al., 1994), 
precluding detailed analysis of the role of HNF-3p in pancreas formation. It is 
envisaged that tissue-specific inactivation of the gene will overcome this limitation. 
HNF-3p has been reported to upregulate the expression of another pancreatic 
transcription factor, Pdxl (Wu et al., 1997; see below), indicating a role in maintaining 
p-cell function. Most recently it has been shown that a p-cell-specific deletion of HNF- 
3p results in downregulation of Pdxl mRNA and a subsequent reduction of Pdxl 
protein levels in islets, providing the first in vivo demonstration that HNF-3p acts 
upstream of Pdxl in the differentiated p-cell (Lee et al., 2002).
Hepatocyte Nuclear Factor (HNF)-3a/Forkhead Box (Fox) a l
HNF-3a, recently reassigned as Foxal, is a member of the same family of 
transcription factors as HNF-3p. Like HNF-3p, it exhibits a wide expression pattern and 
is expressed in the endoderm from E7.5. Targeted disruption of HNF-3a results in a 70 
% reduction of glucagon mRNA levels whilst the number of pancreatic a-cells remains 
undiminished (Kaestner et al., 1999). The decreased glucagon level was therefore 
attributed to reduced transcriptional activity of the glucagon gene (Kaestner et al., 
1999).
Hbcb9
The protein Hb9 encoded by the homeobox gene Hlxb9 (Harrison et al., 1994) is 
expressed earliest at E8 in the epithelium of the foregut-midgut junction (Li et al., 
1999). It is transiently expressed in the developing pancreatic anlagen: by E l2.5, its
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expression level decreases but one day later expression increases again in the dorsal and 
ventral region of the pancreas (Harrison et al., 1999). By E17.5, Hb9 is restricted to islet 
cells and in the adult pancreas it becomes further restricted to only the p-cells. Targeted 
disruption of Hlxb9 leads to absence of the dorsal pancreas and a lack of dorsal 
expression of the transcription factors Pdxl and Isll. The ventral portion of the pancreas 
develops normally, expresses Pdxl and subsequently generates exocrine cells and all 
four types of endocrine cell. This would imply that early development of the ventral 
pancreas is independent of Hb9. However, at E l8.5, islets are reduced in size due to a 
specific 65 % decrease in the number of insulin-immunopositive cells. Hb9 is therefore 
required dorsally for specifying gut epithelium to a pancreatic fate and ventrally for 
ensuring the terminal differentiation and maturation of p-cells. The requirement for 
Hlxb9 in pancreatic development also reveals a molecular distinction in the dorsal and 
ventral bud differentiation programs.
Pancreatic Duodenal Homeobox 1 (Pdxl)/Insulin Promoter Factor 1 (Ipfl)
The most prominent of those genes expressed specifically in the early pancreatic 
buds is Pdxl (also known as Ipfl, Idxl, Stfl, Iufl or XlHboxS) (Miller et al., 1994; 
Offield et al., 1996; Ohlsson et al., 1993; Wright et al., 1988). It was initially 
characterised in mammals as a homeobox-containing transcription factor and 
transactivator of the somatostatin (Leonard et al., 1993; Miller et al., 1994) and insulin 
genes (Ohlsson et al., 1993; Peers et al., 1995; Peshavaria et al., 1994; Petersen et al.,
1994). More recently, it has been found to also transactivate the gene promoters of the 
glucose transporter GLUT2 (Waeber et al., 1996), glucokinase (Watada et al., 1996c), 
and amylin (Carty et al., 1997; Watada et al., 1996a). It has been proposed that Pdxl 
activation is dependent to some degree on HNF-3p (Sharma et al., 1996, 1997; Wu et 
al., 1997). Pdxl is homologous to a gene family expressed in the leech gut (Lox 3A, B, 
C; Wysocka-Diller et al., 1995). As invertebrates lack a recognisable pancreas, this 
would suggest that Pdxl has been associated with gut development for a long 
evolutionary period and specifically with the pancreas from vertebrate origins (Slack,
1999). Pdxl is uniformly expressed in the pancreatic bud at the foregut-midgut junction 
at E8.5 and marks the territory of the future pancreas (Ahlgren et al., 1996). In later 
development expression becomes restricted to fully differentiated p-cells and the 
duodenal mucosa, with infrequent expression in 8-cells (Guz et al., 1995; Leonard et al., 
1993; Miller et al., 1994; Offield et al., 1996; Ohlsson et al., 1993; Wright et al, 1988).
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Pdxl has been shown to be integral to pancreas development since its inactivation by 
targeted mutagenesis results in a suppression of pancreas formation (pancreatic 
agenesis), although there is some early bud development (Jonsson et al., 1994; Offield 
et al., 1996). Epithelium-mesenchyme recombinations have shown the defect to be 
associated with the epithelium, since the pancreatic mesenchyme grows and develops 
both morphologically and functionally, independent of the epithelium (Ahlgren et al.,
1996). Pdxl is therefore required for growth and complete differentiation of the 
pancreatic buds. p-Cell-specific inactivation of Pdxl later in development results in a 
3.5-fold increase in the number of glucagon+ cells but a 60 % decrease in the number of 
insulin-expressing cells and a loss of the P-cell phenotype and diabetes (Ahlgren et al.,
1998). In later development, Pdxl positively regulates insulin and amylin expression 
and represses glucagon expression. Therefore, Pdxl also plays an additional role in 
maintaining the insulin production and glucose-sensing system in P-cells.
Hepatocyte Nuclear Factor (HNF)6
HNF6 is a member of the one-cut class of homeodomain transcription factors, 
which share a common single cut domain and a divergent homeodomain (Lannoy et al., 
1998; Lemaigre et al., 1996). During early embryonic development, HNF6 is expressed 
at E9.5 in epithelial cells of the pancreas, in pancreatic ducts, developing acinar cells 
and differentiating endocrine cells (Landry et al., 1997; Rausa et al., 1997). Expression 
is then downregulated in endocrine cells at late gestation, coincident with initiation of 
islet morphogenesis and separation from the ductal epithelium, suggesting that 
persistent HNF6 expression is incompatible with islet maturation. Subsequent studies 
have confirmed that such HNF6 downregulation is essential for the proper formation 
and function of islets (Gannon et al., 2000). Targeted disruption of HNF6 leads to a 
normal exocrine pancreas although endocrine development is severely inhibited 
(Jacquemin et al., 2000). At E9.5, glucagon expression is normal but at E12.5 no 
insulin-immunopositive cells are detected and the number of glucagon-expressing cells 
is reduced by 85 %. Neonatally, null mutants show a markedly reduced number of all 
four endocrine cell types. Furthermore, islet architecture is perturbed; a-cells are seen 
throughout the islet core instead of being restricted to the islet periphery. Expression of 
Pdxl and a second transcription factor, Nkx6.1, is normal in nullizygous mice.
In the absence of HNF6, the epithelial cells are specified but fail to give rise to 
an expected pool of endocrine precursor cells. This hypothesis is supported by the
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greatly diminished expression of neurogenin (ngn)3, a putative marker of endocrine 
precursor cells (Jensen et al., 2000a; Schwitzgebel et al., 2000). HNF6 and ngn3 are 
coexpressed in wild-type embryos in epithelial cells and transfection experiments have 
shown that HNF6 can stimulate the ngn3 promoter (Jacquemin et al., 2000). This 
suggests that HNF6 regulates differentiation of endocrine precursors and identifies it as 
the first positive regulator of the pro-endocrine gene ngn3 in the pancreas. Recent 
studies of the HNF transcriptional network indicate that HNF6 transactivates HNF-3P, 
which in turn transactivates HNF-4a, and then the latter transactivates HNF-la 
(Duncan et al., 1998; Kuo et al., 1992; Rausa et al., 1997). These HNFs are all 
expressed in the fetal and adult pancreas, and HNF-3p, as mentioned, is reported to 
upregulate Pdxl gene expression (Rausa et al., 1997; Wu et al., 1997).
Neurogenin (Ngn)3
Discovered recently, ngn3 is a member of the basic helix-loop-helix (bHLH) 
family of transcription factors and is transiently but abundantly expressed in the 
developing pancreas (Schwitzgebel et al., 2000; Sommer et al., 1996). Ngn3 
immunoreactivity is detected from E9.0-9.5 in the pancreatic anlage; expression 
increases to a peak at E l5.5 then decreases thereafter with only a few ngn3-positive 
cells being detected at E l8.5 (Apelqvist et al., 1999; Jensen et al., 2000a; Schwitzgebel 
et al., 2000). Ngn3 is not detected in the adult pancreas. Ngn3 was found to be 
expressed in ductal and scattered periductal cells, which aroused interest as ductal cells 
are widely presumed to represent an islet cell precursor population. Studies 
demonstrating induction of precocious islet cell differentiation by early (E8.5) 
expression of ngn3 and a lack of expression in mature islet cells have lead to the 
supposition that ngn3 is expressed in islet cell progenitors and functions as a pro- 
endocrine gene driving islet cell differentiation (Apelqvist et al., 1999). Coexpression 
with markers of differentiating endocrine cells, including Pdxl and the P-cell 
differentiation factors Nkx6.1 and Nkx2.2 supports the idea that ngn3 marks islet cell 
precursors (Jensen et al., 2000a; Schwitzgebel et al., 2000). Absence of all islet cells in 
homozygous null mice bearing an otherwise grossly normal pancreas, shows that ngn3 
is required for the formation of a common precursor for all four islet cell types 




The bHLH protein NeuroDl or BETA2 (beta cell E-box transactivator-2) was 
cloned from a hamster insulinoma tumour cell cDNA library and initially identified as a 
differentiation factor for neurogenesis because it can convert Xenopus laevis ectoderm 
into neurons (Lee et al., 1995). Expression commences from E9.5 in the pancreatic bud 
and can be induced by ngn3 (Huang et al., 2000; Naya et al., 1995; Schwitzgebel et al.,
2000). The majority of E9.5 pancreatic epithelial cells expressing NeuroDl also express 
glucagon, indicating that NeuroDl is present in the earliest islet precursors, hi neonates, 
NeuroDl is expressed in a-, (3-, and 8-cells, but not in exocrine cells. In the adult, 
NeuroDl expression becomes restricted to brain and islet a- and p-cells (Naya et al.,
1995). Loss of NeuroDl function results in a reduced number of differentiated p- (75 
%), a- (40 %) and 8- (20 %) cells in neonates as well as disorganised islet architecture 
(Naya et al., 1995, 1997). The depletion in cell number was shown to be largely due to 
apoptosis of endocrine cells. Despite the role of NeuroDl as an activator of the insulin 
gene (Dumonteil et al., 1998), the remaining p-cells in the homozygous null mice 
continued to produce insulin. The neonatal mice became diabetic however, dying 3-6 
days after birth. In addition to activating the insulin gene, NeuroDl also transactivates 
glucagon (Dumonteil et al., 1998) and secretin genes (Mutoh et al., 1998) and regulates 
selective expression of rat Pdxl (Sharma et al., 1997).
Pax4
Pax4 is a paired domain homeobox (paired-box) gene. Pax4 is expressed in the 
early pancreas from E9.5 but becomes restricted to the p-cells in adulthood (Sosa- 
Pineda et al., 1997; Turque et al., 1994). Mice nullizygous for Pax4 appear normal at 
birth, but are growth-retarded by 48 h and die 3-5 days following birth. The pancreas of 
neonatal null mutants is of normal size, but lack of expression of Pdxl and somatostatin 
indicated an absence of mature P- and 8-cells respectively (Sosa-Pineda et al., 1997). 
The Pax4 knockout pancreas bears an unusually large number of a-cells however. 
During development at E l0.5, glucagon- and insulin-producing cells are detected in 
Pax4-null mice at the same level as in wild-type animals at which time Pdxl is also 
expressed. By E l3.5 however, insulin is no longer detected and differentiated P-cell 
markers like Pdxl and a second transcription factor, Nkx6.1 are also absent.
23
Chapter 1: Introduction
These studies demonstrate a requirement for Pax4 in p- and 5-cell 
differentiation. Although Pax4 is not critical for the development of early insulin- 
expressing cells, it is required for their maturation and maintenance. Two hypotheses 
have been proposed to account for the expansion in a-cell numbers in null mutant mice. 
Firstly, a significant proportion of early endocrine precursors could have lost their initial 
commitment to become p-cells and instead become a-cells. Secondly, the absence of 
the p-cell-specific gene Pax4 could lead the progenitor cells towards a program of a- 
cell differentiation, so a-cells would be formed by default.
Nkx2.2
Nkx2.2 is a member of the NK class of homeodomain proteins. It is expressed 
from E9.5 at the onset of pancreatic bud evagination but becomes progressively 
restricted to the a-, p- and PP-cells of the mature islet; expression is absent from the 5- 
cells (Sussel et al., 1998). Disruption of the Nkx2.2 gene not only leads to a reduction in 
a- and PP-cell numbers, but also effects a specific block in late steps of p-cell 
differentiation, leading to an accumulation of incompletely differentiated p-cells (Sussel 
et al., 1998). Such cells express some P-cell markers, like amylin and prohormone 
convertase (PC) 1/3, but not insulin. Amylin is a peptide hormone, normally co-secreted 
with insulin and PC 1/3 is a proinsulin processing enzyme that is restricted to the p- 
cells. In the Nkx2.2-null mutants, the early expression of the transcription factors Pdxl 
and Nkx6.1 is not affected, but their later p-cell-restricted expression is disturbed. These 
mice develop diabetes neonatally and die as a consequence of hyperglycaemia (high 
blood glucose levels). These findings suggest the involvement of Nkx2.2 in the 
differentiation of all endocrine cell types. It would also appear to be required for the 
maintenance of Nkx6.1 expression and the upregulation of Pdxl expression in p-cells, 
which are necessary for terminal p-cell differentiation.
Nkx6.1
Like Nkx2.2, Nkx6.1 is a member of the NK class of the homeodomain family 
of transcription factors (Jensen et al., 1996; Oster et al., 1998; Rudnick et al., 1994). 
Nkx6.1 was cloned from a hamster p-tumour cell (HIT-T15 insulinoma) cDNA library 
(Rudnick et al., 1994). The Nkx6.1 protein is expressed broadly in the pancreatic bud
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from E l0.5 then becomes restricted to insulin-positive cells and some scattered ductal 
and periductal cells by E15.5. In the adult pancreas, Nkx6.1 expression is restricted to 
the (3-cells (Jensen et al., 1996; Sander et al., 2000). Targeted disruption of the Nkx6.1 
gene severely inhibits P-cell formation, but this defect is only manifested after E12.5 
(Sander et al., 2000). Until this stage of development, insulin-producing cells are 
detected at the same level as in wild-type siblings. At birth, p-cells are reduced by 
approximately 95 % in comparison to wild-type animals. Ngn3-expressing progenitor 
cells are present at the same level as in wild-type littermates. Hence, two distinct 
pathways may exist in the developing pancreas for generating insulin-positive cells: an 
early pathway independent of Nkx6.1 and a later pathway dependent on its expression. 
Near the time of birth, a third pathway is invoked comprising the replication of existing 
P-cells.
The presence of Nkx2.2 in the Nkx6.1-null mutant pancreas suggests a function 
upstream of Nkx6.1. Double nullizygous embryos are phenotypically indistinguishable 
from Nkx2.2 single null mutants. Nkx6.1 is therefore required for the expansion and 
terminal differentiation of p-cell progenitors.
Pax6
Pax6, like Pax4, is a paired domain homeobox gene; its protein is expressed in 
discrete cells of the pancreatic epithelium from E9.0 (St.-Onge et al., 1997; Sander et 
al., 1997; Turque et al., 1994). At E10.5, cells coexpressing Pax6 and glucagon are 
seen; at E l5.5, Pax6-positive cells express either glucagon or insulin. In neonates, Pax6- 
positive cells synthesise insulin, glucagon, PP or somatostatin, indicating that Pax6 is 
expressed in all mature endocrine cells in the islet (St.-Onge et al., 1997). A recent cell 
lineage study (Zhang et al., 2003) further suggests that Pax6-expressing progenitors 
contribute not only to the adult islets but also to the pancreatic ducts. Pax6-null mutants 
possess no or few a-cells and a depleted number of p-, 8- and PP-cells; the islets 
themselves display disrupted architecture (St.-Onge et al., 1997; Sander et al., 1997). 
Mice doubly nullizygous for both Pax4 and Pax6 display an entire lack of mature 
endocrine cells (St.-Onge et al., 1997). These studies demonstrate that Pax6 is required 
for the regulation of the number of islet cells, and particularly for the generation of a- 
cells, acting like Pax4, downstream of Pdxl in the islet cell differentiation pathway. 
Pax6 is further involved in organising the endocrine cells into islets and in modulating 
the level of islet hormone synthesis. Pax6 binds to a common element in the glucagon,
25
Chapter 1: Introduction
insulin, and somatostatin promoters, and transactivates the glucagon and insulin 
promoters (Sander et al., 1997).
Isletl (Isll)
M etl (Isll) encodes a LIM-homeodomain transcription factor (Ahlgren et al., 
1997; Karlsson et al., 1990) which has been shown to activate transcription of the 
somatostatin, glucagon, and amylin genes (Leonard et al., 1992; Wang and Drucker, 
1995, 1996). Perhaps more importantly, it is also involved in early pancreatic 
determination (Ahlgren et al., 1997). Isll expression commences at E9.5 in the dorsal 
pancreatic epithelium and in the mesenchyme surrounding the dorsal pancreatic bud. At 
E9.5, all glucagon-expressing cells also express Isll. Subsequently, Isll is detectable in 
all islet cells.
Inactivation of Isll results in arrested development soon after E9.5 and 
subsequent death during embryogenesis, principally due to an absence of motor neuron 
development in which it is usually expressed (Dong et al., 1991; Pfaff et al., 1996; Thor 
et al., 1991). At this stage, no glucagon-positive cells are detected (Ahlgren et al.,
1997). Formation of the dorsal but not the ventral pancreatic bud is suppressed in Isll 
knockout embryos due to a virtually complete depletion of mesenchyme flanking the 
dorsal pancreatic epithelium (Ahlgren et al., 1997). The early embryonic lethality of 
Isll homozygous null embryos dictated that in vitro studies with pancreatic explants 
were necessary to elucidate the role of Isll in pancreas development. Explants from the 
dorsal bud region of Isll nullizygous embryos will not develop in culture unless 
supplied with wild-type mesenchyme, in which case the dorsal bud will form exocrine 
but not endocrine tissue. These experiments show that Isll is initially required in the 
mesenchyme to produce a signal required for pancreatic epithelial development and 
subsequently in the epithelium to permit islet cell differentiation.
Hesl
Hesl encodes a transcriptional repressor of bHLH genes capable of 
counteracting bHLH activators (Sasai et al., 1992) and its expression in the pancreas 
commences at around E9.5. Hesl is normally expressed at E12 in Pdxl-positive cells in 
the pancreatic bud and probably inhibits ngn3-mediated activation of NeuroDl. Hesl 
expression is absent from a-cells. Hesl mutant mice exhibit reduced pancreas growth
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(pancreatic hypoplasia) and consequently reduced pancreas size, and an increased 
number of glucagon-expressing cells at E9 at the expense of Pdxl-positive cells (Jensen 
et al., 2000b). Jensen and coworkers attribute pancreatic hypoplasia to premature 
endocrine differentiation with a consequent depletion of pancreatic precursor cells. 
Absence of Hesl therefore results in premature differentiation of endocrine cells due to 
the absence of the negative regulation by Hesl.
PTFl/p48 (PTFla)
PTF1 is a hetero-oligomeric protein complex composed of three distinct 
subunits, all of which are bHLH proteins. The PTF1 complex binds to transcriptional 
enhancers of genes specifying the products of the exocrine pancreas but for 
transcriptional activation of target genes, PTF1 must cooperatively interact with other 
transcription factors (Cockell et al., 1989). The p75 subunit does not contact the DNA 
directly but is required for import of the factor into the cell nucleus (Sommer et al., 
1991). The two DNA-binding subunits, p64 and p48 or PTFla, recognise as a 
heterodimer a bipartite cognate site that contains two distinct sequence motifs. The p48 
subunit is the only cell-specific constituent of the PTF1 complex (Krapp et al., 1996). 
An antisense RNA-mediated reduction of p48 synthesis in exocrine pancreatic cells in 
culture inhibits the exocrine transcription program, showing that the protein is essential 
for maintaining the terminally differentiated state (Krapp et al., 1996). In the mouse 
embryo, p48 synthesis precedes the appearance of PTF1 at E l5 by several days (Krapp 
et al., 1996; Petrucco et al., 1990), suggesting that p48 on its own plays an alternate role 
during early embryogenesis. Mice homozygous for a null mutation of the p48 allele 
exhibit a complete absence of exocrine tissue and its specific products including a- 
amylase and carboxypeptidase A whilst development of the endocrine pancreas is 
unaffected (Krapp et al., 1998). Null mutants exhibit all four endocrine cell types in the 
mesentery that normally surrounds the pancreas until E l6 after which, they are found to 
colonise the spleen. The endocrine cells remain in a functional state within the spleen 
until the animal dies shortly after birth. These findings show that p48 is required for 
differentiation and/or proliferation of the exocrine cell lineage and is so far the only 
developmental regulator known to be required exclusively for committing cells to an 
exocrine cell fate. Furthermore, the presence of the exocrine pancreas is required for the 
correct spatial assembly of the endocrine pancreas and in its absence, endocrine cells are 
directed by default to the spleen. A recent study (Kawaguchi et al., 2002) combining
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inactivation of p48/PTFla with P-galactosidase cell lineage labelling has confirmed the 
absence of the exocrine pancreas in null mutants and verified these conclusions. It was 
further shown that Ptfla is expressed in progenitors of all pancreatic cell types and is 
silenced in endocrine and duct cells concomitant with or shortly after the partitioning of 
progenitors into acinar cells. Results from this study suggested that in the absence of 
PTFla, cells normally fated to form ventral pancreas will assume an alternative 
endodermal fate for intestinal epithelium, differentiating into enteroendocrine cells, 
goblet cells, and other gut cell types. Therefore, PTFla plays a further role in governing 
the initial cell-type decision to form the pancreas.
1.5.1. Lateral Specification of Endocrine Cells
Recent studies (Apelqvist et al., 1999; Beatus et al., 1999) have begun to 
establish signalling events upstream of ngn3 and Hesl that determine whether or not 
undifferentiated progenitor cells are driven towards an endocrine fate. Pancreatic 
endocrine cells have been shown to be specified by the process of lateral specification 
via Notch signalling (Apelqvist et al., 1999). This process generates scattered 
differentiated cells from an initially homogenous field of cells as in neuronal 
differentiation and is mediated by the Notch signalling pathway (Beatus and Lendahl, 
1998; Lewis, 1996). Differentiating cells express high levels of the ligands (Delta or 
Serrate) and signal to activate Notch receptors on neighbouring cells to suppress the 
same (“primary”) fate in these cells (Fig. 1.8.). The activated intracellular domain of 
Notch (NIC) interacts with the DNA-binding protein RBP-Jk to activate expression of 
bHLH repressor genes, i.e. the Hes genes, which in turn repress expression of 
downstream target genes (Beatus and Lendahl, 1998; Lewis, 1996), including the ngn 
genes (Fode et al., 1998; Ma et al., 1998) which if expressed would promote the 
primary cell fate. By analysing mice genetically altered at several steps in the Notch 
signalling pathway, lateral specification was found to occur in the pancreas. Mice 
deficient in delta-like gene 1 (Dill) or the intracellular mediator RBP-Jk exhibited 
accelerated differentiation of pancreatic endocrine cells and so, a depleted pool of 
pancreatic precursor cells (Apelqvist et al., 1999). Overexpression of either ngn3 or the 
intracellular form of Notch3, both of which act as repressors of Notch signalling (i.e. 
repressors of Delta signalling to Notch on neighbouring cells), produced a similar 
phenotype (Apelqvist et al., 1999; Beatus et al., 1999). These findings were later 









Figure 1.8. Notch signalling involves 
cell-to-cell signalling between 
neighbouring cells via membrane- 
bound receptors, encoded by the 
Notch genes, and membrane-bound 
ligands, encoded by the Delta and 
Serrate genes. (After Edlund, 2001)











Lateral Inhibition at Early Pancreatic Stages
Figure 1.9. Differentiated endocrine cells appear amongst the pool of early 
pancreatic stem cells in a scattered manner. The specification of pancreatic 
endocrine cells within the pool of equivalent progenitor cells is mediated by 
lateral inhibition through the Notch signalling pathway where ngn3 acts as 
the proendocrine gene. (After Edlund, 2001)
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mentioned above in which mice lacking a functional copy of ngn3 lack differentiated 
endocrine cells whilst embryos deficient for Hesl exhibit accelerated endocrine cell 
differentiation and a depleted pool of pancreatic progenitor cells. These studies 
demonstrate that by altering the Notch signalling pathway at the ligand, receptor, and 
intracellular mediator level, the pancreatic cell differentiation fate is affected. These 
experiments thereby provide evidence that in the developing pancreas, Notch signalling 
controls the choice between differentiated endocrine and progenitor cell fates so that the 
lack of Notch pathway signalling, resulting in high ngn3 levels, promotes the endocrine 
fate (Fig. 1.9.). However, cells with active Notch signalling, and a consequent 
upregulation of Hesl expression, remain as undifferentiated progenitor cells, permitting 
the subsequent proliferation, morphogenesis, and differentiation of the pancreatic 
epithelial precursor cells analogous to the function of Notch signalling during early 
mammalian neurogenesis (Beatus and Lendahl, 1998; Lewis, 1996).
As differentiated endocrine cells appear, they separate from the epithelium and 
migrate into the adjacent mesenchyme where they aggregate. This migration is therefore 
likely to result in a decrease in Notch signalling (so, lateral inhibition) among 
progenitor cells and permit islet formation. This would allow a continued appearance of 
cells with a primary, endocrine fate that can respond to later inductive signals, 
generating distinct endocrine cells throughout pancreatic development depending on the 
combination of inductive signals. Progenitor cells that are not driven towards an 
endocrine fate will subsequently differentiate into acinar cells or ductal cells (Edlund, 
2001).
1.5.1.1. Transcription Factors in Pancreas Development: Summary
Gene targeting studies in mice have helped to begin to elucidate the roles of the 
different transcription factors in pancreas development. Most of the gene-disrupted mice 
mentioned above exhibit defective islet morphogenesis and depleted numbers of 
different types of islet cells. Few genes, when inactivated, can result in a total ablation 
or one or more endocrine cell types throughout pancreas development. These studies 
have contributed to the notion that there exists a common precursor cell, which is 
subject to a cascade of precisely timed gene activation events under the control of an 
increasing number of transcription factors. Some of these factors appear to determine 
the cell fate of the cell lineage whilst others may govern the terminal differentiation. For 
example, ngn3 plays a key role by promoting endocrine differentiation at an early stage.
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Ngn3 also appears to occupy a higher rank in the transcription factor hierarchy than 
most of the genes described above. NeuroDl, Pax6 and Isll appear to be more closely 
related than the other factors, since they are expressed in all types of islet cells. 
However, the genetic relationship among them and the other genes largely remains to be 
determined. The number of transcription factors found to be involved in pancreas 
development seems to be still expanding. Future identification and characterisation of 
these genes will lead to an improved understanding of the cascade of transcription 
factors involved in pancreatic cell differentiation. This work will need to take into 
account different expression levels of a combination of the array of transcription factors 
that have been found to play a role in pancreas development to date.
1.5.2. Involvement o f Transcription Factors in Diabetes Mellitus
I.5.2.I. Maturity Onset Diabetes of the Youns (MODY)
Several of the above transcription factors are implicated in diabetes mellitus in 
humans. The best understood example to date is Pdxl, where a loss of function may 
cause diabetes as a consequence of abnormal development and/or insufficient 
maintenance of mature p-cell function. In particular, mutations of transcription factor 
genes have been associated with a number of genetic forms of type 2 diabetes mellitus, 
clinical symptoms of which usually manifest during early adulthood and are therefore 
referred to as maturity onset diabetes of the young (MODY). To date, five different 
forms are known. MODY1 and 3-5 are associated with transcription factors while 
MODY2 is caused by an inactivating mutation of glucokinase, a key enzyme of the 
glycolytic pathway. All forms are monogenic diseases and are characterised by an onset 
usually before 25 years of age, by an autosomal dominant inheritance and a genetic 
defect in P-cell function. They are of epidemiological significance, as it has been 
estimated that 2-5 % of patients diagnosed with type 2 diabetes mellitus actually suffer 
from MODY. MODY1 is associated with mutations in HNF-4a (Fajans, 1990; 
Yamagata et al., 1996a) whilst heterozygous mutations in the gene encoding HNF-la 
cause MODY3 (Winter et al., 1999; Yamagata et al., 1996b), accounting for the 
majority of MODY cases. Gene inactivation experiments have provided insight into the 
effects of HNF-4a and HNF-la mutation responsible for the diabetic phenotypes of 
MODY 1 and 3 respectively. HNF-4a is an upstream regulator of the HNF-la gene 
which is a weak transactivator of the insulin gene (Emens et al., 1992; Kuo et al., 1992).
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HNF-4a-null embryonic stem cells show a decreased expression of several genes 
encoding components of the glucose-dependent insulin secretion pathway, including 
GLUT2 (Stoffel and Duncan, 1997). It has been shown that the islets of HNF-la-null 
mice are hypoplastic due to p-cell depletion. Consequently, the serum insulin level, 
pancreatic insulin content, and response of insulin secretion to glucose and arginine are 
reduced compared to wild-type animals, leading to diabetes (Lee et al., 1998; Pontoglio 
et al., 1998). As diabetes does not develop in heterozygous HNF-la-null mice, 
heterozygous HNF-la mutations in MODY3 patients are considered to function in a 
dominant negative fashion (Yamagata et al., 1998).
A homozygous point deletion in Pdxl has been found to be responsible for 
pancreatic agenesis and neonatal diabetes mellitus in a human patient (Stoffers et al., 
1997b). The single nucleotide change and consequent frameshift in the Pdxl gene 
results in the production of a truncated protein with a dominant negative effect and 
replicates complete loss of Pdxl function (Stoffers et al., 1998). MODY linked to Pdxl 
mutation is called MODY4. HNF-lp mutations cause MODY5 which account for only 
a very small number of total MODY cases. Only a few families carrying HNF-ip 
mutations have been described to date (Horikawa et al., 1997; Iwasaki et al., 1998; 
Lindner et al., 1999; Nishigori et al., 1998; Weng et al., 2000). This form of diabetes 
mellitus has also been found to be associated with acute kidney disease.
1.5.2.2. Maturity Onset Type 2 Diabetes Mellitus
Very recently, several of these transcription factors have been found to be 
associated with the development of the late onset form of type 2 diabetes mellitus. 
However, to date all reports appear to represent one contributing factor in a polygenic 
disease among others. For example, a single mutation in HNF-4a, several mutations in 
Pdxl and in HNF-3p have been described (Hani et al., 1998, 1999; Zhu et al., 2000). 
Type 2 diabetes mellitus is also associated with mutations in NeuroDl (Malecki et al., 
1999).
1.5.2.3. Pancreas Development and Diabetes Therapies
The finding that mutations in transcription factors involved in pancreas 
development in the mouse underlie several forms of human diabetes, provides evidence
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that the late function of genes such as Pdxl is conserved from mice to humans. These 
recent discoveries justify the study of pancreas development in the mouse as being of 
application to the treatment of human pancreatic disease. The ultimate goal of 
understanding pancreas development must be the cure of pancreatic cancer and diabetes 
mellitus. The different treatment strategies currently in use for the management of 
diabetes, such as intensified insulin therapy, are accompanied by negative side effects 
and the micro- and macrovascular complications cannot be fully overcome. One of the 
most physiologic approaches would be to activate endogenous pancreatic stem cells to 
form p-cells and even intact islets to substitute for the defective ones. In the case of type 
1 diabetes, an additional major task will be to protect the newly grafted cells from 
autoimmune destruction.
1.6. Tissue Transformations Involving Pancreas Tissue
The pancreatic state can also be investigated by studying the conversion of 
pancreas tissue into other tissue types or vice versa since such transformations are likely 
to result from the change of activity of one or a few genes and would therefore indicate 
which other tissues had similar epigenetic codes. Although it is generally accepted that 
the differentiated state is permanent and irreversible, in some cases, terminally 
differentiated cells can interconvert (Slack, 1986, 1992), undergoing phenotypic 
alterations after a proper stimulus and under a permissive environment. Such alterations 
are associated with distinct morphological changes and are accompanied by the 
elaboration of new gene products, indicating activation of genes that are normally 
repressed in that cell type (DiBerardino et al., 1984; Okada, 1986). The phenotypic 
interconversion of one differentiated cell to another usually arises in situations of 
chronic tissue damage and associated regeneration. Some changes may be indirect, 
occurring via an intervening stem cell, whereas others may be direct transformations, 
sometimes called transdifferentiations (Eguchi and Kodama, 1993; Okada, 1991). Many 
examples have been reported, some of which are known to predispose to cancer (Slack, 
1986, 1992). However, the molecular and cellular mechanisms involved remain largely 
uncharacterised.
Pancreatic heterotopia occurs during human embryonic development in about 2 
% of post-mortem examinations and is most frequently seen in the stomach, the 
duodenum, the jejunum, the ileum, the vitellointestinal duct and the gall bladder 
(Branch and Gross, 1935; de Castro Barbosa et al., 1946). These heterotopic patches
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usually bear ducts opening into the gut lumen and the presence of a duct strongly 
suggests in situ differentiation as opposed to migration from elsewhere. It would 
therefore appear that the stomach, intestine and bile duct have very similar epigenetic 
codes to pancreas.
A similar phenomenon is the appearance of pancreatic cells in the liver of a 
human cancer patient (Wolf et al., 1990). Transdifferentiation of liver to pancreas has 
also been found to occur in the livers of rats treated with polychlorinated biphenyls 
(Rao et al., 1986a) and in fish liver tumours induced by chemical carcinogens (Lee et 
al., 1989). Endocrine tissue was not present in any of these examples. Most recently 
however, Horb et al. (2003) demonstrated a conversion of liver tissue to both exocrine 
and endocrine pancreatic tissue in transgenic Xenopus laevis tadpoles overexpressing an 
activated form of the Xenopus homolog of Pdxl, Xlhbox8-VP16, in the liver. 
Furthermore, transfection of the same construct into the human hepatoma cell line, 
HepG2, also converts the liver cells into amylase- or insulin-expressing pancreatic cells, 
confirming that the result is not limited to Xenopus, or to larval stages of development 
(Horb et al., 2003).
In the reverse of the tissue transformation in the cases mentioned above, liver 
cells or hepatocytes have been observed in the pancreas of another primate, the vervet 
monkey (Wolfe-Coote et al., 1996). It has proved possible to induce the metaplasia of 
pancreas to liver experimentally. Hepatic foci have been reported to occur in the 
pancreas of rats or hamsters in response to various experimental treatments, including 
treatment with the protein synthesis inhibitor ethionine (Scarpelli and Rao, 1981) and 
copper depletion of the diet (Rao et al., 1986b; Rao and Reddy, 1995). This causes 
substantial ablation of acinar tissue whilst leaving ducts and islets unaffected. 
Restoration of copper provokes regeneration leading to substantial hepatic 
differentiation which commences in both periductal and interstitial cells (Rao et al., 
1989, 1990). Similar foci of pancreatic hepatocytes have been reported following 
transplantation (Dabeva et al., 1997), or in transgenic mice overexpressing keratinocyte 
growth factor (KGF, also known as FGF7) in the pancreas (Krakowski et al., 1999). 
Most recently, hepatocyte-like cells expressing the liver marker albumin have been 
reported in the islets of mice in which the rat glucagon promoter has been used to drive 
specific FGF8 overexpression in the pancreatic a-cells (Yamaoka et al., 2002). 
Although such whole-organism observations suggest a relatively high-frequency 
conversion between pancreatic cells and hepatocytes, they cannot prove that the 
hepatocytes derive from pancreatic cells. In a recent study, foci of hepatocytes were
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induced in vitro in the pancreatic cell line AR42J-B13 and in cultures of isolated mouse 
embryonic pancreatic buds with the synthetic glucocorticoid dexamethasone (Shen et 
al., 2000). It was demonstrated that a proportion of the hepatocytes arose directly from 
differentiated exocrine-like cells, with no intervening cell division. In all of the above 
cases, the foci of hepatocytes are most probably clones. The fact that liver is the 
predominant phenotype of the transdifferentiated foci suggests that fewer changes are 
required to convert pancreas to liver than to invoke any other transformation (Slack,
1999). This indicates an intimacy in the determined states of liver and pancreas in terms 
of their expression of transcription factors; indeed, pancreatic and hepatic 
developmental programs might be distinguished by a single “master switch gene”. This 
is most probably a reflection of the close anatomical and developmental relationship 
shared by the pancreatic buds and liver which originate from adjacent regions of the 
foregut endoderm (Slack, 1995; Zaret, 2000). As mentioned above, it has recently been 
shown that the ventral foregut region is autonomously programmed to develop into the 
ventral pancreas unless it is exposed to FGF which diverts the differentiation program to 
an hepatic fate (Deutsch et al., 2001). Indeed, the common embryological origin of the 
pancreas and liver may be reflected in certain evolutionary and pathological states. 
Primitive invertebrates such as molluscs possess only a single organ, the 
hepatopancreas, that performs functions of both organs (Hoar, 1975) and the caudal 
pancreas in the sea lamprey is believed to develop by the transdifferentiation of cells in 
the hepatic duct (Elliot and Youson, 1993).
1.7. Cell Lineage Studies
1.7.1. Evidence for a Neural Crest Origin of Pancreatic Endocrine Cells
Until relatively recently, it had frequently been assumed that the pancreatic 
endocrine cells have a distinct embryological origin from the exocrine cells and are 
neural crest-derived, an hypothesis stemming from the “APUD” (Amine Precursor 
Uptake and Decarboxylation) theory of Pearse, identifying common properties of the 
neuroendocrine cells in different tissues and organs (Pearse, 1984; reviewed by Le 
Douarin, 1988). It has been known for many years that the pancreatic endocrine cells 
share numerous morphological and molecular characteristics with neurons, such as 
electrical excitability and their expression of enzymes and hormones including neuron- 
specific enolase, tyrosine hydroxylase, dopa decarboxylase, somastostatin, insulin, 
glucagon, tetanus toxin receptor and A2B5 antigen (reviewed by Le Douarin, 1988) and
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also nerve growth factor (NGF) (Miralles et al., 1998c; Rosenbaum et al., 1998) and the 
high- and low-affinity NGF receptors, Trk-A and p75NGF-R respectively (Kanaka- 
Gantenbein et al., 1995; Miralles et al., 1998c; Rosenbaum et al., 1998; Scharfmann et 
al., 1993; Teitelman et al., 1998). Furthermore, the transcription factors Isll (Ahlgren et 
al., 1997; Pfaff et al., 1996), NeuroDl (Lee et al., 1995; Miyata et al., 1999; Naya et 
al., 1997), Pax4 (Sosa-Pineda et al., 1997), Pax6 (Ericson et al., 1997; St.-Onge et al., 
1997; Sander et al., 1997), and Nkx2.2 (Briscoe et al., 1999; Sussel et al., 1998) which 
are vital for proper pancreatic endocrine differentiation, are also expressed during, and 
in some cases are critical for, neuronal differentiation. Also, during pancreatic 
development, the endocrine cells initially appear in a scattered manner (Ahlgren et al., 
1997; Pictet and Rutter, 1972) that resembles the process of neurogenesis (Beatus and 
Lendahl, 1998; Lewis, 1996). This implies that cell differentiation in the pancreas and 
in the nervous system may be, at least in part, under similar control (Edlund, 2001).
The APUD theory is corroborated by the association of pancreatic endocrine 
cells with neuroendocrine cells in lower animals, suggesting that such cells in mammals 
are of neural crest origin. If the sequence of pancreatic endocrine cell organisation in a 
range of invertebrates and vertebrates of differing complexity, from protostome-type 
invertebrates, invertebrate chordate tunicates and cartilaginous fish, is considered one of 
evolutionary descent, then it can be argued that the pancreatic endocrine cells 
“migrated” from the brain to the gut, then aggregated in the exocrine pancreas. 
However, all of the animals that can be examined today are contemporary species and it 
has proved very difficult to order the divergence times of the major groups of animal in 
evolution using molecular sequence trees. It cannot be assumed that the state found in 
invertebrates today was also that present in the ancestor of all vertebrates 600 million 
years ago.
Initially, all mammalian neuroendocrine cells were proposed by Pearse (1984) to 
have a neural crest origin and although found true in such cases as the C cells of the 
thyroid, the theory was not corroborated in others. Using quail to chick embryo grafts, 
Andrew (1976) tested the theory experimentally with regard to the gut endocrine cells. 
In quail cells, a large mass of DNA is associated with the nucleolus which can easily be 
detected by Feulgen staining (Le Douarin, 1982), rendering the grafted cells 
distinguishable from those of the chick host. Quail neural tube was grafted into chick 
embryos and after differentiation of the pancreas it was examined for the presence of 
quail cells. The sympathetic (enteric) ganglia of the gut were found to exhibit the quail
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nucleolar marker and so were irrefutably shown to be of neural crest origin whereas 
such an origin was not demonstrated for the endocrine cells of the gut and pancreas.
1.7.2. Endocrine and Exocrine Cells are Endoderm-Derived
Although not proving that the endocrine cells derive from the endodermal 
epithelium, descriptive studies make this the most probable origin. Differentiation of 
endocrine cells from isolated pancreatic buds cultured in vitro indicates that they must 
arise from a cell type present in the pancreatic endoderm or in the adjacent mesenchyme 
(Wessells and Cohen, 1967). Unpublished results quoted by Pictet and Rutter (1972) 
suggest that both exocrine and endocrine cells can originate in vitro from isolated 
epithelium. Both tissues could be formed from rudiments isolated prior to the 
appearance of blood vessels or nerves, showing that interactions with these later 
emerging tissues are not necessary for differentiation. These results support an 
endodermal origin for the endocrine cells, but endorse the possibility that there may be 
discrete rudiments for exocrine and endocrine tissue within the epithelium. However, in 
a recent study, it was shown that when pancreatic epithelium from transgenic ROSA-26 
mouse embryos which ubiquitously express Escherichia coli p-galactosidase is 
recombined with mesenchyme from unlabelled embryos, both the resulting exocrine and 
endocrine cells in the cultured recombinants are entirely P-gal-positive (Percival and 
Slack, 1999). This provides robust evidence for an endodermal origin of both the 
exocrine and endocrine cells.
1.7.3. Multihormone Endocrine Progenitors?
Many authors have developed models about islet cell lineage, mostly based on 
studies of coexpression of the different hormones during development as described 
above. The common expression of molecular markers in two cells has for some time 
been taken as evidence that the cells possess a common origin (Le Douarin, 1988; 
Teitelman and Lee, 1987; Teitelman et al., 1993). This has in turn led to the widely-held 
assumption that progenitors that transiently expressed two or more hormones (the early 
“multihormone-expressing population”) gave rise to mature hormone-secreting cells 
(Alpert et al., 1988; Teitelman et al., 1993; Upchurch et al., 1994, 1996). Coexpression 
does not, however, prove a lineage relationship, since cells within one lineage may 
switch given genes on and off at distinct times during development. Furthermore, cells
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are motile, so their place of residence at the time of detection may not be the position of 
origin. The MSL cell line, isolated from a transplantable insulinoma (Madsen et al.,
1996) lends supports to the hypothesis of endocrine cell formation from early 
multihormone-expressing precursors. MSL differentiates in vitro heterogeneously to 
form a diverse range of endocrine cells secreting numerous gut or pancreatic hormones 
but in vivo it can become an insulinoma or glucagonoma. Pdxl expression in the parent 
cell is maintained in the insulinomas but Pdxl is not expressed in the glucagonomas. In 
this way, the MSL cell resembles the embryonic multihormone cells. However, it does 
not constitute evidence of any particular pathway of endocrine cell formation in normal 
development, as it derives from an X-ray-induced tumour and has been passaged for 
many years, most probably undergoing mutations and abnormalities over this duration.
1. 7.4. Evidence from Transgenic Mice
1.7.4.1. Early Toxieenic and Cell Ablation Studies
To obtain more definite results regarding cell lineage of the different islet cells, 
several groups have generated transgenic mice, either stable lines or transient 
transgenics, in which a promoter for one of the endocrine islet cell hormones is 
employed to drive a modifying reporter gene or a toxin. In both cases it is necessary to 
assume that the short promoter drives the transgene with the same tissue-specificity as 
its own endogenous gene. This is not necessarily the case as correct expression of a 
particular gene often requires elements that are located far up- or downstream of the 
actual coding region. Non-specific expression is known to occur when the transgene 
does not include a silencer element sufficient to repress the expression in non-targeted 
cells. In addition, integration of the transgene at random positions in the genome may 
result in an altered expression pattern. This applies to transient transgenics in which 
each embryo is likely to bear a different number of transgene copies that are inserted at 
a different position in the genome. Therefore, the transgenic studies on islet cell lineage 
must be interpreted with caution. In 1988, Alpert et al. conducted a pancreatic cell 
lineage study using transgenic RIP-Tag mice, in which the rat insulin promoter is 
employed to drive expression of the SV40 T antigen. This approach can be considered 
to approximate to a reporter study since the biological effects of the T-antigen are subtle 
in embryonic life (Slack, 1995). In the embryo, most of the endocrine cells express T- 
antigen while postnatally only the adult p-cells do so, supporting the existence of an 
early endocrine progenitor in which several or all the hormones are expressed. A similar
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study (Upchurch et al., 1994) utilised the peptide YY-promoter. T-antigen was 
expressed from El 2 in peptide YY-positive cells. Coexpression of T-antigen with three 
of the four islet hormones (insulin, PP and somatostatin) was found during development 
but very few islet cells expressed T-antigen in adult mice. This is consistent with the 
proposition that all endocrine precursors express peptide YY at an early stage. Promoter 
function does not become fully restricted to one islet cell type until mature islets have 
formed.
Diphtheria toxin A chain causes ablation of cells expressing the toxin by 
curtailing protein synthesis and inducing cell death. As the toxin lacks the B chain 
normally required for entry into intact cells, the ablation effect should be cell- 
autonomous and therefore specific, leading it to being widely-used for studying cell 
lineage relationships in conjunction with a suitable promoter to drive toxin expression 
in target cells (Evans, 1989). Using the elastase promoter, mice deficient in almost all 
exocrine pancreas and with a reduced complement of ductal tissue and islets were 
generated (Palmiter et al., 1987). In a transient transgenic study, Herrera et al. (1994) 
used promoters for insulin, glucagon and pancreatic polypeptide to drive the toxin. 
Toxin expression driven by the insulin or glucagon promoter led only to ablation of the 
targeted cell type, suggesting that a hormone coexpressing cell is not required for a- or 
P-cell development. In contrast, the PP promoter-driven transgene led to a loss not only 
of PP-expressing cells but also of insulin- and somatostatin-producing cells although a- 
cells developed without abnormality. This is unexpected, as PP itself is supposed to be 
expressed only in the late embryo. It was presumed by the authors (Herrera et al., 1994) 
that the PP gene promoter is used either in p-cell progenitors or in cells that are 
necessary (through a paracrine effect on unidentified progenitors) for p-cells to 
differentiate. An associated study using human growth hormone as a reporter 
demonstrated that the putative PP promoter drove expression in 12 % of embryonic PP- 
fold peptide-expressing cells, but it is not clear whether these are a subset of the peptide 
YY cells or precocious PP-cells. One possibility not excluded by the findings of these 
studies is that the PP promoter may display less specificity than the native endogenous 
gene and function in any islet cell. Common to all of these early studies was the fact 
that they were beset by uncertainties such as the specificity of transgene expression, the 




More recently, studies on pancreatic cell lineage in transgenic animals have 
exploited powerful cell marking techniques, most notably the Cre-LoxP system (Sauer, 
1994, 1998). This cell labelling technique can be used to indelibly mark or “tag” all the 
progeny of cells arising from cells in which Cre is transiently expressed. Herrera 
(Herrera, 2000) used the Cre-LoxP system to irreversibly tag cells that transcribed the 
insulin, glucagon or PP genes, or cells that express Pdxl, as a marker of pancreatic 
progenitor cells (Jonsson et al., 1994; Offield et al., 1996). Mice were generated bearing 
two transgenes (Fig. 1.10.). The first “reporter” transgene, placed under the control of 
either the insulin2 (P-cell-specific), or the glucagon (a-cell-specific) gene promoter, 
contains a human growth hormone- (hGH-) coding region placed downstream of a loxP- 
flanked transcription termination site (STOP sequence) (Sauer, 1993). It is assumed in 
such experiments that hGH is not active in promoting cell growth or differentiation. The 
native reporter transgene cannot be expressed in p- or a-cells because of the STOP 
sequence. To be expressed, the Cre recombinase must excise the DNA (comprising the 
STOP sequence) between the two loxP recognition sequences. A second “tagger” 
transgene consists of the Cre recombinase gene placed under the control of a promoter 
active in putative progenitor cells; its expression results in the deletion of the STOP site 
of the reporter transgenes, allowing hGH synthesis. Provided that the promoter of the 
tagger transgene has been activated and Cre recombinase expressed in the progenitor of 
the same target cell(s) in which the reporter transgene is expressed, then crossing of two 
strains carrying a tagger and a reporter transgene respectively will lead to reporter 
expression in the target cell(s) of the doubly transgenic offspring. Mice carrying the 
following tagger transgenes were prepared: insulin2 gene promoter-Cre, glucagon gene 
promoter-Cre, PP gene promoter-Cre and Pdxl gene promoter-Cre. Mouse families 
were selected bearing only stable and complete expression of one of each of the reporter 
or tagger transgenes. Adult doubly transgenic mice with complete and stable transgene 
expression (Cre activity) were analysed for reporter gene expression (hGH) in islet cells 
by immunofluorescence on pancreas sections. As expected, no hGH expression was 
observed in single transgenic mice bearing only either a reporter or a tagger transgene. 
Also as expected, hGH was expressed by P-cells in doubly transgenic animals bearing 
the p-cell-specific reporter gene and p-cell-expressed tagger genes (either driven by the 
insulin2 or Pdxl promoters since Pdxl is expressed in adult p-cells). Similarly, almost 
all a-cells from mice bearing both the a-cell-expressed reporter gene and a-cell-
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Figure 1.10. General Cre/LoxP-Based Strategy to Genetically Label Islet Endocrine Cell Precursors
“reporter” mouse (Transgene 1) “tagger” mouse (Transgene 2)
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For simplicity, only one example is illustrated: the experiment is designed to assess whether adult P-cells 
descend from glucagon- and/or PP-producing progenitors. The reverse experiment, planned to determine 
whether insulin, PP or Pdxl are expressed in the a-cell lineage, was also conducted. (After Herrera, 2000)
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specific tagger gene were hGH*. However, in no case was hGH detected in adult P-cells 
of doubly transgenic animals bearing both the a-cell-specific tagger gene and p-cell- 
specific reporter gene, demonstrating irrefutably that the glucagon gene is not expressed 
in the precursors of P-cells. Similarly, in the reverse experiment, hGH was never 
detected in mature a-cells of doubly transgenic animals bearing both the p-cell-specific 
tagger gene and a-cell-specific reporter gene, showing that the insulin gene is not 
expressed in a-cell progenitors. Therefore, the glucagon- and insulin-coexpressing cells 
reported in early pancreatic buds (Larsson, 1998) are unlikely to be the progenitors of 
either mature a- or P-cells. This finding corroborated the aforementioned results of the 
earlier transient transgenic study by Herrera’s group (Herrera et al., 1994) in which 
diphtheria toxin A chain expression driven by the insulin or glucagon promoter led only 
to ablation of the targeted cell type, which also suggested that a hormone coexpressing 
cell is not required for a- or P-cell development. In this earlier study (Herrera et al., 
1994), PP promoter-driven expression of the toxin transgene was shown to result in a 
loss of insulin- and somatostatin-producing cells as well as PP* cells. Using the Cre- 
LoxP system, Herrera (Herrera, 2000) found that in adult mice bearing only an hGH 
reporter gene (lacking a STOP sequence) driven by the PP promoter, hGH is detected 
only in PP-cells and not in p-cells. This confirmed the widespread assumption that adult 
p-cells do not produce PP and excluded the possibility that the PP promoter is active in 
the mature p-cell. Furthermore, in doubly transgenic mice bearing both a PP promoter- 
driven tagger gene and the P-cell-specific reporter gene, all islet p-cells were found to 
be hGH*. On the contrary, double transgenics bearing the same PP promoter-driven 
tagger gene and the a-cell-specific reporter gene, showed no hGH expression in their a- 
cells (Herrera, 2000). Therefore, these results appear to be consistent with those of the 
earlier toxigenic study (Herrera et al., 1994). Combined, these results imply that adult 
a- and P-cells belong to distinct cell lineages and that mature p-, PP- and 5-cells are 
descended from a PP-expressing progenitor which does not give rise to mature a-cells.
As has been mentioned in some detail, gene inactivation studies affecting 
transcription factors involved in pancreas development have generated a wealth of 
information concerning their role in endocrine cell differentiation. Such experiments do 
not however, prove a lineage relationship. Gene inactivation has particularly focused 
attention on Pdxl and ngn3. The finding that Pdxl inactivation by targeted mutagenesis 
results in pancreatic agenesis has promoted the idea that Pdxl* cells are general 
pancreatic progenitors (Jonsson et al., 1994; Offield et al., 1996). However, Pdxl
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mutants do generate some glucagon- and insulin-expressing cells in early 
embryogenesis and a pancreatic bud forms and later regresses. This raises the question 
of whether a Pdxl -independent pathway exists for pancreas generation. Studies 
demonstrating induction of precocious islet cell differentiation by early (E8.5) 
expression of ngn3 and a lack of expression in mature islet cells have lead to the 
supposition that ngn3 is expressed in islet cell progenitors and functions as a pro- 
endocrine gene driving islet cell differentiation (Apelqvist et al., 1999). The absence of 
all islet cells in ngn3 homozygous null mice bearing an otherwise grossly normal 
pancreas and ngn3 coexpression with Pax6, Nkx6.1 and NeuroDl, three putative 
endocrine progenitor markers, have confirmed this hypothesis (Gradwohl et al., 2000; 
Jensen et al., 2000a; Schwitzgebel et al., 2000).
A very recent study, again using the Cre-LoxP system has examined the origins 
of all of the main pancreatic cell types - the endocrine, acinar and ductal cells (Gu et al., 
2002). This study sought to determine whether cells expressing the putative pancreatic 
progenitor marker Pdxl, do indeed give rise to all pancreatic tissue and whether cells 
expressing the putative endocrine progenitor marker ngn3, produce all endocrine cell 
types. The Pdxl or ngn3 promoters were used to drive expression of CRE or an 
inducible form, CRE-ER™ (Danielian et al., 1998; Metzger et al., 1995; Nagy and Mar, 
2001; Rossant and McMahon, 1999; Sauer, 1998). The progeny of Pdxl+ or ngn3+ cells 
were irreversibly tagged with human placental alkaline phosphatase (HPAP). The 
advantage of using the CRE-ER™ version for lineage analysis is that this protein 
remains in the cytoplasm and is inactive until a ligand, tamoxifen, is provided 
(Danielian et al., 1998; Metzger et al., 1995). When tamoxifen is introduced, 
tamoxifen-bound CRE-ER™ is transported to the nucleus and catalyses recombination, 
allowing expression of the HPAP reporter gene (Lobe et al., 1999). Cells can therefore 
be marked at any time during development, not just at the point when Pdxl or ngn3 is 
first expressed so that by controlling the time at which tamoxifen is administered, it is 
possible to characterise the progeny of specific sets of Pdxl+ or ngn3+ cells bom at 
different stages of development. This avoids the problems of labelled cell accumulation 
accompanying CRE; cells are marked from the time when the promoter driving Cre 
expression is initially switched on. Consequently, marked progeny accumulate as 
development proceeds and new cells activate CRE so that it is not possible to follow the 
progeny of cells bom at defined developmental stages. Using the Pdxl promoter to 
drive expression of Cre recombinase, acini, islets and ducts were all demonstrated to 
express HPAP, showing that all pancreatic cells are derived from Pdx 1-expressing
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progenitors. HPAP was not detected in the mesenchyme-derived endothelial and smooth 
muscle cells showing, as expected, that Pdxl+ cells do not give rise to mesodermal 
tissues (blood vessels and mesenchyme). Furthermore, when using the Pdxl promoter to 
drive expression of CRE-ER™, the HPAP label was only observed in ductal cells if the 
tamoxifen was administered between E9.5-11.5. Based on the frequency with which 
Pdxl+ cells adopt islet, acinar, or duct fates for different time-points of tamoxifen 
injection, Pdxl+ cells at E l0.5 were estimated to be 35 times more likely to adopt an 
adult duct fate than those Pdxl-expressing cells at E8.5. As tamoxifen remains active 
for 24-48 h, it was inferred that in excess of 95 % of the duct progenitors express a high 
level of Pdxl between E9.5-12.5. Acinar and endocrine Pdxl+ precursors are found at 
all stages of embryonic development however. This would suggest that the vast majority 
of progenitors for duct and acinar/islet cells are separated prior to E l2.5. Using the ngn3 
promoter to drive expression of CRE-ER™, and administering tamoxifen at various 
time-points between E8.5-14.5, HPAP expression was detected in endocrine cells of all 
four types, showing that ngn3+ cells from different stages of embryogenesis give rise to 
all four islet cell types. Less than 1/1000 acini or duct cells were seen to be HPAP+ in 
double transgenic animals in which the ngn3 promoter was used to drive CRE 
expression, demonstrating that mature pancreatic ductal cells derive from progenitors 
that do not express ngn3.
However, even these highly informative experiments using Cre-LoxP to mark 
cell progeny indelibly lack the ability to trace the fate of individual cells over time. For 
example, with the experimental designs of the cell labelling experiments mentioned, it 
is not practical to label a single endocrine progenitor during embryogenesis and search 
for its progeny in the adult. Therefore, it cannot be ascertained whether a single ngn3+ 
cell gives rise to all four islet cell types. Until this can be achieved, the exact islet cell 
lineage remains to be determined. It is a point of note that no study has yet provided 
robust evidence supporting the existence of a multihormone-expressing endocrine 
progenitor cell. Common conclusions can, however, be extrapolated from the 
experiments mentioned (Fig. 1.11.). Firstly, it is apparent that the cells of the islets, 
acini and ducts are all descended from a common Pdxl-expressing general pancreatic 
progenitor cell. Secondly, a common ngn3+ endocrine progenitor cell gives rise to all 
four endocrine cell types; ductal cells are instead descended from progenitors that do 
not express ngn3. Thirdly, adult a- and p-cells belong to distinct cell lineages and 
mature P-, PP- and 8-cells are descended from a PP-expressing progenitor which does 
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Figure 1.11. Proposed Pancreatic Cell Lineages as Deduced from Results of 
Cre-LoxP Studies by Gu et a l (2002) and Herrera (2000) and Literature Data 
(Gradwohl et al., 2000; Krapp et al., 1998; Larsson, 1998). (After Herrera, 2000)
The p48 subunit of the exocrine pancreas-specific transcription factor PTF1 is the 
earliest exocrine marker known to date (Krapp et al., 1998). That somatostatin- 
expressing cells could descend from PP-expressing precursors is deduced from the 
cell ablation experiments in transgenic mice (Herrera et al., 1994). cpA, carboxy- 
peptidase A; AMY, amylase; GLU, glucagon; SOM, somatostatin; INS, insulin; GF, 
unknown growth or differentiation factor
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1.7.5. Endocrine Progenitor Cells
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In the light of the above studies, it would appear that the final cell division of a 
pancreatic epithelial cell does not give rise to both endocrine and exocrine daughters 
and so the hypothesis of a common “endocrine progenitor cell” can be justified. The 
ability to identify an endocrine precursor cell population offers many therapeutic 
applications in the management of type 1 and type 2 diabetes. It provides the possibility 
of expanding such cells in vitro and selectively inducing P-cells before amplifying them 
and then grafting them into the patient. Cell lineage and gene inactivation studies have 
contributed to an increasing number of transcription factors being employed as 
molecular markers of putative endocrine progenitor cells. Such endocrine precursor 
cells have variously been characterised by their expression of ngn3, Isll, Nkx2.2, 
Nkx6.1, NeuroDl and Pax6 (Apelqvist et al., 1999; Jensen et al., 2000a; Naya et al., 
1997; St.-Onge et al., 1997; Schwitzgebel et al., 2000).
1.8. Growth Control o f  the Embryonic and Postnatal Pancreas
1.8.1. Mesenchyme Influences Differentiation o f the Fetal Pancreatic 
Epithelium
For 40 years it has been known that inductive signals originating in the 
mesenchyme play an essential role in the development of the pancreatic epithelium. 
Classic studies by Golosow and Grobstein (1962), Rutter et al. (1964) and Wessels and 
Cohen (1967) used recombined embryonic tissues to show that pancreatic buds could 
develop in vitro, but that isolated epithelium would not undergo any growth or 
morphogenesis in the absence of mesenchyme. Pancreatic growth and 
cytodifferentiation is now a classic example of a mesenchymal-epithelial interaction. In 
the study by Golosow and Grobstein (1962), salivary mesenchyme was shown to be 
even more effective than pancreatic mesenchyme in promoting growth and 
differentiation of the mouse pancreatic epithelium in vitro. As the effects of 
mesenchyme could be exerted across a Millipore filter, it was suggested that the 
mesenchyme secreted a soluble growth factor required by the epithelium (Golosow and 
Grobstein, 1962). In some circumstances, the mesenchyme could be substituted by a 
chick embryo extract, the necessary factor being trypsin-sensitive (Rutter et al., 1964). 
Although the mitogen from chick embryos was partially purified (Ronzio and Rutter,
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1973), the identity of the “mesenchymal factor” remains elusive, partly because it may 
in fact comprise multiple substances.
A number of experiments in which isolated pancreatic epithelium was cultured 
in a range of environments have shown that the default state of the pancreatic 
epithelium is to form islets, and mesenchyme provides an instructive signal for 
differentiation of exocrine cells (Gittes et al., 1996; Miralles et al., 1998b). Gittes and 
coworkers (Gittes et al., 1996) isolated pancreatic epithelium of E ll mouse embryos 
from its surrounding mesenchyme and cultured it under various conditions. When 
cultured under the renal capsule, the rudiments gave rise to mature islets only, whilst 
acinar structures developed only in the presence of mesenchyme. Mesenchyme acts 
quantitatively as a repressor of endocrine tissue development; the insulin-expressing 
cells that develop in the absence of pancreatic mesenchyme appear to be four-fold 
greater and also more mature than those that develop in its presence (Miralles et al., 
1998b). It had been hypothesised that the pancreatic epithelium produces factors such as 
activins or bone morphogenetic proteins (BMPs) which act on epithelial cells in an 
autocrine manner to promote endocrine differentiation (Furukawa et al., 1995; Lyons et 
al., 1995; Ritvos et al., 1995). The activin inhibitor follistatin (Nakamura et al., 1990) 
has been shown to be expressed in E12.5 pancreatic mesenchyme. It has been 
demonstrated that exogenous application of this inhibitor promotes amylase expression 
whilst repressing insulin expression and thus mimics the effects of the mesenchyme 
(Miralles et al., 1998b). Furthermore, transforming growth factor pi (TGF-pi) has been 
shown to promote endocrine development whilst epidermal growth factor (EGF) 
stimulates development of ducts (Sanvito et al., 1994). It is, however, unknown whether 
these proteins are expressed in the mesenchyme surrounding the developing pancreas; 
therefore their function for pancreatic growth in vivo is yet to be determined.
1.8.1.1. Requirement for Activin Sisnallins in Later Endocrine Development
In addition to activin being integral for endocrine development in the early 
pancreatic anlage (Miralles et al., 1998b), it also appears necessary for the normal 
development of islets in later development (Yamaoka et al., 1998). Both transgenic 
mice expressing dominant negative and constitutively active forms of activin receptor 
under the control of the insulin promoter exhibit lower survival rates, islet hypoplasia 
and lower pancreatic insulin content with impaired glucose tolerance when compared 
with control transgenic mice expressing an intact activin receptor (Yamaoka et al.,
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1998). The similar phenotypes in the activin receptor mutant animals indicates that a 
precisely regulated intensity of activin signalling is necessary for normal islet 
development. Furthermore, in the transgenic animals expressing the dominant negative 
receptor, the insulin response to glucose was severely impaired. Activin is expressed 
with follistatin in normal adult islets (Ogawa et al., 1993; Wada et al., 1996; Yasuda et 
al., 1993) and greatly enhances the insulin response of rat islets to glucose (Totsuka et 
al., 1988; Yasuda et al., 1993). Activin and betacellulin (a factor purified from the 
conditioned medium of mouse P-tumour cells; Shing et al., 1993; Watanabe et al., 
1994a), or activin and hepatocyte growth factor (HGF) are able to co-ordinately convert 
pancreatic AR42J cells into endocrine cells expressing insulin, GLUT2, glucokinase, 
and PP (Mashima et al., 1996a, 1996b; Shibata et al., 1993). Activin may therefore play 
an important role in the maturation and function of p-cells, in addition to the 
development of endocrine cells.
1.8.2. Effects o f Growth Factors on Fetal and Postnatal Pancreatic 
Growth
The soluble factors that have been shown to exert an influence on both cell 
proliferation and cell differentiation are usually referred to as growth factors 
(Rosenberg, 1995). They act as mitogens, initiating cell growth, cell division and cell 
differentiation and promote cell survival. Growth factors also influence cell function. 
They act in a paracrine or an autocrine manner.
Fibroblast Growth Factors (FGFs)
One candidate for the “mesenchymal factor” mentioned above is FGF. FGF1, 
FGF7 and FGF 10 are all expressed in the pancreas during development and have been 
shown to be capable of activating epithelial cell proliferation in isolated pancreatic 
epithelium in vitro (Bhushan et al., 2001; Mason et al., 1994; Miralles et al., 1999). 
These three FGFs bind to a specific FGF receptor (FGFR), FGFR2mb known to be 
expressed in the fetal pancreatic epithelium (Finch et al., 1995; Orr-Urtreger et al., 
1993). FGF has also been shown to influence differentiation in such isolated pancreatic 
epithelial cultures; FGF can promote exocrine differentiation from isolated pancreatic 
epithelium (Horb and Slack, 2000; Miralles et al., 1999). Also, culturing intact 
pancreatic buds in the presence of a dominant negative form of the FGFR2b receptor
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has the effect of reducing cell proliferation (Miralles et al., 1999). These experiments 
collectively implicate FGFs in pancreatic epithelial cell proliferation.
Experiments in adult animals have shown that FGF7 stimulates cell proliferation 
of pancreatic cells postnatally. Exogenous FGF7 has been shown to be five-fold more 
potent than FGF1 or FGF2 in stimulating DNA synthesis (as measured by tritiated 
thymidine incorporation) within endocrine cells of isolated rat islets (Arany and Hill,
2000). FGF7 also provokes the proliferation of pancreatic ductal cells in adult rats 
following one-two weeks of exposure (Yi et al., 1994) and transgenic mice 
overexpressing FGF7 under the control of the liver-specific apolipoprotein E promoter 
show ductal hyperplasia (Nguyen et al., 1996).
A role for FGFs has also been implicated in the maintenance of the Pdxl- 
expressing pancreatic progenitor cell population during early pancreatic organogenesis. 
Inactivation of FGF 10 results in a reduced number of Pdxl+ pancreatic cells compared 
to wild-type littermates (Bhushan et al., 2001). Although the specification of Pdxl+ 
cells occurs in the absence of FgflO, the maintenance and expansion of the Pdxl+ 
progenitor cell population is dependent upon FGF 10 signalling from the mesenchyme. 
More recently, it has been shown that when the pancreatic epithelium is cultured for 
seven days in the presence of FGF7 or EGF, endocrine differentiation is repressed 
whilst an undifferentiated endocrine progenitor cell population is expanded (Cras- 
Meneur et al., 2001; Elghazi et al., 2002). Furthermore, FGFRl-IHb transcripts have 
been shown to be enriched in pancreatic epithelia cultured with FGF7 or EGF when 
compared with untreated epithelia, suggesting that FGFRl-IHb represents a marker for 
pancreatic progenitor cells (Cras-Meneur and Scharfmann, 2002).
Experiments using dominant negative (dn) forms of the variantly spliced FGF 
receptors have recently provided evidence for a role of FGF signalling in the control of 
the neogenesis and glucose-sensing/insulin processing functions of p-cells. Gene 
inactivation approaches to elucidate the role of FGF signalling in the mouse have been 
hampered by early embryonic lethality or functional redundancy (Kato and Sekine, 
1999; Szebenyi and Fallon, 1999). Hence, dn forms of FGFRs have been used to 
attenuate FGF signalling by binding to and blocking the interaction of FGFs with the 
normal receptor. It is known that FGFR1 and FGFR2, along with the ligands FGF1, 
FGF2, FGF4, FGF5, FGF7 and FGF10 are all selectively expressed in p-cells (Hart et 
al., 2000). Two transgenic mouse lines which express a dn version of FGFRlc (Cheon 
et al., 1994), denoted FRID1, or FGFR2b (Celli et al., 1998; Cheon et al., 1994), 
denoted FRIND2, in the developing pancreas under the control of the Pdxl promoter
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have been generated (Hart et al., 2000). FGFR c splice forms such as FGFRlc have 
been shown to recognise FGF2, FGF4, FGF5, FGF6, FGF8 and FGF9, whilst FGFR2b 
is activated by FGF3, FGF7 and FGF10 (Igarashi et al., 1998; Omitz et al., 1996). 
Although FRIND2 mice remain healthy, FRID1 mice develop diabetes at around 15 
weeks of age. This is most probably due to impaired (3-cell expression of GLUT2 and 
PC 1/3 in FRID1 mice, resulting in impaired glucose sensing and insulin processing 
respectively. This hypothesis is supported by the observed accumulation of proinsulin in 
the p-cells of FRID1 animals which is strikingly similar to the increased proinsulin 
content of p-cells in type 2 diabetic patients (Guiot et al., 2001). These findings indicate 
that FGFRlc signalling in the p-cell is required to ensure normal expression of key 
components in glucose sensing and insulin processing machinery and thus to maintain 
normoglycaemia. Moreover, FRID1 mice also display a reduced number of p-cells 
compared with non-transgenic littermates, implying a role for FGFRlc signalling in the 
expansion of p-cell number. Hyperplasia of P-cells has been observed in both humans 
and rodents under conditions such as pregnancy and non-diabetic obesity when there is 
an increased insulin demand, demonstrating the compensatory capacity of the p-cell 
(Hellerstrom et al., 1988; Marynissen et al., 1983; Parsons et al., 1992). Therefore, the 
reduced p-cell number in FRID1 mice also indicates that FGFRlc signalling is required 
for maintaining the competence of p-cells to proliferate in response to hyperglycaemia. 
It is plausible that analogous to the mouse, FGF signalling will prove to be important 
for human P-cell function and that perturbation of this signalling pathway in adult 
human P-cells could be linked to type 2 diabetes.
Hepatocyte Growth Factor (HGF)
The HGF mRNA level in fetal pancreas-derived fibroblasts is more than 10-fold 
that in adult pancreatic fibroblasts. HGF receptor is preferentially expressed in 
developing P-cells, and their proliferation is stimulated by conditioned medium from 
fetal pancreatic fibroblasts (Otonkoski et al., 1996) or HGF (Otonkoski et al., 1994a). 
HGF has even been shown to stimulate proliferation of adult p-cells (Hayek et al., 
1995). When amylase-producing AR42J cells are incubated with HGF and activin, the 
amylase content decreases, and insulin, PP, GLUT2, and glucokinase are expressed 
(Mashima et al., 1996b). HGF may therefore be a fetal mesenchyme-derived factor 
regulating P-cell growth and differentiation (Beattie et al., 1996).
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EGF receptors are expressed in the endocrine and exocrine cells of fetal 
pancreas (Ebert et al., 1995; Miettinen and Heikinheimo, 1992), but EGF is not 
(Kasselberg et al., 1985), so other factors that can bind to EGF receptors such as 
betacellulin, TGF-a, and heparin-binding EGF-like growth factor (HB-EGF) may be 
more important for islet development than EGF itself. As mentioned, betacellulin and 
activin co-ordinately convert cells of the pancreatic acinar cell line AR42J into insulin- 
secreting cells (Mashima et al., 1996a; Shibata et al., 1993). Betacellulin has been 
shown to induce insulin and glucokinase expression in glucagonoma cells stably 
transfected with Pdxl (Watada et al., 1996b). TGF-a shares a 50 % sequence similarity 
with that of betacellulin (Shing et al., 1993), and is expressed in the fetal pancreas 
(Miettinen and Heikinheimo, 1992). Overexpression of TGF-a in transgenic mice by 
the elastase or metallothionein promoter induces ductular metaplasia containing 
numerous insulin-expressing cells resembling pancreatic ductal precursors (Jhappan et 
al., 1990; Sandgren et al., 1990). This also has the effect of increasing the size of the 
pancreas, though principally by fibrosis. HB-EGF is expressed in fetal endocrine cells 
and primitive ducts, and its expression pattern is similar to that of Pdxl (Kaneto et al.,
1997). Pdxl is able to transactivate the HB-EGF gene promoter. Collectively, these 
findings suggest that signalling via EGF receptors plays an important role in islet 
development.
Growth Hormone (GH) Family
GH, prolactin (PRL), and placental lactogen (PL) all stimulate P-cell 
proliferation as well as insulin production and secretion (Brelje et al., 1993; Hill and 
Hogg, 1991; Nielsen, 1982). Increased P-cell mass and islet hyperplasia are known to 
occur during pregnancy in the mother. Although this has been attributed to high levels 
of glucose in the fetal circulation (Hellerstrom and Swenne, 1985), it is now thought to 
represent intrinsic growth under the control of PL (Sorenson and Brelje, 1997); 
nevertheless, glucose has been shown to be a stimulus for expansion of p-cell mass both 
in vivo and in vitro (Bonner-Weir et al., 1989; Hellerstrom et al., 1988; Schuppin et al., 
1992; Swenne, 1992). GH receptor (Delehaye-Zervas et al., 1994; Lobie et al., 1990; 
Miettinen et al., 1993) and PRL receptor (Freemark et al., 1997; Garcia-Caballero et al., 
1996; Royster et al., 1995) are expressed in pancreatic islets. In rats bearing GH- and
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PRL-producing tumours (Parsons et al., 1983; Sorenson and Parsons, 1985), GH- 
expressing transgenic mice (Parsons et al., 1995), and in pregnant animals (Sorenson 
and Parsons, 1985), p-cell mass increases and insulin secretion is enhanced. In pituitary 
GH- and PRL-deficient dwarf mice, islet volume decreases between two- and five-fold 
(Parsons et al., 1995). PRL increases GLUT2 expression (De Mazancourt et al., 1994; 
Weinhaus et al., 1996) and islet sensitivity to glucose (Boschero et al., 1993; Sorenson 
and Parsons, 1985), and may therefore play a role in p-cell maturation. GH induces 
IGF-I production from islets, resulting in islet DNA replication via IGF-I receptor 
(Swenne et al., 1987).
Parathyroid Hormone-related Protein (PTHrP)
Pancreatic islets are known both to produce PTHrP and to possess PTHrP 
receptors (Gaich et al., 1993; Porter et al., 1998; Vasavada et al., 1996). Transgenic 
mice expressing PTHrP driven by the rat insulin II promoter display hypoglycaemia, 
inappropriate hyperinsulinaemia, and increased total islet number and total islet mass 
(Porter et al., 1998; Vasavada et al., 1996). As these phenotypes are exhibited 
postnatally, PTHrP may regulate the postnatal endocrine tissue mass.
Thyrotropin-Releasing Hormone (TRH)
TRH is expressed in adult (Martino et al., 1978) and fetal islets (Kawano et al., 
1983), and colocalised with insulin in the secretory granules of P-cells (Kawano et al., 
1983; Leduque et al., 1986; Ouafik et al., 1987), resulting in glucose-stimulated 
secretion of TRH from P-cells (Dolva et al., 1983). The roles of TRH in islet 
development and pancreatic hormone secretion are currently controversial. It is known 
however, that TRH-null mutants exhibit hyperglycaemia accompanied by impaired 
insulin secretion in response to glucose (Yamada et al., 1997).
Insulin and Insulin-Like Growth Factor (IGF)
Gene targeting studies have demonstrated that peptides in the extended insulin 
family, insulin, and IGF-I and IGF-II are important trophic hormones during embryonic 
and fetal development whose absence results in profound fetal growth retardation 




The amount of insulin made available to the fetus during development is 
obviously dependent on the volume of the p-cell mass. It has been demonstrated that in 
rats subjected to hyperglycaemia (“hyperglycaemic clamping”) for five days, the islet 
area is more than twice the size of controls, and the number of islets is almost double 
and the level of proinsulin mRNA is increased (Chen et al., 1989), suggesting that 
insulin stimulates P-cell growth in an autocrine manner. p-Cells are equipped to respond 
to secreted insulin: insulin receptors have been shown to be expressed in rat islets and 
on p-cells (Harbeck et al., 1996; Verspohl and Ammon, 1980). In transgenic mice 
expressing mutant forms of human insulin displaying an increased affinity for the 
insulin receptor, the rate of fetal p-cell growth is three-fold higher compared with that in 
non-transgenic littermates (Vincent et al., 1995). Glucose and insulin induce 
phosphorylation of the insulin receptor (INSR) and the insulin receptor substrate (IRS)-
1 and IRS-2 in rat islets (Velloso et al., 1995). Genetic inactivation of these signalling 
components has revealed the mechanism by which insulin promotes p-cell growth. IRS-
2 inactivation has been found to result in a decrease in p-cell mass despite insulin 
resistance in the liver and skeletal muscle, leading to diabetes (Withers et al., 1998). In 
contrast, IRS-1-null mice exhibit both increased p-cell mass and insulin secretion which 
compensate for mild insulin resistance (Araki et al., 1994; Tamemoto et al., 1994). 
Also, the expression level of IRS-2 in rat insulinoma cells is 60-70 times greater than 
that in rat primary p-cells, whereas IRS-1 mRNA levels are equivalent (Schuppin et al., 
1998). These findings suggest that insulin stimulates P-cell growth, especially during 
embryogenesis (Vincent et al., 1995), via the phosphorylation of IRS-2. Insulin 
signalling in p-cells influences insulin secretion in addition to their growth. P-Cells 
overexpressing wild-type insulin receptors display a three-fold increase in cellular 
insulin content and a five-fold elevation in the rate of both basal and glucose-stimulated 
insulin secretion (Xu and Rothenberg, 1998). Conversely, the P-cell-specific disruption 
of insulin receptors results in defective insulin secretion with impaired glucose tolerance 
(Kulkami et al., 1998). IRS-2 also mediates the effects of insulin on the production of 
this hormone: transcription of the insulin gene by insulin itself is activated via IRS-2 
phosphorylation (Leibiger et al., 1998). These mechanisms can therefore explain both 






There is substantial evidence to suggest that continuous P-cell proliferation in 
early life is dependent on IGF-I and II which both exhibit a complex pattern of 
pancreatic expression. IGF-II is expressed most abundantly in fetal rat pancreas and 
then declines neonatally (Hogg et al., 1994; Petrik et al., 1998) as in most other tissues 
(LeRoith, 1991, 1997; Schofield, 1992). Some IGF-II immunoreactivity can be detected 
in the p-cells of healthy rats and humans (Hoog et al., 1996; Maake and Reinecke,
1993). IGF-H mRNA is expressed throughout the islets and in ductal epithelium (Hill et 
al., 1999; Petrik et al., 1998). Conversely, IGF-I expression is low during fetal life and 
does not attain adult levels until after weaning. IGF-I mRNA is barely detectable in the 
islets but its expression in the pancreatic acini increases with age (Hogg et al., 1994). 
IGF-I and IGF-II immunoreactivity are associated with islet cells throughout 
development, suggesting that IGF peptide distribution may be dependent on the 
pancreatic expression of locally-produced IGF-binding proteins or IGFBPs expressed 
within the pancreas (Hogg et al., 1994). At least six IGFBPs modulate the stability, 
biological availability to tissues, and mitogenic effects of IGFs in a wide range of 
human and rat fetal tissues (Hogg et al., 1993; McCusker and Clemmons, 1992). 
IGFBP3, IGFBP4 and IGFBP5 are predominant in the fetal and neonatal periods, while 
increased expression of IGFBP1 and IGFBP2 occurs two-three weeks after birth, 
suggesting a circulatory source during early pancreatic development (Hill et al., 1999). 
The ontogeny of IGFBP gene expression in the pancreas may be related to changes in 
the nutritional input.
Mitogenic Effects In Vitro
Experiments with isolated islets from the rat or human fetus, or using established 
P-cell lines, have shown that exogenous IGF-I and IGF-II will promote DNA synthesis 
in p-cells through the type 1 IGF receptor (Asfari et al., 1995; Hogg et al., 1993; 
Sieradzki et al., 1988; Swenne et al., 1987; Van Schravendijk et al., 1987). 
Upregulation of IGF-H has been shown to be associated with P-cell tumorigenesis 
(Christofori et al., 1994, 1995). A study (Hogg et al., 1993) using fetal rat islets has 
suggested that although IGF-I is a more potent mitogen than IGF-H, IGF-H is released 
in much greater abundance. Some evidence also suggests that IGFs are capable of
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stimulating growth of the exocrine pancreas; IGF signalling has been shown to promote 
growth of cultured acinar cells and enhance amylase gene expression (Ludwig et al., 
1999; O’Brien and Granner, 1996; Williams et al., 1984) and it has been hypothesised 
that acinar tissue growth is mediated by the IGF-II ligand (Louvi et al., 1997). It is 
presumed that both IGF-I and IGF-II operate through the IGF1 receptor (IGF1R; De 
Meyts et al., 1994; LeRoith et al., 1995) which is primarily responsible for initiating 
intracellular mitogenic signalling pathways such as the MAP kinase (ERK) and PI3- 
kinase pathways. The former is usually associated with cell division, but it is probably 
the latter that is more important for overall growth. The IGF1 receptor is abundantly 
expressed on a-, P-, and 5-cells (Fehmann et al., 1996; Van Schravendijk et al., 1987; 
Withers et al., 1999). Studies in fibroblasts from mouse embryos homozygous for null 
alleles of Igfrl have shown that IGF-H can also stimulate cell proliferation through the 
insulin receptor (INSR; Morrione et al., 1997) which is known to be expressed on P- 
cells. IGF-H is known to bind to both the IGF1R and INSR receptors with a high 
affinity (Frasca et al., 1999). It has also been suggested that IGF-I-induced P-cell 
growth is also mediated by IRS-2 phosphorylation (Hugl et al., 1998; Zhang et al.,
1998). In addition to a trophic action on P-cells, IGF can also influence P-cell function 
at least in the adult. Both IGF-I and IGF-H have been shown to alter glucose-stimulated 
insulin release by adult P-cells, with a biphasic action which can be modulated by 
endogenous IGFBPs (Hill et al., 1997; Van Schravendijk et al., 1990).
Mitogenic Effects In Vivo - Transgenic Models
Until recently, evidence for a trophic action of IGF-I or IGF-H on islets in vivo 
has been scarce. Although a general increase in birth size and organ weights of mice 
expressing either IGF-I or IGF-H transgenes was demonstrated (Quaife et al., 1989; 
Wolf et al., 1994), only one study reported substantially increased pancreatic weight at 
birth following IGF-H overexpression (Blackburn et al., 1997). However, the endocrine 
component represents only 1-2 % of the pancreatic volume (Bonner-Weir and Smith,
1994) so significant changes in islet mass may occur without a noticeable change in 
pancreatic weight. So, Petrik and coworkers (Petrik et al., 1999) examined islet 
morphology in IGF-H transgenic animals for possible changes resulting from altered 
pancreatic expression of IGF-H or from increased circulating levels. In these animals, 
the endogenous mouse IGF-H gene becomes widely overexpressed during the second 
half of gestation (Sun et al., 1997) and they exhibit increased fetal weight from E l3,
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often attaining a birth weight 60 % greater than controls. The transgenic IGF-H mice 
also show selective organ overgrowth (organomegaly) of the heart, kidney, liver and 
tongue, all of which demonstrate increased IGF-H mRNA. The model of IGF-H 
transgenesis used was unusual in that the mouse IGF-H transgene driven by fetal 
promoters, is repressed during embryonic development but is associated with an 
increased expression of the endogenous IGF-H gene (Sun et al., 1997). Expression of 
the IGF-H gene is regulated by parental imprinting, leading to expression of only a 
paternal copy in most fetal tissues, excepting the choroid plexus and meninges of the 
brain (DeChiara et al., 1991). The IGF-H gene contains regions that are methylated on 
the paternal allele and could act as silencer sequences (Feil et al., 1994). In the model of 
IGF-H gene transgenesis used, the changes in DNA methylation may suppress the 
transgene but relax imprinting of the endogenous IGF-H gene, leading to its increased 
expression and selective tissue overgrowth (Sun et al., 1997). As the IGF-H- 
overexpressing animals die shortly after birth, fetuses were examined on E l9.5-20. 
Transgenic fetuses exhibited elevated circulating levels of IGF-H and islet abnormalities 
although islet number was no different from control animals. Islets from transgenic 
animals were of irregular shape and mean individual islet area was five-fold greater than 
in controls. Cell size was unchanged however from which increased islet size was 
attributed to hyperplasia (an increase in cell number). Transgenic islets contained 
proportionately fewer p-cells but a greater proportion of a-cells than control islets. 
Overall however, increases were observed in the populations of p-, a-, and 5-cells. 
Many of the a-cells in the islets of IGF-H-overexpressing animals were present in the 
islet core, illustrating a disruption of normal islet architecture. Immunostaining for the 
proliferating cell nuclear antigen (PCNA) showed twice as many islet cells to be in a 
state of active replication in transgenic animals than in controls, whereas the number of 
cells undergoing apoptosis was reduced. Despite islet hyperplasia, circulating insulin 
and serum glucose levels were not significantly increased in transgenic animals. These 
findings show that IGF-H overexpression in fetal life results in islet hyperplasia by 
increasing the populations of all three major endocrine cell types but does not affect the 
number of mature islets. It is unclear however, whether islet hyperplasia was primarily 
caused by increased local pancreatic expression of IGF-H or resulted from exposure to 
the increased circulating levels. Interestingly, the IGF-H-induced islet overgrowth did 
not result in hyperinsulinaemia, possibly because of a downregulation of insulin release 
by IGF-H. A subsequent study by the same group (Hill et al., 2000) on a second 
transgenic mouse model of IGF-H overexpression confirmed these findings. In the
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transgenic Blast line, mouse IGF-H is selectively overexpressed in skin, gut, and uterus 
driven by a keratin 10 promoter, so that circulating IGF-H is retained postnatally until at 
least six months after birth, instead of declining after birth to disappear by weaning as 
usual (Brown et al., 1986; Da Costa et al., 1994). The increased circulating IGF-H is 
available to target tissues and produces a local overgrowth of tissues at sites of targeted 
overexpression (Da Costa et al., 1994; Ward et al., 1994). Islets in IGF-H- 
overexpressing Blast mice exhibited a significantly greater mean area from postnatal 
day (PN)11 to PN16 relative to controls although proportions of p- and a-cells and 
circulating insulin levels were unaltered. Again, IGF-H overexpression was found not to 
influence the total number of islets. The authors concluded that the persistent presence 
of circulating IGF-H postnatally results in an increased mean islet size and increased 
populations of both a- and P-cells. This is due to IGF-H suppression of a wave of islet 
cell apoptosis that occurs in the neonatal pancreas around two weeks after birth (see 
below).
Most recently, it was demonstrated that targeted overexpression of IGF-H in the 
pancreatic P-cells driven by the rat insulin I (RIP) promoter produces a similar 
phenotype to that resulting from elevated levels of IGF-H in the circulation (Devedjian 
et al., 2000). Islets from transgenic animals were shown to display high levels of IGF-H 
mRNA and protein whilst their pancreata exhibited a three-fold increase in P-cell mass 
and a consequent increase in insulin mRNA levels relative to controls. The islets in 
animals bearing the IGF-H transgene were found to be larger than those in controls and 
displayed a more elongated, irregular shape. As in the previous two mouse models of 
IGF-H overexpression (Hill et al., 2000; Petrik et al., 1999), transgenic islets exhibited 
altered architecture with a-cells randomly distributed throughout the islet core. As a 
result of p-cell-targeted IGF-H-overexpression, the transgenic animals exhibited 
hyperinsulinaemia and mild hyperglycaemia and about 30 % of these animals 
subsequently developed overt diabetes when fed a high-fat diet.
Little is known in general about growth factors that mediate exocrine pancreatic 
proliferation (Kim and Hebrok, 2001) and as such, few studies have examined the effect 
of the IGFs on acinar growth. The fact that development of the exocrine pancreas is 
critically dependent upon mesenchymal-epithelial interactions would, however, suggest 
that locally produced growth factors play a significant role in this process (Ahlgren et 
al., 1996; Gittes et al., 1996; Rose et al., 1999; Sanvito et al., 1994). A very recent gene 
inactivation study has provided evidence that IGF-H has a mitogenic effect on the 
exocrine pancreas. Kido and coworkers (Kido et al., 2002) demonstrated that combined
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inactivation of Insr and Igflr decreases mean acinar diameter by approximately 40 % 
due to reduced cellular proliferation whilst islet development is unaffected. Inactivation 
of either receptor alone however, produced no effect. Furthermore, combined ablation 
of the two ligands Igfl and Igf2 results in an identical phenotype. Some studies suggest 
that there is functional overlap between the growth-promoting functions of the two 
receptors. IGF-II has been shown to promote embryonic growth in mice not only 
through its cognate receptor IGF1R, but also through INSR (Efstratiadis, 1998; Louvi et 
al., 1997; Ludwig et al., 1996) and furthermore, IGF-H is known to bind to both the 
IGF1R and INSR receptors with a high affinity (Frasca et al., 1999). Since exocrine 
tissue reduction is not observed in single Insr'A or Igflr'A mutant embryos, it is unlikely 
to be a consequence of impaired insulin or IGF-I signalling, which activate only the 
cognate receptor. On the basis of the known interactions of IGF-H with both IGF1R and 
INSR, the decrease of exocrine tissue in double Insr'1'Igflr'1' mutants is consistent with 
the hypothesis that acinar tissue growth is mediated by the IGF-H ligand (Louvi et al.,
1997).
1.8.3. Growth and Regeneration of the Postnatal Pancreas
1.8.3.1. Remodelling of Neonatal Islets
During fetal and early neonatal life, P-cell mass continues to increase in the 
rodent pancreas. However, there is a transient plateau between one and three weeks 
after birth during which p-cell mass does not increase despite the continued growth of 
the animal (Finegood et al., 1995). This has been attributed to a remodelling of the 
neonatal endocrine tissue compartment in the second week of postnatal life. In 1995, 
Finegood et al. described a postnatal wave of P-cell death in the developing rat pancreas 
using a mathematical model of P-cell mass dynamics. The peak rate of this wave was 
predicted to be 9 % of p-cells/day at PN12. The predicted apoptotic wave was 
subsequently validated by direct histochemical detection of apoptotic cells. Studies in 
rats using the fluorescent dye propidium iodide or terminal deoxynucleotidyl 
transferase- (TdT)-mediated biotin dUTP nick-end labelling (TUNEL) to 
morphologically identify apoptotic cells have identified peaks of P-cell apoptosis 
occurring between PN13 and PN14 (Petrik et al., 1998; Scaglia et al., 1997). More 
recently, this phenomenon has also been shown to occur in the mouse pancreas, with the 
wave of p-cell apoptosis peaking at PN12 (Trudeau et al., 2000). TUNEL staining
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translates into a very high rate of cell removal per day when it is realised that cells can 
only be observed as TUNEL-positive for a short period of a few hours (Petrik et al.,
1998). Estimates of apoptotic rate derived from TUNEL staining are therefore very 
conservative.
Further evidence also implicates an involvement of IGF-II in this wave of 
endocrine cell death. It has been demonstrated that the neonatal wave of islet cell 
apoptosis in the rat pancreas is temporally associated with a fall in the islet cell 
expression of IGF-H (Hill et al., 1999; Hogg et al., 1994; Petrik et al., 1998). It has 
been known for some time that the IGFs are able to prevent apoptosis in a variety of cell 
types (Geier et al., 1992; Stewart and Rotwein, 1996) by mechanisms that include an 
inhibition of caspases (Jung et al., 1996). Moreover, both IGF-I and II have been shown 
to function as islet survival factors in vitro by suppressing cytokine-mediated islet cell 
death in isolated neonatal rat islets (Petrik et al., 1998). In a subsequent study by the 
same group (Hill et al., 2000) mentioned above, it was demonstrated that in transgenic 
mice in which IGF-II is overexpressed, the wave of islet cell apoptosis is substantially 
decreased in comparison to wild-type littermates due to the persistent presence of 
circulating IGF-H postnatally. Islets from these IGF-H transgenic mice consequently 
exhibited a significantly greater mean area from PN11-16 than islets from non- 
transgenic siblings (Hill et al., 2000).
The functional significance of this neonatal remodelling of the islet cell mass is 
unknown. However, in other systems such as in male germ cells (Wang et al., 1998) and 
cardiac myocytes (Kajstura et al., 1995), similar waves of neonatal apoptosis contribute 
to tissue remodelling coincident with changing function or cellular demand. It is 
possible that this remodelling is associated with the maturation of the glucose response 
by p-cells. The glucose sensitivity of p-cells has been reported to be acquired 
neonatally, and the response to glucose matures only after weaning, around three weeks 
after birth (Asplund, 1973; Hole et al., 1988; Otonkoski et al., 1988a; Weinhaus et al.,
1995). The signals that initiate maturation of glucose sensing in islet cells remain 
unknown (Sander and German, 1997).
1.8,3.2. Postnatal Turnover o f the Endocrine Compartment
Until quite recently it was widely believed that there is a fixed population of 
pancreatic p-cells that are incapable of recovery following ablation. Islet cells were 
presumed to exhibit no appreciable growth during adult life (Hellerstrom et al., 1989).
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This belief was based on the sustained lack of function in severe cases of type 1 diabetes 
mellitus and secondly, on the failure of recovery of experimental animals from diabetes 
induced with the p-cell toxin streptozotocin. These effects do not, however, exclude the 
possibility of there being a normal turnover of p-cells in the pancreas. By extrapolating 
the available cell kinetic data (Kaung, 1994; Montana et al., 1994; Swenne and 
Eriksson, 1982), Finegood and colleagues (Finegood et al., 1995) determined that 
approximately 20 % of P-cells in the PN1 neonatal rat pancreas are in a state of active 
proliferation and this figure declines progressively in the weeks following birth. 
However, the replication rate stabilises at an adult level of 3 % P-cell turnover per day 
at approximately PN40. Later studies have confirmed that the P-cell mass does continue 
to grow well into adulthood. Morphometric data from wild-type mice aged from four 
weeks to six months and of the same mixed background (C57B1/6J/129J) (Bruning et 
al., 1997; Kopin et al., 1999; Westphal et al., 1999; Withers et al., 1998) shows that p- 
cell mass increases at least 10-fold over the five-month period examined and is linearly 
correlated with body weight. The p-cell mass also increases throughout the life of the 
male Lewis rat: initially by an increase in cell number and then, from 15 months 
onwards, by an increase in cell size (hypertrophy) of the p-cell (Montanya et al., 2000). 
It was a widespread belief that because p-cell replication after the neonatal period is 
relatively low (3 %), the p-cell mass does not turn over significantly during adult life 
and that the number of p-cells remains virtually static from birth. However, even the 
“low” level of p-cell replication in the adult rodent pancreas is sufficient to bring about 
dramatic changes in p-cell mass. Hellerstrom et al. (1988) pointed out that with a p-cell 
birthrate of just under the adult level of 3 % new cells per day, the P-cell mass would 
double in one month if there were negligible cell death or apoptosis. The p-cell mass 
does not continue to double each month in postnatal life so the P-cell like the majority 
of other cell types, must have a finite life span. The mathematical model of Finegood 
and coworkers (Finegood et al., 1995) suggests a mean turnover time of 20 days for p- 
cells in the adult rat and a life span of approximately 58 days. Indeed, if the rate of P- 
cell death approaches the replication rate of 3 %, then complete replacement of the p- 
cell population could occur in a one-month period. So, the endocrine pancreas of the 
adult should be considered to be a slowly renewed tissue (Finegood et al., 1995). This 
p-cell production can be achieved through the replication of pre-existing P-cells 
(Hellerstrom et al., 1988) or via neogenesis, the budding of endocrine cells from the 
ducts (Bonner-Weir, 2000).
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Evidence for neogenesis or novel tissue formation is found in pancreata from 
obese humans and a number of animal models. Conditions that provoke chronic trauma 
or inflammation of pancreas tissue (pancreatitis) appear to induce novel islet formation 
by budding from ductules (Gu and Sarvetnick, 1993; Gu et al., 1994; Rosenberg et al., 
1983). Such conditions can occur spontaneously during pathological processes or more 
commonly, are induced experimentally in animal models. The rare human condition of 
nesidioblastosis is one example of a pathological condition causing neogenesis in which 
novel islets appear to be formed continuously (Goossens et al., 1989). An experimental 
example is that of wrapping the head of the hamster pancreas with cellophane tape such 
that there is a stasis of secretions in the smaller ducts (Rosenberg et al., 1983). This 
leads to a local inflammation and fibrosis. The ducts exhibit hyperplasia and metaplasia 
to goblet-like cells as in the intestine. Moreover, some budding of islets from the 
hyperplastic ductules is observed. A similar phenomenon is replicated in transgenic 
mice in which expression of interferon y is driven by an insulin promoter (Gu and 
Sarvetnick, 1993; Gu et al., 1994). This provokes an autoimmune attack on the P-cells 
leading to chronic inflammation and tissue destruction with consequent goblet cell and 
hepatic metaplasia. Cell kinetic studies with 5’-bromo-2’-deoxyuridine (BrdU) support 
the origination of P-cells from the ducts.
Ligation of the main pancreatic duct has traditionally been employed to cause 
pancreatic destruction. The effect of this is to prevent the outflow of the pancreatic 
secretions; although most of the enzymes are in the form of inactive precursors, 
sufficient activity is presumably released to lead to a rapid destruction of the acinar 
tissue, and a slower destruction of ducts and islets (Goss, 1978; Hughes, 1956). Whilst 
prolonged ligation leads to a permanent and irreversible fibrosis, temporary ligation 
ablates the majority of the acinar tissue with little detrimental effect on the ducts and 
islets. A similar effect can be obtained by administration of the protein synthesis 
inhibitor ethionine in conjunction with a protein-free diet (Fitzgerald et al., 1966). 
Following termination of any of these damaging treatments, a rapid regeneration of the 
acinar tissue ensues, with complete restoration after a few weeks. These results 
demonstrate that the adult acinar tissue retains a capacity for rapid regenerative growth. 
This capacity is also exhibited following the surgical removal of parts of the pancreas or 
“partial pancreatectomy” although the extent of regeneration is not as dramatic. It is 
possible to remove up to 90 % of the rat pancreas without serious effect on the animal’s
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rate of growth. Studies have shown some regeneration, defined as growth of the 
remnant in excess of that shown by the same region of pancreas in sham-operated 
animals, but total organ size is never completely restored to that of the controls 
(Friedmann and Marble, 1941; Lehv and Fitzgerald, 1968; Sidorova, 1978). Reinforcing 
earlier studies, it has recently been shown that within four weeks of 90 % pancreas 
removal, the P-cell mass was 45 % and pancreatic weight (reflecting exocrine mass) 
was 27 % that of sham-treated animals (Bonner-Weir et al., 1993, 1997; Sharma et al.,
1999), showing that regeneration occurred in a discordant fashion. Although mitotic 
index is elevated both in the acinar and islet cells (Brockenbrough et al., 1988), this 
rapidly declines over the first two weeks post-surgery whereas the slight growth 
advantage of the remnant is maintained for about six months. Although some 
regeneration is due to enhanced replication of pre-existing differentiated cells, it has 
been reported that there is some sprouting of ducts at the cut surface and subsequently 
some differentiation of new acinar and islet cells. Duct cells have been claimed to 
transiently re-express Pdxl before differentiating into islet, acinar or ductal phenotypes 
(Sharma et al., 1999). The numbers of Pdxl+ ductal epithelial cells have been shown to 
increase in the main pancreatic duct of the rat pancreas following the induction of 
necrotising pancreatitis by the intraductal infusion of sodium taurocholate (Taguchi et 
al., 2002). Islet cell hyperplasia can be stimulated by administering nicotinamide or 3- 
aminobenzamide, both inhibitors of poly ADPR synthetase (Yonemura et al., 1984). A 
differential cDNA screen on regenerating pancreata following 90 % pancreatectomy led 
to the cloning of the genes encoding regenerating proteins (Reg) I, n, and m  
(Narushima et al., 1997; Suzuki et al., 1994; Terazono et al., 1988; Unno et al., 1993). 
Reg I has also been shown to be induced by nicotinamide (Watanabe et al., 1990). 
Although usually secreted from pancreatic acinar cells, Reg I is expressed in p-cells of 
hyperplastic islets during regeneration; expression has also been shown to increase 
following cellophane wrapping, and pancreatitis (Rafaeloff et al., 1995; Satomura et al., 
1993; Terazono et al., 1988, 1990). The level of islet Reg I expression has been shown 
to be positively and negatively correlated with islet cell replication and islet cell 
differentiation respectively (Francis et al., 1992; Otonkoski et al., 1994b). Reg I is able 
to stimulate proliferation in the rat pancreatic duct-derived ARIP cell line, but not in 
AR42J (acinar) or RIN ((3-) cell lines (Zenilman et al., 1996). Moreover, intraperitoneal 
administration of recombinant rat Reg I protein is able to ameliorate the diabetic 
symptoms resulting from 90 % pancreatectomy by increasing p-cell mass (Watanabe et 
al., 1994b). Reg I knockout mice recently produced by homologous recombination have
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been found to develop normally although display a reduced rate of islet cell 
proliferation in comparison to control mice (Unno et al., 2002). The related islet 
neogenesis-associated protein (INGAP) is expressed in regenerating hamster pancreas 
(Rafaeloff et al., 1997). It has been shown to stimulate the incorporation of tritiated 
thymidine into hamster duct epithelia in primary culture and a rat pancreatic duct cell 
line, but is without effect on a hamster insulinoma tumour cell line. INGAP may 
therefore invoke ductal cell proliferation, a requirement for islet neogenesis (Rafaeloff 
et al., 1997). Reg I and INGAP therefore appear to be involved in the maintenance of P- 
cell mass, especially in islet neogenesis in adult pancreas. Some evidence (Gorden et 
al., 1997; Oberg-Welsh et al., 1997; Rooman et al., 1997) also suggests that vascular 
endothelial growth factor (VEGF) might act as a mitogen for ductal epithelial cells like 
INGAP since it increases the insulin content in fetal islets and stimulates ductal 
proliferation, a prerequisite for p-cell formation. NGF secretion from islet cells has been 
demonstrated to increase in response to streptozotocin-induced p-cell injury (Teitelman 
et al., 1998), which has lead some to suggest that it might also play an important role in 
islet neogenesis following injury in the adult.
Alloxan and streptozotocin have been widely used to specifically destroy 
pancreatic p-cells and produce animal models of diabetes (Chang and Diani, 1985). 
Both produce rapid p-cell necrosis although streptozotocin has fewer side effects and is 
therefore preferentially used. It is a glucose-conjugated nitrosourea which is presumed 
to gain access to the P-cells via the glucose-sensing machinery. If administered in a 
sufficiently large amount, a single dose will destroy the majority of the p-cells, inducing 
a permanent severe diabetes from which there is no significant recovery in P-cell 
numbers (Brosky and Logothetpoulos, 1969; Hamming and Reynolds, 1977). A lower 
dose will destroy fewer P-cells and provoke a less acute diabetes, although this too is 
permanent (Bonner-Weir et al., 1981; Steiner et al., 1970).
Collectively, these studies of experimentally-induced pancreatic regeneration 
demonstrate that acinar cell destruction is followed by rapid regeneration whereas P-cell 
ablation results in an almost total absence of regeneration. The different tissue 
compartments therefore exhibit very disparate behaviour. However, it would appear that 
all the cell types exhibit some potential for division. It is also apparent that there is no 
systemic means of sensing the total size of the organ as there is in the liver, which 
results in the rapid regeneration of a remnant until its original size is restored, usually 
within a matter of days. The relative health of animals suffering the loss of a significant
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portion of pancreas tissue indicates that the normal pancreas size represents a 
considerable functional excess capacity for both exocrine and endocrine functions. 
These studies also demonstrate the existence of pathological stimuli that can stimulate 
growth of pancreatic tissues, so local signals must exist that possess the capacity for 
promoting growth postnatally. The weight of descriptive evidence supporting the 
budding of acini and islets from hyperplastic ducts, although not conclusive in relation 
to the cell lineage, suggests that the ductal tissue comprises, or contains, a stem cell 
population (Githens, 1988). Indeed, incubation of postnatal ductal tissue with 
embryonic mesenchyme appears able to induce islet formation (Dudek et al., 1991). 
Furthermore, some cells of the normally amylase-secreting AR42J pancreatic cell line, 
if treated with activin A and betacellulin, become neuron-like and secrete insulin or PP 
(Mashima et al., 1996a; Shibata et al., 1993). If this cell line corresponds in behaviour 
with cells in vivo, then it would support long-term competence to generate endocrine 
cells from non-endocrine precursors. A ductal origin for the other pancreatic cell types 
is also consistent with the descriptive reports of endocrine cell production in the 
embryo. The failure of regeneration following treatment with streptozotocin or alloxan 
may suggest that these agents target these putative stem or precursor cells in addition to 
the differentiated P-cells (Slack, 1995). The possibility also cannot be excluded that 
such stem cells reside within the islets themselves. In support of this hypothesis, it has 
been shown both by in situ hybridisation and immunohistochemistry that a subset of 
endocrine cells in the islets of four-week old mice expresses the intermediary filament 
protein nestin, considered to be a marker for stem cells (Hunziker and Stein, 2000; 
Lendahl et al., 1990). These cells were found to express neither insulin, glucose, nor 
somatostatin although expression of PP was not examined. It has also been claimed that 
isolated nestin+ islet cells can differentiate into endocrine and exocrine cells in vitro 
(Zulewski et al., 2001). Most recently however, it was reported that nestin is expressed 
only in mesenchymal cells surrounding the pancreatic epithelium and is not expressed 
in pancreatic epithelial cells at any stage of development, refuting a stem cell role in the 
pancreas (Selander and Edlund, 2002).
It cannot be ascertained whether the continuous, slow turnover of cells in the 
postnatal pancreas is fed from a stem cell population. Certainly, studies on other tissue 
renewal systems show that there is no requirement for a stem cell population to divide 
more rapidly than the other, differentiated cells within that tissue. The existence or 
otherwise of a pancreatic stem cell population and the extent of the limitation on the 
division potential of the differentiated cells, are matters of contention. Very little is
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known about growth control in the pancreas despite the significant period over which 
the organ has been studied.
1.9. Current Studies
The results of the studies reported hereafter on various aspects of differentiation 
and growth of the mammalian (mouse) pancreas, have been segregated into five 
chapters. The results of the studies are described more or less in the order in which the 
work was conducted. Since a specific introduction to each study has been included at 
the beginning of each chapter, only a very brief overview is given here. Chapter 3 
describes the characterisation of a sub-population of motile epithelial cells in 
recombination cultures of p-gal-labelled pancreatic epithelium from El 1.5 P-gal- 
expressing transgenic ROSA-26 strain mouse embryos and unlabelled intact dorsal 
pancreatic buds from El 1.5 MF1 albino strain embryos. Chapter 4 outlines an 
immunocytochemical analysis of cell lineage and clonal development of the major 
pancreatic cell types in the postnatal pancreas using p-gal-expressing H253 X- 
inactivation mosaic mice. Chapter 5 describes an investigation into the three- 
dimensional structure and clonal composition of irregularly-shaped islets observed in 
the H253 mice during the analysis of pancreatic cell lineage. These islets appeared to 
resemble two or more conjoined islets and were hypothesised to represent islet(s) 
undergoing either division (fission) or fusion. Chapter 6 reports the findings of a 
statistical morphometry-based investigation into the effects of specifically targeted and 
hence, local overexpression of the growth factor IGF-II within the exocrine and 
endocrine tissue compartments of the pancreas. Finally, Chapter 7 describes an 
immunocytochemistry-based investigation into the relationship between two sub­
populations of hepatocytes induced in cultures of El 1.5 mouse pancreatic buds by 
exposure to the synthetic glucocorticoid dexamethasone.
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2. Materials and Methods
2.1. Pancreatic Bud Cultures
The protocol employed for establishing pancreatic bud cultures and their 
subsequent immuno- and X-gal staining was essentially that developed by Percival and 
Slack (1999) with some minor procedural modifications.
2.1.1. Dorsal Pancreatic Bud Dissection
Pregnant mice were sacrificed by cervical dislocation and uteri explanted by 
severing their connection with the oviducts. The uteri were then dissected in ice-cold 
sterile phosphate-buffered saline (PBSA, Oxoid). Under a dissecting microscope in a 
laminar flow hood, embryos were removed from the decidua and transferred to ice-cold 
BME medium with Hank’s salts supplemented with 10 % fetal bovine serum (FBS), 1 x 
L-glutamine and 50 pg/ml gentamicin (all Gibco-BRL, Life Technologies) and the gut 
was dissected out. Using a microscalpel and fine forceps the dorsal pancreatic bud was 
excised from its position just posterior to the stomach (Fig. 2.1.). Pancreata were 
collected in ice-cold BME/Hank’s medium.
2.1.2. In Vitro Cultures
Glass coverslips (No. 1, 22 * 22 mm, Chance Propper) were immersed in 2 % 3- 
aminopropyltriethoxysilane (APTES, Sigma) in acetone overnight, rinsed twice in 
acetone and twice in sterile, MilliRO water, and dried at 37°C. They were subsequently 
sterilised by baking for 2 hours (h) at 180°C then placed in 30 mm Petri plates (Nunc). 
In a flow hood, a 40 pi drop of bovine plasma fibronectin (lyophilized, Gibco-BRL, 
Life Technologies) at 50 pg/ml in sterile water was placed on the centre of each 
coverslip and was left to evaporate for 3 h. Plates were stored at 4°C prior to use.
To establish intact dorsal pancreatic bud cultures, 3 ml of BME medium with 
Earle’s salts (Gibco-BRL), 20 % FBS, 1 x glutamine and 50 pg/ml gentamicin was 
added to each dish. The FBS content of the culture medium was doubled from 10 % to 
permit more infrequent replenishment of the medium and so impose less of a
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Figure 2.1. Schematic Depiction of Microdissection of the Developing Mouse 
Foregut and Pancreas. (After Gittes and Rutter, 1992)
(a) 20-somite stage (E9.5) foregut. The area of the incipient stomach and the 
duodenal anlage are shown, (b) 26-somite stage (E10) when the pancreas is first 
beginning to evaginate from the dorsal surface of the foregut. (c) 48-somite 
stage (El 1.5) pancreas. The pancreatic epithelium within the surrounding 
pancreatic mesenchyme is beginning to branch in the formation of early acini
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disturbance. A stainless steel ring (“cloning ring”) of 4 mm internal diameter was placed 
over the fibronectin-coated region, and the pancreatic bud was placed into the centre. 
This cloning ring immobilised the bud during the initial culture period whilst it adhered 
to the substrate. To ensure spreading during culture, the buds were turned if necessary 
with a fine needle so that they were orientated cut-surface downwards. Cultures of 
isolated pancreatic epithelium were established similarly; the epithelium was manually 
segregated from the surrounding mesenchyme by teasing the latter away with fine 
forceps before the epithelial bud was “plated” on to the fibronectin substrate. In a third 
type of culture, isolated epithelium and mesenchyme derived from the same dorsal 
pancreatic bud were explanted on the centre of the same fibronectin-coated coverslip 
whereupon each tissue fragment was immobilised by a separate cloning ring.
All cultures were maintained at 37°C, in 5 % CO2 for up to 9 days. The medium 
was replenished either each day or every other day of the culture period dependent upon 
the experiment, and the stainless steel ring was removed on day 2 in vitro.
2.2. Specimen Fixation and Storage
2.2.1. Cultures
After the desired duration of growth in vitro, cultures were fixed either in 
mammalian MEMFA (10 % formalin, 0.15 M Mops, pH 7.4, 2 mM EGTA, 1 mM 
MgSC>4) for 40 minutes (min) at room temperature, 4 % paraformaldehyde (PFA) for 20 
min or 40 min at room temperature, or in a 1:1 acetone methanol fixative for 5 min at - 
20°C. They were then washed in PBSA and stored in PBSA with the addition of 0.02 % 
NaN3 at 4°C for a few days though occasionally for up to several months.
2.2.2. Embryos
Freshly dissected El 1.5-15.5 wholemount mouse embryos or their dissected 
organs (such as brains and guts) were fixed for 1-2 h and 35 min-2 h respectively 
depending on size in 4 % PFA in PBSA (including 0.1 % H2O2 if subsequent 
immunocytochemistry employed immunoperoxidase detection) at room temperature 
with gentle agitation. Prior to fixation of larger embryos, the fourth ventricle was 
opened to minimise precipitation of reagents within body compartments. Specimens 
were subsequently rinsed and stored in PBSA at 4°C for up to a few days if necessary.
2.2.3. Pancreata
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Animals were sacrificed by cervical dislocation and their pancreata rapidly 
excised. They were then typically divided into two equal-sized portions, one of which 
was subjected to paraffin histology and the other destined for the preparation of frozen 
sections. Pieces of pancreata were either fixed in ice-cold 4 % paraformaldehyde in 
PBSA, pH 7.4 at 4°C for 48 h (paraffin embedding) or 1.5 h (cryoembedding) after 
which they were washed at 4°C in PBSA.
2.3. Staining for 0-Galactosidase Activity
2.3.1. Cultures and Frozen Sections
Histochemical X-gal staining of cultures or frozen pancreas sections (refer 
below) for p-galactosidase activity was performed in freshly-constructed Tissue Stain 
Base: 2 mM MgCh, 0.01 % (weight/volume or w/v) sodium deoxycholate, 0.02 % (w/v) 
Nonidet P-40, 5 mM K3Fe(CN)6 , 5 mM K4Fe(CN)6.6H20 in 100 mM Sorensen’s PO4  
buffer, pH 7.4 (comprising 1 M Na2HPC>4 and 1 M NaH2P0 4 ) with 1 mg/ml of X-gal (4- 
chloro-5-bromo-3-indolyl-p-D-galactopyranoside; Boehringer Mannheim or Melford 
Laboratories). X-Gal was prepared as an 80 mg/ml stock solution in dimethylsulphoxide 
(DMSO) and was diluted immediately prior to use into Tissue Stain Base pre-warmed to 
37°C to prevent precipitation of the substrate. Incubation was at 37°C in the dark; 
cultures were incubated within the 30 mm Petri plates for 2 h whilst frozen sections 
were subjected to overnight incubation. Cultures and frozen sections were then washed 
in PBSA after which they were mounted in Gelvatol medium. The pH of this mountant 
is optimal for fluorescein fluorescence; the 72-propyl gallate contained reduces 
fluorescein quenching. Gelvatol medium was constructed by dissolving 20 g of 
polyvinyl alcohol in 80 ml of 10 mM Tris, pH 8.6, including 0.2 % NaN3 . This was 
mixed with 50 ml glycerol containing 3 g of 72-propyl gallate.
2.3.2. Pancreata and Ear clips
Whole pancreata or earclips were fixed by immersion in Tissue Fixative (4 % 
PFA, 2 mM MgSC>4, 5 mM EGTA in 100 mM Sorensen’s phosphate buffer, pH 7.4) for 
45 min-1.5 h on ice. They were subsequently washed in Tissue Rinse Solution A (2 mM
69
Chapter 2: Materials and Methods
MgCh, 5 mM EGTA in 100 mM PO4 buffer, pH 7.4) for 30 min at room temperature, 
then rinsed in Tissue Rinse Solution B (2 mM MgCb, 0.01 % sodium deoxycholate, 
0.02 % Nonidet P-40 in 100 mM PO4 buffer, pH 7.4) for 5 min at room temperature. 
After draining, the tissue was incubated in freshly constructed, pre-warmed Tissue Stain 
Base with 1 mg/ml of X-gal. For pancreata, incubation was at 37°C or 30°C overnight 
in the dark. Earclips from different animals were incubated separately in distinct wells 
of a 96-well Micro Well™ microplate (Nunc) at 37°C for 2 h in the dark, during which 
the intensity of earclip X-gal staining was periodically monitored. Following reaction, 
pancreata were rinsed in three changes of PBSA in which they were stored at 4°C prior 
to embedding.
2.4. Histology
2.4.1. Preparation of Paraffin Sections
Fixed (and X-gal-stained if performed) pancreata were dehydrated from 70 % 
vol/vol through to 100 % ethanol overnight in a Leica TP 1020 Tissue Processor, and 
were then embedded in paraffin-wax and sectioned at 7 pm on a Leica RM 2155 rotary 
microtome before mounting on glass microscope slides. Slides were either obtained pre­
coated (Polysine™, BDH) or untreated (Single Frost Blue Star, Chance Propper Ltd.) 
and then coated with APTES; slides were initially washed in hot soapy water, rinsed in 
MilliRO water, treated with 95 % ethanol/1 % acetic acid, then dried before immersion 
in 2 % APTES in acetone for 8 min, acetone for 2 x 10 seconds (sec) and MilliRO water 
for 10 sec; prepared slides were dried overnight. The paraffin sections were dewaxed in 
Histoclear (National Diagnostics) and rehydrated through a graded ethanol series prior 
to immunocytochemical processing. If necessary (for examination of pancreata from 
Elijah and Ripley animals), selected slides were counterstained in Ehrlich’s 
haematoxylin and eosin (H & E) then, after dehydration and clearing, were mounted in 
DPX (BDH).
2.4.2. Preparation of Frozen Sections
Fixed pancreata were cryoprotected in 5 %, then 15 % sucrose in 0.1 M 
potassium phosphate buffer (0.1 M KH2PO4 and 0.1 M K2HPO4), pH 7.6 at 4°C over 
successive nights then embedded in O.C.T. compound (BDH). Sealed cryoblocks were
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stored at -20°C for up to several weeks. Frozen sections or cryosections (10 pm or 15 
pm) were cut on a Shandon AS620 cryotome at -17°C and mounted on gelatin-coated 
glass microscope slides (Single Frost Blue Star, Chance Propper Ltd.). To prepare the 
slides, they were first submerged in 1:1 hydrochloric acid and 100 % vol/vol ethanol for 
2 h minimum and washed under running water. Following draining, slides were 
submerged for 10 min in freshly prepared ice-cold gelatin chrome alum solution (0.6 % 
gelatin w/v; 0.03 % w/v chromium potassium sulphate) and allowed to air-dry. 
Following air-drying for 1 h, mounted cryosections were stored in sealed containers at - 
20°C in the presence of silica desiccant.
2.5. Immunostainiti2
2.5.1. Antisera
The primary antibodies used for all immunostaining applications, with source 
and working concentration in 2 % blocking buffer (BB, Boehringer Mannheim) 
containing 0.1 % Triton X-100 were as follows (Table 2.1.):
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Table 2.1. Source and Working Dilution of All Primary Antibodies Used
ANTIBODY SPECIES SOURCE DILUTION



























































Albumin Goat Sigma A-1151 1/300
* This antibody was used at a working concentration of 1/100 for triple­
immunofluorescence cytochemistry on cultures for the simultaneous demonstration of 
insulin, glucagon and amylase.
|  These antibodies were employed at a working concentration of 1/100 in an attempt to 
obtain successful staining of cultures.
J The two anti-neurogenin3 antibodies were employed in conjunction with antigen 
retrieval.
Various secondary, species-specific antibodies were employed in the various 
immunostaining applications. Again, these are given with source and working 
concentration (Table 2.2.):
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Table 2.2. Source and Working Dilution of All Secondary Antibodies Used
ANTIBODY SPECIES SOURCE DILUTION
Fluorescein-Conjugated Anti-Rabbit 
IgG




Horse Vector FI-2000 1/100
Fluorescein-Conjugated Anti-Goat IgG Rabbit Vector FI-5000 1/100
FITC-Conjugated Anti-Rabbit IgG Goat Sigma F-0382 1/300
Fluorescein Streptavidin N/A Vector SA-5001 1/100
Texas Red-Conjugated Anti-Rabbit IgG Goat Vector TI-1000 1/300
Texas Red-Conjugated Anti-Mouse IgG Horse Vector TI-2000 1/300
TRITC-Conjugated Anti-Rabbit IgG Swine DAKO R0156 1/100 or 1/200
t
TRITC-Conjugated Anti-Guinea Pig 
IgG
Rabbit Sigma T-7153 1/300
AMCA-Conjugated Anti-Mouse IgG Horse Vector CI-2000 1/100
Biotin-Conjugated Anti-Mouse IgG Horse Vector BA-2000 1/300
Biotin-Conjugated Anti-Guinea Pig IgG Goat Sigma B-5518 1/300
Biotin-Conjugated Anti-Rabbit IgG Goat Sigma B-9642 1/200
* This antibody was used at a working concentration of 1/150 for staining of cultures 
but at 1/300 for detection of p-galactosidase on frozen sections.
t  This antibody was used at a working concentration of either 1/100 or 1/200 for 
staining of cultures, depending upon the experiment.
2.5.2. Immunofluorescence Cytochemistry
2.5.2.1. General Protocol for Cultures and Frozen Sections
Specimens were successively; (1) permeabilised in 1 % (cultures) or 0.15 % 
(sections) Triton X-100 in PBSA for 30 min (cultures) or 1 h (sections) at room 
temperature; (2) blocked to avoid non-specific staining with 2 % blocking buffer (BB) 
containing 0.1 % Triton X-100 for 2-3 h at room temperature; (3) incubated with 
primary antiserum diluted in 2 % BB/0.1 % Triton X-100 overnight at 4°C; (4)
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incubated with the relevant fluorescence-conjugated secondary antibody diluted in 2 % 
BB/0.1 % Triton X-100 for 2 h at room temperature in the dark and (5) mounted in 
Gelvatol in the dark in the absence of further rounds of antibody incubations. In some 
experiments, specimens were counterstained in 0.5 pg/ml 4’,6-diamidino-2- 
phenylindole (DAPI; Sigma D-9542) in PBSA for 5 min before mounting. Following 
each incubation, specimens were washed in PBSA for 3 x 10 min (cultures) or 3 x 15 
min (sections). Where more than one primary antibody was used, the first staining cycle 
was completed before the second was commenced. Incubations with primary antisera 
were performed overnight at 4°C or occasionally, for 3 h at room temperature; 
secondary antibody incubations were conducted for 2 h at room temperature.
2.5.2.2. Modifications for Cultures
Staining was performed within the 30 mm Petri plates. Although the first 
staining cycle was usually completed before the second was commenced, as an 
exception to this, when double-staining for CPS I and GS only one incubation was 
conducted with both primary antibodies: polyclonal rabbit anti-CPS I (gift from 
Professor Wouter Lamers [University of Amsterdam, Amsterdam, The Netherlands], 
1/500) and monoclonal mouse anti-GS (Transduction Laboratories, 1/500), and one 2.5 
h incubation (at room temperature) for the two secondary antisera: TRITC-conjugated 
swine anti-rabbit (DAKO, Denmark R0156, 1/100) and fluorescein-conjugated horse 
anti-mouse (Vector FI-2000,1/100).
In some experiments, cultures stained with either of the two anti-neurogenin3 
primary antibodies (mouse monoclonal; Transduction Laboratories N63520 or rabbit 
polyclonal; Abeam ab7560) were subjected to antigen retrieval. This was performed by 
incubation with pH 6.0 citrate buffer (9.5 mM citric acid and 41.5 mM sodium citrate) 
for 1 h at 37°C or with 50 mM ammonium chloride in PBSA for 30 min at room 
temperature (as recommended by accompanying literature) following permeabilisation 
in 1 % Triton X-100. (In some experiments, 1:1 acetone:methanol-fixed cultures were 
not subjected to the subsequent permeabilisation step). Cultures were subsequently 
rinsed in PBSA prior to blocking. Also, some cultures stained for neurogenin3 were 
subjected to avidin-biotin signal amplification. Following primary antibody incubation 
and washing, cultures were incubated with biotinylated horse anti-mouse antibody 
(Vector BA-2000) diluted 1/300 in 2 % BB/0.1 % Triton X-100 for 2 h at room 
temperature. After washing, cultures were incubated with fluorescein streptavidin
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(Vector SA-5001) diluted 1/100 in 2 % BB/0.1 % Triton X-100 for 1 h at room 
temperature in the dark. Following washing, cultures were either mounted or the second 
cycle of staining was commenced.
2.5.2.3. Modifications for Frozen Sections
The frozen sections were processed at 4°C in a humid chamber. Adjacent serial 
sections on the same slide were isolated using a hydrophobic barrier pen (ImmEdge™ 
Pen, Vector) to permit them to be differentially immunostained (for distinct antigens 
such as insulin or glucagon, or their absence as control) and to conserve antisera. Prior 
to permeabilisation, frozen sections were washed for 3 x 5 min to solubilise the O.C.T.
2.5.3. Immunoveroxidase Cytochemistry
2.5.3.1. Paraffin Sections
Sections were processed at 4°C in a humid chamber according to the 
streptavidin-biotin peroxidase complex (ABC) method in which horseradish peroxidase 
(HRP) was visualised using 3,3’-diaminobenzidine (DAB) as substrate, yielding a 
brown reaction product. The deparaffinized and rehydrated sections were successively; 
(1) treated with 0.6 % H2O2 in PBSA for 30 min at room temperature; (2) washed in 
running water; (3) permeabilised in 0.1 % Triton X-100 in PBSA for 1 h at room 
temperature; (4) blocked to avoid non-specific staining with 2 % BB containing 0.1 % 
Triton X-100 for 1 h at 4°C; (5) incubated with primary antiserum diluted in 2 % 
BB/0.1 % Triton X-100 overnight at 4°C; (6) incubated with the relevant biotin- 
conjugated secondary antiserum diluted in 2 % BB/0.1 % Triton X-100 for 1 h at 4°C; 
(7) treated with the HRP-labelled streptavidin-biotin complex kit (StreptABComplex; 
DAKO, Denmark) for 1 h at 4°C according to the manufacturers’ instructions (45 pi 
streptavidin and 45 pi biotinylated peroxidase in 5 ml of 0.1 M Tris, pH 7.4) and (8) 
treated with 0.1 M Tris buffer, pH 7.4, containing 0.67 mg/ml DAB (Sigma) and 0.03 % 
H2O2 until appearance of reaction product (approximately 3-15 min) at room 
temperature. When colour development had reached the desired stage, the reaction was 
halted with tap water, intensifying the reaction product. Between each incubation, 
sections were washed in PBSA for 3 x 15 min. Sections were counterstained in nuclear
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Fast Red (Vector), dehydrated in graded ethanol, cleared in Histoclear and mounted in 
DPX (BDH).
Either the primary antibody or secondary biotinylated antiserum was omitted 
from the immunocytochemical procedure as one type of control procedure to 
substantiate specific immunocytochemical staining. Lack of staining demonstrates the 
absence of electrostatic and hydrophobic binding of immunocytochemical reagents to 
tissues (Leduque et al., 1987) as well as the absence of endogenous peroxidase.
2,5.3.2. Wholemounts (Embryos)
Following post-fixation in 4 % PFA in PBSA, larger (> E l3.5) embryos and 
brains were halved dorsolaterally on dry ice to facilitate penetration. Specimens were 
then successively; (1) blocked overnight in blocking buffer (PBST - 1 % Triton X-100 
in PBSA - containing 1 % BSA, 10 % heat-inactivated FBS and 2 % Boehringer 
Mannheim blocking buffer); (2) incubated in primary antibody in blocking buffer for 4 
days and (3) incubated overnight in alkaline phosphatase- (AP-) or biotin-conjugated 
secondary antibody in blocking buffer. Between incubations, specimens were washed at 
room temperature for 3 x 10 min then 3 x 45 min in PBST. All washing and incubation 
steps were conducted with gentle agitation and all incubations were performed at 4°C. 
For AP detection, embryos were washed for 3 x 10 min in alkaline phosphatase buffer 
(APB; 0.1 M Tris-HCl, pH 9.5, 50 mM MgCl2, 100 mM NaCl, 0.1 % Tween 20 and 1 
mM levamisole). They were then incubated in the dark at room temperature in a change 
of APB containing 337.5 pg/ml Nitro Blue Tetrazolium (NBT) and 175 pg/ml 5-bromo- 
4-chloro-3-indolylphosphate (BCIP) until colour reaction developed then washed twice 
in PBSA. Immunoperoxidase detection was conducted according to the ABC method. 
Following washes in PBST, embryos were incubated overnight at 4°C in HRP-labelled 
streptavidin biotin complex (StreptABComplex; DAKO, Denmark) then washed again 
in PBST then in 0.1 M Tris, pH 7.4 for 2 x 20 min and were then pre-incubated in 0.5 
mg/ml DAB (Sigma) in 0.1 M Tris, pH 7.4 for 1 h at 4°C in the dark with gentle 
agitation. H2O2 was added to a final concentration of 0.003 % and embryos were 
incubated for 5-20 min at room temperature. When colour development had reached the 
desired stage, the reaction was halted with tap water.
76
Chapter 3: Migratory Cells in the Embryonic Pancreas
3. Migratory Cells in the Embryonic Pancreas
In Vitro
3.1. Introduction
3.1.1. A Novel In Vitro Culture System for Pancreatic Rudiments
Percivai and Slack (1999) recently devised a novel system for the in vitro culture 
of pancreatic buds from the mouse embryo. This culture system enables the developing 
organ to grow as a flat, branched structure, which is sufficiently thin to be amenable to 
wholemount immunostaining methods. Differentiation of each of the principal cell types 
in culture, as monitored by immunostaining, was shown to closely resemble the 
situation in vivo with a slight one-day delay over a four-day culture period. The obvious 
advantage afforded by this system is that it permits the visualisation of complete acini or 
islets as opposed to the partial view provided by histological sections. Using their novel 
in vitro system, Percivai and Slack (1999) investigated cell lineage in the pancreatic 
islets and acini and aimed to ascertain whether there is an identifiable endocrine 
precursor cell population at an early stage of pancreas development. The ROSA-26 
mouse was employed as a source of lineage-labelled tissue. This is a gene trap strain 
engineered by Zambrowicz et al. (1997), in which the lacZ reporter transgene, is 
expressed constitutively, at all stages of development in all tissues. The lacZ gene 
encodes the enzyme p-galactosidase (P-gal), which is readily detectable by X-gal 
histochemistry in individual cells. p-Gal cleaves the colourless substrate 4-chloro-5- 
bromo-3-indolyl-P-D-galactopyranoside (X-gal) to a robust, blue-coloured indole 
derivative. The level of p-gal expression was found to vary between tissues: expression 
in the epithelium of the developing intestine and pancreas was shown to be greater than 
that in the mesenchyme. However, it was demonstrated that all parts of the pancreas 
expressed the transgene at all time-points examined (Fig. 3.1.) and furthermore, that this 
expression was retained in vitro (Percivai and Slack, 1999). In combinations of 
pancreatic epithelium from p-gal-expressing ROSA-26 embryos with mesenchyme from 
strain MF1 albino embryos, X-gal staining was found to coincide exactly with the 
boundary of the epithelium. These experiments demonstrated the eminent suitability of 
p-gal expressed by ROSA-26 tissue as a lineage label in embryological experiments. 
Similar combination cultures of pancreatic epithelium from El 1.5 ROSA-26 embryos
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Figure 3.1. Ubiquitous LacZ Expression in the ROSA-26 Pancreas 
(Professor J. M. W. Slack)
Section of an X-gal-stained E16.5 ROSA-26 embryo. Part of the pancreas 
lies in the centre. All tissues are stained although the epithelia show 
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Figure 3.2. Map of the ROSA-26 Genomic Region
Line indicates genomic DNA drawn with the scale and restriction enzyme 
sites as indicated. The position and orientation of the ROSApgeo retroviral 
integration is indicated. LTR, long terminal repeat. B, BglU; Nc, Ncol; No, 
Notl; S, AV//1; pA, poly(A) addition signal. (Zambrowicz et al., 1997)
SApgeo
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with mesenchyme from El 1.5 unlabelled MF1 embryos revealed that both the acinar 
cells and the P-cells arise from the endoderm while the smooth muscle cells arise from 
the mesenchyme (Percivai and Slack, 1999). This constituted the first formal proof of 
the endodermal origin of both the exocrine and endocrine cells.
3.1.2. Blue Dot Cells
In these recombinant cultures of ROSA-26-derived, P-gal-expressing pancreatic 
epithelium and unlabelled MF1 pancreatic mesenchyme, p-cells could be clearly 
visualized by immunostaining for insulin (Percivai and Slack, 1999). As in intact 
pancreatic bud cultures, they were present both as single cells and as islet-like 
aggregates and were seen both in the P-gal-expressing epithelium and at some distance 
away, in the unlabelled mesenchyme. Unexpectedly, following X-gal histochemistry, 
the p-cells did not stain blue with the same intensity and uniformity as the exocrine 
cells. Rather, the P-cells were found to contain prominent blue spots indicative of P-gal 
expression (Percivai and Slack, 1999). PYY-expressing cells in such recombinant 
cultures similarly exhibited this pronounced blue dot-type expression of p-gal, implying 
that they too originate from the epithelial bud. Although a minority of these blue dot 
cells produced recognised endocrine products such as insulin or PYY, the majority did 
not. The blue spot-type P-gal expression by early endocrine cells could not be explained 
though was presumed to be a consequence of cell processing of the bacterial p-gal 
protein (Percivai and Slack, 1999). The possibility that the expression pattern represents 
phagocytosis of labelled debris by unlabelled cells was dismissed since blue dot cells 
could occur at some distance from uniformly stained cells and second, the mesenchymal 
cells immediately adjacent to the X-gal-stained epithelial tissue did not contain the blue 
dots. Blue dots were therefore perceived to be representative of endogenous p-gal 
synthesis and the cells themselves were assumed to be genuinely of epithelial origin.
3.1.3. Current Study
Blue dot expression in cells expressing PYY, known to characterise immature 
endocrine cells, and their high degree of motility (as demonstrated by their frequent 
occurrence in the unlabelled mesenchyme at some distance from the p-gal+ epithelium) 
led to the proposal that such blue dot cells (BDCs) represented a population of
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committed endocrine precursor cells. Therefore, the first aim of the current study was to 
further characterise these blue dot cells in combinations of p-gal-labelled pancreatic 
epithelium from El 1.5 ROSA-26 strain mouse embryos and unlabelled intact dorsal 
pancreatic buds from El 1.5 MF1 albino strain embryos. Physical parameters relating to 
the occurrence of blue dot cells were investigated, including the frequency of isolated 
and grouped BDCs and the size of BDC clusters as well as their distance from the 
labelled epithelium. In the combination cultures of P-gal-labelled epithelium and 
unlabelled intact bud used here, it could also be investigated whether blue dot cells 
preferentially migrated away from the epithelium on a stratum of epithelial or 
mesenchymal cells. A further aim of the study was to determine whether migration of P- 
gal-labelled cells from the epithelium is restricted to the BDCs. In the event of other, 
uniformly expressing migratory epithelial cells being detected, these too were to be 
characterised in the same way as the BDCs.
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3.2. Materials and Methods
The protocol employed for establishing pancreatic bud cultures and their 
subsequent immuno- and X-gal staining was essentially that developed by Percivai and 
Slack (1999) with some minor procedural modifications.
3.2.1. ROSA-26 and MF1 Mouse Embryos
Mouse embryos were generated by timed matings. The day of appearance of the 
vaginal plug was designated day 0.5 (E0.5). The ROSApgeo26 (ROSA-26) mouse 
strain was originally generated by random retroviral gene trapping in embryonic stem 
cells (Zambrowicz et al., 1997) and demonstrates ubiquitous expression of the proviral 
Pgeo/lacZ reporter gene (Fig. 3.2.). The lacZ gene encodes the enzyme p-galactosidase 
(p-gal) which is readily detectable by X-gal histochemistry in individual cells.
3.2.1.1. Outbreeding of the ROSA-26 Colony
The ROSA-26 mice were originally of strain 129, but owing to low homozygous 
survival, they were outcrossed to the Pathology Oxford albino strain at the University of 
Oxford. Homozygotes of this background proved completely viable during two years of 
breeding within the colony at the University of Bath. However, following a decline in 
embryo viability when small litters (< 7), in utero resorption and cranial deformities 
were prevalent, further ROSA-26 outbreeding was necessary.
ROSA-26 animals were initially crossed with the MF1 albino strain, generating 
pups that were heterozygous for the ROSA-26 transgene. Upon attaining sexual 
maturity, crosses were performed between these heterozygous animals. Conforming to 
Mendelian rules, 50 % of the offspring were expected to be heterozygous for the 
ROSA-26 transgene, 25 % to be homozygous for the transgene and 25 % were expected 
to be non-transgenic. Genotyping was performed via an assay of comparative rates of 
X-gal reaction catalysed by the P-gal in earclips from the litters. Earclips from pups 
lacking the transgene fail to stain with X-gal. Although tissues from offspring 
heterozygous or homozygous for the ROSA-26 transgene both stain ubiquitously with 
X-gal, the staining reaction proceeds at a visibly greater rate in homozygotes due to 
their tissues harbouring twice as much P-gal as heterozygous pups. Earclips from each
81
Chapter 3: Migratory Cells in the Embryonic Pancreas 
animal were fixed and X-gal-stained in a 96-well MicroWell™ microplate (Nunc) as in 
Chapter 2, Section 2.3.2. During incubation in the reaction mixture, the intensity of X- 
gal staining was monitored. Subsequent X-gal staining assays of offspring from crosses 
between 61 putative homozygotes and MF1 animals revealed only eight of the 61 to be 
heterozygous, giving a 53/61 = 86.9 % success level for distinguishing between pups 
heterozygous vs. homozygous for the ROSA-26 transgene by the staining assay used.
Following outbreeding, mean ROSA-26 litter size increased from 7.4 (n = 19 
' litters) to 9.3 (n = 39 litters) and the viability of the embryos increased substantially.
3.2.2. Pancreatic Bud Dissection and Establishing Cultures
Dorsal pancreatic buds were dissected and intact pancreatic bud cultures were 
established as in Section 2.1. Recombinations of pancreatic epithelium from a ROSA- 
26 strain embryo and an intact dorsal pancreatic bud from an MF1 strain embryo were 
established by preparing 30 mm Petri plates coated with 2 ml of 1 % molecular biology 
grade agarose dissolved in L-15 medium (Gibco-BRL, Life Technologies) with 25 
fig/ml gentamicin. The agarose was covered with 2 ml of the normal culture medium, 
BME with Earle’s salts, 20 % FBS, 1 x glutamine, and 50 pg/ml gentamicin. Using fine 
forceps, a well was made in the agarose and the ROSA-26 pancreatic epithelium and 
MF1 intact bud were placed in the well in close apposition with each other. As adhesion 
of the two tissue fragments takes several hours, they were incubated overnight and then 
plated the following morning on a fibronectin-coated coverslip as for intact buds.
3.2.3. X-Gal Staining and Immunofluorescence Cytochemistry
Cultures were fixed after 4, 5 or 6 days in vitro as described in Section 2.2.1. 
Then, immediately thereafter or following storage, cultures were subjected to X-gal 
staining or immunofluorescence cytochemistry as in Sections 2.3.1. and 2.5.2. 
respectively. In the latter case, P-galactosidase was demonstrated with fluorescein and 
TRITC or Texas Red was employed to localise the endocrine marker being stained for 
(insulin, glucagon, Ipfl/Pdxl or neurogenin3). The first staining cycle was completed 
before the second was commenced. Immunostaining for P-galactosidase was performed 
as the first cycle to avoid cross-reactivity between antisera. In some experiments when
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staining for neurogenin3, antigen retrieval was performed and occasionally, staining 
intensity was enhanced by avidin-biotin signal amplification as in Section 2.5.2.2.
3.2.4. Wholemount Immunocvtochemistry
Freshly dissected El 1.5-15.5 MF1 strain whole embryos, intact guts and brains 
wTere fixed in 4 % PFA in PBSA then subjected to wholemount immunocytochemistry 
as described in Sections 2.2.2. and 2.5.3.2. respectively. The antigen was demonstrated 
either with the alkaline phosphatase substrates NBT and BCIP or by immunoperoxidase 
detection using DAB as a substrate to visualise horseradish peroxidase (HRP).
3.2.5. Scoring Misratory Epithelial Cells and Image Capture
X-Gal- and immunostained pancreatic bud cultures were examined using a Leica 
DMRB fluorescent microscope. Numbers of single and aggregated P-gal-labelled 
migratory epithelial cells (including blue dot cells) were recorded in 18 X-gal-stained 
recombinant cultures as were the locations of such cells and their distance from the 
labelled epithelium. The 18 cultures comprised 11 cultures fixed after four days in vitro, 
two cultures fixed after five days and five cultures fixed after a six-day period in vitro. 
Measurements were generally made directly from the observed culture but where very 
large numbers of migratory cells were evident, data was collected from hard copies of 
images at up to 230 x magnification following spatial calibration of the printed images. 
An image was collected of the calibration slide at the same magnification employed for 
collecting images of the cultures. All images were then printed at the same, suitable 
scale for measuring from and spatial calibration was performed by determining the 
factor of magnification between the 1 mm calibration slide scale and its printed length 
on paper. Distance was measured from the periphery of the nearest branch of p-gal+ 
epithelium to the centre of the cell or cell cluster. Images of stained specimens were 
taken with a Spot RT Color digital camera (National Diagnostics Inc.) driven by the 
Spot 3.3 software and stored as uncompressed 24-bit TIFF images. Colocalisation of p- 
gal-labelled migratory epithelial cells with immunofluorescence staining for insulin or 
glucagon was scored from merged images of eight four-day cultures and six five-day 
cultures following adjustment of the two colour channels using the Adobe Photoshop
6.0 package.
83
Chapter 3: Migratory Cells in the Embryonic Pancreas
3.3. Results
3.3.1. Growth o f Pancreatic Bud In Vitro
The two components of each recombinant pancreatic bud - the ROSA-26- 
derived epithelium and the unlabelled intact MF1 dorsal pancreatic bud - had usually 
adhered to one another by six hours following their being brought into contact with each 
other. Once placed on to the fibronectin substrate, the recombinant or intact buds 
adhered within a few hours and gradually flattened out over the first one-two days as 
described by Percivai and Slack (1999). Mesenchymal cells spread rapidly out of the 
explant to form a monolayer of cells both above and below the mass in the centre and 
on the second or third day of culture, branches began to appear in the epithelia. The 
epithelia developed a number of buds at their periphery which then spread out and 
produced further buds. In the recombinant cultures, two populations of pancreatic 
epithelium developed - one p-gal-labelled and one unlabelled - both of which were 
surrounded by unlabelled mesenchyme (Fig. 3.3.), Over the subsequent three days in 
vitro, the epithelium became an extended branched structure radiating from the original 
centre (Fig. 3.4.). The mesenchyme resolved into a periphery mainly composed of 
smooth muscle cells and an inner region dominated by fibroblastic cells with occasional 
patches of lymphoid tissue, consistent with the work by Percivai and Slack (1999).
3.3.2. Incidence of Blue Dot Cells
No X-gal staining for p-galactosidase activity was ever observed in any of the 
negative control unlabelled MF1-derived intact pancreatic bud cultures. Staining was 
obtained as expected in both intact ROSA-26-derived intact bud cultures and 
recombinant pancreatic bud cultures. Blue dot cells (BDCs) were observed in a number 
of these recombinant cultures. As described (Percivai and Slack, 1999), these cells did 
not stain blue following X-gal incubation with the same intensity and uniformity as the 
exocrine cells, but instead contained prominent blue spots indicative of p-gal 
expression. They must therefore be derived from the epithelium. BDCs occurred with 
differing frequency between individual recombinant cultures. Certain cultures examined 
were completely devoid of such cells whereas in others, BDCs were seen to be present 
in abundance throughout the unlabelled pancreatic mesenchyme (Fig. 3.5.). BDCs 
where present were evident both as isolated cells and in closely associated groups
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(c). (d).
Figure 3.3. Recombinant Pancreatic Bud Cultures Showing X-Gal Staining of |3-Gal+ 
ROSA-26-Derived Pancreatic Epithelium
The two populations of epithelium are evident: the more obvious p-gal-labelled 
epithelium and the unlabelled MFl-derived epithelium (arrowheads). Both 
populations are surrounded by unlabelled mesenchyme
(a) 5 day (5d) culture, (b) and (c) 6d cultures, (d) 7d culture. Bar = 200 pm
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Figure 3.4. An 8d Intact Pancreatic Bud Culture Showing the Extended 
Branched Epithelial Structure and Peripheral Mesenchyme. Bar = 200 pm
(a). (b).
Figure 3.5. Recombinant Pancreatic Bud Cultures Showing Abundant BDCs 
(Arrowheads) Throughout the Unlabelled Mesenchyme
(a) 4d culture; (b) 6d culture, (a) Bar = 50 pm; (b) Bar =100 pm
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or “clusters” (Fig. 3.6.), consistent with the previous report (Percivai and Slack, 1999). 
BDCs were infrequently observed within labelled epithelium, probably because the 
surrounding p-gal-labelled epithelial cells hindered their identification. BDCs were 
most evident against the unlabelled background epithelium or mesenchyme (Fig. 3.6.). 
Their epithelial origin and incidence at some distance from the labelled epithelium 
indicated that they must have migrated from the P-gal+ epithelium. Hence the size of 
BDC clusters and their localisation within the pancreatic bud culture were quantitatively 
examined in order to further characterise such cells and test the hypothesis that they 
might represent a population of endocrine precursor cells. These parameters were 
measured in 18 recombinant cultures maintained for either four days (11 cultures), five 
days (two cultures) or six days (five cultures) in vitro. Any increase in size of clusters or 
increased distance from the p-gal+ epithelium could be followed with culture duration.
3.3.3. Occurrence of “Uniformly Stained Cells”
In a number of cultures, uniformly stained cells (USCs) were observed within 
the unlabelled epithelium and mesenchyme following X-gal incubation (Fig. 3.7.). 
These large, rounded cells displayed homogeneous blue X-gal staining throughout as 
did the exocrine cells within the labelled epithelium. The USCs could be clearly 
distinguished from the BDCs by focusing the microscope on the cell(s) concerned. In a 
BDC, a definite blue dot of X-gal staining could be resolved within the otherwise 
unstained cytoplasm at the correct focal plane whilst a USC never demonstrated such a 
blue dot at any focal plane and always appeared to exhibit uniform X-gal staining 
throughout the entire cell. As for the BDCs, the presence of p-gal expression in the 
USCs indicated an epithelial origin and their localisation within the MF1-derived 
pancreatic tissue was consistent with such USCs being a second class of migratory 
epithelial cell. USCs occurred in the majority of cultures examined. Their presence was 
not dependent on that of BDCs as USCs were on occasion absent from cultures 
containing abundant BDCs (one of 18 BDC-containing cultures lacked USCs). 
Conversely, cultures could be devoid of BDCs yet contain abundant USCs (one of 18 
cultures), disputing the obligatory dependence of one on the other. Like BDCs, USCs 
could occur either in isolation (Fig. 3.7.) or in aggregates. USCs were also found in 
association with BDCs on occasion. As for the BDCs, the size of USC clusters and their 
separation from the labelled epithelium were quantified in the same sample of four-, 
five- or six-day recombinant cultures to further characterise these cells.
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(e). (0.
Figure 3.6. BDCs Occur Either as Isolated Cells or as Clusters
Isolated BDCs (arrowheads) and BDC clusters (arrows) are evident in the 
unlabelled mesenchyme
(a) 4d culture, (b) and (c) 5d cultures, (d) and (e) 6d cultures, (f) 7d culture, (a) and
(d) Bar = 50 urn; (b), (c), (e) and (tf) Bar -  100 ^m
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Figure 3.7. Isolated Uniformly Stained Cells (USCs) in the Unlabelled Mesenchyme 
(Arrowheads)
(a) 4d culture, (b)-(d) 6d cultures, (a) and (d) Bar = SO pm; (b) Bar * 200 pm;
(c) Bar = 100 pm
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3.3,4. Spatial Distribution
3.3.4.1. Increase in Number of BDC and USC Clusters Per Culture Over Culture 
Period
The mean number of both BDC and USC clusters identified in each culture 
increased over the 48 h culture period. The mean (± standard error [S.E.] of the mean) 
number of BDC clusters per culture after four days of culture (4d) was found to be 14.5 
± 5.14, increasing to 168.5 ± 34.3 at 5d and attaining 172.6 ± 85.1 by 6d (Table 3.1. and 
Graph 3.1.). This resulted in the mean total number of BDCs per culture after 4d, 5d 
and 6d maintenance in vitro being 119.7 ± 25.3 cells, 602 ± 169.7 cells and 667.2 ± 
234.4 cells respectively (Table 3.1.). Similarly, the mean number of USC clusters per 
culture increased from 53.1 ± 10.8 at 4d to 68 ± 38.2 at 5d and by 6d, each culture 
contained on average 102 ± 34.2 USC clusters (Table 3.1. and Graph 3.1.). The mean 
total number of USCs per culture over the 48 h culture duration was found to be 139.2 ±
31.0 cells, 90 ± 50.2 cells and 175 ± 62.5 cells respectively (Table 3.1.).
3.3.4.2. No Increase in Mean Cluster Size with Duration o f Culture
To investigate whether clusters of BDCs or USCs grow in size with duration of 
culture, the mean cluster size was determined for each class of migratory epithelial cell 
after either four, five or six days in vitro. Since the inclusion of isolated cells (a cluster 
size of one cell) reduces the mean cluster size, values were calculated to reflect either 
the inclusion or exclusion of single cells (Table 3.1. and Graphs 3.2. and 3.3.). No 
increase was seen in mean cluster size for either the BDC or USC aggregates over the 
48 h in vitro that was examined. Mean (± S.E.) BDC cluster size, including isolated 
cells decreased from 8.23 ± 1.02 cells at 4d to 3.57 ± 0.229 cells at 5d and by 6d was 
3.87 ± 0.191 cells. Mean size excluding BDCs occurring in isolation was greater at each 
time-point as expected, but reflected the same trend: 12.5 ± 1.47 cells at 4d, 5.07 ± 
0.320 cells at 5d and 6.05 ± 0.302 cells by 6d. At all time-points during culture, the 
mean size of clusters of USCs was markedly reduced compared with sizes of BDC 
aggregates. Mean USC cluster size (single USCs inclusive) decreased from 2.62 ± 0.247 
cells at 4d to 1.32 ± 0.0605 cells at 5d and attained 1.72 ± 0.112 cells by 6d. Again, the 
mean USC cluster size excluding single cells was greater for each of the three days but
90
Table 3.1. Summary of Total and Mean (± S.E.) Number of Blue Dot Cell and Uniformly Stained Cell Clusters and Total Cells Per Culture 
and Cluster Size and Distance from |3-Gal+ Epithelium Over Days 4-6 in Culture
BLUE DOT CELLS UNIFOF1MLY STAINEE CELLS
Day 4 Day 5 Day 6 Day 4 Day 5 Day 6
No. of Cultures Examined Per Day 
of Culture *
11 2 5 11 2 5
Total No. of Clusters in All Cultures: 
Isolated Cells INCLUDED
160 337 863 584 136 510
Mean (± S.E.) Cluster No. 
Per Culture
14.5 ±5.14 168.5+34.3 172.6 ±85.1 53.1 ±10.8 68.0 ±38.2 102.0 ±34.2
Mean (± S.E.) Total Cell No. 
Per Culture
119.7 + 25.3 602.0 + 169.7 667.2 ± 234.4 139.2 ±31.0 90.0 ± 50.2 175.0 ±62.5
Mean (± S.E.) Cluster Size: 
Isolated Cells INCLUDED
8.23 ± 1.02 3.57 + 0.229 3.87 ±0.191 2.62 ± 0.247 1.32 ±0.0605 1.72 ± 0.112
Mean (± S.E.) Cluster Size: 
Isolated Cells EXCLUDED
12.5 + 1.47 
n — 1011
5.07 + 0.320 
n = 213 t
6.05 ± 0.302 
n = 490 f
5.57 ±0.649 
n = 207 f
2.42 ±0.143 
« = 31 f
3.59 ±0.361 
n=  141 f
Mean (± S.E.) Distance from 
P-Gal+ Epithelium (fim)
154.3 +13.58 450.3 ± 16.97 486.9 ±11.50 525.5 ±14.16 717.0 ±33.32 657.4 ± 14.27
* The spatial distribution and migratory properties of both the BDC and USC clusters were recorded from the same 18 recombinant cultures 
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Graph 3.1. Mean Number of Blue Dot Cell or Uniformly Stained Cell Clusters Per 
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followed the same trend: 5.57 ± 0.649 cells at 4d, 2.42 ± 0.143 cells at 5d and 3.59 ± 
0.361 cells by 6d.
33.4.3. Increasing Distance of BDCs from 6-G at Epithelium with Culture Duration
To investigate whether BDCs and USCs migrate away from the labelled 
epithelium from which they originate, the mean distance of BDCs and USCs from the 
P~gal+ epithelium was determined after 4d, 5d and 6d in vitro. There was an obvious 
increase in the mean distance of separation of BDCs from the epithelium over the 48 h 
in culture: 154.3 ± 13.58 pm, 450.3 ± 16.97 pm and 486.9 ± 11.50 pm at 4d, 5d and 6d 
respectively (Table 3.1. and Graph 3.4.). The BDCs found to be furthest from their 
point of origin were measured to be at distances of 665 pm, 1722 pm and 1744 pm 
from the p-gal+ epithelium at 4d, 5d and 6d respectively. Using the mean distance 
values, a BDC migration speed of 166.3 pm/day was calculated: (486.9-154.3)/2. This 
could not be presented as a migration velocity however, as the directional component 
was not known and could not be assumed to take a linear path. The pattern of increase 
in distance from the labelled epithelium was less obvious for the USCs however. At 4d, 
mean distance was found to be 525.5 ± 14.16 pm, increasing to 717.0 ± 33.32 pm at 5d 
and then dropping to 657.4 ± 14.27 pm by 6d (Table 3.1. and Graph 3.4.). The 
maximum distances of USCs at 4d, 5d and 6d were ascertained to be 2340 pm, 2157 pm 
and 2326 pm respectively.
3.3.4.4. BDCs and USCs Predominantly Mesenchyme-Localised
To investigate whether BDCs and USCs prefer to migrate on a substratum of 
epithelium or mesenchyme, epithelial or mesenchymal localisation of migratory 
epithelial BDCs and USCs was determined. It was found that only 57/1360 or 4.19 % of 
BDC clusters were identified on (unlabelled) pancreatic epithelium with the remainder 
being localised within the mesenchyme. This corresponded to 616/5857 or 10.5 % of 
the total number of BDCs being resident in the epithelium. Similarly, just 38/1230 or
3.09 % of USC clusters were found within the epithelium, representing 79/2586 or 3.05 
% of total counted USCs. This indicates that both the blue dot and uniformly stained 
epithelial cells prefer to migrate on a mesenchymal substratum as opposed to the 
pancreatic epithelium.
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3.3.4.5. BDC and USC Cluster Sizes Inconsistent with Clonal Groups
To investigate whether clusters of BDCs and USCs are clonal in size (two cells, 
four cells, eight cells, 16 cells, 32 cells etc.) as might be expected if the clusters 
contained symmetrically-dividing stem cells, the frequency of clusters of each size was 
determined. Peaks in the frequency of cell clusters of such sizes were not observed for 
either the BDCs (Table 3.2. and Graph 3.5.) or USCs (Table 3.2. and Graph 3.6.). 
The frequency of both BDC and USC cluster sizes declined sharply from one-two cells. 
Whereas 556 isolated BDCs were found, the frequencies of BDC clusters of two, three, 
four and five cells were found to be 215, 139, 89 and 73 respectively. For any clusters 
of 15 cells or more, no more than 10 clusters were observed of any given size. The 
maximum size of BDC cluster observed was a sole 74-cell aggregate in a 4d culture. 
Similarly, 851 isolated USCs were observed although the frequencies of USC clusters 
of two, three, four and five cells were found to be only 165, 84, 33 and 29 respectively. 
No more than 10 clusters were observed of any given size for clusters of nine cells or 
greater. The largest USC cluster identified was a 77-cell aggregate in a 4d culture.
3.3.4.6. Greater Tendency of USCs to Exist as Isolated Cells
Comparing the frequency distribution for cluster size between BDC clusters and 
USC aggregates, it was found that the USCs exhibited a greater tendency to occur as 
either isolated cells or in small (< 5 cells) clusters than did the BDCs (Table 3.2. and 
Graph 3.7.). The decline in frequency was markedly greater over cluster sizes of one to 
20 cells for the USCs than the BDCs (Table 3.2. and Graph 3.7.). Of the 1230 USC 
clusters scored, 851 or 69.2 % were found to occur as isolated cells compared with just
40.9 % (556 of 1360 clusters) of BDC aggregates. Of the USC sample, 94.5 % of cell 
aggregates were composed of five cells or less, compared with 78.8 % of BDC clusters.
To verify the divergence in the frequency distribution of the sizes of BDC and
• * * 0USC clusters in each population sample, a chi-square (x ) test was conducted to
compare the observed BDC cluster size distribution with the “expected” distribution 
based on the USC cluster size frequency data (Table 3.3. and Graph 3.8.). The 
proportion of the total sample of USC cluster sizes within each size category was 
multiplied by the total sample number of BDC clusters to give the “expected” number 
of BDC cell clusters of that size from the USC data. In this way, the BDC and USC 
cluster size frequency distributions could be compared directly. There was found to be a
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Table 3.2. Frequency Distribution of Sizes of Blue Dot Cell Clusters and Uniformly






EILUE DOIT CELLS UNIFORMLY STAINED CELLS
Day 4 Day 5 Day 6 Total Day 4 Day 5 Day 6 Total
1 59 124 373 556 377 105 369 851
2 14 62 139 215 82 23 60 165
3 12 46 81 139 35 4 45 84
4 6 28 55 89 18 3 12 33
5 11 16 46 73 20 1 8 29
6 4 15 36 55 11 0 4 15
7 9 11 20 40 8 0 3 11
8 3 4 19 26 5 0 6 11
9 4 9 12 25 5 0 0 5
10 2 3 14 19 5 0 2 7
11 3 6 12 21 3 0 0 3
12 4 2 10 16 3 0 0 3
13 2 2 7 11 3 0 0 3
14 4 1 6 11 1 0 0 1
15 2 0 6 8 1 0 0 1
16 0 2 3 5 1 0 0 1
17 1 0 3 4 0 0 0 0
18 4 0 4 8 0 0 0 0
19 0 1 2 3 0 0 0 0
20 0 1 0 1 1 0 0 1
21 0 0 1 1 0 0 0 0
22 0 0 2 2 1 0 0 1
23 1 1 2 4 0 0 0 0
24 0 1 0 1 0 0 0 0
25 0 0 0 0 0 0 0 0
26 1 0 0 1 0 0 0 0
27 1 0 0 1 0 0 0 0
28 1 0 1 2 0 0 0 0
29 0 0 1 1 0 0 0 0
30 2 0 1 3 0 0 0 0
31 1 0 0 1 0 0 0 0
32 0 0 0 0 0 0 0 0
33 0 0 1 1 0 0 0 0
34 1 2 0 3 0 0 0 0
35 0 0 2 2 0 0 0 0
36 1 0 1 2 1 0 0 1
37 0 0 0 0 0 0 0 0
38 0 0 0 0 0 0 0 0
39 0 0 0 0 0 0 0 0
40 0 0 1 1 0 0 0 0
41 0 0 0 0 0 0 0 0
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42 0 0 0 0 0 0 0 0
43 1 0 0 1 0 0 0 0
44 0 0 0 0 0 0 0 0
45 0 0 0 0 0 0 0 0
46 0 0 0 0 0 0 0 0
47 0 0 0 0 0 0 0 0
48 0 0 0 0 0 0 0 0
49 0 0 0 0 0 0 0 0
50 0 0 0 0 0 0 1 1
51 1 0 0 1 0 0 0 0
52 2 0 0 2 0 0 0 0
53 0 0 0 0 0 0 0 0
54 0 0 0 0 0 0 0 0
55 0 0 0 0 0 0 0 0
56 1 0 0 1 0 0 0 0
57 0 0 0 0 0 0 0 0
58 0 0 0 0 0 0 0 0
59 0 0 0 0 0 0 0 0
60 0 0 0 0 0 0 0 0
61 0 0 0 0 0 0 0 0
62 0 0 1 1 0 0 0 0
63 0 0 0 0 0 0 0 0
64 0 0 0 0 0 0 0 0
65 0 0 0 0 0 0 0 0
66 0 0 0 0 0 0 0 0
67 0 0 0 0 0 0 0 0
68 0 0 0 0 0 0 0 0
69 0 0 0 0 0 0 0 0
70 0 0 0 0 0 0 0 0
71 0 0 1 1 0 0 0 0
72 0 0 0 0 0 0 0 0
73 1 0 0 1 0 0 0 0
74 1 0 0 1 2 0 0 2
75 0 0 0 0 0 0 0 0
76 0 0 0 0 0 0 0 0
77 0 0 0 0 1 0 0 1
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Graph 3.6. Frequency Histogram Showing Size Distribution of Uniformly Stained Cell Clusters (and Isolated Cells)
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Graph 3.7. Frequency Histogram Comparing Sizes of Blue Dot Cell and Uniformly Stained Cell Clusters
Blue Dot Cells n = 1360
Uniformly Stained Cells n = 1230
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Graph 3.8. Frequency Histogram Comparing the Observed Sizes of Blue Dot Cell Clusters with the “Expected” Frequency
Distribution Calculated from the Uniformly Stained Cell Cluster Size Distribution
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highly significant difference (P < 0.01) between the frequency distributions of BDC and 
USC cluster sizes.
X2 = S  (Observed - Expected)2 with d f  = c (number of categories) - 1 
Expected
Table 3.3. Calculating %2 to Test Whether the Observed BDC Cluster Size 
















1 851 556 940.9 -384.9 148181.2 157.5
2 165 215 182.4 32.6 1060.2 5.81
3 84 139 92.9 46.1 2127.2 22.9
4 33 89 36.5 52.5 2757.5 75.6
5 29 73 32.1 40.9 1675.7 52.3
6 15 55 16.6 38.4 1475.7 89.0
7 11 40 12.2 27.8 774.9 63.7
8 11 26 12.2 13.8 191.5 15.7
9 5 25 5.53 19.5 379.1 68.6
10 7 19 7.74 11.3 126.8 16.4
11-20 13 88 14.4 73.6 5420.8 377.1
21-77 6 35 6.63 28.4 804.6 121.3
z 1230 1360 1360 0 164975.3 1065.8
(x2)
NB: Data was segregated into the above categories of cluster size by considering that:-
(1). in the %2 test, the expected frequency of each category under the null hypothesis 
must be at least five,
(2). the higher the number of categories, the greater the sensitivity of the test.
%2 = 24.72, df=  11, p  = 0.01. As the calculated value of %2 is greater, the null hypothesis 
can be rejected.
The frequency distribution of USC cluster sizes was therefore determined to be 
significantly different to that for the BDC aggregates. The USC cluster size distribution 
was shifted towards the lower end of the size spectrum compared with the BDCs and 
USCs exhibited a much greater tendency to occur as isolated cells.
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3.3.5. Immunofluorescence Cytochemistry
3.3.5.L A Proportion of BDCs and USCs are Glucason- or Insulin-Immunopositive
In order to test the hypothesis that BDCs represent a population of committed 
endocrine precursor cells, immunofluorescence cytochemistry was performed on eight 
4d and six 5d recombinant cultures for either p-gal and glucagon or P-gal and insulin. 
Intact MF1 and ROSA-26 pancreatic bud cultures were employed as negative and 
positive controls for detection of p-galactosidase activity respectively (Fig. 3.8.). 
Immunofluorescence analysis was conducted in preference to immunohistochemical 
approaches because of its high resolution and to avoid problems afflicting the latter 
approach caused by the superposition of one chromogen by a more dense stain resulting 
in masking. Of the 83 BDCs identified by immunofluorescence signal for P-gal, 13 cells 
or 15.7 % were glucagon-immunopositive whilst 12 of 67 BDCs (17.9 %) were found to 
be immunopositive for insulin (Fig. 3.9. and Graph 3.9.). Of 351 USCs localised by 
immunofluorescence staining for p-gal, 57 cells or 16.2 % displayed staining for 
glucagon whilst 24.7 % (21 cells) of 85 USCs were ascertained to be insulin- 
immunopositive (Fig. 3.9. and Graph 3.9.).
3.3.5.2. Unsuccessful Immunocvtochemistry for Neuroeenin3
With the aim of further characterising the BDCs, efforts were made to conduct 
immunofluorescence analysis for the bHLH protein neurogenin3 (ngn3) which has been 
used as a marker of endocrine cell progenitors (Apelqvist et al., 1999; Jensen et al., 
2000a; Schwitzgebel et al., 2000). Despite repeated attempts, immunofluorescence 
cytochemistry using either of the two anti-ngn3 antibodies (mouse monoclonal, 
Transduction Laboratories N63520 and rabbit polyclonal, Abeam ab7560) proved to be 
unsuccessful. Pancreatic bud cultures maintained in vitro for either 4d, 5d or 6d 
consistently failed to display any ngn3-immunopositive cells irrespective of whether 
fixation had been achieved using MEMFA, 4 % PFA or 1:1 acetone:methanol. Since the 
latter fixative exerts a permeabilisation effect on cells, subsequent permeabilisation in 1 
% Triton X-100 for 30 min was omitted in some experiments to ensure that cells were 
not being excessively permeabilised. However, this course of action had no effect on the 
unsuccessful outcome. Incorporation of citrate buffer or ammonium chloride 
(recommended by Abeam) antigen retrieval and/or avidin-biotin signal amplification 
steps into the staining protocol also failed to yield a satisfactory result.
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(a). MF1 (5-Gal -ve Control Insulin (b). ROSA-26 p-Gal +ve Control Glucagon
(c). 5d Recombinant Glucagon (d). 4d Recombinant Insulin
(e). 4d Recombinant Insulin (f). 5d Recombinant Insulin
Figure 3.8. Immunofluorescence Staining for (5-Gal and Glucagon or p-Gal and 
Insulin in Recombinant Pancreatic Bud Cultures
(a) 4d intact MF1 culture devoid of p-gal staining (but showing staining for insulin).
(b) 4d intact ROSA-26 culture shows p-gal staining in epithelium and mesenchyme 
(staining for glucagon also visible), (c)-(f) 4d or 5d recombinant cultures stained for 
P-gal and glucagon or P~gal and insulin. Bar = 200 pm
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(a). Glucagon (b). Insulin
(c). Insulin (d). Glucagon
(e). Glucagon (0* Insulin
Figure 3.9. A Small Proportion of BDCs and USCs are Immunopositive for Glucagon 
or Insulin
Arrowheads denote:
(a) glucagon+ BDC; (b) insulin* BDC; (c) insulin BDC; (d) three glucagon+ USCs;
(e) glucagon USC; (f) insulin USC. Bar = 50 pm
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Graph 3.9. Percentage of Blue Dot Cells and Uniformly Stained Cells that are 
Immunopositive for Glucagon or Insulin
■  Glucagon
■  Insulin
Blue Dot Cells Uniformly Stained Cells
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Wholemount immunostaining for ngn3 was performed on El 1.5, E12.5, E13.5, 
E14.5 and E l5.5 whole MF1 strain embryos, intact guts and brains as a positive control 
for specific immunostaining with the same two antibodies as above. Maximal pancreatic 
expression of ngn3 protein is reported to occur at E15.5 (Schwitzgebel et al., 2000). 
Widespread non-specific immunostaining was observed throughout the tissues using 
either alkaline phosphatase or immunoperoxidase detection, despite precautions to 
suppress endogenous enzyme activity (1 mM levamisole or 0.1 % H2O2 respectively).
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3.4. Discussion
3.4.1. Incidence o f Migratory Epithelial Cells
Blue dot cells or BDCs were observed in a number of recombinant pancreatic 
bud cultures as previously reported (Percival and Slack, 1999). Their prominent X-gal 
staining indicated that they must be of an epithelial origin. The total number of both 
BDC and USC clusters and total cells in each culture was found to increase over the 48 
h culture period. However, the frequency of BDC occurrence varied greatly between 
individual recombinant cultures: some were completely devoid of such cells whereas in 
others, BDCs were present in abundance, distributed throughout the unlabelled 
mesenchyme. Although the surrounding p-gal-labelled epithelial cells hindered their 
identification, blue dot cells were observed within labelled epithelium in recombinant 
cultures and so should be present within intact ROSA-26 pancreatic bud cultures. 
However, BDCs were most evident against an unlabelled background and so were most 
obviously identified against unlabelled MF1 epithelium or mesenchyme in recombinant 
cultures. Their epithelial origin and incidence at some distance from the labelled 
epithelium indicated that they must have migrated from the P-gal+ epithelium.
3.4.1.1. Uniformly Stained Cells: A Second Class of Migratory Epithelial Cell?
In the great majority (17 of 18) of recombinant cultures, a second class of large, 
rounded X-gal staining cell was observed. These cells exhibited uniform blue staining 
throughout each cell following incubation with X-gal and so were termed uniformly 
stained cells or USCs. Unlike the BDCs, no blue dot of X-gal stain could be resolved at 
any focal plane within any of the USCs, rendering the two cell types clearly 
distinguishable. Like the BDCs, the P-gal expression in the USCs was indicative of an 
epithelial origin and their segregation from the p-gal+ epithelium further suggested them 
to be migratory like the BDCs. As a consequence of their uniform staining, USCs 
within the labelled epithelium would not have been distinguishable from neighbouring, 
homogeneously staining exocrine cells and so their incidence or otherwise in the P-gal+ 
epithelium could not be ascertained. The presence of either class of migratory epithelial 
cell was found not to be dependent on the presence of the other since either class of cell 
could occur in the absence of the other.
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3.4.I.2. Preferential Migration on the Mesenchyme
Confirming the migratory nature of the BDCs, their mean distance from the 
labelled epithelium where they originate was found to increase from 154.3 ± 13.58 pm 
to 486.9 ± 11.50 pm over 48 h of culture, implying a migration speed of at least 166.3 
pm/day. Similarly, the mean distance of USCs from the labelled epithelium showed an 
increase over the 2d culture period examined, from 525.5 ± 14.16 pm to 717.0 ± 33.32 
pm after 24 h. Only 4.19 % of BDC clusters and 3.09 % of USC clusters were found 
within the pancreatic epithelium of the recombinant cultures, indicating that both the 
blue dot and uniformly stained epithelial cells prefer to migrate on a mesenchymal 
substratum as opposed to the pancreatic epithelium. This conclusion holds true even 
when it is considered that the area of unlabelled epithelium in each recombinant culture 
is less than the area of lacZ mesenchyme, such is the predominance of mesenchymal 
BDC and USC localisation. Reasons for this substratum preference might include the 
provision of trophic factors from the monolayer of mesenchymal cells or the lower 
resistance to cell movement afforded by the less densely packed mesenchyme as 
opposed to the pavement-like arrangement of epithelial cells.
3.4.2. BDCs: A Population of Committed Endocrine Precursor Cells?
3.4.2.1. Expression of Endocrine Markers
To test the hypothesis that BDCs represent a population of committed endocrine 
precursor cells, immunofluorescence cytochemistry was performed for p-gal and for 
one of the endocrine markers glucagon or insulin. Consistent with previous findings, 
although a minority of BDCs produced recognised endocrine products, the majority did 
not. 15.7 % of BDCs and 16.2 % of USCs were found to be glucagon-immunopositive 
whilst 17.9 % of BDCs and 24.7 % of USCs were shown to be immunopositive for 
insulin. More conclusive identification of the BDC and USC populations was hindered 
by lack of success in performing immunofluorescence analysis for the endocrine 
progenitor marker ngn3 (Apelqvist et al., 1999; Jensen et al., 2000a; Schwitzgebel et 
al., 2000). Ngn3 expression within the mouse embryonic pancreas is maximal at E l5.5 
when scattered immunopositive cells can be seen throughout the pancreatic bud 
(Schwitzgebel et al., 2000). Hence, a high level of immunofluorescence staining for 
ngn3 would have been expected especially in the 4d pancreatic bud cultures, even
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considering the one-day delay of differentiation in vitro compared with developmental 
events in vivo (Percival and Slack, 1999).
3.4.2.2. Sensitivity Differences in 3-Gal Detection Methods
It was obvious from the data that the number of BDCs and USCs identified in 
each culture by immunofluorescence detection was markedly less than the number of 
such migratory cells identified per culture by histochemical X-gal staining. The mean 
total number of BDCs per culture detected by X-gal staining after 4d and 5d was 119.7 
± 25.3 cells and 602 ± 169.7 cells respectively whereas only 10.5 ± 3.51 and 11.0 ± 2.96 
BDCs/culture were detected by immunofluorescence analysis after 4d and 5d 
respectively. Similarly, the mean total number of X-gal-stained USCs per culture after 
4d and 5d was 139.2 ±31.0 cells and 90 ± 50.2 cells respectively whilst only 13.9 ± 
6.62 and 54.2 ± 17.8 USCs were identified per culture by immunofluorescence 
detection after 4d and 5d of culture respectively. This was attributed to there being a 
marked distinction between the thresholds of P-gal detection between histochemical X- 
gal staining and immunofluorescence analysis in conjunction with an anti-P-gal 
antibody. The former method which relies on the catalysis of a chemical reaction by the 
P-galactosidase enzyme, is more sensitive than is localisation of the protein using an 
antibody. The extent of this difference in practical terms was quantified as described in 
Chapter 4, Sections 4.3.3.I. and 4.3.3.2.
3.4.2.3. Technical Difficulties
The evidence obtained in this work is clearly insufficient to determine whether 
or not the blue dot cells are representative of a population of committed endocrine 
precursor cells. This was in large part a consequence of protracted technical difficulties. 
These included the long period of time (23 months) to obtain sufficient numbers of 
high-quality El 1.5 ROSA-26 embryos after a decline in embryo viability made 
outbreeding with MF1 animals a necessity. During the first 12 months of the project 
prior to outbreeding, 60 % of ROSA-26 plugs were found not to bear embryos. 
Furthermore, the successful construction of recombinant cultures proved initially to be 
very challenging, especially concerning the satisfactory adherence of the components to 
one another and the minimisation of “contamination” by P-gal+ mesenchyme inclusion.
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3.4.2.4. Markers o f Endocrine Precursors
The second area of complications concerned the immunofluorescence 
characterisation of BDCs (and USCs) on the basis of their expression of endocrine 
markers. A small proportion, approaching a quarter of both the BDC and USC 
population identified by immunofluorescence staining for p-gal, expressed either insulin 
or glucagon. This shows that a proportion of the migratory BDCs and USCs are 
endocrine cells. It could not be determined from these experiments what proportion of 
the BDC population expressed both insulin and glucagon which might have afforded 
greater characterisation of these cells. It is a widely held belief that cells transiently 
expressing two or more hormones such as insulin and glucagon give rise to mature 
hormone-secreting cells and represent a population of endocrine precursor cells (Alpert 
et al., 1988; Teitelman et al., 1993; Upchurch et al., 1994, 1996). Technical difficulties 
ensured that neither the BDCs nor USCs could be subjected to immunofluorescence 
analysis for Pdxl or ngn3 which could have yielded the most informative evidence on 
their endocrine precursor role or otherwise. Other proposed markers of endocrine 
precursors which might be stained for in future work include Isll, Nkx2.2, Nkx6.1, 
NeuroDl, and Pax6. A proportion of the migratory cells are, however, endocrine cells.
3.4.2.5. Cell Clusters Disassresate and are Not Clonal
It was found that the mean cluster size of both USC and BDC clusters decreased 
over the 48 h culture period. Mean BDC cluster size, including isolated cells decreased 
from 8.23 ± 1.02 cells to 3.87 ± 0.191 cells over the two days whilst the mean USC 
cluster size (single USCs inclusive) decreased from 2.62 ± 0.247 cells to 1.72 ±0.112 
cells over the same period. This would suggest that the cell clusters disintegrate over the 
culture period. This progressive decrease in cluster size might be due to migration of 
cells away from the cluster or by the death of cells within the group. This latter 
hypothesis might be tested by subjecting cultures to TUNEL analysis for the detection 
of cells undergoing apoptosis.
Although many migratory BDCs and USCs occurred in groups, clusters of 
neither migratory cell type were found to be clonal in size (two cells, four cells, eight 
cells, 16 cells, 32 cells etc.) as might be expected if such clusters contained 
symmetrically-dividing stem cells able to give rise to further stem cells as consistent 
with an endocrine precursor role. In order to examine whether the BDCs and USCs are
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actively proliferating, staining for the proliferating cell nuclear antigen PCNA, might be 
conducted in one avenue of future work. Alternatively, an index of cell proliferation 
could be derived by the incorporation of BrdU and its subsequent immunodetection in 
pancreatic bud cultures.
One source of BDC and USC scoring error was determining what constituted a 
“cluster”. When large numbers of P-gal+ migratory epithelial cells were distributed 
throughout the mesenchyme (especially after 5d or 6d in vitro), on occasion it proved 
difficult to establish the boundaries of given cell clusters. It was speculated that the 
decrease in mean BDC and USC cluster sizes over the 48 h culture period might 
partially be a consequence of the greater difficulty in determining boundaries of clusters 
in 4d cultures when the migratory cells are less well distributed from the labelled 
epithelium. However, this factor was not deemed to be problematic in terms of the 
integrity of the overall data.
3.4.2.6. A Distinction Between BDCs and USCs?
At all time-points during culture, the mean size of clusters of USCs was 
markedly reduced compared with sizes of BDC aggregates. Indeed, USCs exhibited a 
greater tendency to occur as either isolated cells or in small (< 5 cells) clusters than did 
the BDCs. As a result of this, the frequency distribution of USC cluster sizes was 
determined to be significantly different to that for the BDC aggregates (%2 = 1065.8; P < 
0.01). USCs also tended to occur at greater distances from the (3-gal-labelled epithelium 
than did the BDCs. It therefore appears that despite their superficial similarities, the 
BDCs and USCs represent distinct classes of migratory cells since their patterns of 
distribution are so significantly different from one another.
3.4.3. Explaining Blue Spot B-Gal Expression
3.4.3.1. Endogenous 3-Gal Synthesis
In the study by Percival and Slack (1999), the blue spot-type P-gal expression of 
BDCs could not be explained though was presumed to be a consequence of cell 
processing of the bacterial P-gal protein. The possibility that the expression pattern 
represents phagocytosis of labelled debris by unlabelled cells was dismissed since blue 
dot cells could occur at some distance from uniformly stained cells and second, the
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mesenchymal cells immediately adjacent to the X-gal-stained epithelial tissue did not 
contain the blue dots. Both observations were confirmed in the current study. It was 
therefore considered that the blue dots were representative of endogenous (3-gal 
synthesis and the cells were genuinely of epithelial origin.
3.4.3,2. Blue Spots a Product of Culture Stress?
Similar blue spot-type P-gal expression in a second study provides further 
explanations for the observations of BDCs. Beddington and coworkers (Beddington et 
al., 1989) studied the deployment of cells during gastrulation and early organogenesis 
using the lacZ gene as a cell marker to follow cell fate. Using pronuclear DNA 
injection, they created a transgenic mouse strain expressing six copies of the E. coli lacZ 
gene under the control of the rat p-actin promoter. X-Gal staining of postimplantation 
hemizygous mouse embryos during gastrulation and early organogenesis demonstrated 
p-gal expression to be ubiquitous and constitutive in all epiblast derivatives of the E10 
embryo. No p-galactosidase activity was seen in trophectoderm and primitive endoderm 
derivatives. In late primitive streak stage (E8.5) embryos, whilst mesoderm and 
presumptive definitive endoderm cells demonstrated uniform, generalised cytoplasmic 
X-gal staining, staining in the epiblast was punctate as if the p-galactosidase was 
localised to intracellular vesicles. In excess of 80 % of epiblast cells demonstrated a 
blue spot following incubation in X-gal. In early somite stage (E9.5) embryos, 
neurectoderm and somatic and lateral mesoderm were also found to exhibit this punctate 
pattern of X-gal staining. By E l0.5, the entire cytoplasm of cells stained with X-gal 
(Beddington et al., 1989). As mentioned, in the current study, it could not be determined 
whether the BDCs lose their blue spot expression pattern to become USCs. In the study 
of Beddington et al. (1989), punctate staining was speculated to be a feature of cells 
expressing P-galactosidase at low levels. Cleavage-stage blastomeres, with low bacterial 
p-galactosidase activity, show a similar punctate staining pattern (Ueno et al., 1987), 
but there was no evidence for segregation of enzyme activity with particular subcellular 
fractions. Therefore, the blue spots were considered to represent cytoplasmic oxidation 
centres which facilitate the deposition of insoluble pigment (Ueno et al., 1987). So, the 
blue spot X-gal staining pattern might be indeed representative of endocrine precursors 
which specifically express low levels of P-galactosidase enzyme relative to other cells 
in the cultures for some unknown reason. Alternatively, blue spots might simply occur
113
Chapter 3: Migratory Cells in the Embryonic Pancreas 
in any cell (exocrine or endocrine) in the cultures if that cell expresses low levels of the 
enzyme, perhaps as a response to stress. This hypothesis is not supported by the 
observation that a markedly greater proportion of BDCs and USCs express the 
endocrine hormones insulin or glucagon than might be expected amongst the general 
epithelial cell population in the pancreatic bud culture. As the endocrine component 
represents only 1-2 % of the pancreatic volume (Bonner-Weir and Smith, 1994), then it 
might reasonably be expected that only 1-2 % of BDC or USC cells express insulin or 
glucagon, not the 15.7-24.7 % observed. However, this hypothesis is consistent with the 
great variation observed in the incidence of BDCs between individual cultures. In some 
cultures, no BDCs were observed whilst in others, BDCs were abundantly distributed 
throughout the entire mesenchyme. It might be speculated that the latter cultures might 
have been exposed to a higher level of stress whilst being cultured in vitro than other 
cultures, inducing a high amount of BDC formation.
3.4.4. Summary
3.4.4.1. Future Work
It remains to be seen which, if either of these hypotheses is correct and whether 
the BDCs (and USCs) represent a committed endocrine precursor population. Although 
this study has quite comprehensively determined the properties of the BDCs in terms of 
their physical distribution, it has raised more questions than it set out to address 
regarding their identity. Further work is needed to characterise the BDCs and USCs 
more fully by their expression of the aforementioned endocrine and exocrine markers, 
including insulin, glucagon, amylase, peptide YY, ngn3 and Pdxl. Thus, double- or 
triple-immunofluorescence analysis for p-galactosidase and a second cellular marker 
must be perfected localising amylase, peptide YY, ngn3 and Pdxl (Ipfl) before this 
work can be undertaken. If the BDCs or USCs can be identified as being endocrine 
precursors, then their proliferative behaviour should first be investigated as mentioned. 
Future avenues of work would involve studying their differentiation in various 
environments (for example, in combination with normal epithelium or with 
mesenchyme) with the long-term objective being the isolation of BDCs into pure 




Chapter 3: Migratory Cells in the Embryonic Pancreas
Irrespective of whether the BDCs represent an endocrine precursor population, 
this work has conclusively demonstrated the existence of epithelial migratory cells 
within the mouse embryonic pancreas. Many of these migratory cells occur in clusters 
and at least a proportion of them are endocrine cells. Exploiting the lacZ cell lineage 
label has allowed us to identify such motile pancreatic cells in vitro and investigate their 
spatial distribution as they migrate on the mesenchyme.
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4. Cell Linease Analysis
4.1. Introduction
4.1.1. Origin of the Pancreatic Structural Units
Little is known regarding the origin of the main structural units in the pancreas: 
the islets, acini and pancreatic ducts. Do they arise from individual cells or from groups 
of cells? The origin of islets has been examined in only a very limited number of 
studies. Using the human C-peptide/proinsulin product as a cell marker in aggregation 
mouse chimaeras, Deltour et al. (1991) tested three hypotheses of islet growth: (1) a 
single progenitor cell gives rise to all the precursors of the islets, (2) each of a few 
progenitor cells is the founder of a different islet, or (3) each islet is a mixture of cells 
originating from a pool of progenitor cells. If all the p-cells of a given pancreatic islet 
are derived from a single progenitor cell, each islet in mouse chimaeras will be entirely 
of one parental genotype or the other. However, if an islet is derived from multiple 
progenitor cells, it will be composed of a mixture of cells from both genotypes. In two 
of the four aggregation chimaeras, islets containing cells from both aggregated embryos 
were demonstrated. This finding was taken to support the third hypothesis above, 
suggesting that islets originate by cell aggregation. This conclusion was later supported 
by the mixed cellular composition of individual islets in combination cultures of a lacZ- 
expressing and an unlabelled pancreatic epithelium with an unlabelled mesenchyme 
(Percival and Slack, 1999). However, both studies were affected by limitations. In the 
aggregation chimaera study, only a very small number of animals and so, islets were 
examined. The second is restricted by it being in vitro.
4.1.2. Stem Cells in the Small Intestine
Clonal development of structural units from stem cells has been extensively 
studied in the intestinal crypts of Lieberkuhn of the mouse small intestine (Li et al., 
1994; Ponder et al., 1985; Schmidt et al., 1988; Winton et al., 1988; Winton and 
Ponder, 1990) and more recently, in the gastric glands of the stomach (Canfield et al., 
1996; Nomura et al., 1998). Stem cells are the cells which establish the cell lineages 
which form tissues and organs in the embryo. They are also responsible for the 
sustained production of cells in tissues characterised by constant renewal. The small
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intestinal murine crypt provides an elegant system for studying the control of stem cell 
proliferation and differentiation.
The adult mouse small intestine is lined with an epithelial monolayer which is 
morphologically highly organised into the villi and crypts which function as the source 
of intestinal proliferation. The 1.1 million or so crypts (Hagemann et al., 1970) each 
contain approximately 250 cells (Kellett et al., 1992). Cell proliferation is confined to 
the crypt base, from where cells migrate to the villi, whereupon they are shed (Potten 
and Hendry, 1983). These basal crypt cells are candidate stem cells owing to the 
frequent localisation of stem cells at the origin of cell flux (Wright, 2000). Evidence 
from experiments with mutagens which induce phenotypic crypt changes, suggests the 
number of active actual stem cells in each crypt to range from four to 16 (most probably 
about four). The proliferating basal crypt stem cells divide asymmetrically (at least on a 
statistical basis) to produce daughter cells which migrate up towards the crypt mouth 
and are known as transit amplifying (TA) cells. Whilst migrating, they undergo a further 
series of divisions, proliferating rapidly and then differentiating, appearing at the mouth 
of the crypt as postmitotic, terminally differentiated cells which line the upper parts of 
the crypts and villi (Potten and Loeffler, 1990). Hence, the concept of a few basally 
sited crypt stem cells which supply progeny to the proliferative compartment of dividing 
transit cells has emerged. A stem cell hierarchy is established in which stem cells with 
maximum pluripotency and proliferative potential reside in the stem cell zone near the 
crypt base with cells lying above this zone displaying reduced pluripotency and 
proliferative potential, which reduces further as the distance from the stem cell zone 
increases (Potten and Loeffler, 1990).
4.1.3. Clonal Purification of Intestinal Crypts
Ponder and coworkers (Ponder et al., 1985) examined clonality of the intestinal 
crypts using mouse aggregation chimaeras constructed from inbred mouse strains 
exhibiting differences in binding of the Dolichos biflorus agglutinin (DBA) lectin. 
These differences resulted from a carbohydrate polymorphism which was exploited as a 
cell marker. The epithelium of individual crypts in small and large intestine of adult 
animals was always seen to be composed of cells of a single parental type. It was 
inferred that the epithelium of each adult intestinal crypt forms a clonal population, with 
each adult crypt being derived from a single progenitor or stem cell. Although 
polyclonal intestinal crypts have been observed in neonatal mice up to two weeks of age
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they rapidly disappear (Schmidt et al., 1988) to give way to the monoclonal units of the 
adult. This progression of polyclonal embryonic crypts to a state of monoclonality is an 
obscure process that has been called “crypt cleansing”.
Mechanisms proposed to account for this clonal purification process always 
involve the overgrowth of one stem cell lineage in the crypt and the loss of others so the 
progeny of one stem cell eventually displace all others (Fig. 4.1. (a)). This model 
assumes that stem cell divisions are random in respect to replacement versus 
commitment to differentiation (Loeffler et al., 1993). If a stem cell can produce two 
stem cells or two cells committed to differentiate, or one of each, then there will 
necessarily be a progressive reduction of the number of cell lineages within the crypt, 
because when a stem cell produces two progeny committed to differentiate then this cell 
line is lost from the stem cell pool of that crypt. A 12-week renewal time for the crypt 
epithelium has been determined (Winton and Ponder, 1990). If a single “crypt- 
populating stem cell” were to provide directly the average daily output of a single crypt 
of approximately 250-300 cells (Potten and Loeffler, 1987) that stem cell would need to 
undergo about seven amplifying transit divisions, resulting in complete turnover or 
repopulation of the crypt epithelium (excluding any long-lived cells) by at the latest 5.5 
days (Winton and Ponder, 1990). The fixation of one stem cell lineage can also be 
explained by crypt division (or crypt fission) (Li et al., 1994; St. Clair and Osborne, 
1985), a significant mechanism of crypt reproduction in which a crypt splits from the 
base upwards. Over the first two weeks of postnatal life, crypt number is increasing 
rapidly by division of pre-existing crypts (Cheng and Bjerknes, 1985). If each crypt 
initially contains a small number of stem cells and these are partitioned randomly 
between the daughter crypts, then the number of stem cells within individual crypts will 
progressively reduce (Fig. 4.1. (b)).
4.1.4. Clonal Purification in the Pancreatic Islets?
It was hypothesised that a similar process might occur in the development of the 
pancreatic islets. It was proposed that the neonatal islets are polyclonal, having been 
formed from multiple progenitor cells and subsequently undergo a process of “clonal 
purification” to achieve monoclonality. If shown to occur, this purification might be 
explained by similar mechanisms proposed to account for crypt cleansing such as the 
overgrowth and extrusion of existing cells at the expense of one stem cell lineage or by 




Figure 4.1. Mechanisms for Clonal Purification of the Intestinal Crypts
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4.1.5. X-Inactivation Mosaic Mice
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To follow the clonal development of the pancreatic islets, acini and ducts, X- 
inactivation mosaic mice were used to study the postnatal cell lineage in these structural 
units of the pancreas. The H253 line (Tam and Tan, 1992) of transgenic mice was 
exploited as a source of lineage-labelled tissue. It has 14 copies of the E. coli lacZ 
reporter gene insert in tandem close to the Hprt locus (Tan et al., 1995). The transgene 
is driven by the promoter of the ubiquitously expressed 3-hydroxy-3-methylglutaryl 
coenzyme A reductase (HMG CoA reductase) gene. The transgene is transmitted in an 
X-linked pattern and, due to X-inactivation in which one of the two X-chromosomes in 
early embryonic cells of female mammals is randomly transcriptionally silenced (Lyon, 
1961), it stably marks approximately 50 % of the cells of H253 female hemizygotes. 
This results in a mosaic pattern of P-gal expression in all tissues of female X- 
inactivation mosaic mice including the pancreas.
4.1.6. Current Study
An immunohistochemical and immunofluorescence analysis was conducted on 
paraffin and frozen sections of pancreas from H253 mosaic females using, respectively, 
X-gal histochemistry and an anti-p-gal antibody to visualise the distribution of the cell 
marker in the islets, acini and pancreatic ducts. Numbers of cells of each genotype in the 
islets were counted at a number of postnatal time-points to infer their clonal state. 
Returning to the three hypotheses of islet growth (Deltour et al., 1991), if a single 
progenitor cell gives rise to all precursors of the islets, then all islets in the pancreas will 
be composed of p-gal+ or P-gal" cells, but not both; the islets will be homogeneous. If 
each of a few progenitor cells is the founder of a different islet then each islet will be 
composed of P-gal+ or p-gal" cells, but not both; again, all islets will be homogeneous. 
If, however, each islet is a mixture of cells originating from a pool of progenitor cells 
then one would expect islets to be predominantly mixed or mosaic, comprising cells of 
both genotypes (Fig. 4.2.). If mixed, polyclonal islets undergo a shift or clonal 
purification towards homogeneous islets in later animals, then mixed or heterogeneous 
p-gal+/p-gal" islets would be expected in the immediate neonatal pancreas followed by 
their replacement by homogeneous islets of a single genotype in the later postnatal 
organ.
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4.2. Materials and Methods
4.2.1. X-Inactivation Mosaic H253 Mice
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H253 mice were obtained from Harwell and housed under standard conditions 
on a 13 h light: 11 h dark cycle (lights on 06:30-19:30, including 30 min periods of dim 
lighting to provide false dawn and dusk) at 21 ± 2°C and at a relative humidity of 55 ± 
10 %. Food (CRM formula; Special Diets Services, Witham, Essex, UK) and water was 
provided ad libitum. The transgenic H253 mouse line was originally created by 
pronuclear injection of a DNA fragment containing the lacZ reporter gene under the 
control of a ubiquitously active promoter of the HMG Co A reductase gene (Tam and 
Tan, 1992). The line carries 14 tandem copies of an 8.9 kb fragment containing the 
promoter of a ubiquitously expressed mouse housekeeping gene, 3-hydroxy-3 - 
methylglutaryl coenzyme A reductase, linked to the E. coli lacZ gene incorporating a 
SV40 T-antigen nucleus localisation signal sequence. Breeding and chromosome 
hybridisation experiments with the H253 line confirmed that the lacZ gene is integrated 
in the A6 region of the X-chromosome (Tan et al., 1993, 1995). Male H253 animals 
express the X-linked lacZ gene in all cells of the embryo, including the developing 
nervous system (Tan and Breen, 1993; Tan et al., 1993). Females possess two X- 
chromosomes per cell but to maintain dosage parity with males, one of the two X- 
chromosomes in each cell is randomly and irreversibly inactivated during early 
embryogenesis (Lyon, 1961). This phenomenon is unique to mammals and is known as 
X-inactivation. The initial process of random inactivation is virtually completed before 
E9.5, and provides an ideal method of generating mosaicism amongst embryonic cells. 
In hemizygous females, only one of the two X-chromosomes will bear the lacZ 
transgene and this chromosome will be randomly turned off in approximately 50 % of 
cells (Tan et al., 1993). The cell-marking process is therefore indelible and heritable, 
and with each division of a cell, the lacZ gene and its active or inactive status is 
transmitted to the progeny of that cell. This process results in a marked clone in the 
absence of extensive cell mixing.
4.2.1.1, Generation and Genotypins of H253 Animals: Time-Series One
Transgenic H253 male mice were mated to Fi (C57BL/6xCBA) females (Fig.
4.3.). All female offspring from this mating scheme were hemizygous for the X-linked
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Figure 4.3. Two Common H253 Mouse Crosses 
H253 XtacZY M Fj (C57BL/6xCBA) Non-Tg F H253 X ^ Y  M H253 XtocZX F
®  = LacZ transgene 
Tg = Transgenic





H253 X ^ X 1*'2 F H253 XtecZX F H253 XtacZY M Non-Tg M 
Ubiquitous Mosaic Ubiquitous No
expression expression expression expression
1:1:1:1
Chapter 4: Cell Lineage Analysis
lacZ transgene. A developmental series of animals was analysed at postnatal days (PN)3 
(n or number of animals examined = 2), PN7 (n = 2), PN14 (n = 2), PN21 (n = 2), PN28 
(n = 1), PN12weeks (n = 2), PN26wk (n = 3) and PN52wk (n = 2) (“Time-Series One”). 
Animals were sacrificed by cervical dislocation, their pancreata rapidly excised and the 
tissue analysed immunocytochemically. In the second mating scheme (Fig. 4.3.), male 
H253 stud mice were mated to female H253 hemizygotes. Conforming to Mendelian 
laws, 25 % of offspring were females homozygous for the lacZ transgene, 25 % were 
hemizygous females, 25 % were hemizygous males (effectively homozygous) and the 
remaining 25 % of the offspring were non-transgenic males. Offspring from crosses 
were genotyped on the basis of P-gal expression pattern in the crypts of the small 
intestine or gastric glands of the stomach; both the crypts (Ponder et al., 1985) and 
gastric glands (Canfield et al., 1996; Nomura et al., 1998) have previously been shown 
to be monoclonal. Following X-gal staining, homozygous females and hemizygous 
males bear ubiquitously-stained organs whilst hemizygous females exhibit a striking 
mosaic of homogeneous p-gal+ and homogeneous p-gal' crypts (Fig. 4.4.) and gastric 
glands. However, with wholemount staining, X-gal penetrates the intestinal tissue to a 
depth of 3-4 crypt layers, resulting in only partial staining of (ubiquitously lacZ- 
expressing) deeper tissues. Genotyping must therefore be conducted by examining only 
the p-gal expression pattern of the most superficial 3-4 crypt layers at the surface of the 
wholemount specimen. X-Gal staining must be performed prior to paraffin-embedding 
as very little p-gal activity persists after processing and paraffin-embedding procedures.
Pancreatic tissue from non-transgenic male and homozygous female (or 
hemizygous male) littermates at each time-point was analysed to act as a negative 
control in the former case and as a positive control in the latter to ensure that the 
promoter drives transgene expression ubiquitously throughout the pancreas.
4.2.2. Time-Series One: Immunoveroxidase Immunocvtochemistry ofX-  
Gal-Stained Paraffin Sections
Fixed pancreata from Time-Series One were stained for P-gal activity as in 
Chapter 2, Section 2.3.2. then processed, paraffin-embedded and 7 pm sections cut 
from the tissue blocks as in Section 2.4.1. The paraffin sections were processed for 
immunoperoxidase demonstration of either insulin or glucagon then counterstained in 
nuclear Fast Red and mounted in DPX as in Section 2.5.3.I.
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(a). Female Homozygote (b). Female Homozygote
(c). Female Hemizygote (d). Female Hemizygote
Figure 4.4. Characteristic Pattern of X-Gal Staining for (3-Gal Activity in the Intestinal 
Crypts of H253 Homozygous (a and b) and Hemizygous (c and d) Females
(a), (c) and (d) Bar = 200 pm; (b) Bar = 50 pm
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4.2.3. Time-Series Two: Immunofluorescence Cytochemistry of Frozen
Sections
Superposed X-gal and electron-dense DAB stains can be difficult to resolve. To 
determine labelling of distinct islet cell types in H253 mosaic mice with greater 
resolution, immunofluorescence cytochemistry for P-galactosidase in conjunction with 
glucagon or insulin was performed. This was necessarily conducted on frozen tissue 
sections (see Section 4.3.2.). As Time-Series One had indicated a significant clonal 
purification by PN30, pancreata from a second developmental series of animals were 
analysed at PN5, PN10, PN15, PN20, PN25 and PN30 (n or number of animals 
examined = 5 per time-point) (“Time-Series Two”). Mice were sacrificed by cervical 
dislocation and their pancreata rapidly excised.
Pancreata were divided into two equal-sized portions, one of which was 
subjected to paraffin histology as described above. The portion destined for the 
preparation of frozen sections (cryosections) was fixed, cryoprotected, embedded in 
O.C.T. and 10-15 pm frozen sections cut as in Section 2.4.2. Cryosections were then 
processed for immunofluorescence demonstration of P-gal and glucagon or P-gal and 
insulin, counterstained in DAPI and mounted in Gelvatol as described in Section 2.5.2.
4.2.4. Time-Series Three: Analysis o f Simvastatin-Treated PN30 Animals
4.2.4.I. Simvastatin Treatment
Results from Time-Series One and Two indicated some variability in the 
expression of p-galactosidase in islet cells, agreeing with previous observations (Stone 
et al., 2002). To decrease this variability and to elevate the overall production of p- 
galactosidase in cells retaining the active marker, simvastatin (Calbiochem 567020) was 
administered orally (1 mg/100 ml drinking water for 10 days between PN20 and PN30 
when the animals were sacrificed) to two litters of H253 mice examined at PN30. 
Simvastatin lowers cholesterol, a negative inhibitor of HMG CoA reductase (Goldstein 
and Brown, 1990). Lower cholesterol results in an increase in the transcription of HMG 
CoA reductase mRNA and in H253 mice, an increase in expression of the lacZ gene 
driven by the HMG CoA reductase promoter (Stone et al., 2002).
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4.2.4.2. X-Gal Staining and Immunofluorescence Cytochemistry o f Frozen Sections
To assess the effectiveness of simvastatin treatment in ensuring ubiquitous 
constitutive p-gal expression in islets, and to compare the sensitivity of p-gal detection 
between X-gal staining and immunofluorescence cytochemistry, pancreata from two 
simvastatin-treated litters of two transgenic males and three hemizygous females were 
analysed at PN30. Mice were sacrificed by cervical dislocation and their pancreata 
rapidly excised. As for the animals of Time-Series Two, pancreata were divided into 
two equal-sized portions, one of which was subjected to paraffin histology as described. 
The remaining portion was fixed, cryoprotected, embedded in O.C.T. and 15 pm frozen 
sections cut. One of each pair of adjacent serial cryosections was processed for 
immunofluorescence demonstration of p-gal and glucagon, counterstained in DAPI and 
mounted in Gelvatol. The adjacent section was X-gal-stained as described in Section 
2.3.1., counterstained in nuclear Fast Red and DAPI and mounted in Gelvatol.
4.2.5. Scorins Islet 0-Gat/0-Gat Cell Composition
Sections selected for analysis were spaced throughout each pancreas such that 
no islet was examined more than once. Specimens were examined and scored using a 
Leica DMRB fluorescent microscope. Histochemically-stained islets from Time-Series 
One were scored directly from the paraffin sections. Under x 400 magnification islets 
were identified using DAB staining for glucagon to highlight the islet periphery. An 
islet was defined as five or more contiguous glucagon-immunopositive cells. The 
number of p-gal+ versus P-gal' cells within each islet in each section was determined. It 
is unknown to what extent the mixing of P~gal+ and p-gal' cells in heterogeneous islets 
is consistent throughout their volume from a single two-dimensional (2D) section 
through an islet. The larger the size of the islet, the less representative will be a single 
2D section of the three-dimensional (3D) volume. However, examination of a large 
number of sections of different islets would suggest that the cell mixing is consistent 
throughout the volume.
Images of specimens were taken with a Spot RT Color digital camera (National 
Diagnostics Inc.) and stored as uncompressed 24-bit TIFF images. 
Immunofluorescence-stained islets from Time-Series Two and the simvastatin-treated 
PN30 animals of Time-Series Three were scored from hard copies of merged images
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following adjustment of the three colour channels using the Adobe Photoshop 6.0 
package. The total number of p-gal+ and p-gal' cells in each islet in each of the analysed 
sections was scored. Cell composition of all of the islets within the examined sections 
was therefore determined from a single cross-section through each islet. For Time- 
Series Two, the number of glucagon- and insulin-immunopositive cells colocalising 
with the p-gal label was also determined. X-Gal-stained islets in frozen sections from 
the simvastatin-treated Time-Series Three animals were identified from glucagon 
immunofluorescence staining in the adjacent section and images were taken under 
Nomarski optics. The numbers of p-gal+ and P-gal' cells within each islet were scored 
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Cell lineage relationships in the structural units of the pancreas were first 
investigated by examining paraffin sections of wholemount X-gal-stained organs from 
PN3-365 (PN52wk) H253 animals.
43.1.1. Constitutive LacZ Expression in Intestinal Crypts
Wholemount X-gal staining demonstrated uniform P-gal activity in the crypts of 
transgenic (hemizygous) males and homozygous females and an X-inactivation mosaic 
of staining in the hemizygous female crypts (Fig. 4.4.) as was expected. This allowed 
female offspring from crosses between a male transgenic and female hemizygote (Fig.
4.3.) to be genotyped from the characteristic staining patterns.
43.1.2. Constitutive LacZ Expression in Islets and Ducts
Non-transgenic animals did not show any X-gal staining activity in the pancreas. 
We were satisfied on this basis that the staining observed in transgenic animals was 
attributable to p-gal expression from the lacZ transgene and was not a consequence of 
endogenous P-gal activity.
To ensure that pancreas cells constitutively expressed HMG CoA reductase- 
driven lacZ, pancreata were examined from male transgenic and female homozygous 
animals as a positive control for ubiquitous staining activity. Uniform X-gal staining of 
islets in the centre of wholemount-stained pancreata indicated a satisfactory, high 
penetration of the stain throughout the pancreatic tissue.
Almost uniform p-gal activity was observed in the pancreatic acini of E l5.5 
embryos although from PN3 onwards, p-gal activity decreased in the acinar cells (Fig.
4.5.). Some variability was seen in timing of the onset of this reduction such that some 
individuals still displayed acinar p-gal activity at PN14. However, all acinar cells in all 
animals examined were P-gal' from PN21. It was considered that this postnatal loss of 
P-gal activity in the acini was probably due to a reduced activity of the HMG CoA 
reductase promoter. Cell lineage analysis of the acini was therefore discontinued.
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(c). PN14 (d). PN28
Figure 4.5. Decline in (3-Gal Activity in Acinar Cells from PN3 Onwards
(a) Acini in the E15.5 embryonic pancreas showing X-gal staining for P-gal activity.
(b) X-Gal staining absent in some acini in a PN7 transgenic male, (c) PN14 
homozygous female showing absence of p-gal activity in some acini, (d) Complete 
loss of P-gal activity in the acini of a PN28 homozygous female, (b)-(d) are 
immunoperoxidase-stained for glucagon
(a) and (c) Bar = 200 pm; (b) and (d) Bar = 100 pm
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Uniform p-gal activity was observed in all pancreatic islets and ducts of all 
animals under PN18wk (Fig. 4.6.). Low intensity X-gal staining and a complete absence 
of staining were seen in a number of cells in some islets of a small number of PN18wk 
individuals (Fig. 4.6.). This may also be due to promoter shutdown. Loss of endocrine 
cell p-gal activity in adult mice was not considered detrimental to the study however 
since it occurred at such a late stage in postnatal life. Testing of the hypotheses could 
most probably be accomplished by examining animals up to PN30, well outside the 
time-frame of diminishing islet p-gal activity.
4.3.1.3. Ducts Consistently Heteroseneous
At all time-points and in all female hemizygous animals examined, pancreatic 
ducts were consistently seen to be of a heterogeneous p-gal+/p-gal' cell composition 
(Fig. 4.7.). No homogeneous ducts composed only of P-gal+ cells or entirely of p-gal' 
cells were ever observed, implying that pancreatic ducts arise from multiple progenitor 
cells and maintain this polyclonal state throughout postnatal life.
4.3.1.4. Islet Identification
For cell lineage analysis, islets were identified by immunoperoxidase staining 
for glucagon or insulin, the hormone products of a- and P-cells respectively. Glucagon 
staining was preferred as it stains only the peripheral cells of the islet, resulting in 
minimal superimposition with X-gal staining. To distinguish them from isolated 
endocrine cells, islets were defined as five or more contiguous glucagon- 
immunopositive cells.
4.3.1.5. Neonatal Heteroseneous Islets Become Homogeneous
In the PN3-365 female hemizygous animals examined in Time-Series One, islets 
of all three possible conformations were observed: mixed p-gal+/p-gaf, homogeneous 
P-gal+ or homogeneous p-gal'. At the earliest neonatal time-points studied, islets were 
predominantly seen to be of a heterogeneous p-gal+/p-gal' cell composition (Fig. 4.8.). 
A fine-grained mosaicism of neonatal islets was evident with widespread intermingling 
of unlabelled endocrine cells and labelled cells expressing the active marker. After four
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(e). PN12wk (f). PN18wk
(c). PN14 (d). PN28
Figure 4.6. X-Gal Staining Shows P-Gal Activity is Retained in All Islet Cells Until 
PN18 Weeks
(a)-(c) and (f) Transgenic males, (d) and (e) Homozygous females, (f) Loss of P-gal
activity can be seen in the islet on the left at the PN18wk time-point
All immunoperoxidase-stained for glucagon
(a) and (e) Bar = 200 pm; (b)-(d) and (0 Bar = 100 pm
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Figure 4.7. Pancreatic Ducts were Consistently of a Heterogeneous p-Gal+/p-Gal' Cell 
Composition
(a) PN28 female hemizygote (Time-Series One), (b)-(d) X-Gal staining in frozen sections 
from simvastatin-treated PN30 female hemizygote (Time-Series Three); images 
collected under Nomarski optics
(a) Bar = 100 pm; (b)-(d) Bar = 50 pm
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Figure 4.8. In Hemizygous Mosaic Females, Neonatal Islets are of a Heterogeneous 
P-Gal+/P-Gal' Cell Composition but Undergo a Conversion to a Homogeneous State 
Comprising Cells of a Single Genotype by One Month After Birth
Heterogeneous islets in PN3 (a and b) and PN7 (c) neonates. Note fine-grained 
mosaicism and widespread intermingling of P-gaP and p-gal' cells, (d) Homogeneous 
P-gal+ islets in a PN14 pancreas; note high P-gal activity in the acini in this individual 
All immunoperoxidase-stained for glucagon. Bar = 100 pm
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(e) Homogeneous P-gaI+ islets in a PN21 animal, (f) Homogeneous P-gal' islets in a 
PN26wk animal and homogeneous p-gal+ islets in two PN52wk females (g and h)
(f)-(h) immunoperoxidase-stained for glucagon. Bar = 100 pm
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weeks of age however, the great majority of islets were composed of cells of a single 
genotype. Islets were seen to be either of a homogeneous (3-gal+ cell composition or 
were composed entirely of cells not expressing the lacZ marker (Fig. 4.8.). This 
conversion of heterogeneous islets to a homogeneous state with age was then quantified. 
The final time-point examined was PN84 or PN12wk since the study of homozygous 
controls had indicated some loss of expression of the active marker from PN18wk 
onwards.
4.3.1.6. Increasing Frequency o f Incidence o f Homogeneous Islets with Ase
The incidence of homogeneous islets amongst a sample of the total islet 
population was found to increase rapidly in the neonatal period (Table 4.1. and Graph
4.1.). Islets were predominantly mixed at PN3, with fewer than 2 % of the islet sample 
being homogeneous. Between one and three weeks, the greatest rate of conversion to 
homogeneity was occurring so that at PN14, 42.6 % of islets were of a single genotype 
and by PN21, almost 95 % were homogeneous. The same Time-Series One islet sample 
was then subjected to further analysis as described in this chapter and in Chapter 5.
Table 4.1. Increasing Frequency of Homogeneous Islets with Age
Age 
(Days PN)
Homogeneous Islet Frequency 
(% of Total Sample)
Islet Sample 
Size, it
3 1.79 ± 1.43 55
7 0.96 ± 0.961 95
14 42.6 ± 14.5 57
21 93.4 ±6.67 26
28 92.9 ±7.14 58
84 95.9 ±4.17 26
4.3.1.6.1. Prevalence o f Homogeneous (3-Gaf Islets Over Unlabelled Islets
Overall examination revealed homogeneous islets to more frequently be 
composed of cells of the labelled genotype than to be homogeneously P-gal' (Table 4.2. 
and Graph 4.2.). This selective effect was evident at all time-points studied. The 
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Graph 4.1. Increase in Frequency of Homogeneous Islets with Age
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pancreata examined, homogeneous islets exhibited a tendency to be composed of 
unlabelled cells.
Table 4.2. Selective Effect Towards P-Gal+ Over P-Gal" Homogeneous Islets
Age 
(Days PN)
Homogeneous Islet Frequency 




3 1.79 ±0.961 0 ± 0 55
7 0.96+14.5 0 ± 1.11 95
14 40.8 ±8.18 1.67 ±14.8 57
21 71.8 ±2.62 21.5 ±14.8 26
28 74.0 ±4.17 18.8 ±0 58
84 95.8 ±19.1 0 ± 18.0 26
To verify the divergence in the observed ratios of the homogeneous p-gal+ to 
homogeneous unlabelled islets from the expected 1:1 distribution, a chi-square (%2) test 
was conducted. The proportion of homogeneous islets of each genotype as a percentage 
of the total sample was calculated for each time-point (Table 4.3.). On account of the 
formula:
X2 = Z (Observed - Expected)2 with d f = c (number of categories) - 1 
Expected
for the situation here in which there are only two categories, the expression
(Observed -  Expected)
Expected
is the same value for each category as each of the two observed percentages deviate 
from the expected 50 % frequency by the same value. % was therefore calculated 
simply by determining the square of the deviation divided by the expected 50 (%) and 
then multiplying this figure by two. In this manner, % was calculated for each islet 
sample at each time-point (Table 4.3.).
138
Chapter 4: Cell Lineage Analysis
Table 4.3. Calculating x2 to Test Whether the Observed Ratio of Homogeneous P- 
Gal+ to p-Gal' Islets Deviates Significantly from the Expected 1:1 Distribution
Age 
(Days PN)
Observed Distribution of 




(E; 50 %) 
(Disregarding 
Sign)
2 tO -E l2 
E
= x2p-Gal+ P-Gal"
3 100 0 50 100
7 100 0 50 100
14 96.1 3.93 46.1 84.9
21 77.0 23.0 27.0 29.1
28 79.7 20.3 29.7 35.4
84 100 0 50 100
X2 = 6.64, d f = 1, p  = 0.01. As all of the calculated values of %2 are greater, the null 
hypothesis can be rejected. The observed frequency distribution of homogeneous P-gal+ 
to P-gal' islets therefore deviates significantly from the expected 1:1 distribution, 
indicating a significant bias towards homogeneous labelled islets over unlabelled ones. 
The existence of this effect means that the expression of the p-gal enzyme itself may 
exert an effect on the relative survival of stem cells, and so not be a truly neutral 
marker. Alternatively, the observed bias towards homogeneous p-gal+ islets may be a 
consequence of the genetic background of the animals examined.
4.3.1.7. Increasing Homogeneity o f Islets with Age
The disadvantage of expressing the conversion from heterogeneous to 
homogeneous islets in terms of the frequency of homogeneous islets is that no 
distinction is made between heterogeneous islets that are mixed to different extents. At 
the extreme of its definition a heterogeneous islet can contain a single cell of the less 
predominant genotype. For example, an islet that is composed of 90 p-gal+ cells and 10 
p-gaf cells is less heterogeneous than an islet composed equally of P-gal+ and p-gal" 
cells. So, an index of the extent of homogeneity was devised. By definition, the 
“percentage homogeneity” of an islet is a measure of the extent of clonal purification of 
the islet and is calculated as: (number of cells of the prevailing genotype/total number of 
cells) x 100 (Fig. 4.9.). This figure therefore ranges between 50 % and 100 %. The 
mean index of homogeneity for all islets at a given time-point calculated in this manner
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Figure 4.9. Calculating Islet-Weighted and Cell-Weighted Percentage 
Islet Homogeneity of P-Gal+/p-Gal‘ Cell Composition
(a).
Mean islet-weighted 
% islet homogeneity (78.9 + 59.5+ 100 + 57.1 + 73.7  ^
5
= 73.8%
15 B-gal~ cells 
19 cells total x 100
= 78.9 % homogeneity
22 B-eal+cells 
37 cells total x 100
= 59.5 % homogeneity
* 7 p-gal+ cells 7 cells total x 100
= 100 % homogeneity
4 B-gal+ cells 
7 cells total x 100
= 57.1 % homogeneity
14 P-gal cells 
19 cells total x 100
= 73.7 % homogeneity
(b).
Mean cell-weighted 
% islet homogeneity = 15 + 22 + 7 + 4+14 (1 of cells of predominant genotype')
19 + 37 + 7 + 7+19 (I of total cells in all islets) x 100
= 69.7%
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is independent of islet size. Equal weighting is given to islets of different sizes. Hence, 
this figure was termed the “Islet-weighted percentage homogeneity”
The islet-weighted percentage homogeneity of islets was seen to increase with 
age from 69.3 % at PN3 to in excess of 98 % by PN21 (Table 4.4. and Graph 4.3.). 
Again, the maximum rate of conversion to the homogeneous state occurred between one 
and three weeks after birth.







3 69.3 ± 2.76 55
7 61.5 ±2.20 95
14 82.4 ± 5.34 57
21 98.9 ± 1.11 26
28 98.2 ± 1.83 58
184 99.4 ± 0.650 26
4.3.1.8. Rate of Hetero2eneous-Homoseneous Conversion is Independent of Islet Size
It might be expected that the smaller the size of the islet and the fewer the 
number of cells, the greater the rate with which homogeneity is attained. However, islet- 
weighted percentage homogeneity as mentioned above, assigns equal weighting to islets 
of different sizes and so cannot be used to test this hypothesis. Instead, any effect of 
islet size on the rate of conversion to homogeneity can be inferred by comparing islet- 
weighted homogeneity with a similar, cell-weighted index of homogeneity. “Cell- 
weighted percentage homogeneity” fs-dependent on islet size and is calculated as: (sum 
of the number of cells of the prevailing genotype in each islet for all islets of 
sample/total number of cells of all islets in sample) x 100 (Fig. 4.9.).
The cell-weighted percentage homogeneity of islets at each time-point was very 
similar to the islet-weighted homogeneity figure (Table 4.5. and Graph 4.4.), 
increasing with age from 68.4 % at PN3 to 98.6 % by PN28, with the greatest rate of 
conversion being between one and three weeks of postnatal life. This close similarity 
between the islet-weighted and cell-weighted data implied that islet size exerted a 
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3 68.4 ±2.13 55
7 60.9 ± 2.07 95
14 82.3 ± 5.38 57
21 96.8 ± 0.386 26
28 98.6 ±1.44 58
184 99.4 ± 0.600 26
To confirm this finding, the islet-weighted percentage homogeneity data was 
segregated according to islet size (Table 4.6.). No significant effect of islet size class on 
rate of conversion to homogeneity was seen.
Table 4.6. Islet-Weighted Homogeneity of Islets Segregated by Size with Age
Islet Size 
(Cell No.)
Islet-Weighted Percentage Islet Homogeneity i[%)
PN3 PN7 PN14 PN21 PN28
0-50 67.6 63.2 82.0 99.5 99.6
51-100 69.2 59.5 80.5 89.2 89.1
101-150 74.0 60.0 83.0 100 100
151-200 64.1 62.1 78.2 100 100
201-250 68.8 61.8 73.5 100 —
251-300 62.8 57.5 — 100 100
301-350 66.8 55.5 90.5 — —
351-400 — 67.7 — — 100
401-450 — — — 100 100
451-500 — — — 100 —
4.3.1.9. Islet Size Does Not Increase Neonatallv
Islet size was investigated to determine whether the islets are increasing in cell 
number as they are undergoing the heterogeneous-homogeneous conversion. No 
significant increase in mean islet cross-sectional area was seen during the first four 
weeks of postnatal life when the conversion is occurring (Table 4.1.).
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Table 4.7. Islet Size Does Not Increase Significantly Over PN3-28
Age (Days PN) Islet Size (Cell Number) Islet Sample 
Size, n
3 92 ± 3.45 55
7 85 ± 14.4 95
14 81 ± 19.8 57
21 103 ± 17.7 26
28 69 ±0 58
4.3.2. Tim e-Series Two
Having obtained preliminary evidence for a conversion to homogeneity of 
heterogeneous islets, the decision was made to investigate the cell lineage of the 
different endocrine cell types using immunofluorescence cytochemistry in conjunction 
with an anti-P-gal antibody (rabbit polyclonal; Molecular Probes A-11132). This would 
permit colocalisation of P-gal with the endocrine markers glucagon and insulin with a 
high degree of resolution. Immunofluorescence does not suffer from the same problem 
as immunohistochemistry where one chromogen can mask another when stain 
superposition occurs.
Immunofluorescence staining of paraffin sections for p-gal proved to be 
unsuccessful despite successful demonstration of the endocrine markers. Frozen 
sections were instead prepared and proved highly amenable to p-gal staining using an 
appropriate fluorescein-conjugated secondary antibody (Fig. 4.10.); the fluorescence 
signal was clearly nuclear-localised within the H253 islet cells as expected. Once single 
immunofluorescence staining for p-gal was successfully accomplished, double-staining 
with either the anti-glucagon or anti-insulin antibodies (demonstrated with Texas Red 
and TRITC respectively) was conducted. The numbers of p-gal-labelled and unlabelled 
glucagon- or insulin-immunopositive islet cells were then determined from a second 
time-series of H253 female hemizygote animals at PN5, PN10, PN15, PN20, PN25 and 
PN30 (n or number of animals examined = 5 per time-point).
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Figure 4.10. Immunofluorescence Demonstration of p-Gal in Islets of a PN10 Month 
H253 Female in 15 pm Frozen Sections
Images collected on a Zeiss LSM510 confocal microscope
(a)-(c) Bar = 20 pm; (d) Bar = 10 pm
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4.3.2.1. Hish Resolution Detection of Colocalisation
Using immunofluorescence analysis, colocalisation of the p-gal label with the 
endocrine markers could be detected with a high degree of resolution. Furthermore, 
because the p-gal label is nuclear while the hormones exhibit a cytoplasmic distribution, 
it was possible to prepare two-colour superposed images in which there is virtually no 
overlap of the two signals (Fig. 4.11.),
4.3.2.2. No Evidence for Heteroeeneous-Homoeeneous Conversion from 
Immunofluorescence Analysis: Reduced Endocrine 0-Gal Production?
In the PN5, PN10, PN25 and PN30 female hemizygous animals examined, the 
samples of a- and P-cell populations in individual islets appearing in section were 
predominantly recorded as being of a heterogeneous p-gal+/p-gal' cell composition 
(Table 4,8.). PN15 and PN20 islets were therefore not examined. Islets as a whole 
appeared to be heterogeneously composed of cells of both genotypes. Homogeneous 
unlabelled a- and p-cell populations were seen with varying frequency (5.71 % to 42.8 
% of the total islet cell population sample) at each time-point, some of these populations 
comprising almost 100 cells (98, 95 and 90 cells). In contrast, only one of the 394 a-cell 
populations and two of the 395 p-cell populations analysed were p-gal+ homogeneous, 
these being three of the smallest cell populations assessed (8 cells and 5 and 6 cells in 
size respectively).
To verify the divergence in the observed ratios of the homogeneous P-gal’ to 
homogeneous p-gal-labelled islet cell populations from the expected 1:1 distribution, a 
chi-square (%2) test was conducted as described in Section 4.3.1.6.1. above. The 
proportion of homogeneous a- or P-cell populations of each genotype as a percentage of 
the total number of homogeneous cell populations was calculated and x2 calculated for 
each time-point (Table 4.9.).
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(a). PN5 p-Gal + Glucagon (b>.
-
PN10 (3-Gal + Glucagon
fSM.
W - ; *
(e). PN25 p-Gal + Insulin
(d).




PN10 P-Gal + Insulin
PN25 p-Gal + Insulin
Figure 4.11. No Obvious Conversion from Heterogeneity to Homogeneity was 
Observed in Mosaic Females of Time-Series Two for which p-Gal was Detected 
by Immunofluorescence Cytochemistry
Double-labelling for p-gal (fluorescein) and glucagon (Texas Red) (a and c) or 
p-gal (fluorescein) and insulin (TRITC) (b and d-f). Bar = 20 jim
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Table 4.8. Immunofluorescence Analysis Showed No Obvious Increase in the Homogeneity of Glucagon- or Insulin-Producing a- and P-Cell 






















P-Gal+ P-Gaf 1:1 
P-Gal V
Glucagon 5 0 23.1 86.0 ±4.46 87.4 ±4.38 7.69 91.0 1.28 78
Insulin 0 22.2 84.4 + 2.66 86.8 ± 1.80 8.89 91.1 0 45
Glucagon 10 0.690 42.8 92.6 ±1.63 93.1 ±1.34 2.07 97.9 0 145
Insulin 1.16 14.5 77.0 ± 2.22 72.4 ± 2.52 15.1 82.0 2.91 172
Glucagon 25 0 15.2 81.7 ±2.38 79.9 ±2.73 10.6 89.4 0 66
Insulin 0 15.9 74.2 ± 3.80 71.7 ±4.19 24.6 75.4 0 69
Glucagon 30 0 5.71 68.7 ±1.31 65.1 ±2.91 14.3 80.0 5.71 105
Insulin 0 23.9 82.0 ±3.41 73.0 ±0.559 1.83 98.2 0 109
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Table 4.9. Calculating %2 to Test Whether the Observed Ratio of Homogeneous p- 








Observed Distribution of 
Homogeneous Cell 




(E; 50 %) 
(disregarding 
sign)




Glucagon 5 0 100 50 100
Insulin 0 100 50 100
Glucagon 10 1.59 98.4 48.4 93.8
Insulin 7.41 92.6 42.6 72.6
Glucagon 25 0 100 50 100
Insulin 0 100 50 100
Glucagon 30 0 100 50 100
Insulin 0 100 50 100
X2 = 6.64, d f  = 1, p  = 0.01. As all of the calculated values of x2 are greater, the null 
hypothesis can be rejected. The observed frequency distribution of the homogeneous p- 
gal' to p-gal+ islet cell populations therefore deviates significantly from the expected 1:1 
distribution, indicating a significant bias towards unlabelled a- and p-cell populations 
over p-gal+ ones.
Similarly to the above, the frequency of predominantly P-gal' islet cell 
populations was consistently greater than the frequency of predominantly p-gal-labelled 
populations at all time-points (Table 4.8.). Predominantly P-gal' a- or P-cell 
populations outnumbered those cell populations composed mostly of p-gal-labelled 
cells by a factor of between 3.07 and 53.7 depending upon the sample. Although great 
variation in the degree of homogeneity was seen amongst the mixed p-gal+/p-gal' 
populations, no trend towards homogeneity with age was evident. Furthermore, a great 
variability was observed in the level of p-gal fluorescence signal in cells within the 
same islet expressing the active marker. The data was consequently not at all consistent 
with that obtained from the first time-series assessed by X-gal staining (Graph 4.5.). 
One feature of this data was a considerable variability in the intensity of p-gal staining 
between cells. Another was the preponderance of unlabelled cells. It was considered that 












Graph 4.5. Percentage Islet Homogeneity with Age: Data from Immunofluorescence Cytochemistry 
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immunostaining is less sensitive than histochemical X-gal staining and does not detect 
all positive cells.
4.3.3. Simvastatin-Treated PN30 Animals
In an attempt to decrease the variability of p-gal expression in islet cells and to 
elevate the overall production of p-galactosidase in cells retaining the active marker, 
simvastatin was administered to a third and final group of animals. Simvastatin lowers 
cholesterol, a negative inhibitor of HMG Co A reductase (Goldstein and Brown, 1990), 
resulting in increased transcription of HMG CoA reductase mRNA. During the course 
of this work it was shown that in H253 mice this leads to an increase in expression of 
the lacZ gene driven by the HMG CoA reductase promoter (Stone et al., 2002).
As in Time-Series One, overall islet clonality was assessed in sections. Adjacent 
serial 15 pm frozen sections were stained independently for p-gal activity either 
histochemically with X-gal or by immunofluorescence cytochemistry so that detection 
sensitivity could be compared. In the latter case, sections were double-stained as in 
Time-Series Two for p-gal and glucagon. Islets were identified by fluorescence 
labelling of glucagon-immunopositive cells and numbers of p-gal+ and P-gal' islet cells 
determined. The same islet was identified in the adjacent frozen section and the 
numbers of labelled and unlabelled cells as revealed by X-gal staining were counted. 
Owing to time constraints, islets were examined from just three H253 female 
hemizygotes at a single PN30 time-point. The ubiquity of constitutive expression of the 
HMG CoA reductase-driven lacZ in the islet cells of simvastatin-treated animals was 
assessed in two H253 male transgenic pancreata.
4.3.3.1. Constitutive LacZ Expression in Islets Revealed by Histochemical Detection 
but Not by Immunofluorescence Analysis
Uniform p-gal activity as assayed by X-gal staining was observed in islets of the 
two H253 transgenic males (Fig. 4.12.). Of the 2803 islet cells of the 28 islets counted 
in the two animals, X-gal staining was not evident in only 11 cells restricted to just two 
of these islets; 99.6 % of the islet cells were determined to be p-gal+ by histochemical 
detection of p-gal activity. By comparison, of the 1853 cells of the same 28 islets 
double-stained for p-gal and glucagon, only 1516 cells (81.8 %) were revealed to be P-
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(a). (b).
(e). (0. P-Gal + Glucagon
Figure 4.12. X-Gal Staining Shows P-Gal Activity is Effectively Uniform Across All Islets 
in PN30 Simvastatin-Treated Transgenic Males but Immunofluorescence Analysis 
Reveals that Islet-Weigh ted Islet Homogeneity in the Same Islets is Only 80.5 %
(a)-(b) Uniform X-gal staining in all islets (x 100). (c)-(f) X-Gal staining and double­
labelling for |3-gal (fluorescein) and glucagon (Texas Red) in adjacent frozen sections 
through the same islet, (a)-(c) and (e) Images collected under Nomarski optics 
(a)-(b) Bar = 200 pm; (c)-(f) Bar = 50 pm
(d). p-Gal + Glucagon
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gal-immunopositive by immunofluorescence detection (Fig. 4.12.). Three of the 28 
islets were recorded as being of a homogeneous p-gal+ cell composition by 
immunofluorescence detection. Mean islet-weighted and cell-weighted islet 
homogeneity were determined to be 99.5 % and 99.6 % respectively as determined by 
X-gal histochemistry but 80.5 % and 80.6 % respectively as revealed by 
immunofluorescence analysis (Table 4.10.). So, the mean difference in islet-weighted 
islet homogeneity recorded from the same islets using the two methods was 20.8 %. 
This apparent difference in sensitivity of p-gal detection between histochemical X-gal 
staining and immunofluorescence analysis therefore caused differences in the values for 
cell-weighted and islet-weighted homogeneity calculated for the same set of islets but 
derived from the two different staining techniques.
Table 4.10. Disparity in Detection of p-Gal in Islets of H253 Transgenic Males by 
Histochemical Staining vs. Immunofluorescence Analysis




X-Gal 99.5 ± 0.071 99.6 ± 0.255
Immunofluorescence 80.5 ±3.94 80.6 ±6.16
As the greater values for islet homogeneity given by the two detection methods 
(namely those obtained from X-gal staining) were so near to 100 %, it was decided that 
simvastatin-enhanced islet p-gal expression could be considered uniformly constitutive 
to all intents and purposes. Isolated groups of acinar cells were also seen to stain for p- 
gal activity with X-gal (Fig. 4.13.) though were never detected by immunofluorescence 
analysis.
4.3.3.2. Homogeneity o f Islets in Mosaic Females is Approximately 75 %
The majority of the 37 islets analysed in the three PN30 H253 female 
hemizygotes appeared to be of a heterogeneous p-gal+/p-gal' cell composition although 
three small (< 40 cells) homogeneous p-gal+ islets were observed (Fig. 4.14.). There 
appeared to be some individual variation in the extent of islet homogeneity amongst the 
three experimental animals. Mean islet-weighted and cell-weighted islet homogeneity 
were determined to be 76.0 % and 74.9 % respectively as determined by X-gal
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Figure 4.13. Simvastatin-Induced p-Gal Activity in PN30 Pancreatic Acini is 
Detected by X-Gal Staining but Not by Immunofluorescence Cytochemistry
(a)-(b) X-Gal staining in isolated groups of acinar cells in two PN30 transgenic males. 
(c)-(d) p-Gal activity in the acini of a PN30 hemizygous female is detected by X-gal 
staining (c) but not by immunofluorescence staining for p-gal with fluorescein in an 
adjacent frozen section (d)
(a)-(c) Images collected under Nomarski optics. Bar = 50 pm
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(d). 0-Gal + Glucagon
(f). P-Gal + Glucagon
Figure 4.14. Islet-Weighted Islet Homogeneity in PN30 Simvastatin-Treated Mosaic 
Females Determined to be 76.0 % by X-Gal Staining but Only 68.8 % by 
Immunofluorescence Cytochemistry
X-Gal staining (a, c and e) and immunofluorescence double-labelling (b, d and f) for 
p-gal (fluorescein) and glucagon (Texas Red) in adjacent frozen sections through the 
same islet, (a)-(d) Predominantly p-gai+ islets; (e)-(f) predominantly p-gal' islet 
(a), (c) and (e) Images collected under Nomarski optics. Bar = 50 pm
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histochemistry and 68.8 % and 68.9 % respectively as revealed by immunofluorescence 
analysis (Table 4.11.). On account of the apparently lower resolution of detection of p- 
galactosidase protein by immunofluorescence staining, results generated from this 
technique were not subjected to further analysis.
Table 4.11. Homogeneity of Islets in H253 Female Hemizygotes as Revealed by X- 
Gal Staining and Immunofluorescence Analysis















68.8 ± 2.07 68.9 ± 1.94
It was expected that in the absence of extensive cell mixing, islets (and other 
tissues) in the H253 hemizygote mosaic females would be composed of p-gal+ and P- 
gal" cells in approximately equal numbers. However, this group of PN30 animals 
revealed quite clearly that this was not the case in the islets. So, the same data set was 
subjected to further analysis.
4.3.3.3. Prevalence o f Predominantly 0-Gat Islets
Of the 37 islets examined, 27 were predominantly (> 50 %) composed of P-gal+ 
cells, the remaining 10 being composed mainly of unlabelled cells, x2 was calculated as 
described in Section 4.3.I.6.I. above to verify this divergence in the observed ratios of 
the predominant genotypes of the islets from the expected 1:1 distribution. Of the 37 
islets, 50 % or 18.5 would be expected to be composed primarily of p-gal+ cells whilst 
the remaining 18.5 would be expected to contain predominantly unlabelled cells 
(excluding the existence of any islets containing equal numbers of cells of each 
genotype). As explained, in this situation with only two categories across which the 
distribution is expected to be symmetrical:
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%2 = 2 (Observed - Expected)2
Expected
:.y2 = 2 (12.25) = 7.81
18.5
X2 = 6.64, df=  1, p  = 0.01. As the calculated value of %2 is greater, the null hypothesis 
can be rejected. The observed frequency distribution of the predominantly p-gal+ to 
predominantly unlabelled islets therefore deviates significantly from the expected 1:1 
distribution, indicating a significant bias towards P-gal-labelled islets over unlabelled 
ones. This selective effect was also evident in the animals from Time-Series One, when 
at all time-points studied, homogeneous P-gal+ islets outnumbered homogeneous p-gal- 
negative islets. This finding confirms the suggestion that the expression of the p-gal 
enzyme itself may exert an effect on the relative survival of stem cells, and not be a 
truly neutral marker.
4.3.3.4. Rate o f Heterogeneous-Homoseneous Conversion is Dependent on Islet Size
To test the hypothesis that the smaller the size of the islet, the greater the rate 
with which cell homogeneity is attained, the islet-weighted percentage homogeneity 
data was segregated according to islet size (Table 4.12. and Graph 4.6.). In contrast to 
the results from Time-Series One, there was an inverse relationship between islet size 
and islet homogeneity such that smaller islets exhibited greater percentage homogeneity 
than did islets of larger cell number, supporting the hypothesis.







0-99 74.5 ± 3.61 27
100-199 71.9 ±8.13 5
200-299 64.6 ± 9.38 4
300-399 52.6 ± 0 1
Note that the frequency of islets decreases as islet area increases. Very few islets in the 














Graph 4.6. Islet-Weighted Homogeneity of Islets is Inversely Related to their Size
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4.4. Discussion
4.4.1. Loss of HMG CoA Reductase Promoter Activity
4.4.1.1. Loss o f Acinar Expression from PN3 Onwards
Analysis of pancreata from male transgenic and female homozygous animals of 
Time-Series One revealed there to be almost uniform P-gal activity in the acini of E15.5 
embryos as assayed by histochemical X-gal staining. However, in the immediate 
neonatal period, between PN3 and PN21, p-gal activity was lost from the acinar cells. 
This phenomenon was also observed in female hemizygotes, in which little acinar P-gal 
activity was detected through X-gal staining (Time-Series One) or immunofluorescence 
analysis (Time-Series Two). In this neonatal stage, the loss of enzymic activity was 
restricted to only the acinar compartment. The uniform X-gal staining of islets in the 
centre of < PN18wk wholemount-stained control pancreata (surrounded by non-staining 
acini) was indicative of a satisfactory, high penetration of the stain throughout the 
pancreatic tissue. Although there are other possible explanations, the decline in p~ 
galactosidase activity after birth was attributed to a loss of activity of the HMG CoA 
reductase promoter driving the lacZ transgene. The evidence in favour of this is that 
there is some recovery of acinar P-gal in the simvastatin-treated animals of Time-Series 
Three. The loss of activity of the promoter of this ubiquitously expressed gene in 
pancreatic acini has not been reported previously. As a result of the dramatic loss of 
acinar p-gal activity, cell lineage analysis of the acini was forcibly abandoned.
4.4.1.2. Loss o f  Islet Expression in Older Animals C> PN18 wk)
In contrast to the acini, uniform p-gal activity was observed in all pancreatic 
islets and ducts of all male transgenic and female homozygous animals under PN18wk. 
Low intensity X-gal staining of some endocrine cells and a small number of completely 
unstained cells was however seen in some islets of a small number of PN18wk 
individuals. From this it was inferred that activity of the HMG CoA reductase promoter 
might be diminishing in a fraction of islet cells of some older animals. Due to the 
possible loss of p-gal for this reason, analysis of the experimental cases was confined to 
the first 84 days (12 weeks) of postnatal life, during which the controls all showed 
uniform, persistent p-gal expression in the islets and ducts.
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4.4.I.3. HMG CoA Reductase: A Closely Resulated Enzyme
The housekeeping gene 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) 
reductase is the rate-limiting enzyme in the synthesis of mevalonate, a crucial 
intermediate in the formation of sterols and non-sterol isoprenoid compounds (Goldstein 
and Brown, 1990; Qureschi and Porter, 1981) (Fig. 4.15.). Cholesterol is synthesised in 
virtually all tissues from acetyl CoA. Cytosolic acetyl CoA is initially condensed to 
acetoacetyl CoA in a reaction catalysed by a cytosolic thiolase enzyme. Acetoacetyl 
CoA then condenses with a further molecule of acetyl CoA catalysed by HMG CoA 
synthase to form 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) as an 
intermediate leading to the six-carbon compound mevalonate. HMG CoA is then 
converted to mevalonate in a two-stage reduction by NADPH catalysed by HMG CoA 
reductase, a cytosolic isozyme of the mitochondrial enzymes.
HMG CoA reductase is an interconvertible enzyme that is inactivated by 
phosphorylation. It is subjected to control at the levels of transcription, translation, 
protein stability, and activity modulation (Goldstein and Brown, 1990). Both steroid and 
non-steroid products of mevalonate are required for total suppression of HMG CoA 
reductase activity in an example of multivalent regulation (Brown and Goldstein, 1980). 
Via a feedback mechanism, HMG CoA reductase is inhibited by mevalonate and 
cholesterol. Increased cholesterol concentrations lead to formation of cholesterol 
derivatives, which allosterically inhibit the enzyme. As a more long-term form of 
control, high levels of cholesterol derivatives lead to increased degradation and 
decreased synthesis of the enzyme. Steroids are assumed to suppress transcription of the 
HMG CoA reductase gene via an octanucleotide sequence in the promoter region 
(Osborne, 1991). HMG CoA reductase is known to be regulated by hormones, including 
those of the pancreas. Insulin and thyroid hormone both increase HMG CoA reductase 
activity, whereas glucagon and glucocorticoids decrease it.
4.4.1.4. Speculation on Causes o f Loss o f Acinar 3-Gal
The loss of acinar activity of this ubiquitously expressed promoter has not been 
previously reported. Causes of this acinar-specific decline in expression in the neonatal 
period can be speculated upon. As an adaptation for their secretory role, the pyramidal 
cells of the acini contain very prominent regular arrays of rough endoplasmic reticulum, 
an extensive basal Golgi complex and numerous secretory zymogen granules containing
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Figure 4.15. HMG CoA Reductase Plays an Integral Role in the Synthesis of 
Mevalonate, a Crucial Intermediate in the Formation of Cholesterol
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digestive enzymes. It follows from this high density of membranes that the cholesterol 
content of such cells will be high. Furthermore, the endoplasmic reticulum of the cell is 
principally responsible for cholesterol synthesis. High steroid levels might directly 
suppress the HMG CoA reductase promoter to inhibit transcription of the endogenous 
gene and also the HMG CoA reductase-driven lacZ transgene in the pancreatic acini 
(Osborne, 1991). It is also a possibility that maternally-derived compounds during 
embryonic development in utero and during the early phase of weaning delivered in the 
colostrum, act to maintain high promoter activity by lowering cholesterol. This would 
account for the observed acinar P-gal activity at E l5.5 and subsequent inactivity with 
neonatal growth. It is similarly likely that as the animals age, tissue cholesterol 
deposition occurs on a widespread scale, particularly given their sedentary lifestyle. 
Such a rise in plasma cholesterol would have the effect of suppressing HMG CoA 
reductase transcription throughout many tissues and organs of the adult’s body, 
including, eventually, the pancreatic islets.
4.4.1.5. Loss o f  HMG CoA Reductase Promoter Activity in Neonatal Islets in Animals 
o f Time-Series Two - Transgene Hyyer-Methvlation?
It was suggested (Patrick Tam, personal communication) that loss of transgene 
expression could be attributable to hyper-methylation of the HMG CoA reductase- 
driven transgene in the germline. This can result in widespread variations in transgene 
expression. H253 transgenic males have been observed (Patrick Tam, personal 
communication) to transmit the transgene to their first litters efficiently and then to 
subsequently sire progeny exhibiting marked variations in P-gal expression throughout 
their tissues. The first animals examined in Time-Series Two were bom more than eight 
months after the last of the animals of Time-Series One. It would, in principle, be 
possible to investigate this by examining the methylation state of the transgene with 
methylation-sensitive and insensitive restriction enzymes. However, there was 
insufficient time for this in the current study.
4.4.1.6. Drue-Enhanced Increase in HMG CoA Reductase Promoter Activity
According to Patrick Tam (personal communication), variation in p-gal 
expression amongst H253 litters can be resolved by re-screening the H253 colony for 
strong expressers of the lacZ transgene by assaying the intensity of X-gal staining of
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earclips. High or strong expressers can then be bred from to reconstitute the line. 
However, again, time constraints dictated that this was impracticable. Instead, drug 
treatment was employed in an attempt to upregulate transgene expression.
Its role as the rate-determining enzyme for the overall pathway of cholesterol 
synthesis has resulted in HMG CoA reductase being the site of action of the most 
effective class of cholesterol-lowering drugs, the statins. These fungal metabolites act as 
inhibitors of synthesis of the enzyme and include mevastatin (compactin), lovastatin 
(mevinolin), provastatin, and simvastatin. The negative feedback that exists between 
HMG CoA reductase expression and cholesterol can be manipulated to our advantage 
by administering statins to enhance activity of the HMG CoA reductase promoter. 
Through the ad libitum oral administration of simvastatin, the level of plasma 
cholesterol which negatively inhibits expression (Goldstein and Brown, 1990), is 
lowered, and synthesis of HMG CoA reductase is increased (Fig. 4.16.). Treatment of 
LDL receptor-deficient mice for two weeks with simvastatin has been shown to induce 
a 4.1-fold increase in hepatic HMG CoA reductase mRNA levels (Bisgaier et al., 1997). 
In H253 mice, elevation of HMG CoA reductase production results in a concomitant 
increase in expression of the lacZ transgene driven by the HMG CoA reductase 
promoter (Stone et al., 2002).
Analysis of X-gal staining in two PN30 male transgenic animals treated for 10 
days with simvastatin prior to sacrifice showed P-gal expression to be effectively 
ubiquitous in the islets and ducts. Within these two control pancreata, 99.6 % of islet 
cells examined exhibited P-gal activity. Furthermore, groups of acinar cells in the PN30 
pancreata were also seen to stain for P-gal activity with X-gal, a phenomenon not seen 
in untreated PN28 animals. Simvastatin treatment was therefore considered to be 
effective in enhancing activity of the HMG CoA reductase promoter. It ensured that 
transgene expression was effectively ubiquitous in islet cells and also partially restored 
the p-gal expression in the acinar cells. H253 X-inactivation mosaic females could not 
however be used to examine acinar cell lineage even whilst undergoing a programme of 
simvastatin treatment since P-gal activity was not completely restored to all acinar cells. 
It is possible that ubiquitous P-gal activity in the acini of H253 transgenic males or 
homozygous females could be demonstrated by subjecting animals to a longer time- 
course of simvastatin treatment or by raising the dosage. In the current experiments, the 
duration of the weaning period restricted the length of statin treatment of the PN30 
animals. It is difficult to know with accuracy the dose of simvastatin received by pre­
weaning offspring in the milk if the mother is provided with the drug ad libitum; risks to
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Figure 4.16. Statin-Induced Upregulation of HMG CoA Reductase Transcriptional Activity
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< PN20 animals from treatment are also possible because simvastatin treatment may 
interrupt fetal steroid synthesis. However, there have been few reports of congenital 
birth abnormalities associated with the statins (Manson et al., 1996). Treatment with 
more potent statins might also effect a complete restoration of acinar transgene 
expression. Treatment of LDL receptor-deficient mice for two weeks with atorvastatin 
and lovastatin has been shown to induce 17.2- and 10.7-fold increases in hepatic HMG 
CoA reductase mRNA levels respectively, in comparison to the 4.1-fold increase 
observed following treatment with simvastatin (Bisgaier et al., 1997).
4.4.2. Differences in Sensitivity Between Methods of 0-Gal Detection
The variability in the level of P-gal fluorescence signal amongst immunopositive 
cells in pancreas sections from the mosaic females of Time-Series Two also raised the 
possibility of there being a marked distinction between the thresholds of p-gal detection 
between histochemical X-gal staining and immunofluorescence analysis in conjunction 
with an anti-p-gal antibody. It might be envisaged that the former method, which relies 
on the catalysis of a chemical reaction by the P-galactosidase enzyme, is more sensitive 
than is localisation of the protein using an antibody. However, the extent of this 
difference in practical terms was unknown. So, to test this hypothesis, a direct 
comparison between the two detection methods was made by determining the 
proportion of P-gal+ cells in the same islets of H253 transgenic males. Adjacent 
cryosections through the same islets were each stained by a different technique and the 
cell composition data compared. The difference was found to be quite striking and much 
greater than expected. Approximately one fifth of the P-gal+ islet cells detected by X-gal 
staining in the male transgenic animals were not detected as being P-gal+ by 
immunofluorescence analysis. It would appear that the threshold for P-gal detection by 
X-gal staining is significantly lower than for detection by immunofluorescence analysis. 
The observation that isolated groups of acinar cells in the PN30 pancreata were seen to 
stain for p-gal activity with X-gal but not by immunofluorescence, is also consistent 
with this.
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4.4.3. Credibility o f  Data
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In light of these findings, the data from Time-Series One and the results from the 
X-gal staining of simvastatin-treated Time-Series Three animals appeared to be most 
credible since:-
(1). p-gal expression was known to be effectively ubiquitous in the islets of these 
animals from X-gal staining of pancreata from positive control transgenic male and 
homozygous female animals,
(2). islet p-gal+/p-gal' cell composition data in female hemizygotes was obtained from 
histochemical X-gal staining which is believed to reveal all P-gal+ cells.
4.4.4. Pancreatic Ducts Arise from Multiple Progenitors and Remain 
Polyclonal
At all time-points and in all female hemizygous animals examined, pancreatic 
ducts were consistently seen to be of a heterogeneous p-gal+/p-gal* cell composition. 
Variation was observed in the extent of homogeneity with there being a great range in 
the ratio of numbers of cells of the two genotypes. No homogeneous ducts composed 
only of P-gal+ cells or entirely of P-gal' cells were ever observed. This mixed state 
implies that pancreatic ducts are polyclonal and arise from the association of multiple 
progenitor cells. This polyclonal state is then maintained throughout pancreas 
development and postnatal life with a number of self-renewing stem cells feeding 
relatively slow turnover of the duct cell compartment.
4.4.5. Homogeneous Islets Tend to be 0-Gat: A Selective Advantase of 
0-Galactosidase?
An unexpected finding was that in the mosaic females of Time-Series One and 
the three PN30 animals, homogeneous islets were found to be more frequently 
composed of P-gal+ cells than unlabelled cells. This selective effect was apparent at all 
time-points studied. The direction of selection varied between individual animals 
however; in a minority of animals, homogeneous islets tended to be composed of 
unlabelled cells. No asymmetry in the numbers of homogeneous p-gal+ vs. 
homogeneous P-gal" gastric glands was reported by Nomura and colleagues (Nomura et
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al., 1998) when they used H253 animals for gastric gland lineage analysis. They 
describe X-chromosome inactivation as a “physiological and neutral cell marking 
technique”. Also, P-galactosidase has been reported to be biologically neutral in the 
mouse (Beddington et al., 1989). One explanation for this asymmetry is that expression 
of the p-gal protein provides a selective advantage over cells not expressing the 
transgene, perhaps by aiding cell attachments or by enhancing the proliferative capacity 
of a lac'/? cell. Although predominantly nuclear, small amounts of enzyme might leak 
out of expressing cells and degrade P-galactoside linkages in extracellular 
carbohydrates. A counter-argument to this is that in a minority of animals, 
homogeneous islets tended to be p-gal', although homogeneous P-gal+ islets were 
observed in these animals at a low frequency. One further possibility is that of 
reactivation of the previously silent X-chromosome carrying the transgene in certain 
islet cells. Nomura et al. (1998) considered this phenomenon when analysing gastric 
gland cell lineage by examining mice doubly heterozygous for the H253 lacZ transgene 
and Searle’s translocation (lacZ +/+ T16H). Most, if not all, cells in adult females 
heterozygous for the translocation inactivate the normal X-chromosome (Lyon et al., 
1964; McMahon and Monk, 1983). Hence, the transgene carried on the normal silent X- 
chromosome in these mice would not be expressed unless a cell reactivates the silent X- 
chromosome, resulting in two active Xs per cell (Wareham et al., 1987). At PN10, no 
reactivation was observed in the glands of Searle’s mice, though in PN6wk stomachs, 
reactivation was detected in 0.04 % of fundic and 0.14 % of pyloric glands. In PN15wk 
stomachs, 0 % reactivation was detected in fundic glands and 0.19 % in pyloric glands. 
This data suggests insignificant rates of reporter gene reactivation so it seems 
improbable that it could account for the observed predominance of homogeneous P-gal+ 
islets.
4.4.6. Islets Arise from Multiple Pro2enitor Cells
The collated data suggest that pancreatic islets, like the ducts, are initially 
formed from multiple progenitor cells. The mixed p-gal+/p-gal" cell composition of 
more than 98.2 % of PN3 neonatal islets supports one of the hypotheses of islet growth 
proposed by Deltour et al. (1991), namely that “each islet is a mixture of cells 
originating from a pool of progenitor cells”. This evidence contradicts hypotheses (1) “a 
single progenitor cell gives rise to all the precursors of the islets” and (2) “each of a few
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progenitor cells is the founder of a different islet”, both of which involve clonal growth 
from a single cell. Hence, nascent islets are polyclonal, being formed from the 
aggregation of multiple precursor cells. This finding is consistent with the mixed 
cellular composition of individual islets in combination cultures of a /acZ-expressing 
and an unlabelled pancreatic epithelium with an unlabelled mesenchyme (Percival and 
Slack, 1999). Isolated patches of cells of a single genotype were never seen in neonatal 
islets. PN3 islets instead displayed a fine-grained mosaicism of intermingled labelled 
and unlabelled cells although typically cells of one genotype predominated by an excess 
of approximately 40 %. This “salt and pepper” phenotype suggests widespread mixing 
between daughter cells of different progenitors within the forming islets.
4.4.7. Neonatal Heterogeneous Islets Rapidly Become Homogeneous
However, the islets do not maintain their nascent heterogeneous state throughout 
postnatal life in the same manner as the pancreatic ducts. The heterogeneous islets 
rapidly became replaced by homogeneous islets in the first month. This conversion 
occurred at its greatest rate between one and three weeks after birth. In animals of Time- 
Series One, the frequency of homogeneous islets increased from 1.79 % at PN3 to 42.6 
% at the two-week time-point; by three weeks, almost 95 % of islets were 
homogeneous. The index of homogeneity, calculated to track the changes in cell 
composition with greater resolution, showed a similar pattern. The size-independent 
islet-weighted percentage homogeneity of islets increased with age from 69.3 % at PN3 
to in excess of 98 % by PN21 with the maximum rate of conversion to the 
homogeneous state occurring between one and three weeks after birth. The mean islet- 
weighted and cell-weighted islet homogeneity (76.0 % and 74.9 % respectively) as 
calculated from X-gal staining of pancreata from the three simvastatin-treated PN30 
female hemizygotes agree with this progression to islet homogeneity. These figures 
depart markedly from the 50 % homogeneity values expected in the absence of a 
heterogeneous to homogeneous shift. In Time-Series Two, no homogeneous islets were 
seen but this is probably because of the insufficient sensitivity of the 
immunofluorescence detection of P-gal. In Time-Series Three there were some 
homogeneous islets at PN30, although not as many as seen in Time-Series One. The 
conclusion is that homogeneous islets are a reality, but the timescale may not always be 
as rapid as shown in Time-Series One.
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The observation of homogeneous islets in adult mice appears at first to be 
inconsistent with the results of a previous study on pancreatic islet chimaerism by 
Deltour and coworkers (Deltour et al., 1991). Using the human C-peptide/proinsulin 
product as a cell marker in aggregation mouse chimaeras, they demonstrated that in two 
of four animals examined at 1.5 months or 4.5 months of age, all islets contained cells 
from both aggregated embryos. This finding was taken to suggest that islets originate by 
cell aggregation as was found in the current study. The aggregation chimaera study is 
not necessarily incompatible with the present investigation because, firstly only four 
animals were examined of which two exhibited homogeneous islets, and secondly no 
time-series was conducted. The data of the current study suggest that there is a trend to 
homogenisation of islets although the time-course may vary somewhat.
4.4.7.2. Polyclonal Neonatal Islets Become More Monoclonal
The most obvious explanation for a homogeneous islet is that it is monoclonal, 
i.e. that all cells are derived from a single progenitor. The shift in the cell composition 
of islets that was observed in the present study suggests that neonatal islets become 
progressively less polyclonal with age in the initial month after birth. That mixed islets 
are polyclonal is self-evident, but the possibility remains that a proportion of the 
homogeneous islets are polyclonal even though all the cells within a homogeneous islet 
have the same staining phenotype. For example, if adult islets are renewed by two 
progenitor or stem cells, then the likelihood of that islet appearing as homogeneous is 
0.5 - the probability that both stem cells are of the same genotype - either p-gal+ and p- 
gal+ or P-gal' and P-gal'. Of course as the number of stem cells supplying the islet 
increases, then the probability that they are all of the same genotype giving a 
homogeneous islet, declines exponentially. It cannot, therefore be stated emphatically 
that a homogeneous islet is monoclonal but one can infer from the above data that a 
shift towards monoclonality is occurring in the islets. The data indicate a rapid decline 
in the number of progenitors in each islet so that the number of cell lineages within each 
islet is reduced or “stream-lined” presumably by endocrine cell turnover in the neonatal 
period. Eventually, the number of stem cells is reduced to a very small number, 
probably just one. No islets were ever observed in which the cells of the peripheral 
mantle of the islet, primarily composed of a-cells were of a different genotype to the p-
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cells of the central islet core. This implies that there must be a common endocrine 
progenitor or stem cell that continues in postnatal life to give rise to all four endocrine 
cell types within the islet.
4.4.7.3. A Similar Process to Clonal Purification o f the Crypts and Gastric Glands?
A conversion or “clonal purification” from a neonatal polyclonal state to one of 
monoclonality has been well documented in the crypts of the small intestine (Schmidt et 
al., 1988). After a 14-day purification period, intestinal crypts are, with little exception, 
found as monoclonal units (Ponder et al., 1985; Schmidt et al., 1988). A similar process 
has been recorded more recently in the gastric glands of the stomach by conducting 
lineage analysis with H253 mosaic mice as here (Nomura et al., 1998). Neonatal glands 
are predominantly polyclonal, each requiring a minimum of three progenitor cells for 
their formation. Subsequently, the majority become monoclonal from PN6wk although 
around 10 % persist as a sub-population of polyclonal glands in the adult stomach 
(Canfield et al., 1996; Nomura et al., 1998). This residue of persistent polyclonal gastric 
glands has been suggested to contain larger numbers of stem cells than the general gland 
population and so function as a reservoir for replenishing damaged glands.
4.4.7.4. Mechanisms for Clonal Purification
A number of possible mechanisms have been put forward to account for the 
observed “clonal purification” from polyclonal to monoclonal composition (Fig. 4.1.). If 
there are a small number of stem cells within the gland, some of these could perhaps 
divide symmetrically while others divide asymmetrically (Potten and Loeffler, 1990). A 
stem cell can produce two stem cells or two cells committed to differentiate, or one of 
each. When a stem cell produces two progeny committed to differentiate then this cell 
lineage is lost from the stem cell pool. With time, the symmetrically dividing stem cells 
will “outlive” the asymmetric ones (Potten and Loeffler, 1990). In this scenario, all stem 
cell lineages would eventually be extruded from the islet at the expense of one stem cell, 
which gains the ascendancy. An alternative candidate mechanism could be gland 
fissioning. Crypt fission is a relatively well-documented phenomenon (Li et al., 1994; 
St. Clair and Osborne, 1985). Gastric glands have also been reported to undergo fission 
by splitting across the longitudinal extent of the parental gland (Nomura et al., 1998). 
Extremely active replication of intestinal crypts by fission during the period that they
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undergo clonal purification has lead to the hypothesis of segregation of cell lineages by 
this process. If again, an islet is considered to be fed by a small number of stem cells, 
perhaps four, then fission of that islet will partition the stem cells at random between the 
daughter islets, reducing the number of cell lineages within the newly-formed islets. 
This spatial restriction of progenitor cells will lead eventually to monoclonality. 
Nomura and colleagues (Nomura et al., 1998) found that heterogeneous p-gal+/p~gal' 
gastric glands appeared to give rise to mixed daughter glands, indicating that 
monoclonal glands do not necessarily arise immediately following fission of a 
polyclonal gland, but perhaps due to subsequent renewal by descendants of the resulting 
stem cell pool (Nomura et al., 1998).
4.4.7.4.1. Overgrowth by the Progeny o f a Single Cell
It is quite feasible that one stem cell might gain the ascendancy and populate the 
islet at the expense of other stem cells, which are extruded and undergo apoptosis or 
programmed cell death. In this manner, a relatively rapid conversion from a 
heterogeneous to a homogeneous islet is achieved. If one islet cell were to divide to give 
two daughter cells, which in turn, each divided to give two daughters, then a single cell 
would need only to undergo 10 divisions to populate a 1000-cell islet with its progeny 
(210 = 1024) provided that all daughter cells are retained. It is not easily possible to 
extend such a simple calculation to construct a mathematical model of such islet cell 
overgrowth. This is due to the great variability in the indices of both cell division and 
cell death of islet cells as determined from many cell kinetic studies. Most notably, by 
extrapolating data from the work of others (Kaung, 1994; Montana et al., 1994; Swenne 
and Eriksson, 1982), Finegood and colleagues (Finegood et al., 1995) estimated the 
replication rate of p-cells in the neonatal rat pancreas (Graph 4.7.). Although 
approximately 20 % of P-cells in the pancreas are in a state of active proliferation at 
PN1, this figure declines progressively in the weeks following birth to 14 % at PN5 and 
9 % at PN15. By 30 days after birth, 5 % of the P-cells are replicating. The replication 
rate does not stabilise at the adult level of 3 % p-cell turnover per day until 
approximately PN40. Finegood and coworkers (Finegood et al., 1995) showed that 
despite the initial high rate of p-cell proliferation, p-cell mass remains stable in the 
neonatal rat between PN7 and PN21. This was proposed to be due to a postnatal wave 
of p-cell death in the developing rat pancreas peaking at 9 % of P-cells/day at PN12. 
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detection of apoptotic cells. Using the fluorescent dye propidium iodide to 
morphologically identify apoptotic cells, Scaglia et al. (1997) demonstrated a peak of 
3.5 % in the apoptotic index of (3-cells occurring at PN13 in the neonatal Sprague- 
Dawley rat. A separate study of Wistar rats using TUNEL revealed a similar neonatal 
wave of islet cell apoptosis peaking at PN14 with a value of 13.2 % cell death/day 
(Petrik et al., 1998). More recently, this phenomenon has also been shown to occur in 
the mouse pancreas. Using the TUNEL method, a neonatal wave of islet cell apoptosis 
commencing at PN5 and peaking at PN12 (9.4 % apoptosis/day) was demonstrated in 
BALB/c mice (Trudeau et al., 2000) (Graph 4.8. (b)). These studies together 
demonstrate the great variability in the rate of islet cell proliferation and cell death 
occurring in the neonatal islet, which makes it very difficult to present a model of islet 
cell overgrowth. It is also difficult to relate indices of either cell division or cell death to 
actual cell turnover. The cell kinetic studies show that P-cell replication in the neonatal 
rodent pancreas is sufficiently high and sustained to permit a single cell to populate a 
1000-cell islet by undergoing 10 cycles of division. It is therefore credible that clonal 
purification might be achieved in one month if all of the progeny of the progenitor cell 
are retained. Even levels of p-cell replication in the adult rodent are sufficient to bring 
about dramatic changes in P-cell mass. Hellerstrom et al. (1988) pointed out that with a 
p-cell birthrate of just under the adult level of 3 % new cells per day, the p-cell mass 
would double in one month if there were negligible cell death or apoptosis. 
Alternatively, if the rate of p-cell death approaches the replication rate of 3 %, then 
complete replacement of the P-cell population could occur in that one-month period. 
Indeed, cells can only be observed as TUNEL-positive for a short period of a few hours 
(Petrik et al., 1998), revealing estimates of apoptotic rate derived from TUNEL staining 
to be very conservative. This widens the possibility that levels of endocrine cell 
turnover in the neonatal rodent pancreas are sufficient to allow for islet clonal 
purification in one month via population by the progeny of a single proliferating cell. 
The maximum level of islet cell apoptosis coincides with the greatest rate of islet 
conversion from heterogeneity to homogeneity between one and three weeks after birth 
(Graph 4.8.).
The functional significance of the neonatal remodelling of the islet cell mass is 
unknown. However, in other systems such as in male germ cells (Wang et al., 1998) and 
cardiac myocytes (Kajstura et al., 1995), similar waves of neonatal apoptosis contribute 
to tissue remodelling coincident with changing function or cellular demand. The wave 
of p-cell apoptosis in the pancreas occurs just prior to weaning and it seems
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Graph 4.8. Peak of Apoptotic Wave in the Neonatal Rodent Pancreas is Coincident 
with the Greatest Rate of Conversion of Heterogeneous Islets to Homogeneity
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(b). Islet Cell Apoptosis (% TUNEL-Positive Nuclei) as a Function of Age in Female 
BALB/c Mice (Trudeau et al., 2000). Reproduced with Permission
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probable therefore that this remodelling may prepare the (3-cell mass for changing 
functional demands (Trudeau et a l , 2000). Neonatal remodelling of the endocrine 
pancreas marks a change from a fetal phenotype of the p-cell, which is proliferative, has 
poor glucose sensitivity, and lacks acute phase insulin release, to an adult phenotype, 
which has a low replicative capacity but high sensitivity to glucose and an ability to 
rapidly release insulin (Hellerstrom and Swenne, 1991). Clonal purification perhaps 
plays a role in producing the adult islet by “synchronising” the functions of newly- 
generated adult phenotype P-cells formed within a short time-frame from a single stem 
cell. Clonal purification might alternatively simply be a by-product of the endogenous 
cell turnover that occurs during neonatal remodelling of the islets.
In the study of Petrik et al. (1998) mentioned above, the neonatal wave of islet 
cell apoptosis that peaks at PN14 in the rat pancreas was shown to be temporally 
associated with a fall in the islet cell expression of IGF-II. This growth factor was 
shown to function as an islet survival factor in vitro by suppressing cytokine-mediated 
islet cell death in isolated neonatal rat islets. A subsequent study (Hill et al., 2000) by 
the same group using an IGF-II-overexpressing transgenic mouse showed that the 
retention of circulating IGF-II postnatally largely prevents the wave of developmental 
apoptosis of the islets. Consequently, islets from IGF-II transgenic mice exhibited a 
significantly greater mean area from PN11-16 than those of non-transgenic littermates. 
It would be interesting to determine whether the hyperplastic islets in such transgenic 
animals retain their polyclonality beyond the neonatal period. This question could be 
assessed by crossing the IGF-II transgenic strain with the H253 line and performing cell 
lineage analysis on mosaic females by staining for p-gal activity as in the current study. 
If clonal purification results from the progeny of a single cell populating the islet then it 
would be expected that if neonatal islet apoptosis is suppressed, the islet would continue 
to grow as islet cell replication is unabated. (Some evidence suggests that islet cell 
replication is actually increased in IGF-II transgenic mice on PN13 and PN16; Hill et 
al., 2000). The islet cannot be “purged” of the cells usually extruded in the absence of 
the growth factor. Islet clonal purification can therefore not proceed resulting in 
hyperplastic polyclonal islets. It remains to be seen whether this hypothesis is validated.
4.4.7.4.2. Islet Fission
Strong histological and islet cell composition evidence have been collected in 
support of the “Islet Fission” model of islet clonal purification (Chapter 5). In this
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model, as an islet grows by cell proliferation, fission is initiated, producing two 
daughter islets when a threshold size is attained, perhaps involving a doubling of stem 
cell number (Loeffler et al., 1993, 1997). If islet growth and fission occur 
simultaneously or partially so, then little overall increase in mean islet size would result, 
agreeing with data obtained to this effect. The random segregation of a small number of 
stem cells between the daughter islets would reduce the number of cell lineages within 
the newly-formed islets. This compartmentalisation of progenitor cells will lead 
eventually to monoclonality. Division of a polyclonal islet into two daughters has the 
same effect on reducing stem cell lineages within an islet as apoptosis of 50 % of islet 
cells, on average halving progenitor cell number within the islet(s). The Islet Fission 
model though, is disadvantaged by the slower rate of progression to monoclonality than 
would be achieved by the population of an islet by the progeny of a single cell. This 
handicap is, however, lessened if the number of stem cells is small (four or less). There 
is no reason to suggest that the two mechanisms are mutually exclusive. It is also 
possible that following islet fission, one of the remaining, reduced number of stem cells 
proliferates at the expense of the other islet cells, hastening the conversion to islet 
homogeneity initiated by islet fission. It is equally plausible that during islet population 
by the progeny of a single stem cell, the islet undergoes fission, partitioning the 
remaining stem cells, again reducing the time taken to attain homogeneity (Fig. 4.17.). 
Nomura et al. (1998) found that fission of heterogeneous P-gal+/p-gaf gastric glands 
appeared to give rise to mixed daughter glands, indicating that monoclonal glands do 
not arise immediately following fission of a polyclonal gland, but perhaps due to 
subsequent renewal by descendants of the resulting stem cell pool (Nomura et al., 
1998). Interestingly, they also found that in adult mice, mixed glands appeared in a state 
of fission much more frequently than would be expected, suggesting a greater fission 
capacity than homogeneous glands, possibly related to their increased stem cell number.
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Figure 4.17. Clonal Purification of Islets by a Combination of Cell Overgrowth and Islet Fission
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4.4.8. Summary
Chapter 4: Cell Lineage Analysis
Clonal development of the pancreatic islets, acini and ducts was followed in X- 
inactivation mosaic mice with the specific aim of testing the hypothesis that neonatal 
polyclonal islets undergo a process of “clonal purification” to achieve monoclonality. 
An unreported neonatal loss of activity of the p-gal cell lineage marker in the acinar 
cells was attributed to downregulation of the transgene HMG CoA reductase promoter, 
possibly by steroids within the pancreatic acini. In support of this, some recovery of 
acinar p-gal was observed upon treatment with the cholesterol-lowering drug 
simvastatin. Clonal analysis of the acini was therefore abandoned. However, p-gal 
expression was retained in all cells of islets and ducts in animals < PN18wk to which 
analysis of the experimental cases was confined. At all time-points examined pancreatic 
ducts were consistently seen to be heterogeneously composed of P-gal-labelled and 
unlabelled cells implying that ducts in the pancreas arise from the association of 
multiple progenitor cells. This polyclonal state is retained throughout postnatal life 
presumably by a number of self-renewing stem cells feeding relatively slow turnover of 
the duct cell compartment. Immediately after birth, the pancreatic islets were also of a 
mixed p-gal+ and p-gal" cell composition, suggesting that the islets, like the ducts, are 
initially formed from multiple progenitor cells, consistent with previous studies (Deltour 
et al., 1991; Percival and Slack, 1999). However, the nascent heterogeneous islets 
rapidly became replaced by homogeneous islets in the first month so that by three weeks 
after birth, almost 95 % of islets were homogeneous. The shift in islet cell composition 
observed in this study suggests that neonatal islets become progressively less polyclonal 
with age in the initial month after birth and progress towards monoclonality via a 
process of clonal purification similar to that described in the intestinal crypts and gastric 
glands of the stomach. This is presumed to be brought about by a rapid decline in the 
number of progenitors in each islet to probably just one, presumably by endocrine cell 
turnover in the neonatal period. As no islets were observed in which cells in the mantle 
were of a different genotype to those in the islet core there must be a common endocrine 
stem cell that continues in postnatal life to give rise to all four endocrine cell types 
within the islet. Clonal purification can be explained by a number of mechanisms which 
reduce the number of stem cells in the islet such as the overgrowth and extrusion of islet 
cells at the expense of one stem cell lineage which gains the ascendancy. A single cell 
would need only to undergo 10 divisions to populate a 1000-cell islet with its progeny. 
Islet stem cell number could also be reduced by the partitioning of stem cells into
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daughter islets by the division or fission of an islet, a phenomenon for which strong 
evidence is presented (Chapter 5). It appears most probable that a combination of the 
two mechanisms is responsible for the observed clonal purification of initially 
polyclonal islets towards a monoclonal state.
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5. Dumbbell Islets and Islet Fission
5.1. Introduction
5.1.1. Fission of Intestinal Crypts
As mentioned in Chapter 4, it was hypothesised that islets, if initially 
polyclonal, undergo a conversion to monoclonality in a similar process to the intestinal 
crypts of Lieberkuhn (Li et al., 1994; Winton et al., 1988; Winton and Ponder, 1990). 
The crypts are initially polyclonal, with multiple stem cells forming individual crypts, 
but become converted to a monoclonal state by “crypt cleansing”. Mechanisms 
proposed to account for this “clonal purification” include the overgrowth and extrusion 
of one stem cell lineage by other lineages in the crypt. An alternative mechanism 
however, is that of crypt fission (Li et al., 1994; St. Clair and Osborne, 1985). Crypt 
fission is an important mechanism of crypt reproduction thought to involve stem cells in 
which a crypt splits from the base upwards. In some instances, fission occurs 
asymmetrically with respect to the crypt axis, and in this case the process is termed 
“budding”. Crypt fission of pre-existing crypts is known to be responsible for the rapid 
increase in crypt number which occurs over the first two weeks of postnatal life (Cheng 
and Bjerknes, 1985). The initially polyclonal crypt contains a small number of stem 
cells, most probably four although this number is assumed to vary slowly with time 
(Loeffler et al., 1986; Loeffler and Grossman, 1991). Upon fission of the crypt, these 
stem cells are partitioned randomly between the daughter crypts, so the number of stem 
cell lineages within the crypt will progressively reduce. Over time and with successive 
crypt divisions, monoclonal crypts will result.
5.1.2. Fission of Gastric Glands
More recently, clonal purification of gastric glands has been shown to occur in 
the stomach of the mouse (Nomura et al., 1998). Between 75 % and 85 % of glands are 
clonally mixed immediately after birth but by three months, only 5-15 % remain mixed. 
Fission of gastric glands has been suggested to be responsible for this conversion. 
Invariably, fissioning glands were found with a cleft at the base from which daughter 
glands appeared to unzip along the longitudinal axis of the parent gland. Two rounds of 
fissioning with spatial restructuring of descendant glands were demonstrated to be
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sufficient to explain the observed clonal dynamics on the assumption that the stem cell 
number is small.
5.1.3. Islet Fission?
So, when testing the hypothesis of clonal purification of the pancreatic islets, 
similar mechanisms were considered. Observations of an analogous process to crypt 
fission in the form of any morphologically aberrant islets were to be noted.
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5.2. Materials and Methods
5.2.1. Examination o f  H is to r ic a l  Sections
A morphological examination of islets was made from the 7 pm paraffin 
sections of wholemount X-gal-stained pancreas tissue from the X-inactivation mosaic 
H253 hemizygous female mice of Time-Series One which were subjected to cell lineage 
analysis in Chapter 4. A preliminary examination of general islet shape was made from 
the same 7 pm paraffin sections already prepared from the Time-Series One 
developmental series of animals analysed at PN3 (n or number of animals examined = 
2), PN7 (« = 2), PN14 (in = 2), PN21 (« = 2), PN28 (n = 1), PN12wk (n = 2), PN26wk (« 
= 3) and PN52wk (n = 2). Similarly-prepared 7 pm paraffin sections of wholemount X- 
gal-stained pancreas tissue from PN3-PN52wk homozygous female and transgenic 
(hemizygous) male H253 animals (Time-Series One control animals for ubiquitous 
constitutive lacZ transgene expression in the pancreas) were also subjected to a rapid 
examination of islet morphology. This examination of islet shape was conducted on 
these particular sections, from mice of the H253 strain purely for convenience. There 
was no underlying reason to examine islet morphology in this particular strain 
expressing the p-gal label. Histological sections were cut, processed for 
immunoperoxidase demonstration of either glucagon or insulin then counterstained in 
nuclear Fast Red and mounted in DPX as described in Chapter 4, Section 4.2.2. 
Specimens were examined using a Leica DMRB fluorescent microscope; islets were 
identified using DAB staining for glucagon to highlight the islet periphery. As in 
Chapter 4, an islet was defined as five or more contiguous glucagon-immunopositive 
cells. Images of specimens were taken with a Spot RT Color digital camera (National 
Diagnostics Inc.) and stored as uncompressed 24-bit TIFF images.
5.2.2. Computer-Aided Dumbbell Islet 3D Reconstruction
This work was carried out in conjunction with Dr. Richard Adams. 
Three-dimensional (3D) reconstructions of a representative “dumbbell” islet (explained 
in Section 5.3.1.) and islet distribution in a typical PN3 pancreas were generated from 
images of histochemically-stained sections. Images were captured from serial paraffin 
sections of X-gal- and glucagon-immunoperoxidase-stained H253 pancreata using the
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Spot RT Color camera (National Diagnostics Inc.) in conjunction with the Leica DMRB 
compound microscope. These were stored as 24-bit uncompressed TIFF files.
Following spatial calibration of the images, a Macro running in NIH Image 1.6 
was employed to spatially align serial images to create a z-stack. A straight line was 
positioned between two reference points on consecutive images. The orientation and 
centre-point of each line was calculated and used to rotate and shift the second image 
relative to the target image. The discrete X-gal staining of the islets permitted the blue 
channel from these image stacks to be extracted to provide black and white images 
giving high contrast between islets and surrounding non-stained acini (Chapter 4, 
Section 4.3.1.2.). Then, using the IDL 5.5 (Research Systems, Inc.) program in 
conjunction with a stylus and touch-sensitive flat-panel monitor, the outlines of islets 
were manually traced from the stacks of aligned sections. A single object identity was 
assigned to each islet appearing in consecutive sections and in this manner a tessellated 
surface mesh was generated. This was then exported to the POV-Ray (“Persistence Of 
Vision”) program which projected views of these outlines defining the surface of the 
mesh. A similar mesh was generated for the entire pancreas volume and this was 
rendered as a transparent object to aid the visualisation of the islets in situ. 
QuickTime™ movie files representing 360° or 720° rotations around the modelled 
objects were generated and four still frames extracted from each movie, each separated 
by a 90° rotation.
183
Chapter 5: Dumbbell Islets and Islet Fission
5.3. Results
5.3.1. Observations of “Dumbbell” Islets
Analysis of paraffin sections of pancreas from both sexes and all genotypes of 
H253 mice revealed the presence of irregularly-shaped pancreatic islets. Such islets 
were also observed in immunofluorescence-stained frozen pancreas sections (Fig. 5.1.). 
In contrast to the characteristic ovoid appearance of typical islets, these aberrantly- 
formed variants appeared to be composed of two or, rarely more, conjoined ovoid parts, 
each of which was similar to a more typically-formed islet. The point of contact of the 
parts was marked by a “neck” or “waist” of glucagon-immunopositive cells (Fig. 5.1.), 
delineating the two bodies of p-cells on either side. These uncharacteristic islets were 
coined “dumbbell” islets on account of their morphology and for subsequent 
unequivocal identification, were defined as:
islets composed o f two (or rarely, more) conjoined parts meeting 
in a visible “neck” o f glucagon-immunopositive cells
In this chapter is presented data on the frequency, the 3D structure and the clonal 
composition of the dumbbell islets. All this work was conducted with H253 mice, 
although the p-gal label is only necessary for the cell composition study.
5.3.2. Declining Frequency of Incidence of Dumbbell Islets with Ase
The incidence of dumbbell islets in the 7 pm paraffin sections of X-gal-stained 
pancreas tissue from the H253 hemizygous female mice of Time-Series One (Chapter 
4) of age range PN3 to PN84/12wk was ascertained. As mentioned above, n, the number 
of animals examined at each time-point, was PN3, n = 2; PN7, n = 2; PN14, n = 2; 
PN21, n = 2; PN28, n = 1 and PN12wk, n = 2. A subset of these same pancreas sections 
was subjected to all further analysis described in this chapter. Islets were identified by 
immunoperoxidase staining for glucagon. The incidence of dumbbell islets amongst a 
sample of the total islet population was found to decline quite sharply in the neonatal 
period (Table 5.1. and Graph 5.1.).
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(c). (d).
Figure 5.1. Dumbbell Islets in Histological Sections
(a) and (b) Paraffin sections of wholemount X-gal-stained PN52wk H253 female 
hemizygote pancreas immunoperoxidase-stained for glucagon and counterstained 
with nuclear Fast Red. (c) Frozen section of PN5 H253 female hemizygote pancreas 
immunofluorescence-stained for glucagon (Texas Red) and p-gal (fluorescein).
(d) H & E-stained paraffin section of PN43wk Ripley non-transgenic pancreas 
(Chapter 6). Non-dumbbell islets also visible in (a). Note neck of glucagon- 
immunopositive cells in (a), (b) and (c) (arrows)


















Graph 5.1. Frequency of Dumbbell Islets with Age
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Table 5.1. Frequency of Dumbbell Islets with Age
Age 
(Days PN)
Dumbbell Islet Frequency 
(% of Total Sample)
Islet Sample 
Size, n
3 30.2 ±3.10 55
7 15.0 ±4.89 95
14 5.56 ±3.70 58
21 1.54 ±1.54 80
28 1.87 ±0.47 783
84 4.17 ±4.17 41
5.3.3. Computer-Aided 3D Reconstruction from Histolosical Sections
5.3.3.1. 3D Dumbbell Islet Reconstruction Reveals Dumbbell’s Conjoined State
In order to determine the three-dimensional form of such dumbbell islets, the 
decision was made to conduct a 3D reconstruction of a typical example by computer- 
driven analysis of images of 2D histological sections. Once a suitable dumbbell islet 
had been located by examining random histologically-stained paraffin sections, adjacent 
serial sections through the islet were similarly immunoperoxidase-stained for glucagon. 
A z-stack of serial images of these slices was captured (Fig. 5.2. (a)-(h)) and using 
multiple computer programs, was used to generate a three-dimensional reconstruction. 
A QuickTime™ movie comprising a 360° rotation around the reconstructed islet was 
produced (see Dumbbell on enclosed Movies CD-Rom) and four still images separated 
by 90° rotations were extracted (Fig. 5.2. (i)-(iv)).
The typical dumbbell islet was elongated along one axis in comparison to more 
characteristic spheroidal islets, representing two ovoid islets in apposition at the “neck” 
of the dumbbell. The narrowing at the neck also occurred in the third dimension.
5.3.3.2. 3D Reconstruction o f PN3 Endocrine Tissue Organisation Reveals Islet 
Aggregation
The relatively high incidence of dumbbell islets in the immediate neonatal 
period (Table 5.1.) led to the computer-generation of a similar 3D reconstruction of the 
islet arrangement in the intact pancreas of a PN3 H253 female hemizygous animal. This 
was achieved in a similar manner to the above. A typical PN3 whole pancreas was 
identified by analysing paraffin sections of whole X-gal-stained neonate pancreata.
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Figure 5.2. Histological Appearance and 3D Computer-Aided Reconstruction 
of a Typical Dumbbell Islet
Facing page: (a)-(h) Dumbbell islet in serial 7 pm paraffin sections of 
(wholemount) X-gal-stained pancreas from a PN52wk H253 female 
hemizygote. Sections immunoperoxidase-stained for glucagon
This page: (i)-(iv) Computer-aided 3D reconstruction of pictured dumbbell 
islet shown in four aspects separated by a 90° clockwise rotation. See enclosed 
CD-Rom for full QuickTime™ movie
Bar = 200 pm in both cases
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Adjacent serial sections through the entire pancreas were then immunoperoxidase- 
stained for glucagon and from a z-stack of consecutive images (Fig. 5.3. (a)-(d)), two 
3D reconstructions were generated (see Exposed PN3 Islets and Shrouded PN3 Islets on 
Movies CD-Rom and stills in Fig. 5.3. (i)-(iv)). The first of these shows the exposed 
islet arrangement whilst in the second reconstruction this islet arrangement is shrouded 
by the surrounding acinar tissue of the pancreas. The opacity of the representation of the 
surrounding tissue was necessarily reduced to permit islet visibility to be retained.
The neonatal islets were aggregated in almost a single mass of endocrine tissue 
confined to one extremity of the pancreas tissue with approximately five dissociated 
islet groups located in close proximity. Islets in the main mass appeared to be arranged 
in a bifurcating pattern; three “branches” of islet tissue diverged from a single “trunk”.
5.3.4. Analysis of ft-Gal-Labelled and Unlabelled Cell Composition of 
Dumbbell and Non-Dumbbell Islets
To test the hypotheses that (1) dumbbell islets represented a parent islet in a 
state of division or fission and (2) such islet fission is a mode of islet production in the 
murine pancreas, islet P-gal+ and P-gal' cell composition was next analysed in the 
paraffin sections of X-gal-stained pancreas tissue from the PN3-PN84/12wk H253 
hemizygous female mice of Time-Series One (Chapter 4). n, the number of animals 
examined at each time-point, was PN3, n — 2; PN7, n = 2; PN14, n = 1; PN21, n -  1; 
PN28, n -  1 and PN12wk, n = 1. Over this age-range, the islets are undergoing the 
putative shift from a heterogeneous to a homogeneous cell composition (Chapter 4). 
The rationale for the cell composition analysis is that in any given H253 female 
hemizygous animal, there will be some variability in the cell composition of the islets. 
If the two parts or “sides” of a dumbbell are very similar in composition this suggests 
fission of one large islet, while if the two sides are as different as random islet pairs, it 
suggests the amalgamation or fusion of two islets.
The number of labelled and unlabelled cells was determined for the two sides of 
each dumbbell islet identified in each of between one and four histochemically-stained 
paraffin sections from each PN3-PN84 H253 hemizygous female pancreas. Cell 
composition was generally determined from sections under the microscope although 
larger specimens were scored from hard copies of images. Each islet subjected to 
analysis in this way was scored from only a single cross-section through its volume. The
percentage of P-gal+ cells was then calculated separately for both sides of each
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Figure 5.3. Histological Appearance and 3D Computer-Aided Reconstruction 
of Neonatal (PN3) Endocrine Tissue Organisation
This page: (a)-(d) Islet arrangement in four sample 7 pm paraffin sections of 
(wholemount) X-gal-stained pancreas from a PN3 H253 female hemizygote 
Sections immunoperoxidase-stained for glucagon. Bar = 500 pm
Facing page: Top panel: (iH*v) Computer-aided 3D reconstruction of 
pictured islet organisation shown in four aspects separated by a 90° clockwise 
rotation. Bar = 250 pm
Lower panel: (i)-(iv) Above reconstructed endocrine arrangement shrouded 
by surrounding acinar tissue (navy blue). Bar = 500 pm 
See enclosed CD-Rom for full QuickTime™ movies
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dumbbell as: (number of P-gal+ cells/total number of p-gal+ + p-gal' cells) x 100. 
Percentage similarity in p-gal+/p-gal" cell composition between the two sides of each of 
the 23 identified dumbbells was then calculated as: 100 - difference in percentage P-gal+ 
cells (Fig. 5.4. and Table 5.2.). It should be noted that this value is the same regardless 
of whether it is calculated by subtracting from 100 the difference in percentage of P-gal+ 
cells or the difference in percentage of p-gal' cells. In each of the dumbbell-containing 
sections, cell composition and percentage of P-gal+ cells was similarly scored in a 
random sample of non-dumbbell pairs and the “edge-to-edge” and “centre-to-centre” 
inter-islet distances between each of the two islets in the pair determined (Fig. 5.4.). 
Again, cell composition analysis was restricted to only a single cross-section through 
each of the selected islets. Percentage similarity in p-gal+/p-gal' cell composition 
between the two non-dumbbell islets of each of 65 islet pairs was calculated as for the 
two sides of each dumbbell islet (Fig. 5.4. and Table 5.3.).
5.3.4.1. Hish Similarity in Cell Composition Between the Two Sides o f  a Dumbbell
Similarity in labelled/unlabelled cell composition between the two parts of each 
dumbbell islet was first analysed. Each of the two parts of each dumbbell islet was 
assigned either “side 1” or “side 2” arbitrarily. Linear regression of percentage P-gal+ 
cell composition of side 1 against percentage P-gal+ cell composition of side 2 
(Minitab™ v. 13 statistical software package) yielded a significant positive correlation 
(Graph 5.2.); R2 = 76.3 %, R2a = 75.2 %. R2 is the coefficient o f determination for a 
multiple regression or correlation and is considered to be a measure of “goodness of fit”
• • 9of a given regression model although R a, the adjusted coefficient o f determination, 
gives a more accurate measure of this. The Spearman rank correlation coefficient rs 
(Spearman, 1904) for non-normal data was calculated to test for a correlation (Table
5.4.). There was found to be a significant positive correlation between the percentage P- 
gal+ cell composition of side 1 and the percentage p-gal+ cell composition of side 2 for 
the 23 dumbbell islets; calculated rs = 0.742; (rs)o.o5(2), 23 = 0.415, so Ho was rejected.
5.3.4.2. Cell Composition Similarity o f  Two Islets is Inversely Related to their 
Separation
Next, similarity in cell composition between the 65 non-dumbbell islet pairs
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Figure 5.4. Calculating Percentage Similarity of p-GaF/p-Gal' Cell Composition 
Between the Two Sides of a Dumbbell Islet and Between Two Random Non- 
Dumbbell Islets
Dumbbell Islet Side 1 Side 2
I
% p-gal+ cells = 10 % p-gal+ cells = 10
9+10 x 100 9+10 x 100
= 52.6 % = 52.6 %
So, % similarity in p-gal+/p-gal* cell composition =
100-(52.6-52.6) = 100%
100
% p-gal+ cells = 5
14+5 x 100
= 26.3 %
So, % similarity in p-gal+/p-gal' cell composition =
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Table 5.2. P-Gal+ and p-Gal" Cell Composition of the Two Sides of Dumbbell Islets 
and Percentage Similarity Between the Two (n = 23)
DUMBBELL ISLET SIDE 1 DUMBBELL ISLET SIDE 2 % Cell 
Composition 
Similarity
p-Gal+ P-Gal- % P-
Gal+
p-Gal+ P-Gal" % P-
Gal+
109 104 51.17 70 106 39.77 88.6
23 36 38.98 14 17 45.16 93.82
30 154 16.3 64 164 28.07 88.23
114 148 43.51 76 95 44.44 99.07
76 108 41.3 76 53 58.91 82.39
124 82 60.19 30 39 43.48 83.29
95 22 81.2 68 23 74.73 93.53
35 19 64.81 35 21 62.5 97.69
127 91 58.26 129 81 61.43 96.83
34 16 68 61 31 66.3 98.3
42 28 60 45 18 71.43 88.57
56 70 44.44 79 72 52.32 92.12
35 34 50.72 81 38 68.07 82.65
73 71 50.69 63 62 50.4 99.71
71 28 71.72 84 66 56 84.28
49 46 51.58 23 23 50 98.42
46 104 30.67 16 71 18.39 87.72
46 38 54.76 61 40 60.4 94.36
13 7 65 12 15 44.44 79.44
29 54 34.94 20 45 30.77 95.83
230 11 95.44 238 3 98.76 96.68
188 14 93.07 437 9 97.98 95.09
147 4 97.35 762 68 91.81 94.46
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Table 5.3. P-Gal+ and P-Gal’ Cell Composition of Two Non-Dumbbell Islets, 
Percentage Similarity Between them and Inter-Islet Distance (Edge-to-Edge) 




ISLET 1 ISLET 2 % Cell 
Composition 
Similarity
P-Gal+ P-Gal' % P-
Gal+
p-Gal+ P-Gal' % P-
Gal+
654.7 46 15 75.41 16 38 29.63 54.22
107.1 35 47 42.68 18 0 100 42.68
1086.2 20 33 37.74 55 42 56.7 81.04
54.8 5 81 5.814 17 109 13.49 92.32
31.1 22 17 56.41 21 7 75 81.41
1011.8 17 18 48.57 9 21 30 81.43
425 31 49 38.75 44 35 55.7 83.05
95.9 49 56 46.67 43 49 46.74 99.93
530 52 33 61.18 56 30 65.12 96.06
114.5 75 45 62.5 38 5 88.37 74.13
224.1 32 13 71.11 138 95 59.23 88.12
982.1 27 30 47.37 135 78 63.38 83.99
714.2 36 17 67.92 36 44 45 77.08
39.8 30 38 44.12 30 30 50 94.12
24.9 24 58 29.27 24 82 22.64 93.37
1259.8 34 69 33.01 13 52 20 86.99
7.47 34 50 40.48 49 57 46.23 94.25
649.8 47 37 55.95 49 37 56.98 98.97
320 98 56 63.64 36 85 29.75 66.11
19.9 27 12 69.23 22 11 66.67 97.44
734.1 19 6 76 81 49 62.31 86.31
89.6 58 84 40.85 58 86 40.28 99.43
64.7 247 7 97.24 61 0 100 97.24
139.4 112 0 100 76 0 100 100
79.7 328 16 95.35 74 4 94.87 99.52
174.3 43 5 89.58 38 0 100 89.58
430 148 6 96.1 33 2 94.29 98.19
5420 632 0 100 0 80 0 0
2420 69 2 97.18 0 348 0 2.82
1071.4 123 8 93.89 14 11 56 62.11
154.4 22 54 28.95 424 26 94.22 65.27
907.7 28 123 18.54 358 69 83.84 34.7
1408.6 4 13 23.53 12 37 24.49 99.04
42.3 0 18 0 3 12 20 80
29.9 22 32 40.74 17 49 25.76 85.02
744 21 4 84 13 57 18.57 34.57
390 39 27 59.09 92 155 37.25 78.16
234.1 39 67 36.79 64 159 28.7 91.91
14.9 33 11 75 45 25 64.29 89.29
808.5 19 80 19.19 20 20 50 69.19
75.9 10 19 34.48 10 24 29.41 94.93
1011.8 14 14 50 7 16 30.43 80.43
4.98 37 45 45.12 44 45 49.44 95.68
615 5 5 50 36 23 61.02 88.98
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67.2 27 22 55.1 78 167 31.84 76.74
892.8 73 48 60.33 17 20 45.95 85.62
714.2 36 42 76.31 44 19 69.84 76.31
26.1 47 47 50 10 6 62.5 87.5
78.4 14 9 60.87 16 7 69.57 91.3
405 29 26 52.73 35 66 34.65 81.92
902.7 11 47 18.97 17 15 53.13 65.84
1121 14 58 19.44 98 94 51.04 68.4
52.3 32 90 26.23 64 203 23.97 97.74
525 84 74 53.16 30 28 51.72 98.56
395 8 1 88.89 24 45 34.78 45.89
244 73 45 92.63 9 4 69.23 92.63
27.4 6 13 31.58 29 47 38.16 93.42
725 46 75 38.02 33 22 60 78.02
1720 27 38 41.54 37 37 50 91.54
140 102 95 51.78 303 169 64.19 87.59
672.5 4 49 7.547 5 74 6.329 98.78
273.9 115 23 83.33 132 162 44.9 61.57
1061.4 15 234 6.02 91 178 33.83 72.19
143.2 4 5 44.44 7 12 36.84 92.4
694.4 0 18 0 43 50 46.24 53.76
NB: Centre-to-centre inter-islet distances were not recorded as the data was not 
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Graph 5.2. Relationship Between the Percentages of P-GaP Cells in the 
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Table 5.4. Calculation of the Spearman Rank Correlation Coefficient rs to Test for 
a Correlation Between the Percentage P-Gal+ Cell Composition of Side 1 Against 










Rank of Xi % P-Gal+ 
T O
Rank of Yi
51.17 10 39.77 4 6 36
38.98 4 45.16 8 -4 16
16.3 1 28.07 2 -1 1
43.51 6 44.44 6.5 -0.5 0.25
41.3 5 58.91 13 -8 64
60.19 15 43.48 5 10 100
81.2 20 74.73 20 0 0
64.81 16 62.5 16 0 0
58.26 13 61.43 15 -2 4
68 18 66.3 17 1 1
60 14 71.43 19 -5 25
44.44 7 52.32 11 -4 16
50.72 9 68.07 18 -9 81
50.69 8 50.4 10 -2 4
71.72 19 56 12 7 49
51.58 11 50 9 2 4
30.67 2 18.39 1 1 1
54.76 12 60.4 14 -2 4
65 17 44.44 6.5 10.5 110.25
34.94 3 30.77 3 0 0
95.44 22 98.76 23 -1 1
93.07 21 97.98 22 -1 1
97.35 23 91.81 21 2 4
Edi2 522.5
Spearman rank correlation coefficient, rs = 1 - 6 x (Edh
n3 -n
;.rs = 1 - 6 x 522.5 = 1 - 3135
233 - 23 12167 - 23
:.rs = 1 - 3135 = 1 -0.258 = 0.742
12144
Wo.o5(2), 23 = 0.415, so Ho is rejected. There is a significant positive correlation between
the percentage p-gal+ cell composition of side 1 and the percentage p-gal+ cell
composition of side 2 for the identified dumbbell islets.
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with inter-islet (edge-to-edge) distance between each pair was investigated. A linear 
regression plot was generated (Minitab™ v. 13) for similarity of cell composition 
against inter-islet distance (Graph 5.3.); R2 = 38.6 %, R2a = 37.7 %. rs was again 
calculated (Table 5.5.). There was found to be a significant negative correlation 
between the similarity in cell composition between two non-dumbbell islets and the 
distance between them; calculated rs = -0.441; (rJ)o.o5(2), 65 = 0.244, so Ho was rejected. 
As the plot (Graph 5.3.) revealed the existence of two outlying data points (outlier A = 
5420 pm inter-islet distance/0 % cell composition similarity and outlier B = 2420 pm 
inter-islet distance/2.82 % cell composition similarity) outside the main body of data, a 
second regression plot was produced excluding both of these two outliers (Graph 5.4.); 
R2 = 7.3 %, R2a = 5.7 %. rs was then calculated for this smaller data set (Table 5.6.). 
There was found to be a slightly weaker although still significant negative correlation 
between the similarity in cell composition between two non-dumbbells and their 
distance of separation; calculated rs = -0.387; (rs)0 .05(2), 63 = 0.248, so Ho was rejected. 
Two further regression plots were then generated excluding either outlier A alone 
(Graph 5.5.; R2 = 21.3 %, R2a = 20.0 %) or outlier B alone (Graph 5.6.; R2 = 32.6 %, 
R2a = 31.5 %). rs was then calculated for the data set excluding outlier A (Table 5.7.) 
and for the data set excluding outlier B (Table 5.8.). The removal of either outlier alone 
gave the same value for rs of -0.415, and since (rs)o.o5(2), 64 = 0.246 then this gave a 
significant negative correlation of intermediate strength between that calculated for the 
complete data set and that determined for the same data set excluding both outliers. 
Clearly, even in the absence of the two outliers which strengthen the correlation, there is 
a significant negative correlation between the similarity in cell composition between 
two non-dumbbell islets and the distance between them.
5.3.4.3. Mean Cell Composition Similarity o f the Two Sides o f a Dumbbell Islet 
Agrees with that for Two Non-Dumbbells at Zero Separation
The y-intercepts of 89.3 % (whole data set), 87.0 % (data set excluding both 
outliers), 89.7 % (data set excluding outlier A) and 88.7 % (data set excluding outlier B) 
on the linear regression plots (Graphs 5.3. to 5.6.) represent the percentage similarity of 
cell composition between islets whose edges are separated by zero distance. Dumbbell 
islets comply with such a criterion; mean percentage similarity of cell composition 
between the two sides of the 23 dumbbell islets at 91.8 %, is in very close accordance 
with these values.
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Graph 5.3. Relationship Between Percentage Similarity of (3-Ga!7 
(3-Gal' Cell Composition of Two Non-Dumbbell Islets with Edge-to- 
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Table 5.5. Calculation of the Spearman Rank Correlation Coefficient rs to Test for 
a Correlation Between the Similarity in Cell Composition Between Non-Dumbbell 
Islet Pairs with Inter-Islet (Edge-to-Edge) Distance Between Each Pair (n = 65)
Distance 
(pm) (Xi)




Rank of Yi di
(Xi-YO
A ^di
654.7 42 54.22 8 34 1156
107.1 21 42.68 5 16 256
1086.2 59 81.04 25 34 1156
54.8 13 92.32 44 -31 961
31.1 9 81.41 26 -17 289
1011.8 55.5 81.43 27 28.5 812.25
425 36 83.05 29 7 49
95.9 20 99.93 64 -44 1936
530 39 96.06 53 -14 196
114.5 22 74.13 17 5 25
224.1 28 88.12 37 -9 81
982.1 54 83.99 30 24 576
714.2 45.5 77.08 20 25.5 650.25
39.8 10 94.12 49 -39 1521
24.9 5 93.37 47 -42 1764
1259.8 61 86.99 34 27 729
7.47 2 94.25 50 -48 2304
649.8 41 98.97 60 -19 361
320 32 66.11 13 19 361
19.9 4 97.44 55 -51 2601
734.1 48 86.31 33 15 225
89.6 19 99.43 62 -43 1849
64.7 14 97.24 54 -40 1600
139.4 23 100 65 -42 1764
79.7 18 99.52 63 -45 2025
174.3 27 89.58 40 -13 169
430 37 98.19 57 -20 400
5420 65 0 1 64 4096
2420 64 2.82 2 62 3844
1071.4 58 62.11 10 48 2304
154.4 26 65.27 11 15 225
907.7 53 34.7 4 49 2401
1408.6 62 99.04 61 1 1
42.3 11 80 23 -12 144
29.9 8 85.02 31 -23 529
744 49 34.57 3 46 2116
390 33 78.16 22 11 121
234.1 29 91.91 43 -14 196
14.9 3 89.29 39 -36 1296
808.5 50 69.19 15 35 1225
75.9 16 94.93 51 -35 1225
1011.8 55.5 80.43 24 31.5 992.25
4.98 1 95.68 52 -51 2601
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615 40 88.98 38 2 4
67.2 15 76.74 19 -4 16
892.8 51 85.62 32 19 361
714.2 45.5 76.31 18 27.5 756.25
26.1 6 87.5 35 -29 841
78.4 17 91.3 41 -24 576
405 35 81.92 28 7 49
902.7 52 65.84 12 40 1600
1121 60 68.4 14 46 2116
52.3 12 97.74 56 -44 1936
525 38 98.56 58 -20 400
395 34 45.89 6 28 784
244 30 92.63 46 -16 256
27.4 7 93.42 48 -41 1681
725 47 78.02 21 26 676
1720 63 91.54 42 21 441
140 24 87.59 36 -12 144
672.5 43 98.78 59 -16 256
273.9 31 61.57 9 22 484
1061.4 57 72.19 16 41 1681
143.2 25 92.4 45 -20 400
694.4 44 53.76 7 37 1369
Ed,2 65960
Spearman rank correlation coefficient, rs = 1 - 6 x (Edh
n3 - n
:.rs = 1 - 6 x 65960 
653 - 65
:.rs = 1 - 395760
274625 - 65




Wo.05(2), 65 = 0.244, so Ho is rejected. There is a significant negative correlation between
the similarity in cell composition between two non-dumbbell islets and the distance
between them; calculated rs = -0.441.
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Table 5.6. Calculation of the Spearman Rank Correlation Coefficient rs to Test for 
a Correlation Between the Similarity in Cell Composition Between Non-Dumbbell 
Islet Pairs with Inter-Islet (Edge-to-Edge) Distance Between Each Pair (Excluding 
Both of the Two Outliers from the Data Set Used in Table 5.5.; n = 63)
Distance 
(pm) (XO




Rarfk of Yj di
(Xi-Yi)
di2
654.7 42 54.22 6 36 1296
107.1 21 42.68 3 18 324
1086.2 59 81.04 23 36 1296
54.8 13 92.32 42 -29 841
31.1 9 81.41 24 -15 225
1011.8 55.5 81.43 25 30.5 930.25
425 36 83.05 27 9 81
95.9 20 99.93 62 -42 1764
530 39 96.06 51 -12 144
114.5 22 74.13 15 7 49
224.1 28 88.12 35 -7 49
982.1 54 83.99 28 26 676
714.2 45.5 77.08 18 27.5 756.25
39.8 10 94.12 47 -37 1369
24.9 5 93.37 45 -40 1600
1259.8 61 86.99 32 29 841
7.47 2 94.25 48 -46 2116
649.8 41 98.97 58 -17 289
320 32 66.11 11 21 441
19.9 4 97.44 53 -49 2401
734.1 48 86.31 31 17 289
89.6 19 99.43 60 -41 1681
64.7 14 97.24 52 -38 1444
139.4 23 100 63 -40 1600
79.7 18 99.52 61 -43 1849
174.3 27 89.58 38 -11 121
430 37 98.19 55 -18 324
1071.4 58 62.11 8 50 2500
154.4 26 65.27 9 17 289
907.7 53 34.7 2 51 2601
1408.6 62 99.04 59 3 9
42.3 11 80 21 -10 100
29.9 8 85.02 29 -21 441
744 49 34.57 1 48 2304
390 33 78.16 20 13 169
234.1 29 91.91 41 -12 144
14.9 3 89.29 37 -34 1156
808.5 50 69.19 13 37 1369
75.9 16 94.93 49 -33 1089
1011.8 55.5 80.43 22 33.5 1122.25
4.98 1 95.68 50 -49 2401
615 40 88.98 36 4 16
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67.2 15 76.74 17 -2 4
892.8 51 85.62 30 21 441
714.2 45.5 76.31 16 29.5 870.25
26.1 6 87.5 33 -27 729
78.4 17 91.3 39 -22 484
405 35 81.92 26 9 81
902.7 52 65.84 10 42 1764
1121 60 68.4 12 48 2304
52.3 12 97.74 54 -42 1764
525 38 98.56 56 -18 324
395 34 45.89 4 30 900
244 30 92.63 44 -14 196
27.4 7 93.42 46 -39 1521
725 47 78.02 19 28 784
1720 63 91.54 40 23 529
140 24 87.59 34 -10 100
672.5 43 98.78 57 -14 196
273.9 31 61.57 7 24 576
1061.4 57 72.19 14 43 1849
143.2 25 92.4 43 -18 324
694.4 44 53.76 5 39 1521
Id ,2 57768
Spearman rank correlation coefficient, rs = 1 - 6 x (Ixl?}
n3 - n
:.rs = 1 - 6 x 57768 
63s - 63
.*. rs = 1 - 346608
250047 - 63




(a )o .o 5(2), 63 =  0 .248, so Ho is rejected. There is a significant negative correlation between
the similarity in cell composition between two non-dumbbell islets and the distance
between them; calculated rs = -0 .387.
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Graph 5.5. Relationship Between Percentage Similarity of P-Gal+/ 
p-Gal‘ Cell Composition of Two Non-Dumbbell Islets with Edge-to-Edge 
Inter-Islet Distance (Outlier A - 5420 pm/0 % - Excluded; n = 64 Pairs)
R2 = 21.3 % 
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Graph 5.6. Relationship Between Percentage Similarity of P-Gal+/
P-Gal Cell Composition of Two Non-Dumbbell Islets with Edge-to-Edge 
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Table 5.7. Calculation of the Spearman Rank Correlation Coefficient rs to Test for 
a Correlation Between the Similarity in Cell Composition Between Non-Dumbbell 
Islet Pairs with Inter-Islet (Edge-to-Edge) Distance Between Each Pair (Excluding 
Only Outlier A - 5420 pm/0 % - from the Data Set Used in Table 5.5.; n = 64)
Distance 
(pm) (Xi)




Rank of Yi di
(Xi-Yi)
di2
654.7 42 54.22 7 35 1225
107.1 21 42.68 4 17 289
1086.2 59 81.04 24 35 1225
54.8 13 92.32 43 -30 900
31.1 9 81.41 25 -16 256
1011.8 55.5 81.43 26 29.5 870.25
425 36 83.05 28 8 64
95.9 20 99.93 63 -43 1849
530 39 96.06 52 -13 169
114.5 22 74.13 16 6 36
224.1 28 88.12 36 -8 64
982.1 54 83.99 29 25 625
714.2 45.5 77.08 19 26.5 702.25
39.8 10 94.12 48 -38 1444
24.9 5 93.37 46 -41 1681
1259.8 61 86.99 33 28 784
7.47 2 94.25 49 -47 2209
649.8 41 98.97 59 -18 324
320 32 66.11 12 20 400
19.9 4 97.44 54 -50 2500
734.1 48 86.31 32 16 256
89.6 19 99.43 61 -42 1764
64.7 14 97.24 53 -39 1521
139.4 23 100 64 -41 1681
79.7 18 99.52 62 -44 1936
174.3 27 89.58 39 -12 144
430 37 98.19 56 -19 361
2420 64 2.82 1 63 3969
1071.4 58 62.11 9 49 2401
154.4 26 65.27 10 16 256
907.7 53 34.7 3 50 2500
1408.6 62 99.04 60 2 4
42.3 11 80 22 -11 121
29.9 8 85.02 30 -22 484
744 49 34.57 2 47 2209
390 33 78.16 21 12 144
234.1 29 91.91 42 -13 169
14.9 3 89.29 38 -35 1225
808.5 50 69.19 14 36 1296
75.9 16 94.93 50 -34 1156
1011.8 55.5 80.43 23 32.5 1056.25
4.98 1 95.68 51 -50 2500
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615 40 88.98 37 3 9
67.2 15 76.74 18 -3 9
892.8 51 85.62 31 20 400
714.2 45.5 76.31 17 28.5 812.25
26.1 6 87.5 34 -28 784
78.4 17 91.3 40 -23 529
405 35 81.92 27 8 64
902.7 52 65.84 11 41 1681
1121 60 68.4 13 47 2209
52.3 12 97.74 55 -43 1849
525 38 98.56 57 -19 361
395 34 45.89 5 29 841
244 30 92.63 45 -15 225
27.4 7 93.42 47 -40 1600
725 47 78.02 20 27 729
1720 63 91.54 41 22 484
140 24 87.59 35 -11 121
672.5 43 98.78 58 -15 225
273.9 31 61.57 8 23 529
1061.4 57 72.19 15 42 1764
143.2 25 92.4 44 -19 361
694.4 44 53.76 6 38 1444
M a. 61800
Spearman rank correlation coefficient, rs = 1 - 6 x fUd/)
n3 -
:.rs = 1 - 6 x 61800 
643 - 64
;.rs = 1 - 370800
262144 - 64




fa)0.05(2), 64 = 0.246, so Ho is rejected. There is a significant negative correlation between
the similarity in cell composition between two non-dumbbell islets and the distance
between them; calculated rs = -0.415.
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Table 5.8. Calculation of the Spearman Rank Correlation Coefficient rs to Test for 
a Correlation Between the Similarity in Cell Composition Between Non-Dumbbell 
Islet Pairs with Inter-Islet (Edge-to-Edge) Distance Between Each Pair (Excluding 
Only Outlier B - 2420 pm/2.82 % - from the Data Set Used in Table 5.5.; n = 64)
Distance 
(pm) (XO




Rank of Yi di
(Xi-Yi)
di2
654.7 42 54.22 7 35 1225
107.1 21 42.68 4 17 289
1086.2 59 81.04 24 35 1225
54.8 13 92.32 43 -30 900
31.1 9 81.41 25 -16 256
1011.8 55.5 81.43 26 29.5 870.25
425 36 83.05 28 8 64
95.9 20 99.93 63 -43 1849
530 39 96.06 52 -13 169
114.5 22 74.13 16 6 36
224.1 28 88.12 36 -8 64
982.1 54 83.99 29 25 625
714.2 45.5 77.08 19 26.5 702.25
39.8 10 94.12 48 -38 1444
24.9 5 93.37 46 -41 1681
1259.8 61 86.99 33 28 784
7.47 2 94.25 49 -47 2209
649.8 41 98.97 59 -18 324
320 32 66.11 12 20 400
19.9 4 97.44 54 -50 2500
734.1 48 86.31 32 16 256
89.6 19 99.43 61 -42 1764
64.7 14 97.24 53 -39 1521
139.4 23 100 64 -41 1681
79.7 18 99.52 62 -44 1936
174.3 27 89.58 39 -12 144
430 37 98.19 56 -19 361
5420 64 0 1 63 3969
1071.4 58 62.11 9 49 2401
154.4 26 65.27 10 16 256
907.7 53 34.7 3 50 2500
1408.6 62 99.04 60 2 4
42.3 11 80 22 -11 121
29.9 8 85.02 30 -22 484
744 49 34.57 2 47 2209
390 33 78.16 21 12 144
234.1 29 91.91 42 -13 169
14.9 3 89.29 38 -35 1225
808.5 50 69.19 14 36 1296
75.9 16 94.93 50 -34 1156
1011.8 55.5 80.43 23 32.5 1056.25
4.98 1 95.68 51 -50 2500
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615 40 88.98 37 3 9
67.2 15 76.74 18 -3 9
892.8 51 85.62 31 20 400
714.2 45.5 76.31 17 28.5 812.25
26.1 6 87.5 34 -28 784
78.4 17 91.3 40 -23 529
405 35 81.92 27 8 64
902.7 52 65.84 11 41 1681
1121 60 68.4 13 47 2209
52.3 12 97.74 55 -43 1849
525 38 98.56 57 -19 361
395 34 45.89 5 29 841
244 30 92.63 45 -15 225
27.4 7 93.42 47 -40 1600
725 47 78.02 20 27 729
1720 63 91.54 41 22 484
140 24 87.59 35 -11 121
672.5 43 98.78 58 -15 225
273.9 31 61.57 8 23 529
1061.4 57 72.19 15 42 1764
143.2 25 92.4 44 -19 361
694.4 44 53.76 6 38 1444
Xd|2 61800
Since for the two outliers A and B, XA (5420 pm) is ranked 65 of 65 and Xb (2420 pm) 
is ranked 64 of 65 and their corresponding figures for percentage cell composition 
similarity are ranked 1 of 65 (YA = 0 %) and 2 of 65 (Y b = 2.82 %) then removal of 
either outlier from the data set gives the same value for rs. As Zdj2 = 61800 as was 
calculated for Table 5.7. and n = 64 as before, then the calculated rs = -0.415. As 
Wo.05(2), 64 = 0.246, then Ho is rejected. There is a significant negative correlation 
between the similarity in cell composition between two non-dumbbell islets and the 
distance between them.
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5.3.5, Islets of Similar Cell Composition Occur in Discrete Groups
Analysis of the histochemically-stained pancreas sections from the 
developmental series of H253 hemizygous females revealed that islets of a certain p- 
gal+ or p-gal' cell composition showed a tendency to occur together. Discrete groups of 
homogeneous P-gal+ islets and heterogeneous p-gal+/p-gal" islets were seen within the 
same tissue section; patches of homogeneous unlabelled islets were also observed (Fig. 
5.5.).
5.3.6. No Marked Distinction Between Ranges o f Dumbbell and Non- 
Dumbbell Islet Areas
It would be expected that if dumbbells are islets undergoing fission, they would 
be larger than non-dumbbell islets. This hypothesis was tested by comparing the cross- 
sectional areas (cell number) of the 23 dumbbell and 130 (65 pairs of) non-dumbbell 
islets (Graph 5.7.), calculated from Tables 5.2. and 5.3. The data ranges for the two 
islet classes were seen to superpose to quite some extent. However, minimum and 
maximum dumbbell islet areas were 5.2- and 2.9-fold greater than those for non­
dumbbells and the mean islet areas were 295 ± 43.6 cells and 102 ± 8.76 cells for 
dumbbell and non-dumbbell islets respectively (Table 5.9.). Using the two-sample £-test 
(Minitab™ v. 13), there was found to be a significant difference between cross-sectional 
area of dumbbell and non-dumbbell islets (at a(2) = 0.05, t = 4.35; P = 0). Dumbbell 
islets exhibit a significantly greater cross-sectional area than that of non-dumbbell islets.
Table 5.9. Islet Cross-Sectional Area Descriptive Statistics
Statistic Sectional Area (Cell Number)
Dumbbells Non-Dumbbells
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Figure 5.5. Islets of Similar Cell Composition Occur in Groups
(a) and (b) Patches of homogeneous P-gal+ islets, (c) Group of heterogeneous P- 
gal+/p-gal islets and (d) homogeneous P-gal islets







Graph 5.7. Frequency Histogram of Cross-Sectional Areas of Dumbbell and Non-Dumbbell Islets
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5.3.7. Areas on Both Sides of Dumbbell Islets are Generally Equal
Finally, an examination was made into whether the dumbbells of fissioning 
islets divide symmetrically. Linear regression plots were generated (Minitab™ v. 13) for 
area (total number of cells) on side 1 against the area (total number of cells) on side 2 
for the identified dumbbell islets (Graph 5.8.). rs was again calculated (Table 5.10.). 
There was found to be a significant positive correlation between the number of cells on 
each side of the dumbbells; calculated rs = 0.736; (r y )0.05(2), 23 = 0.415, so Ho was 
rejected. As the plot (Graph 5.8.) revealed the existence of two outlying data points 
outside the main body of data, a second regression plot was produced excluding both of 
these two outliers (Graph 5.9.); R2 = 56.4 %, R2a = 54.1 %. rs was then calculated for 
this smaller data set (Table 5.11.). Excluding these two outlying data points there was 
found to be an even stronger significant positive correlation between the number of cells 
on each dumbbell side; calculated rs = 0.750; (rs)o.o5(2),2 i = 0.435, so H0 was rejected.
5.3.7.1. Observations o f Dumbbell Islets with Asymmetrical and/or Multiple “Sides”
On rare occasions when examining the X-gal-stained paraffin sections from the 
PN3-PN52wk H253 female hemizygote pancreata (Time-Series One), dumbbell islets 
were observed displaying highly asymmetrical sides in 2D sections (Fig. 5.6.). Such 
dumbbell islets therefore reflect the existence of the outlying data points mentioned 
above when plotting the area (total number of cells) on side 1 against the area (total 
number of cells) on side 2 for the 23 identified dumbbell islets. Also and again very 
infrequently, morphologically aberrant islets complying with the dumbbell islet 
criterion (islets composed o f two or rarely, more conjoined parts meeting in a visible 
“neck” o f glucagon-immunopositive cells) were observed in histochemically-stained 
paraffin sections from PN52wk H253 female hemizygote pancreata (Fig 5.7.). Such 
dumbbell islets exhibited more than two “sides”. Both forms of morphologically 
atypical dumbbell islets occurred at a markedly lower frequency than the typical 
dumbbell islets with two sides of equal area and the atypical dumbbell islets also tended 
to occur in older (PN52wk) animals.
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Graph 5.8. Relationship Between the Areas (Total Numbers of Cells) 
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Graph 5.9. Relationship Between the Areas (Total Numbers of Cells) of 
the Two Sides of Each of 21 Dumbbell Islets (Both Outliers Excluded)
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Table 5.10. Calculation of the Spearman Rank Correlation Coefficient rs to Test 
for a Correlation Between the Area (Total Number of Cells) on Side 1 and the 















213 4 176 6 -2 4
59 20 31 22 -2 4
184 7.5 228 4 3.5 12.25
262 1 171 7 -6 36
184 7.5 129 10 -2.5 6.25
206 5 69 17 -12 144
117 13 91 15 -2 4
54 21 56 20 1 1
218 3 210 5 -2 4
50 22 92 14 8 64
70 18 63 19 -1 1
126 12 151 8 4 16
69 19 119 12 7 49
144 11 125 11 0 0
99 14 150 9 5 25
95 15 46 21 -6 36
150 10 87 16 -6 36
84 16 101 13 3 9
20 23 27 23 0 0
83 17 65 18 -1 1
241 2 241 3 -1 1
202 6 446 2 4 16
151 9 830 1 8 64
Ed,2 533.5
Spearman rank correlation coefficient, rs = 1 - 6 x (Udh
3n - n
:.rs = 1 - 6 x 533.5 = 1 - 3201
233 - 23 12167 - 23
:.rs = 1 - 3201 = 1 -0.264 = 0.736
12144
(rs)o.o5(2), 23 = 0.415, so Ho is rejected. There is a significant positive correlation between 
the number of cells on each side of the identified dumbbell islets.
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Table 5.11. Calculation of the Spearman Rank Correlation Coefficient rs to Test 
for a Correlation Between the Area (Total Number of Cells) on Side 1 and the 
Area (Total Number of Cells) on Side 2 for Dumbbell Islets (Excluding Both of the 















213 4 176 4 0 0
59 18 31 20 -2 4
184 6.5 228 2 4.5 20.25
262 1 171 5 -4 16
184 6.5 129 8 -1.5 2.25
206 5 69 15 -10 100
117 11 91 13 -2 4
54 19 56 18 1 1
218 3 210 3 0 0
50 20 92 12 8 64
70 16 63 17 -1 1
126 10 151 6 4 16
69 17 119 10 7 49
144 9 125 9 0 0
99 12 150 7 5 25
95 13 46 19 -6 36
150 8 87 14 -6 36
84 14 101 11 3 9
20 21 27 21 0 0
83 15 65 16 -1 1
241 2 241 1 1 1
Zdt2 385.5
Spearman rank correlation coefficient, rs = 1 - 6 x (Z dh
n3 - n
:.rs = 1 - 6x  385.5 = 1 - 2313
213 - 21 9261 -21
:.rs = 1 - 2313 = 1 -0.250 = 0.750
9240
Mo .05(2), 21 0.435, so Ho is rejected. There is a significant positive correlation between
the number of cells on each side of the identified dumbbell islets.
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(a). (b).
Figure 5.6. Infrequent Dumbbell Islets with Asymmetrical Sides
Paraffin sections of wholemount X-gal-stained PN52wk H253 female hemizygote 
pancreas immunoperoxidase-stained for glucagon and counterstained with nuclear 
Fast Red. (b) Asymmetrically dividing dumbbells are visible on the lower left and 
upper right; a larger, more typical symmetrically dividing dumbbell is shown on 
the upper left, (a) Bar = 100 pm; (b) Bar = 200 pm
(a). (b).
Figure 5.7. Infrequent Dumbbell Islets with Multiple “Sides”
Paraffin section of wholemount X-gal-stained PN52wk H253 female hemizygote 
pancreas immunoperoxidase-stained for glucagon and counterstained with nuclear 
Fast Red. (a) Bar = 200 pm; (b) Bar = 100 pm
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5.4. Discussion
5.4.1. Observations of “Dumbbell” Islets and their Frequency with Age
Uncharacteristically-shaped islets were observed in paraffin and frozen sections 
of pancreas from both sexes and all genotypes of H253 animals although presumably 
occur in all strains of mice. They were coined dumbbell islets on account of their 
(generally) hourglass form in 2D sections, comprising, in the vast majority of cases, two 
conjoined ovoid parts. In all dumbbell islets, an obvious neck or waist of glucagon- 
immunopositive a-cells delineated the two (or more) sides of the islet and this waist sets 
such islets apart from more typically-formed islets. Computer-aided 3D reconstruction 
of a typical dumbbell showed these islets to comprise two ovoids conjoined to form a 
neck, resembling a pair of rugby balls fused together at their pointed ends. This 
narrowing at the neck was seen to occur in the third dimension so that the dumbbell islet 
truly possesses this hourglass waist as seen from all aspects.
Dumbbell islets were found to occur most frequently in the pancreas of neonates 
immediately after birth, comprising almost one-third of the islets in three-day old mice. 
Their incidence then declined sharply to 15.0 % by one week of age and by 28 days 
after birth, dumbbell islets comprised less than 2 % of all islets.
5.4.2. Islet Fission or Fusion?
It was a point of interest whether these morphologically atypical dumbbell islets 
are islets in a state of fission or division, analogous to that described in the intestinal 
crypts of Lieberkuhn (Li et al., 1994; St. Clair and Osborne, 1985). As with the 
intestinal crypts in the gut, fission of islets in the mouse might be a mechanism for 
expanding the number of islets. The initially high dumbbell incidence during the 
neonatal period suggested that this mode of new islet production is prevalent 
immediately following birth and contributes to expansion of islet number especially 
during the first few weeks of postnatal life.
Of course, the equally valid hypothesis that such dumbbell islets instead 
represent smaller aggregating islets in a state of fusion could not be discounted. The 
obvious neck of a-cells in the centre of the P-cell mass of the elongated islet counters 
arguments that such dumbbells are malformed or aberrantly-shaped islets. The a-cells, 
usually localised to the peripheral islet mantle, are clearly “sandwiched” between two
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bodies of P-cells and so internalised within the dumbbell. It is suggested that the a-cell 
layer is delaminating from the islet mantle to separate the two bodies of P-cells before 
generating the two daughter islets. The presence of the a-cell neck though, can be 
equally well incorporated into the islet fusion hypothesis as representing the residual a- 
cell mantle of the nearest points of the two recently fused islets.
5.4.3. Cell Composition Analysis Supports Islet Fission
So, to test the hypotheses that (1) dumbbell islets represented a parent islet in a 
state of division or fission and (2) such islet fission is a mode of islet production in the 
murine pancreas, an examination was made of the p-gal-labelled and unlabelled cell 
composition of both dumbbell and non-dumbbell islets in paraffin sections of X-gal- 
stained pancreata from PN3-PN84/12wk H253 female hemizygous mice. Over this age- 
range, the islets are undergoing the putative shift from a heterogeneous to a 
homogeneous cell composition (Chapter 4). With endogenous cell turnover within the 
endocrine compartment, if islets are generated by fission at least to a measurable extent 
then as daughter islets are produced and separate within the pancreatic tissue, the 
similarity of the p-gal+/p-gal' cell composition of two islets (their “relatedness”) would 
be expected to decrease the greater the distance between the two. By this hypothesis, the 
labelled/unlabelled cell composition of the two sides of a dumbbell or putative 
fissioning islet would be identical (or almost so), and certainly greater than the 
relatedness of pairs of non-dumbbell islets. However, if the two sides of dumbbells 
show similar variation to random pairs, this would support the islet fusion hypothesis 
(Fig. 5.8.).
Linear regression of percentage P-gal+ cell composition between the two sides of 
each dumbbell islet and subsequent calculation of rs gave a significant strong positive 
correlation (rs = 0.742). So, the relatedness of the two sides of a dumbbell islet is 
significantly higher than between two non-dumbbell islets. Moreover, there was found 
to be a significant negative correlation (absence of the two outliers withstanding: rs = - 
0.441 for the intact data set, -0.387 excluding both outliers and -0.415 excluding one 
outlier or the other) between the similarity in cell composition between two non­
dumbbell islets and the inter-islet distance. So, the relatedness of two randomly selected 
islets decreases as the distance between them increases. Using the non-dumbbell data, 
the extrapolated values (87.0-89.7 %) for the percentage similarity of cell composition
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Figure 5.8. Predicted Outcomes of Cell Composition Analysis in the 
Event of Islet Fission (a) or Islet Fusion (b)
(a). Cell composition equal 










(b). Low cell composition similarity 





No correlation between cell 
composition similarity and 
inter-islet distance
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between the two sides of a dumbbell islet are in strong agreement with the actual mean 
value measured from the dumbbells themselves (91.8 %).
All of the results of the cell composition analysis strongly support the argument 
for islet fission. The results support both hypotheses that (1) dumbbell islets represent a 
parent islet in a state of division or fission and (2) such islet fission is a mode of islet 
production in the pancreas of the mouse. In light of the above, it is highly improbable 
that dumbbell islets are formed from the amalgamation of smaller islets. Islet fission as 
a mode of expansion of islet number is also favoured by related though more 
circumstantial evidence: that of similar islets occurring in clusters. Islets of a certain 13- 
gal* or (3-gal' cell composition showed a tendency to occur together in the H253 female 
hemizygote pancreas. This suggests that islets occurring in a patch are formed by the 
fission of one or a small number of parent islets. Pancreatic islets in a wide range of 
mammalian species have been shown to cluster together within the exocrine tissue, 
resulting in a spatial distribution pattern that suggests that mammalian islet formation 
follows an iterative or fractal growth law used to describe branching structures 
(Hastings et al., 1992; Schneider et al., 1996). The authors suggested that islet patterns 
can be explained by a fractal branching structure for exocrine ductules and random islet 
formation at their tips, concordant with the belief that islets bud from tips of ductules 
during embryogenesis (Falkmer, 1985). This finding does not exclude the possibility 
that an islet derived from the ductule epithelium subsequently undergoes fission to 
produce daughter islets retaining a close affinity with the duct system.
5.4.4. Comparison with Crypt Fission: Stimuli for Fission
Studies of the dynamics of fission of the intestinal crypts (Bjerknes, 1995, 1996; 
Totafumo et al., 1987) have led to the concept of the crypt cycle. Crypts in the mouse 
small intestine, generated by fission, gradually increase in size and undergo fission after 
about 108 days. This process of division takes approximately 12 h to complete. Crypts 
at the upper end of the size distribution were found to initiate fission. These studies 
suggest that crypts must attain a given size before fission commences. It has been 
proposed (Loeffler et al., 1993, 1997) that the threshold for initiation of fission is a 
doubling of the stem cell number. A further proposal is that there exists a given 
threshold value for the number of stem cells per crypt which, when reached, triggers 
fission.
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5.4.5. No Threshold Islet Size for Trisserins Fission
An analysis was then made of the sectional areas in terms of cell number of both 
dumbbell and non-dumbbell islets to test the hypothesis that islet size is bivariate; that 
islets fall within two size categories (Fig. 5.9.).
Figure 5.9. Bivariate Distribution of Islet Areas if a Threshold Size for Islet Fission 
Exists
Non-Dumbbells = Dumbbells =
Daughter Islets Fissioning Islets
Islet Area
Dumbbell islet areas would be expected to be two-fold greater than the non­
dumbbell daughter islets that they generate upon division, suggesting there to be a 
threshold islet size at which islet fission is initiated. Dumbbell islets were found to be 
significantly larger than non-dumbbell islets; mean dumbbell islet area (295 ± 43.6 
cells) was almost three-fold greater than non-dumbbell islet area (102 ± 8.76 cells). This 
translates to dumbbell islets being 3.48-fold greater in volume and hence, mass, than the 
non-dumbbells if the assumptions are made that non-dumbbell islets are perfect spheres, 
that dumbbell islets represent two spheres conjoined at their very periphery with no 
overlap and that the sectional areas are “equatorial”. However, the ranges in islet area 
for the dumbbell and non-dumbbell population samples superposed to some extent, 
meaning that no clear size/area threshold for triggering fission could be discerned.
5.4.5.1. Could a Change in a-Cell:0-Cell Ratio Trisser Fission?
The islet is a microorgan whose functionality is dependent on the relationships 
between the four different endocrine cell types of which it is composed. The islet
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comprises a heterocellular peripheral mantle composed mainly of a-cells and a small 
number of somatostatin-secreting 8-cells and a homocellular core of p-cells. The thin 
mantle of a-cells is therefore more a function of surface area than the p-cell core. 
Neighbouring cells are able to communicate via junctional complexes (Orci et al., 
1975). Somatostatin is able to powerfully inhibit insulin and glucagon secretion from 
neighbouring p- and a-cells respectively. Owing to their arrangement within the islet, 
the percentage of the total a-cell mass in contact with 8-cells must be greater than the 
percentage of the p-cell mass, the majority of which has no 8-cell contacts. It has been 
speculated (Orci and Unger, 1975) that if somatostatin functions as a local inhibitor of 
neighbouring a- and P-cells, it would have a greater influence upon pancreatic glucagon 
secretion than on insulin secretion. In addition, insulin is known to inhibit glucagon 
secretion (Marks, 1971; Samols et al., 1969). If the islet diameter doubles, surface area 
of the islet will increase four-fold but volume will increase by a factor of eight. So, as 
the islet grows in size, the relative surface areas of the a-, p- and 8-cells exposed to one 
another will change and so too will the paracrine effects of somatostatin and insulin. It 
is conceivable that there will exist a maximum islet size at which any further increase in 
islet volume leads to declines in efficiency of function of the microorgan as a whole. It 
is speculated that the ratio between different endocrine cell types, especially the a- and 
P-cells and their inter-relationships play a role in initiating islet fission, perhaps when 
the islet has attained a certain size at which efficiency of function is declining. If 
endocrine cells similarly require trophic signals from different endocrine cell types for 
maintaining their survival then this might also limit the maximum islet volume. If so, 
endocrine cell expansion and increase in islet diameter would be halted when the 
diffusible distance between different cell types is in excess of that required for 
satisfactory trophic support, resulting in cell death of some islet cells. Elevated levels of 
endocrine cell apoptosis within the islet might then trigger fission.
5.4.6. Mechanism of Islet Fission: Significance o f Aberrant a-Cell 
Localisation in Dumbbells
As mentioned, a definite neck of a-cells was observed in the centre of the p-cell 
mass of the dumbbell islets. a-Cells, usually restricted to the peripheral islet mantle, are 
internalised within the two bodies of p-cells of the dumbbell. It can be speculated that 
the a-cell layer delaminates from the islet mantle and drives the division of the two
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bodies of p-cells to generate the daughter islets. Migration of a-cells from the mantle 
would result from changes in cell adhesion properties of different endocrine cell types, 
most notably the a- and p-cells. The mechanisms for cell rearrangement during 
development including segregation of unlike cells were explained by Holfreter as 
differences in tissue affinities (Townes and Holfreter, 1955). Steinberg and Takeichi 
(1994) showed that two motile cell types differing only in the levels of expression of a 
single adhesion system, will segregate from one another but moreover arrange 
themselves in the form of an envelope of less cohesive cells surrounding a core of more 
cohesive cells. According to the differential adhesion hypothesis, p-cells, forming the 
islet core, should be more cohesive than peripheral a-cells. Through the overexpression 
of dominant negative E-cadherin, members of the cadherin family were shown to be 
required for the aggregation of endocrine cells into islets and the typical cell 
organization of islets in vivo (Dahl et al., 1996). N-CAM (neural cell adhesion 
molecule) was shown to be expressed more strongly on peripheral (a-) cells of the islet 
than central P-cells and so to play a role in islet cell segregation in vitro (Cirulli et al., 
1994). By knocking out N-CAM, Esni et al. (1999) showed that cadherin-mediated 
adhesion in islets is increased. As a result of this, they suggested that N-CAM 
negatively influences the cadherin-mediated basic adhesion machinery in islets. 
Differential expression of N-CAM in a-cells would render them less cohesive than p- 
cells, resulting in their typical peripheral islet distribution. In more than two-thirds of 
the islets of N-CAM knockout mice, a-cells were found centrally within the p-cell core. 
This can be attributed to increased cadherin-mediated adhesion between a-cells in the 
absence of N-CAM. Similarly, an increased cadherin-mediated adhesion between 
dumbbell islet a-cells in the neck region might be responsible for their migration into 
the p-cell mass, driving division of the islet.
5.4.7. Islet Fission is Generally Symmetrical
The aforementioned theoretical bivariate distribution of islet areas in the event 
of there being a threshold size for islet fission, will only hold true if a dumbbell islet 
divides symmetrically. Determining whether this is so is very challenging. The p- 
gal+/p-gal' cell composition of the two spheroidal (and so 3D) sides of a dumbbell islet 
(as with a non-dumbbell islet) can be compared fairly robustly from 2D sections if it is 
assumed that the cell composition throughout each islet is homogeneous and so
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equivalent to the analysed section. Volume of a sphere or spheroid cannot, however be 
extrapolated from a 2D section with quite the same robustness. The equations defining 
the relationship between the apparent size distribution - that observed in a section - and 
the actual size distribution of spherical and ellipsoidal bodies were derived by Wicksell 
(1925, 1926). With the assumption that these bodies are evenly distributed, the 
relationship can be expressed in the form of Abelian integrals. As mentioned, however, 
islets in a wide range of mammalian species are not distributed randomly in the 
exocrine tissue but instead cluster together (Hastings et al., 1992; Schneider et al., 
1996).
If a comparison is made between the area of side 1 with that of side 2 for each of 
the 23 dumbbell islets, the ratio of the two areas is highly susceptible to effects from the 
plane of section through the dumbbell. Thus, even if the areas of the two sides of a 
dumbbell are exactly equal, the plane of section must pass through the “equator” of each 
side of the dumbbell for the two areas to be measured as being equal from that 2D 
section (Fig. 5.10.). Considering the multitudes of possible combinations between 
orientation of the dumbbell and plane of section, it is highly improbable that this will 
occur. The plane of section through the islet was not problematic for the comparison of 
dumbbell vs. non-dumbbell islet area above since the outcome of the analysis is less 
affected by plane of section. Bearing this limitation in mind, rs was still calculated to 
test for a correlation between the area (total number of cells) on side 1 and the area 
(total number of cells) on side 2 for the identified dumbbell islets. There was found to 
be a significant positive correlation (rs = 0.736 and 0.750 including and excluding the 
two outliers respectively) between the numbers of cells on each side of the dumbbells. 
So, especially in light of the above critique, it can be assumed that dumbbells generally 
divide symmetrically and the two daughter islets generated are of equal size.
5.4.8. Asymmetrical Islet “Budding” and “Multiple” Islet Fission
There were notable exceptions to the symmetrical division of dumbbell islets, as 
demonstrated by the two pairs of outlying data points in the data set for examining this 
question (Graph 5.8.). Observations were made of dumbbells exhibiting highly 
asymmetrical sides in 2D sections (Fig. 5.6.) when plane of section effects were 
considered i.e. it was considered highly improbable that these images simply represent 
oblique sections of symmetrically-dividing dumbbells. For example, if the section 
depicted in Fig. 5.6. (a) represented an oblique section through a symmetrical dumbbell
226
Figure 5.10. Susceptibility of the Ratio of the Areas of the Two Dumbbell Sides to Effects 
from the Plane of Section Through the Dumbbell
Even if the areas of the two sides of a dumbbell are exactly equal, the plane of section must pass through the “equator” 
of each side of the dumbbell (a) for the two areas to be measured as being equal. Deviation from this plane (b) will 
result in an asymmetry of the two sides being extrapolated from that 2D section
Equators
Section through the same 
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from the above planes of 
section
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islet, then one would expect that the section “glancing” one of the dumbbell sides would 
be separated from the more equatorial section through the other dumbbell side by 
intervening acinar tissue. This of course excludes the possibility that the side appearing 
smaller in the section exhibits a highly aberrant shape. The similar appearance of 
apparently non-symmetrical dumbbells in adjacent serial sections (not shown) supports 
to some extent the notion that highly asymmetrical dumbbells are a reality. Of the 23 
dumbbells examined, two (Table 5.2.; final two rows), exhibited particularly 
asymmetrical cell distributions between the two sides of the dumbbell; 202 cells vs. 446 
cells and 151 cells vs. 830 cells. These figures translate to total dumbbell cell 
distributions between the two sides of 31.2 % to 68.8 % and 15.4 % to 84.6 % 
respectively.
In some instances, fission of intestinal crypts into two daughters occurs 
asymmetrically with respect to the crypt axis, and in this case the process is termed 
“budding”. This lead to speculation that such budding might apply to islets also. In 
more infrequent cases than the above, islets might also divide asymmetrically into one 
smaller and one larger daughter islet.
There are two types of crypt fission. That described here so far is the typical 
binary fission and involves a crypt dividing into two daughters. A much more 
infrequent event is multiple fission which involves the crypt splitting simultaneously 
into many crypts, notably following radiation (Caimie and Millen, 1975). In the 
immediate neonatal period, islets initially occur in multi-complex clusters (Fig. 5.3.) 
exhibiting very atypical morphology in relation to the more mature spheroidal islets. It 
is speculated that these complexes undergo fission, generating more than two distinct 
islets from a single mass of endocrine tissue. This therefore resembles multiple fission 
of crypts but applies only to the dispersion of the initial endocrine tissue mass formed 
during the embryonic period. This does not discount the possibility that “multiple 
fission” of a recognisably distinct islet can occur in the later pancreas. Very 
occasionally in adult (PN52wk) animals, aberrantly-shaped islets complying with the 
dumbbell islet criterion were observed that exhibited more than two parts or “sides” 
(Fig. 5.7.). It is speculated that such adult islets are undergoing multiple fission, 
paralleling the multiple fission of intestinal crypts. As with the crypts however, this 
event would appear to be much more infrequent that the more typical binary fission of a 
dumbbell islet into two symmetrical daughters.
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5.4.9. Proposed Role o f Islet Fission in the Normal and Reeeneratins
Pancreas
It was a widespread belief that because p-cell replication after the neonatal 
period is low, the P-cell mass does not turn over significantly and that the number of P- 
cells remains virtually static from birth. However, the p-cell mass continues to grow 
well into adulthood. Morphometric data from wild-type mice aged from four weeks to 
six months and of the same mixed background (C57B1/6J/129J) (Bruning et al., 1997; 
Kopin et al., 1999; Westphal et al., 1999; Withers et al., 1998) shows that P-cell mass 
increases at least 10-fold over this period and is linearly correlated with body weight, p- 
Cell production can be achieved through the replication of pre-existing P-cells 
(Hellerstrdm et al., 1988) or via neogenesis, the budding of endocrine cells from the 
ducts (Bonner-Weir, 2000). Islets formed by neogenesis are initially likely to be 
clustered together in close apposition to the ducts (Fig. 5.3.). They may migrate a small 
distance from the ducts (aided by expansion of the surrounding exocrine tissue) and 
undergo islet fission, generating “islet fields”. In the study presented in Chapter 4, 
there was found to be very little increase in the size of individual islets in the H253 
animals in the neonatal period (Chapter 4, Section 4.3.I.9.). It follows that the rapid 
increase in P-cell mass must be accompanied by a large increase in islet number after 
birth (Nielsen et al., 2001). According to Hughes (1956), the number of islets increases 
from 664 in the neonatal rat to 4673 in the adult. It is likely that islet fission plays a 
large role in expanding the number of islets in the immediate neonatal period by 
redistributing the endocrine tissue; dumbbell islets were found to occur with greatest 
incidence in the early neonate. High cell proliferation in neonatal islets accompanied by 
rapid fission would lead to little detectable increase in islet size. In this way, total 
endocrine mass does not change but the number of islets increases. It can be speculated 
that this redistribution of endocrine tissue also optimises the association of islets with 
blood vessels, ensuring that islets retain optimal access to blood supply.
Cell turnover of the endocrine (and exocrine) compartment does not cease after 
the neonatal period however. Hellerstrom et al. (1988) demonstrated that with a p-cell 
birth rate of just less than 3 % new cells per day, rodent p-cell mass would double in 
one month if there were negligible cell death. The p-cell mass does not continue to 
double each month in postnatal life so the P-cell like the majority of other cell types, 
must have a finite life span (Finegood et al., 1995). If the rate of p-cell death
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approaches the replication rate, complete replacement of the p-cell population could 
occur within a one-month period. So, the endocrine pancreas of the adult should be 
considered to be a slowly renewed tissue (Finegood et al., 1995). As above, cell renewal 
can come from the replication of pre-existing P-cells (Hellerstrom et al., 1988) and by 
neogenesis from the adult ductal epithelium. Evidence for neogenesis is found in 
pancreata from obese humans and a number of animal models. In the partial 
pancreatectomized rat model of pancreatic regeneration (Bonner-Weir et al., 1993, 
1997; Sharma et al., 1999) within four weeks of 90 % pancreas removal, the p-cell mass 
was 45 % and pancreatic weight (reflecting exocrine mass) was 27 % that of sham- 
treated animals. Rapid regeneration of both endocrine and exocrine tissues occurred in a 
discordant fashion, due to both enhanced replication of pre-existing differentiated cells 
and expansion of duct tissue and its subsequent differentiation of new acinar and islet 
cells. Whole new lobes of pancreas were formed in patterns seeming to recapitulate 
embryonic development. Islet fission might be speculated to play a role in such 
endocrine regeneration. The fission of existing islets or islets newly formed by 
neogenesis from precursors residing in the ductal epithelium would expand islet 
numbers post-surgery. The continued growth of the novel daughter islets would permit 
further cycles of fission and would account for pancreatic regeneration and the 
production of new lobes in the manner described. It is probable that the lack of 
identification of dumbbell islets until now in the normal pancreas has also meant their 
lack of detection in the regenerating organ. Dumbbell islets have been observed in adult 
animals, albeit rarely (Figs. 5.1., 5.6. and 5.7.). It therefore seems reasonable to suggest 
that islet fission, like neogenesis, might play a small role in the normal, slow turnover of 
the endocrine compartment in postnatal life by redistributing endocrine tissue, 
maintaining optimal access to the blood supply. It is also reasonable to suggest that 
dumbbell islets might feature in certain pathophysiological conditions. Neogenesis 
appears to occur in certain pathological processes, particularly those causing chronic 
trauma or inflammation of the pancreas (Gu and Sarvetnick, 1993; Gu et al., 1994; 
Rosenberg et al., 1983). Novel islets appear to be formed continuously in the rare 
human condition of nesidioblastosis (Goossens et al., 1989). So, might islet production 
by fission also be stimulated in this disease? This proposal could be investigated by 
scoring the incidence of dumbbell islets in histopathological specimens against sections 
from control pancreas. Although there was insufficient time to pursue this avenue in the 
current study, this might form the basis of future work.
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Morphologically atypical islets with two or rarely, more “sides” and a 
characteristic “neck” of a-cells were observed in histological pancreas sections from 
male and female mice, appearing with decreasing frequency with age from neonates to 
mature animals. Computer-aided 3D reconstruction confirmed the three-dimensional 
morphology of such “dumbbell” islets which emulated conjoined spheroidal islets. 
Analysis of the p-gal-labelled and unlabelled cell composition of dumbbell and non­
dumbbell islets in PN3-PN84/12wk X-inactivation mosaic mice showed that (1) the 
relatedness of the two sides of a dumbbell islet is significantly higher than between two 
non-dumbbell islets and (2) the relatedness of two randomly selected islets decreases as 
the distance between them increases. Cell composition evidence therefore supports the 
hypotheses that (1) dumbbell islets represent a parent islet in a state of fission and (2) 
islet fission is a mode of islet production in the murine pancreas, consistent with the 
observation that islets of a similar p-gal+/p-gal‘ cell composition tend to occur in 
clusters. Like fission of the intestinal crypts, islet fission might be initiated by an islet 
doubling its number of stem cells or attaining a threshold stem cell number. The process 
might be driven by delamination of the a-cell layer from the islet mantle to segregate 
the two bodies of P-cells. A significant positive correlation between the numbers of 
cells on each side of the dumbbells shows that dumbbells generally divide 
symmetrically although some histological evidence provides support for asymmetrical 
islet “budding” and the “multiple fission” of islets into more than two daughters. It is 
likely that islet fission contributes quite markedly to the dramatic expansion of islet 
numbers that occurs in the immediate neonatal period and continues to act as a source of 
novel islets in later life, playing a role in the normal, slow turnover of the endocrine 
compartment. Redistribution of endocrine tissue in this way would help to optimise the 
association of islets with blood vessels.
5.4.10.1. Therapeutic Applications and Further Work
The morphological and cell composition evidence presented above provides 
clear evidence for islet fission. This is the first discovery of the phenomenon. It would 
appear probable that this process contributes quite markedly to expansion of islet 
numbers in the normal pancreas. It is of interest to determine what role islet fission 
plays in the redistribution of islet cells generated by neogenesis of ductal tissue. The
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involvement of this putative process in regeneration models and pathophysiological 
states affecting the pancreas is also worthy of examination.
The discovery also opens the possibility of new therapeutic applications in the 
treatment of diabetes. A major obstacle to successful islet transplantation for both type 1 
and type 2 diabetes is an adequate supply of insulin-producing tissue. This requirement 
for transplantable human islets has intensified efforts to expand existing pancreatic 
islets and/or grow new ones. If the trigger for islet fission were to be elucidated, then 
this would raise the possibility of harvesting limited numbers of islets and expanding 
them in vitro before re-implanting them into diabetic recipients. This approach may 
provide a potential new source of pancreatic islets for transplantation.
Further work is needed to characterise the frequency of fission in varying 
regeneration and disease states of the pancreas. The stimulus for initiation of fission and 
its mechanism will be challenging to elucidate.
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6. Characterisation of IGF-II Transsenic Lines
6.1. Introduction
6.1.1. The Extended Insulin Family
The phenomenon of growth is one of the least well understood aspects of 
development. Growth is achieved largely by cell division supplemented by secretion of 
extracellular matrix and by some increase in cell size (hypertrophy). The coordination 
of growth between different regions and organs of the body remains an obscure process. 
Gene targeting studies have demonstrated that peptides in the extended insulin family, 
insulin, and insulin-like growth factors (IGFs)-I and -II are important trophic hormones 
during embryonic and fetal development whose absence results in profound fetal growth 
retardation (DeChiara et al., 1990; Duvillie et al., 1997; Liu et al., 1993). IGF-II is 
synthesised primarily by the liver, but is also produced locally by many tissues, where it 
acts in an autocrine or paracrine manner (LeRoith, 1991, 1997; Schofield, 1992). 
Although it is expressed at high levels during embryonic development, its expression is 
progressively extinguished in most tissues after birth (LeRoith, 1991, 1997; Schofield, 
1992).
6.1.2. IGFs and Pancreas Development
There is substantial evidence that continuous p-cell proliferation in early life is 
dependent on the IGFs. Exogenous IGF-I and IGF-II can promote DNA synthesis in P- 
cells in vitro through the type 1 IGF receptor (Asfari et al., 1995; Hogg et al., 1993; 
Sieradzki et al., 1988; Swenne et al., 1987; Van Schravendijk et al., 1987). A role for 
IGFs in islet cell development is further supported by the complex pattern of pancreatic 
expression. IGF-I expression is low during fetal life and does not attain adult levels until 
after weaning. IGF-I mRNA is barely detectable in the islets but its expression in the 
pancreatic acini increases with age (Hogg et al., 1994). Conversely, IGF-II is expressed 
most abundantly in the fetal rat pancreas in the islets and ductal epithelium, and then 
declines neonatally, immediately preceding the developmental wave of neonatal islet 
cell apoptosis (Hill et al., 1999; Hogg et al., 1994; Petrik et al., 1998). IGF-I and IGF-II 
have both been shown to function as islet survival factors in vitro by suppressing 
cytokine-mediated islet cell death in isolated neonatal rat islets (Petrik et al., 1998).
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6.1.3. Pancreas Development in IGF-II Overexpression Mouse Models
Until recently, few studies had yielded evidence for a trophic action of IGF-I or 
IGF-n on islet development in vivo. In 1999, Petrik and coworkers (Petrik et al., 1999) 
examined IGF-II transgenic animals for possible changes in pancreatic islet morphology 
that might result from altered pancreatic expression of IGF-II or from an increase in its 
circulating levels. In these mice the endogenous mouse IGF-II gene becomes widely 
overexpressed during the second half of gestation (Sun et al., 1997). E19.5-20 
transgenic fetuses were found to exhibit significantly elevated circulating levels of IGF- 
II, compared with control mice. Islets in transgenic animals were of irregular shape and 
mean islet area was five-fold greater than in controls as a result of islet cell hyperplasia 
(increase in cell number). The mean number of islets per tissue section was found to be 
unaltered however. Transgenic islets were shown to be composed of proportionately 
fewer P-cells but a greater proportion of a-cells than islets in control mice and normal 
islet morphology was disrupted with the appearance of a-cells in the islet centre. Whilst 
cell proliferation in transgenic islets was twice that in non-transgenic siblings, the 
apoptotic index was significantly reduced. These findings show that IGF-II 
overexpression in fetal life has a profound effect on islet morphology, causing islet 
hyperplasia with an increased population of all three major endocrine cell types. It is 
however, unclear whether islet cell hyperplasia in the transgenic animals is primarily 
caused by increased local pancreatic IGF-II expression or from exposure to the 
increased circulating levels.
The same group (Hill et al., 2000) subsequently investigated whether IGF-II 
regulates p-cell apoptosis in vivo using the Blast line of IGF-II transgenic mouse. In this 
line, mouse IGF-II is selectively overexpressed in skin, gut, and uterus driven by the 
keratin 10 promoter. Circulating IGF-II is retained postnatally instead of declining after 
birth to disappear by weaning as occurs in normal animals (Brown et al., 1986) 
resulting in local overgrowth of tissues at sites of targeted overexpression (Ward et al., 
1994). The two- to three-fold rise in islet cell apoptosis observed in control animals 
between PN11 and PN16 was substantially decreased in IGF-II transgenic mice. Islets 
from transgenic pancreas consequently exhibited a significantly greater mean area from 
PN11 to PN16 although proportions of p- and a-cells were unaltered. The persistent 
presence of circulating IGF-II postnatally largely prevents the neonatal wave of islet cell 
apoptosis, resulting in an increased mean islet size with increases in both a- and p-cell 
populations.
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Most recently, Devedjian et al. (2000) demonstrated that a local increase in IGF- 
II in the pancreas leads to islet hyperplasia by overexpressing IGF-II specifically in the 
pancreatic p-cells under the control of the rat insulin I (RIP) promoter. Islets from 
transgenic animals displayed high levels of IGF-II mRNA and protein and their 
pancreata as a whole exhibited a three-fold increase in p-cell mass and a consequent 
increase in insulin mRNA levels relative to controls. The islets in transgenic mice were 
enlarged compared with controls and displayed a more elongated, irregular shape. As in 
the previous two mouse models of IGF-II overexpression (Hill et al., 2000; Petrik et al., 
1999), transgenic islets exhibited altered architecture with a-cells randomly distributed 
throughout the islet core. The transgenic mice exhibited hyperinsulinaemia and mild 
hyperglycaemia with about 30 % of these animals subsequently developing overt 
diabetes when fed a high-fat diet.
6.1.4. Current Study
The aim of the present study was to investigate the effects of specifically 
targeted and hence, local overexpression of IGF-II within the main tissue compartments 
of the pancreas: the pancreatic acini and the islets and to compare the effects of 
expression in distinct tissue compartments. Little is known about growth factors that 
mediate exocrine pancreatic proliferation (Kim and Hebrok, 2001). However, several 
studies have shown that development of the exocrine pancreas is critically dependent 
upon mesenchymal-epithelial interactions, suggesting that locally produced growth 
factors play a significant role in this process (Ahlgren et al., 1996; Gittes et al., 1996; 
Rose et al., 1999; Sanvito et a l, 1994). While most growth factors are able to promote 
growth of pancreatic explant cultures in vitro (Vila et al., 1995), the factors acting 
physiologically in vivo are unknown. Hence, it is particularly interesting to investigate 
the morphological effects of targeted expression of IGF-II within the pancreatic acini.
Unlike in the IGF-II overexpression models of the first two studies above (Hill 
et al., 2000; Petrik et al., 1999) in which additional IGF-II is made available to the 
pancreas by the circulation, the intention was to create a local and well-defined source 
of IGF-H. Two IGF-II-overexpressing transgenic mouse lines were generated. In the 
first line, expression of an IGF-H transgene was driven by the rat elastase I promoter 
within the acini. In the second line, the rat insulin I promoter (RIP) was used to drive 
expression of the IGF-H transgene specifically within the pancreatic islets as in the 
study of Devedjian et al. (2000). These two lines were named Elijah and Ripley
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respectively after the transgene constructs used to generate them. IGF-II transgenic 
animals were examined for possible changes in pancreatic morphology of the acini 
and/or islets that might result from altered pancreatic expression of IGF-II. Animals 
were examined at mature adult stages well after endogenous gene expression had ceased 
to ensure that the only source of IGF-II in the pancreas was that expressed from the 
transgene. A specific aim of the study was to investigate whether the exogenous IGF-II 
protein can traverse different tissue compartments within the pancreas to impact on 
growth of another tissue (e.g. the islets) to that in which it is expressed (e.g. the acini).
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6.2. Materials and Methods
6.2.1. Generation o f  Transgenic Animals
Transgenic lines were constructed by Dr. Bill Bennett as described fully in 
Appendices, Section 8.1. Briefly, two transgene constructs were generated: the ~3.5 kb 
coding region of the mouse Ig£2 gene (exons 4 to 6 of the Igf2 gene, including introns) 
was either coupled with a 213 bp promoter region of the rat elastase I gene (EIP-Igf2 
construct) or a 720 bp rat insulin I gene promoter (RIP) fragment (RIP-Igf2 construct). 
Fertilised eggs were harvested from PN4wk-6wk super-ovulated Fi (C57BL/6xCBA) 
females mated with stud Fi (C57BL/6xCBA) males and the transgene DNA constructs 
were inserted into the single cell embryos with visible pro-nuclei by pronuclear 
injection. Successfully injected embryos were then implanted into pseudopregnant MF1 
female mice. Potential founders were tested by PCR of earclip biopsies for the presence 
of the transgene at around PN3wk. Positive potential founders were crossed to non- 
transgenic Fi (C57BL/6xCBA) animals and two or three litters of offspring were tested 
for transmission. Only one founder for each construct was found to transmit 
consistently. The line carrying the EIP-Igf2 construct was designated Elijah, and the 
line carrying the RIP-Igf2 construct was designated Ripley.
6.2.2. Serum Collection and Histology
Transgenic and non-transgenic littermate control animals were identified on the 
basis of earclip markings before weighing. After being sacrificed by cervical 
dislocation, blood samples were rapidly collected by cardiac puncture and tail tips and 
liver lobes taken for DNA analysis. Blood samples were centrifuged at 15000 rpm for 
10 min and the supernatant serum drawn off for measurement of glucose, insulin, and 
IGF-H. The complete gut was removed to facilitate careful dissection of the whole 
pancreas. Pancreatic wet weight was recorded before the organ was divided into two 
equal portions for regular paraffin histology and the preparation of frozen sections as 
described in Chapter 2, Sections 2.2.3. and 2.4.
Representative paraffin sections separated by a distance of not less than 150 pm 
were counterstained in Ehrlich’s haematoxylin and eosin (H & E) or subjected to 
immunoperoxidase staining for glucagon or insulin by the avidin-biotin peroxidase 
(ABC) method (Section 2.5.3.I.). Further Elijah and Ripley, as well as non-transgenic
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control pancreas sections were also immunoperoxidase-stained to localise IGF-II (work 
performed by Dr. Janet Smith, University of Birmingham).
6.2.3. Morphometric and Statistical Analysis
Histological sections from five transgenic Elijah and five transgenic Ripley 
pancreata were subjected to morphometric analysis. For each study, five pancreata from 
non-transgenic littermates of the same sex were similarly examined as controls. 
Analysis of H & E-stained paraffin sections was performed using the Leica DMRB 
compound microscope at a magnification of x 50 (Elijah line) or x 200 (Ripley line). 
Images of one randomised field (representing only a partial section) from each section 
examined (Elijah) or each islet in all analysed sections (Ripley) were captured with a 
Spot RT Color digital camera (National Diagnostics Inc.). Also, using a binocular 
dissecting microscope, images of whole pancreas sections were captured for the Ripley 
characterisation study. Analyses of the uncompressed 24-bit TIFF images were 
performed with the Image-Pro Plus™ version 3.0.1 morphometric analysis software 
(Media Cybernetics, Maryland, USA). The stylus of a wireless graphics tablet (Trust 
Wireless Design and Work Tablet 200) was used to manually trace around acini or islets 
in images and in conjunction with the area measurement tool was used to determine 
acini or islet area. The relative area of each random field occupied by pancreatic acini 
and islets (Fig. 6.1.) was calculated from five sections of each Elijah pancreas. The 
number and area of islets (Fig. 6.2.) was calculated from five sections of each Ripley 
pancreas, representing the head region. Islets were defined on the criterion that they 
were composed of five or more contiguous endocrine cells (as for determination of cell 
lineage in Chapter 4) as identified by H & E histochemistry. Finally, total section area 
was determined for each section of Ripley pancreas examined (Fig. 6.3.). Manual grey 
scale thresholding (“gating”) was performed on grey scale images to distinguish the 
object area (pancreas section) from the background and when the section image was 
correctly highlighted, the section area was obtained. In all cases sections selected for 
analysis contained a minimum of five islets. Differences between mean values for each 
variable were compared for statistical difference by the student’s paired /-test using the 
Minitab™ Version 13 statistical software package (and for the Elijah study, were further 
compared by the Wilcoxon paired-sample test). Finally, the number of islets within each 
immunoperoxidase-stained section of transgenic pancreas displaying aberrant glucagon- 
immunopositive cell localisation was ascertained.
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Figure 6.1. Example of Morphometric Analysis with Image ProPlus™ 
for a Random Field of a Transgenic Elijah Pancreas Section (Above; 
Bar = 400 pm) with Calculated Measurements of the First Ten 
Highlighted Areas (Below)
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Figure 6.2. Example of Morphometric Analysis with Image ProPlus™ 
for an Islet in a Transgenic Ripley Pancreas Section. Bar = 100 pm
Figure 6.3. Image of a Whole Transgenic Ripley Pancreas Section 
Captured for Total Sectional Area Measurement with Image 
ProPlus™. Bar = 2 mm
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6.3. Results
6.3.1. Statistical Considerations
Differences between mean values for each variable examined were compared for 
statistical difference initially by the student’s paired /-test. Mean values for transgenic 
and control animals were only compared directly between animals of the same sex from 
the same litter and sacrificed at the same time (and so of the same age when examined). 
Hence, the data could be considered as being paired. Of the five Elijah transgenic and 
five control animals examined, four of each were from a different litter. Similarly, the 
five Ripley transgenic (and five non-transgenic) mice were obtained from three different 
litters. When more than one transgenic animal of a given sex and age was obtained from 
the same litter, mean values were calculated and compared between the transgenic and 
control littermates and in this way, the mean figures could be considered as being 
paired. Four pairs of mean values were therefore compared in a pair-wise manner in the 
Elijah study and three pairs of means were similarly compared in the Ripley work.
Similar studies (Devedjian et al., 2000; Hill et al., 2000; Petrik et al., 1999) in 
which equivalent numbers of animals have been examined have compared mean values 
for statistical difference by parametric tests such as ANOVA, Scheffe’s test or the 
Student-Newman-Keuls test (multiple comparison procedures). In such cases as here, 
the sample size is so reduced that one cannot assume a Gaussian or normal distribution 
of data to be compared (although there is no reason to suggest that this is not the 
situation). Hence, the decision was made to compare mean values for each variable by 
the student’s paired /-test (using MiniTab™ v.13) and the Wilcoxon paired-sample test 
as a confirmation of the outcome from the former. The Wilcoxon test is a nonparametric 
analogue to the paired-sample /-test. The testing procedure involves the calculation of 
differences, as does the paired-sample /-test. The absolute values of the differences are 
then ranked, from low to high and the sign of each difference is affixed to the 
corresponding rank. The ranks of each sign are then each summed separately and for a 
two-tailed test if either summed value (T+ and 71) is less than or equal to the critical 
value Ta(2),n, then the null hypothesis Ho is rejected. Whenever the paired-sample /-test 
is applicable, the Wilcoxon paired-sample test is also applicable. However, if the data 
being compared are from a normal distribution, then the Wilcoxon test has only 3In (i.e. 
95 %) of the power in detecting differences as the former (Conover, 1980; Mood, 1954). 
Both statistical tests were used to compare the four paired mean values for each variable
241
Chapter 6: Characterisation o f  IGF-II Transgenic Lines 
from the Elijah study. The small size of the data sets for comparison meant that null 
hypotheses could only be tested at a(2) = 0.20, so that even comparably (to a(2) = 0.05) 
very small differences in a variable were deemed as being of statistical significance. 
However, the three pairs of mean values in the case of the Ripley animals were too few 
for analysis by the Wilcoxon test and only the paired-sample t-test was conducted.
6.3.2. Elijah Line
6.3.2.1. IGF-II Expressed by Both Acinar and Islet Cells in Adult Elijah Transsenic 
Animals
Immunoperoxidase staining (Dr. Janet Smith) demonstrated that IGF-II is 
expressed exogenously in adult Elijah transgenic pancreas in scattered cells throughout 
the pancreatic acini and in a small number of cells within the islets (Fig. 6.4.). Some 
staining was also observed in pancreatic ducts of both transgenic and control pancreata 
which was also attributed to endogenous expression by connective tissue. This result 
shows that the transgene expression is mostly in exocrine tissue. When the line was 
generated, the elastase element used was believed to be exocrine-specific. However, we 
now know that expression can occur also in some endocrine cells (Kruse et al., 1993). It 
cannot be known for sure whether the immunopositive islet cells in Dr. Smith’s images 
are endocrine or some other cell type such as ductule or capillary. Scattered islet cell 
expression might be attributable to the transgene integrating into a random position 
within the genome. However, despite there being only one line carrying the EIP-Igf2 
transgene, the study by Kruse and coworkers (Kruse et al., 1993) using the same rat 
elastase I promoter element suggests that the transgene behaved as expected.
6.3.2.2. No Significant Difference in Pancreatic Weight
To determine whether rat elastase I promoter-driven expression of IGF-II in the 
pancreatic acini resulted in an increase in pancreas mass, pancreatic wet weight was 
compared between ten intact pancreata from transgenic animals and ten organs from 
control non-transgenic littermates of the same sex. Wet weight of transgenic pancreata 
was found to be 497 ± 30 mg, (mean ± S.E.) compared with 496 ±31 mg for control 
pancreata (Table 6.1.). For the five transgenic pancreata subjected to morphometric 
analysis, mean wet weight was 533 ± 50 mg, in comparison to 525 ± 54 mg for the five 
non-transgenic organs (Graph 6.1.). No significant difference in pancreatic weight
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(a). Control x 40 (b). Transgenic x 40
Figure 6.4. Immunoperoxidase Staining for IGF-II in Pancreas Sections from 
PN35wk Elijah Transgenic and Control Animals (Dr. Janet Smith)
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between control animals and those carrying the IGF-II transgene was evident (for all 
data in Table 6.1., t = 0.24; P = 0.818; T+ = 12, T. = 9; 70.20(2),4 = 0; for the animals 
subjected to morphometric analysis, t = 0.32; P = 0.770; T+ -  5, T. = 5; 7o.20(2),4 = 0)-
Table 6.1. Wet Weight of Elijah Transgenic and Control Intact Pancreata
LITTER/SEX AGE
(Wks)






















Mean ± S.E. N/A 497 ±30 496 ± 31
* Pancreata subjected to morphometric analysis.
63.2.3. Area o f Pancreas Tissue Within Each Field is Significantly Greater in Elijah 
Transgenic Animals
For subsequent direct comparisons between total islet and acini area in randomly 
selected fields in transgenic and control pancreas sections, it was necessary to show that 
total pancreas area per field was not significantly different between transgenic and 
control subjects. However, total mean area of pancreas per field did tend to be greater in 
transgenic than control animals (3.35 ± 0.169 mm and 2.89 ± 0.163 mm respectively; 
Table 6.2., Graph 6.2. and Tables 8.1. (a), and (b)., Appendices), and this difference 
did reach statistical significance (t = 3.75; P = 0.033; T+ = 10, T. = 0; 7o.20(2),4 = 0). 
Hence, endocrine and acinar contribution to pancreas area were necessarily calculated 
as percentage of total pancreas area before being compared. This had the disadvantage 
of reducing the power to detect differences in the variables since statistical tests were to 
be performed on data subjected to manipulation.
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Table 6.2. Summary of Individual Animal Mean Values from Statistical Morphometry Study of Pancreas Sections from Elijah Transgenic 































TG CTL TG CTL TG CTL TG CTL TG CTL TG CTL TG CTL
1/Male 35 3.409 3.269 3.222 3.184 95.37 97.41 83187 26073 2.010 0.8010 5.6 1.8 9233 13376
2/Female 33 3.775 3.053 3.655 2.976 96.86 97.59 33995 37422 0.8878 1.084 6 4.4 3813 6074
3/
Male
31 3.327 2.840 3.184 2.756 96.45 97.15 79955 45661 1.828 1.510 3.4 4.2 11818 9804
3.559 3.072 3.458 2.950 97.05 95.05 56812 63042 1.640 1.857 2.2 4.4 17953 14806
3/Female 32 2.654 2.213 2.590 2.076 97.56 93.89 5749 52835 0.2216 2.305 1.6 3.8 4535 13234
Mean ± 
S.E.
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Graph 6.2. Mean Area of Pancreas Tissue Per Field for Elijah Transgenic 
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6.3.2.4. No Significant Difference in Percentage Acini Area Per Field
Mean percentage acini area per field for transgenic animals at 96.7 ± 0.329 % 
was not significantly different from the control value of 96.2 + 0.663 % (Table 6.2. and 
Graph 6.3.) (t = 0.32; P = 0.770; T+ = 5, T. = 5; T0.20(2)a = 0). As a consequence of the 
greater total area of pancreas tissue per field in transgenic animals, the absolute area of
* • 9acinar tissue per field in transgenic animals at 3.22 ± 0.161 mm , was greater than that
» 9 • • • •in non-transgenic siblings (2.79 ± 0.170 mm ). This difference still failed to reach 
statistical significance at a(2) = 0.05 according to the outcome of the paired-sample t- 
test (t = 3.10; P = 0.053) although it was proved significant by the Wilcoxon paired- 
sample test at a(2) = 0.20 (T+ = 10, T. = 0; 7o.20(2),4 = 0).
6.3.2.5. No Sisnificant Difference in Percentage Endocrine Contribution to Pancreas 
Area
Endocrine tissue represented a 1.32 ± 0.299 % contribution to total pancreas area 
per field in animals carrying the IGF-II transgene compared with a 1.51 ± 0.240 % 
contribution in non-transgenic siblings (Table 6.2. and Graph 6.4.). This difference 
was not statistically significant (t = -0.37; P = 0.733; T+ = 4, T. = 6; 7o.20(2),4 = 0). As 
with the absolute acini area per field, the absolute area of islet tissue per field was 
greater in transgenic animals than control (51939 ± 13024 pm and 45007 ± 5667 pm 
respectively) as a result of the greater total area of pancreas tissue per field in transgenic 
animals. This difference however, failed to reach statistical significance (t = 0.24; P = 
0.826; 7+ = 6, T. = 4; 7o.20(2),4 = 0).
6.3.2.6. No Sisnificant Difference in Islet Number Per Field
The number of islets was counted in the random fields from sections of 
transgenic and control pancreas to determine whether the IGF-II transgene affects islet 
number. Islets within the field and those contacting its upper and right boundaries were 
counted whilst those touching the bottom and left edges were excluded from the count 
as per typical quadrat sampling protocol. Islet number was found to be very similar 
between transgenic and control animals: 3.76 ± 0.791 and 3.72 ± 0.440 islets/field
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Graph 6.3. Mean Percentage Acini Area Per Field for Elijah Transgenic 










Graph 6.4. Mean Percentage Islet Area Per Field for Elijah Transgenic 
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respectively (Table 6.2. and Graph 6.5.) with no significant difference being evident (t 
= 0.30; P = 0.781; TV = 6,T. = 4; T0.2o(2)a = 0).
6.3.2.7. No Sisnificant Difference in Mean Islet Area
As a preliminary assessment of whether rat elastase I promoter-driven IGF-II 
exerts any effect on islet size, mean islet area was determined from those islets present 
within the random fields examined. Areas were not obtained for islets falling only 
partially within the field so as not to artificially reduce the calculated sample mean. The 
mean islet area for transgenic animals at 9470 ± 2314 pm was not significantly 
different (t = -1.34; P = 0.272; T+ = 2, T. = 8; 7o.2o(2),4 = 0) from the control figure of 
11459 ± 1411 pm2 (Table 6.2. and Graph 6.6.).
6.3.2.8. Oversized Islets f> 0.1 mm ) in Elijah Transeenic Animals
The frequency of islets of distinct size (area) classes was compared between 
transgenic and control animals to ascertain whether there was any difference in islet size 
distribution as a result of the IGF-II transgene (Graphs 6.7. and 6.8.). The normal range 
of islet areas as inferred from non-transgenic animals could be segregated into “small” 
(0-19999 pm2), “intermediate” (20000-39999 pm2) and “large” islets (40000-59999 
pm ). When this was done, the size distribution of smaller-sized islets in transgenic and 
control animals was very similar (Table 6.3. and Graph 6.7.); 83.7 % of the 92-islet 
sample in transgenic pancreata fell within the “small” category compared with 83.9 % 
of the 87 control islets. Of the transgenic islets, 7.61 % were categorised as 
intermediate-sized with 9.2 % of the non-transgenic islets being categorised as such. 
The remaining 6.9 % of the control islet sample were classified as large islets in the 
normal islet size spectrum. In the transgenic animals however, only 2.17 % of islets 
exhibited a cross-sectional area of 40000-59999 pm2. The remaining six islets (or 6.52 
%) of the 92-islet sample exceeded the normal islet size range seen in the control 
animals. These “mega-islets”, from three different transgenic pancreata, possessed areas 
of 60466, 67395, 79255, 104905, 176359 and 180194 pm2. The largest two islets were 
more than three-fold the largest control islets measured. Such mega-islets were typically 
of a very irregular shape in cross-section, compared with the more characteristic 
spherical islet profile; furthermore, fibrous inclusions were often visible within these 
islets (Fig. 6.5.).
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Graph 6.5. Mean Number of Islets Per Field for Elijah Transgenic Animals 
and Non-Transgenic Sibling Controls
Transgenic Control
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Graph 6.8. Frequency Histogram Comparing Observed Islet Areas in Elijah Transgenic Animals
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Observed n = 92
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Transgenic (b). Control
(c). Transgenic (d). Control
(f). Control(e). Transgenic
Figure 6.5. “Mega-Islets” in H & E-Stained Pancreas Sections from PN31wk 
Elijah Transgenic and Control Animals
(a)-(b) Bar = 250 i^m; (c)-(f) Bar =100 fim
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Table 6.3. Size Distribution of Islets in Elijah Transgenic and Control Animals
ISLET AREA (pm2) PROPORTION OF TOTAL ISLET 
SAMPLE (%)
Transgenic (n = 92) Control (n = 87)
0-19999 - “Small” 83.7 83.9
20000-39999 - “Intermediate” 7.61 9.2
40000-59999 - “Large” 2.17 6.9
> 60000 6.52 0
To verify the divergence in size distribution of the transgenic and control islet 
population samples, a chi-square (x ) test was conducted to compare “expected” size 
distribution, based on data from control animals, with the “observed” distribution of 
islets in transgenic pancreata (Table 6.4. and Graph 6.8.). There was found to be a 
highly significant difference (P < 0.01) between observed and expected (control) islet 
size distributions.
X2 = S  (Observed - Expected)2 with d f  = c (number of categories) - 1 
Expected
Table 6.4. Calculating %2 to Test Whether the Observed Islet Size Distribution in 




NUMBER OF ISLETS Observed
Expected






0-9999 55 71 58.2 12.8 165 2.83
10000-
19999
18 6 19.0 -13.0 170 8.93
20000-
39999
8 7 8.50 -1.46 2.13 0.252
>
40000
6 8 6.34 1.66 2.74 0.432
I 87 92 92 0 340 12.4
(y2)
NB: Data was segregated into the above categories of islet area by considering that:-
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(1). in the x2 test, the expected frequency of each category under the null hypothesis 
must be at least five,
(2). the higher the number of categories, the greater the sensitivity of the test.
X2 = 11.34, d f= 3, p  = 0.01. As the calculated value of %2 is greater, the null hypothesis 
can be rejected.
63,2,9. Mega-Islets Formed by Hyperplasia. Not Hypertrophy
In order to ascertain whether over-sized mega-islets in transgenic animals were a 
result of hyperplasia of endocrine tissue, or hypertrophy (increase in cell size) of 
existing islet cells, the area of individual islet cells was determined in transgenic mega­
islets and control islets in both transgenic and non-transgenic animals. The area of 
control islets selected for comparison was less than 60000 pm , within the normal range 
of islet size in control animals. The mean area of individual islet cells in mega-islets 
was found to be 76.6 ± 9.28 pm , in comparison with mean cell areas of 71.7 ± 5.71 
pm2 and 77.2 ±5.14 pm2 for endocrine cells within control islets in transgenic and non- 
transgenic animals, respectively (Table 6.5. and Graph 6.9.). No significant difference 
was found between these values (for comparison between mega-islets and transgenic 
control islets t = 1.05; P = 0.403; between mega-islets and non-transgenic control islets t 
= -0.37; P = 0.774; insufficient paired data for Wilcoxon paired-sample test). Mega­
islets were therefore a product of islet hyperplasia.
Table 6.5. Mean Area of Individual Islet Cells in Mega-Islets from Elijah 














Litter 1 Male 35 55.06 57.88 78.44
Litter 3 
Male
31 80.99 76.72 65.75
93.67 80.50 87.44



















Graph 6.9. Mean Individual Islet Cell Area in Mega-Islets vs. Control Islets in Elijah Transgenic Animals and in Control Islets 
in Non-Transgenic Siblings
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6.3.2.10. “Hepatocvte-Like” Cells in an Elijah Transgenic Islet
In one of the transgenic pancreata, H & E histochemistry revealed the presence 
of large cells which morphologically resembled hepatocytes (Fig. 6.6.). These cells 
were clearly distinguishable from adjacent endocrine cells by their abundant 
eosinophilic cytoplasm and were located at the islet periphery.
6.3.2.11. Aberrant a-Cell Localisation in Elijah Transsenic Islets
Immunoperoxidase staining for glucagon revealed a disruption in the 
distribution of a-cells in many islets of transgenic animals. In control animals, a-cells 
were restricted to the peripheral mantle of the islet but in 44.6 % (n = 74) of islets in 
transgenic animals, a large number of centrally-located a-cells were visible in addition 
to those at the islet periphery (Fig. 6.7.). Immunoperoxidase staining for insulin showed 
no apparent difference in P-cell distribution between islets in transgenic or control 
animals (Fig. 6.7.). Furthermore, no difference was seen in the intensity of 
immunohistochemical staining for either glucagon or insulin between transgenic or 
control islets.
6.3.2.12. Glucaeon-Immunopositive Acinar Cells in an Elijah Transsenic Pancreas
In one of the transgenic pancreata, immunoperoxidase staining revealed a 
marked proportion of acinar cells to be immunopositive for glucagon (Fig. 6.8.). These 
isolated acinar cells were widely scattered throughout the exocrine tissue of a few 
pancreatic lobes where they were evident both within acini and at the acinus periphery.
6.3.3. Ripley Line
6.3.3.1. IGF-II Expressed Exclusively in Islets in Adult Ripley Transsenic Animals
Immunoperoxidase analysis (Dr. Janet Smith) demonstrated high levels of IGF- 
II in the islets of adult Ripley transgenic animals (Fig. 6.9.). The IGF-II protein was 
localised throughout the islet cells of transgenic pancreas. Islets in control animals 
demonstrated a complete absence of immunoperoxidase staining for IGF-II (Fig. 6.9.). 
Despite there being only one line carrying the RIP-Ig£2 transgene, results from the study 
by Devedjian and coworkers (Devedjian et al., 2000) using the same RIP promoter to
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Figure 6.6. Large “Hepatocyte-Like” Cells (Arrowheads) at Islet 
Periphery in an H & E-Stained Elijah Transgenic Pancreas Section
Such cells exhibit abundant eosinophilic cytoplasm. Bar = 50 pm
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Figure 6.7. Aberrant a-Cell Localisation in Islets from Elijah Transgenic Pancreas
Immunoperoxidase staining for glucagon (a-cell marker) or insulin ((3-cell marker) 
in adjacent pancreas sections from PN31wk Elijah transgenic (c-f) or control (a 
and b) animals. a-Cells seen in islet core in transgenic islets. Bar = 100 pm
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Figure 6.8. Immunoperoxidase Staining Reveals Scattered Glucagon- 
Immunopositive Acinar Cells Throughout the Exocrine Tissue of a 
Few Lobes in a PN35wk Elijah Transgenic Pancreas. Bar = 100 pm
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Figure 6.9. Immunoperoxidase Staining for IGF-II in Pancreas Sections from 
PN43wk Ripley Transgenic and Control Animals (Dr. Janet Smith)
Islets in non-transgenic control pancreas, all of which show no immunoperoxidase 
staining, are highlighted (red dashed lines) in (c) and (e). Staining for IGF-II is 
clearly visible in the islets of Ripley transgenic pancreas in (b), (d) and (f)
(c). Control x 10
(e). Control x 20
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drive IGF-D expression in the islet (3-cells suggest that the transgene behaved as 
expected.
6.3.3.2. Increased Ripley Transsenic Pancreatic Weieht
To determine whether rat insulin I promoter-driven expression of IGF-D in islets 
resulted in an increase in pancreas mass, pancreatic wet weight was compared between 
five intact pancreata from transgenic animals and five organs from control non- 
transgenic littermates of the same sex. Wet weight of transgenic pancreata was 540 ± 23 
mg compared with 479 ± 25 mg for control pancreata (Table 6.6. and Graph 6.10.). 
Although pancreatic weight tended to be greater in transgenic animals, this just failed to 
reach statistical significance (t = 3.67; P = 0.067).
Table 6.6. Wet Weight of Ripley Transgenic and Control Intact Pancreata
LITTER/SEX AGE
(Wks)











Mean ± S.E. N/A 540 ± 23 479 ± 25
6.3.3.3. No Sisnificant Difference in Islet Number Per Section
The number of islets per pancreas section was counted for transgenic and control 
animals to determine whether the IGF-D transgene affects islet number. Mean islet 
number per section was found to be similar between transgenic and control animals:
30.6 ±6.18 and 26.3 ± 2.81 islets/section respectively (Table 6.7., Graph 6.11. and 
Table 8.2., Appendices) with one notable exception. The mean islet number per section 
of pancreas from the transgenic male from litter 1 was found to be 56.0 ± 5.18 as 
compared to 15.8 ± 1.66 for the non-transgenic littermate control. Overall, no 
significant difference was determined (t = 0.68; P = 0.565).
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Graph 6.10. Mean Pancreatic Wet Weight for Ripley Transgenic Animals 





Graph 6.11. Mean Number of Islets Per Section for Ripley Transgenic 
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Table 6.7. Summary of Individual Animal Mean Values from Statistical 
Morphometry Study of Pancreas Sections from Ripley Transgenic (TG) and Age- 
and Sex-Matched Non-Transgenic Littermate Control (CTL) Animals
LITTER AGE VARIABLE (MEAN)
/ Number of Islets/ Total Section Mean Islet
SEX (Wks) Section Area (mm2) Area (pm2)
TG CTL TG CTL TG CTL
1/ 43 21.6 28.2 25.21 30.10 7944 14920
Female 22.8 23.4 28.58 35.03 8322 11131
1 / Male 46 56 15.8 26.83 20.93 25737 34020
2 / 43 34.2 34 36.94 29.46 12098 8627
Male 18.2 30.2 27.97 21.17 38904 18039
Mean ± N/A 30.56 ± 26.32 ± 29.10 ± 27.34 ± 18601± 17347 ±
S.E. 6.176 2.805 1.825 2.452 5384 3995
63.3.4. No Sisnificant Difference in Total Section Area
To ensure that a direct comparison could be made between mean number of 
islets per pancreas section in transgenic and control animals, total section area was 
compared. Total mean section area was very similar between transgenic and control 
animals: 29.1 ± 1.83 mm2 and 27.3 ± 2.45 mm2 respectively (Table 6.7. and Graph 
6.12.); no significant difference was found (t = 0.60; P = 0.609). Hence, absolute islet 
number per section could be directly compared.
6.3.3.5. No Significant Difference in Mean Islet Area
As a preliminary assessment of whether the RIP-driven IGF-II exerts any effect 
on islet size, mean islet area was determined. The mean islet area for transgenic animals 
at 18601 ± 5384 pm2 was not significantly different (t = -0.05; P  = 0.963) from the 
control figure of 17347 ± 3995 pm2 (Table 6.7. and Graph 6.13.)
6.3.3.6. Greater Proportion o f  Large Islets in Ripley Transsenic vs. Control Animals
The frequency of islets of distinct size (area) classes was compared between 
transgenic and control animals to determine any difference in islet size distribution as a 
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Graph 6.12. Mean Section Area for Ripley Transgenic Animals and Non- 
Transgenic Sibling Controls
Transgenic Control
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Graph 6.15. Frequency Histogram Comparing Observed Islet Areas in Ripley Transgenic Animals
with “Expected” Islet Size Distribution as Calculated from Non-Transgenic Sibling Controls
Expected n = 764 
Observed n = 764
■  E xpected
■  Observed
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transgenic and control animals appeared to be generally very similar (Table 6.8. and 
Graph 6.14.), However when compared with control values, a smaller proportion of the 
islets in transgenic pancreata fell within the lower end of the normal islet size spectrum 
whereas a greater proportion (compared with control) tended to lie at the upper end of 
the islet size range. 730 or 95.5 % of the 764-islet sample in transgenic pancreata were 
below 100000 pm (0.1 mm ) in cross-sectional area compared to 642 or 97.6 % of the 
658 control islets. Of these islets, 76.0 % (transgenic) and 78.7 % (control) fell below 
20000 pm2. In transgenic animals, 32 islets (4.19 %) possessed an area of 100000- 
399999 pm compared with 16 islets (2.43 %) in control mice. The largest control islet 
observed in the “normal” islet size spectrum was 313362 pm2 in cross-sectional area. 
However, two “mega-islets” of 414088 and 417005 pm2 in area, well exceeding the size 
of the largest control islet, were observed in two of the transgenic pancreata. As with 
those mega-islets observed in transgenic pancreas sections from animals of the Elijah 
line, the largest islets present in Ripley transgenic pancreata displayed a very irregular 
shape (Fig. 6.10.).
Table 6.8. Size Distribution of Islets in Ripley Transgenic and Control Animals
ISLET AREA (pm2) PROPORTION OF TOTAL ISLET 
SAMPLE (%)






As with the Elijah study, to verify the divergence in size distribution of the 
Ripley transgenic and control islet population samples, a chi-square (x2) test was 
conducted to compare expected size distribution, based on control data, with the 
observed distribution of transgenic islets (Table 6.9. and Graph 6.15.). There was 
found to be a highly significant difference (P < 0.01) between observed and expected 
(control) islet size distributions.
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(a). Control x 20 (b). Control x 20
(c). Transgenic x 20 (d). Transgenic x 10
(e). Transgenic x 20 (f). Transgenic x 10
Figure 6.10. “Mega-Islets” in H & E-Stained Pancreas Sections from PN43wk 
Ripley Transgenic and Control Animals
Islets in (c) and (e) pictured at lower magnification in (d) and (f) respectively.
(a)-(c) and (e) Bar = 100 pm; (d) and (f) Bar = 200 pm
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Table 6.9. Calculating %2 to Test Whether the Observed Islet Size Distribution in 




NUMBER OF ISLETS Observed
Expected








542 615 629.3 -14.3 205 0.326
25000-
49999
61 74 70.8 3.17 10.1 0.142
50000-
74999
27 26 31.3 -5.35 28.6 0.913
75000-
99999
12 15 13.9 1.07 1.14 0.0817
>
100000
16 34 18.6 15.4 238 12.8
z 658 764 764 0 483 14.3
(y2)
X = 13.28, d f -  4, p  = 0.01. As the calculated value of % is greater, the null hypothesis 
can be rejected.
6.3.3.7. “Hepatocvte-Like” Cells in a Ripley Transgenic Islet
As in one of the Elijah transgenic pancreata, H & E histochemistry revealed the 
presence of large cells which morphologically resembled hepatocytes within a Ripley 
transgenic islet (Fig. 6.11.). Such cells could be clearly distinguished from adjacent 
endocrine cells by their abundant eosinophilic cytoplasm and were located at the islet 
periphery.
6.3.3.8. Aberrant a-Cell Localisation in Ripley Transsenic Islets
Immunoperoxidase staining for glucagon revealed a disruption in the 
distribution of a-cells in many islets of transgenic animals. In control animals, a-cells 
were restricted to the peripheral mantle of the islet but in 41.7 % (n = 72) of islets in 
transgenic animals, a-cells were seen to be much reduced in number in the mantle 
and/or were centrally-located (Fig. 6.12.). In some transgenic islets, isolated a-cells
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Figure 6.11. Large “Hepatocyte-Like” Cells (Arrowheads) at the 
Periphery of an Islet (Lower Left) in an H & E-Stained PN43wk 
Ripley Transgenic Pancreas Section
Such cells exhibit abundant eosinophilic cytoplasm. Bar = 100 pm
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(e). Transgenic Glucagon (f). Transgenic Insulin
Figure 6.12. Aberrant a-Cell Localisation in Islets from Ripley Transgenic Pancreas
Immunoperoxidase staining for glucagon (a-cell marker) or insulin (0-cell marker) 
in adjacent pancreas sections from Ripley transgenic (c-f) or control (a and b) 
animals. a-Cells in mantle depleted and also seen in islet core in transgenic islets 
Bar = 100 pm
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were scattered no more than one cell layer deep around the islet periphery and in 
extreme cases, no glucagon-immunopositive cells were evident within the entire islet 
cross-section. Immunoperoxidase staining for insulin showed no apparent difference in 
(3-cell distribution between islets in transgenic or control animals (Fig. 6.12.). No 
obvious difference was seen in the intensity of immunohistochemical staining for either 
glucagon or insulin between transgenic or control islets.
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6.4. Discussion
6.4.1. IGF-II Transsene Expression
6.4.1.1. IGF-II Expressed by Both Acinar and Islet Cells in Adult Elijah Transgenic 
Animals
Immunoperoxidase staining (Dr. Janet Smith) demonstrated that IGF-II was 
expressed ectopically in adult Elijah transgenic pancreas in scattered cells throughout 
the pancreatic acini and in a small number of cells within the transgenic islets. Some 
staining was evident in ducts of control animals which was attributed to endogenous 
expression in the mesenchyme. Scattered islet cell expression might be attributable to 
inappropriate random integration of the transgene within the genome. However, the 
limited islet cell expression in transgenic animals was attributed to the non-specificity 
of the IGF-H transgene promoter. Between the construction and phenotypic 
characterisation of the Elijah line, it was noted that the rat elastase I promoter fragment 
used is not entirely specific to the pancreatic acini (Kruse et al., 1993). Therefore, 
despite there being only one line carrying the EIP-Igf2 transgene, the study by Kruse et 
al. (1993) using the same rat elastase I promoter element suggests that the transgene 
behaved as expected in the current study. The rat elastase I promoter fragment used here 
was selected to drive transgene expression in the acini owing to initial reports of 
specificity of its activity within this tissue compartment. However, some transgene 
expression within the islets was not considered particularly detrimental to the study 
since transgene expression was mostly confined to exocrine tissue and IGF-II 
expression was still confined to within the pancreas. However, the specific aim of 
investigating the ability of the IGF-II protein to act across tissue compartments within 
the pancreas could not be achieved with the anticipated level of integrity.
6.4.1.2. IGF-II Expressed Exclusively in Islets in Adult Ripley Transgenic Animals
Immunoperoxidase staining (Dr. Janet Smith) demonstrated that IGF-II is 
exclusively expressed throughout the endocrine tissue in the pancreas of adult Ripley 
transgenic animals. The IGF-II protein was seen to be localised throughout the islet 
cells of transgenic pancreas. Islets in control animals demonstrated a complete absence 
of staining, showing that endocrine IGF-II expression in transgenic animals is 
exogenous and that the RIP-driven transgene is expressed exclusively throughout the 
transgenic islets. Devedjian and coworkers (Devedjian et al., 2000) similarly
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demonstrated high levels of immunoreactive IGF-II restricted to the islets of PN4month 
transgenic mice in which the RIP promoter was used to drive p-cell-specific expression 
of IGF-H. Islets from PN4month non-transgenic animals displayed an absence of IGF-II 
immunoreactivity (Devedjian et al., 2000). So, despite there being only one line 
carrying the RIP-Igf2 transgene in the current study, the transgene behaved as expected. 
The absence of IGF-II immunostaining in islets from control mice in the present study 
is consistent with the findings of Devedjian et al. (2000). IGF-H immunoreactivity has, 
however, been detected in p-cells of healthy rats and humans (Hoog et al., 1996; Maake 
and Reinecke, 1993). Devedjian and colleagues (Devedjian et al., 2000) attributed the 
lack of immunodetection to a high threshold of detection by the IGF-H antibody (rabbit 
anti-human; GroPep Pty. Ltd., North Adelaide, Australia) used in the study, which 
probably detects only high levels of the IGF-H protein.
6.4.2. Pancreatic Weight
6.4.2.1. No Difference in Pancreatic Weight Between Elijah Transgenic and Control 
Animals
There was no significant difference in pancreatic wet weight between Elijah 
transgenic animals and control (497 ± 30 mg vs. 496 ±31 mg respectively; t = 0.24; P  = 
0.818). This finding was not consistent with a significant increase in the volume and 
mass of exocrine tissue but it was not unexpected in the light of the observed islet 
hyperplasia. The relatively small (1-2 %) contribution of endocrine tissue to the total 
pancreas mass means that quite substantial changes in islet morphology and size can 
occur with no noticeable increase in overall weight of the organ.
6.4.2.2. No Sisnificant Increase in Ripley Trans2enic Pancreatic Wei2ht
Pancreatic wet weight tended to be greater amongst transgenic animals of the 
Ripley line than controls (540 ± 23 mg vs. 479 ± 25 mg respectively). This increase just 
failed to reach statistical significance however (t = 3.67; P = 0.067). Mean pancreas 
weight for RIP-IGF-H transgenic animals was also found to be greater than for control 
animals by Devedjian et al. (2000). Transgenic pancreas mean weight at 157.0 ± 4 mg 
was 29.3 % greater than control at 121.4 ± 12 mg. This compares to an increase of 12.7 
% over control pancreatic weight in the present study. It might be expected that with
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increasing age, the effects of the RIP-Igf2 transgene diminish and that the extent of the 
IGF-E-induced islet overgrowth decreases. This might perhaps be as a result of a 
decrease in endocrine tissue growth as a compensatory response to maintain 
normoglycaemia. Hence, the IGF-E-induced increase in overall pancreatic weight in 
REMgf2 transgenic animals relative to non-transgenic sibling controls might be 
expected to decline with age.
6.4.3. Area of Pancreas Tissue Within Each Field is Si2nificantlv Greater 
in Elijah Trans2enic Animals
The total mean area of pancreas tissue per field was found to be significantly 
greater in animals carrying the IGF-E transgene than in control animals, meaning that it 
was necessary to express the acinar and endocrine contribution to pancreas area as a 
proportion of total area. This was unfortunate as it removed some of the statistical 
power of subsequent comparisons although this was not felt to be a significant 
disadvantage. In the absence of alternative explanations, the increased area of pancreas 
tissue per field in transgenic animals would imply that the lobes of transgenic pancreas 
are more closely arranged than in control animals, such that the pancreas is more 
“dense”. A more close-packed arrangement of tissue in the organ would result in a 
greater area of pancreatic tissue coverage within the same area of field. Spaces are 
commonly observed between adjacent pancreatic lobules in tissue sections as a fixation 
artefact. Hence, different durations of fixation might be expected to cause differing 
extents of separation between pancreatic lobules and so different spatial densities of 
tissue within two-dimensional sections. However, excised pancreas tissue from animals 
carrying the IGF-E transgene and non-transgenic siblings was subjected to the same 
program of fixation and processing for paraffin wax embedding. The reason for this 
finding therefore remains obscure.
6.4.4. No Increase in Percentase Acini or Islet Contribution to Pancreas 
Area in Elijah Transgenic Animals
Mean percentage acini area per field for transgenic animals at 96.7 ± 0.329 % 
was not significantly different from the control value of 96.2 ± 0.663 % (t = 0.32; P = 
0.770). Neither was there found to be any difference between the percentage
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contribution of endocrine tissue in transgenic animals (1.32 ± 0.299 %) vs. controls 
(1.51 ± 0.240 %; t = -0.37; P = 0.733). It was assumed from this result that IGF-E 
expression in the pancreatic acini (and islets to some extent) does not selectively 
influence the postnatal growth of the acinar tissue (or islets). In the transgenic mouse 
IGF-E overexpression model of Petrik et al. (1999), in which widely-overexpressed 
IGF-E was made available to the pancreas in the circulation, no increase in exocrine 
tissue was apparent. No such change was investigated however and the difficulty in 
evaluating the wet weight of the fetal (El9.5-20) pancreas accurately meant that this 
parameter was not measured. The total mean area of pancreas per section did tend to be 
greater in transgenic than in control animals however, implying a greater organ volume 
and mass (Petrik et al., 1999). In transgenic mice in which the keratin 10 promoter was 
used to drive IGF-E overexpression producing high circulating levels of IGF-E 
postnatally, pancreatic weight did not differ from control animals (Hill et al., 2000). 
This would imply no significant increase in exocrine tissue mass in transgenic mice 
although again, morphological changes in acinar tissue were not analysed. The apparent 
lack of a significant overgrowth effect of rat elastase I promoter-driven IGF-E 
overexpression on the pancreatic acini was unexpected. Using 1251-labelled IGFs and 
insulin, distinct receptors for IGF-I, IGF-E, and insulin have been demonstrated on 
isolated mouse pancreatic acini (Williams et al., 1984). mRNA for IGFBP2, one of the 
IGFBPs which modulate the biological availability to tissues and mitogenic effects of 
IGFs (Hogg et al., 1993; McCusker and Clemmons, 1992) has been shown to be 
localised in postnatal rat acinar tissue (Hill et al., 1999). Therefore, the pancreatic acinar 
cells appear competent to respond to an increased local availability of IGF-E. The 
apparent absence of significant IGF-E-induced acinar hyperplasia in the current study is 
also inconsistent with the results from a recent study demonstrating that combined 
inactivation of the Insulin receptor (Insr) and the Igfl receptor (Igflr) result in a 
reduced size of the exocrine pancreas due to reduced cellular proliferation whilst islet 
development is unaffected (Kido et al., 2002). Compared to wild-type mice, mean 
acinar diameter was reduced by approximately 40 % in Insr AIgfl r A embryos whilst 
islet diameter and architecture was unchanged. Inactivation of either receptor alone 
however, produced no effect. Furthermore, combined ablation of the two ligands Igfl 
and Igf2 resulted in an identical phenotype (Kido et al., 2002). Some data suggest that 
there is functional overlap between the growth-promoting functions of the two receptors 
(Efstratiadis, 1998); IGF-E stimulates embryonic growth in mice not only through its 
cognate receptor IGF1R, but also in part through INSR (Louvi et al., 1997). Mice
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lacking both IGF receptors, IGF1R and IGF2R, are rescued from perinatal lethality by 
IGF-D acting through INSR to promote growth (Ludwig et al., 1996). Since exocrine 
tissue reduction is not observed in single InsrA or Ig flrA mutant embryos, it is unlikely 
to be a consequence of impaired insulin or IGF-I signalling, which activate only the 
cognate receptor. IGF-E is known to bind to both the IGF1R and INSR receptors with a 
high affinity (Frasca et al., 1999). On the basis of the known interaction of IGF-E with 
both IGF1R and INSR, the decrease of exocrine tissue in double Insr AIgfl r A mutants 
but not in single InsfA or Ig flfA mutant embryos is consistent with the hypothesis that 
acinar tissue growth is mediated by the IGF-E ligand (Louvi et al., 1997). This was 
further supported by the finding that at E l2.5 when the mutational consequences of the 
lack of IGF-E alone begin manifesting (preceding those from IGF-I ablation by one 
day), exocrine pancreas reduction was already apparent. The findings from the 2002 
study (Kido et al., 2002) are consistent with the observation that IGF signalling 
promotes growth of cultured acinar cells and amylase gene expression (Ludwig et al., 
1999; O’Brien and Granner, 1996; Williams et al., 1984).
It was considered that the method used to compare exocrine and endocrine 
contribution to total pancreas area was not sufficiently accurate to detect small 
differences in exocrine area and so exocrine tissue mass within the pancreas. As 
mentioned, the preferred method of comparing absolute areas of exocrine tissue and 
islet tissue per field between Elijah transgenic and control animals could not be 
conducted due to the increased total pancreas area per field in animals carrying the IGF- 
E transgene. The necessity of expressing the area of exocrine (and endocrine) tissue as a 
proportion of total pancreas area removed some of the statistical power with which 
transgenic and control data sets could be compared. The very large (96-97 %) exocrine 
contribution and very small (1-2 %) endocrine contribution to pancreas area mean that 
the percentage exocrine tissue area is highly robust and very resistant to change. 
Conversely, the exocrine:endocrine tissue area ratio is highly susceptible to variation 
resulting from the number of islets within an area field. Islets do not occur in a random 
arrangement within the surrounding acinar tissue; they instead cluster together in a 
pattern of spatial distribution that can be explained by a fractal branching structure for 
ductules and random islet formation at their tips (Hastings et al., 1992; Schneider et al., 
1996). Hence, random sampling of fields for area measurement within a pancreas tissue 
section produces great variation in the number of islets per field, vastly affecting the 
exocrine:endocrine tissue area ratio measured for each field. Nevertheless, this sample 
variation should be comparable for data obtained from Elijah transgenic and control
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animals. An alternative of measuring the separation distance between islet centres as an 
index of acinar tissue area is also impeded by the same considerations. To obtain an 
absolute measure of exocrine pancreatic size, mean acinar diameter might have been 
measured as in the study of Kido et al. (2002). However, no noticeable difference was 
evident between the size of individual acini in Elijah transgenic and control pancreata.
6.4.5. Similar Islet Morphology in Transgenic Animals of Elijah and 
Ripley Lines
6.4.5.1. No Difference Between Islet Number in Elijah and Ripley Transgenic 
Animals and Respective Controls
Neither Elijah nor Ripley transgenic animals exhibited any difference in islet 
number from control animals. In transgenic Elijah mice, a mean of 3.76 ± 0.791 islets 
were counted in each field vs. 3.72 ± 0.440 islets/field in control animals {t = 0.30; P = 
0.781). Transgenic Ripley mice exhibited a mean of 30.6 ±6.18 islets per tissue section 
whilst this was not significantly different (t = 0.68; P = 0.565) from the 26.3 ± 2.81 
islets counted per pancreas section in non-transgenic littermates. This direct comparison 
was justified by the lack of difference in total sectional area between transgenic (29.1 ± 
1.83 mm2) and control (27.3 ± 2.45 mm2) animals (t = 0.60; P = 0.609).
6.4.5.2. Mean Islet Area Unaltered in Animals Carrying the IGF-II Transeene
Islets from both Elijah and Ripley transgenic animals showed no difference in 
mean area in section to those from control mice. The mean islet area for Elijah 
transgenic animals at 9470 ±2314 pm was not significantly different (t = -1.34; P = 
0.272) from the control figure of 11459 ±1411 pm2. Ripley mice overexpressing IGF-E 
bore islets with a mean area of 18601 ± 5384 pm2 vs. 17347 ± 3995 pm2 in control 
siblings (t = -0.05; P = 0.963).
6.4.5.3. “Mega-Islets” Exceeding the Normal Islet Size Ranee Seen in Elijah and 
Ripley Transgenic Animals
In both Elijah and Ripley transgenic mice, the samples of the islet population 
showed a broadly similar size (area) distribution to those in control animals, with a
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significant shift towards larger islets. In both cases, a significant number of strikingly 
large “mega-islets” were seen which far exceeded the normal islet size range evident in 
control animals. Of the 92-islet sample measured in Elijah mice bearing the transgene,
83.7 % of islets were categorised as small (below 20000 pm2 in area) compared with 
83.9 % of control islets. 7.61 % of islets in transgenic animals were 20000-39999 pm2 in 
area vs. 9.2 % of islets in non-transgenic siblings. The remaining 6.9 % of the control 
islet sample were classified as large (40000-59999 pm2) in the normal islet size 
spectrum but only 2.17 % of islets in the transgenic animals fell into this category. 
Instead, 6.52 % or six “mega-islets” from three of the five pancreata from transgenic 
animals exhibited areas of 60466-180194 pm , up to three-fold the largest control islets 
measured. Similarly, of the much larger islet population sample (764 islets) in
• • 9transgenic animals of the Ripley line, 95.5 % were below 100000 pm in area compared 
to 97.6 % of the 658 control islets, of which 76.0 % (transgenic) and 78.7 % (control) 
fell below 20000 pm2. In Ripley animals overexpressing IGF-E, 4.19 % of the islet 
sample exhibited an area of 100000-399999 pm2 vs. 2.43 % of the control sample. Two
'y
mega-islets of 414088 and 417005 pm in area, well exceeding the size of the largest 
control islet, were observed in two of the transgenic pancreata.
In both the Elijah and Ripley studies, the observed size distribution of islets in 
the transgenic animals diverged highly significantly (P < 0.01) from the expected size 
distribution extrapolated from the respective control animals (Elijah: calculated %2 = 
12.4; x2 = 11-34, d f -  3,p  = 0.01; Ripley: calculated %2 = 14.3; x2 = 13.28, df=  4, p  = 
0.01). The discrepancy in size distribution was greatest at the upper end of the size 
spectrum, reflecting a shift amongst the islet population in transgenic animals towards 
larger islets. In both Elijah and Ripley mice expressing the IGF-E transgene, the mega­
islets displayed a very irregular shape and fibrous inclusions were often visible within 
them.
6.4.5.3.1. Mesa-Islets Result from Hyperplasia
The frequent incidence of unusually large and irregularly-shaped mega-islets in 
both Elijah and Ripley transgenic mice suggested that local IGF-E overexpression led to 
islet cell hyperplasia. To ensure that increased islet size was not a consequence of 
hypertrophy, the area of individual endocrine cells within islets was measured. The lack 
of difference in mean islet cell areas between cells in Elijah mega-islets (76.6 ± 9.28
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pm2) and smaller, control islets (transgenic; 71.7 ± 5.71 (am2 and non-transgenic; 77.2 ± 
5.14 pm2; t = 1.05; P = 0.403 and t = -0.37; P = 0.774 respectively) was taken to 
support the hypothesis that mega-islets are hyperplastic, resulting from islet overgrowth. 
Considering the similarity of islet morphology between animals of the Elijah and Ripley 
lines carrying the transgene, it would appear valid to assume that mega-islets in Ripley 
transgenic animals are similarly a product of hyperplasia.
6,4.53.2. Aberrant Islet Architecture
Immunoperoxidase staining for glucagon revealed a disruption in the 
distribution of a-cells in many islets of Elijah and Ripley transgenic animals. In animals 
overexpressing IGF-E, 44.6 % of islets in Elijah transgenic animals demonstrated a 
large number of centrally-located a-cells. Amongst the islet sample from Ripley mice 
carrying the transgene, 41.7 % of islets exhibited altered architecture including aberrant 
presence of a-cells in the islet core but also markedly reduced a-cell number in the islet 
mantle; in extreme cases a-cells were completely absent. In neither of the two lines 
were any differences in islet p-cell distribution seen between transgenic and control 
animals.
6.4.5.3.3. IGF-II-Induced Islet Hyperplasia
It has been postulated that the mitogenic signalling of IGF-E is mediated by the 
type 1 IGF receptor (De Meyts et al., 1994; LeRoith et al., 1995). As a-, p- and 8-cells 
all express type 1 IGF receptors (Fehmann et al., 1996; Van Schravendijk et al., 1987; 
Withers et al., 1999), the presence of islet overgrowth in the Ripley transgenic animals 
suggests that the IGF-E produced by the p-cells probably interacted in a paracrine or 
autocrine manner with IGF-1 receptors on the islet cells. Studies in fibroblasts from 
mouse embryos homozygous for null alleles of Igfrl have shown that IGF-E can also 
stimulate cell proliferation through the insulin receptor (Morrione et al., 1997). p-Cells 
also express insulin receptors, and mice lacking insulin receptor specifically in P-cells 
show reduced islet size and insulin content (Kulkami et al., 1999). Therefore, IGF-E 
produced by p-cells of transgenic mice might also induce P-cell proliferation through 
the insulin receptor. Devedjian et al. (2000) found that the hyperplastic islets of their 
RIP-IGF-E transgenic mice were composed of similar percentages of a-, p- and 8-cells
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as in controls. It was inferred from this result that overexpression of IGF-H in p-cells 
led to induction of islet hyperplasia, providing a mitogenic stimulus to all endocrine cell 
types. Consistent with this, Hill and coworkers (Hill et al., 2000) found that in neonatal 
transgenic mice overexpressing IGF-H, hyperplastic islets exhibited the same 
proportions of a- and p-cells as control siblings. In their transgenic mouse IGF-H 
overexpression model, Petrik et al. (1999) discovered that the proportions of a- and P- 
cells in hyperplastic islets were increased and decreased respectively relative to controls 
although absolute numbers of a- and p-cells were still increased over control islets 
(Petrik et al., 1999). Owing to time constraints, proportions of a- and p-cells within the 
mega-islets of Ripley transgenic animals were not determined in the current study. 
However, it was evident from immunoperoxidase staining for glucagon that in a marked 
proportion of total islets in transgenic animals, the proportion of a-cells was reduced 
compared with control islets even considering centrally-located a-cells in transgenic 
islets. Satisfactory immunostaining within other islets in the same tissue section and 
within different sections on the same slide implied that absence of glucagon staining in 
such islets was a genuine phenomenon. It might be speculated from this result that IGF- 
H production by the p-cells in some transgenic islets causes P-cell hyperplasia at the 
expense of a-cell growth. In such cases, a-cells might be extruded from the islet by p- 
cell overgrowth. No noticeable difference in immunoperoxidase staining for insulin was 
seen between Ripley transgenic and control animals, though p-cell proportion in islets 
was not determined so a small (< 5 %) but significant increase in p-cell proportion at 
the expense of a-cells cannot be excluded. Further work to determine a-, P- and 8-cell 
proportions within islets of Ripley transgenic and control mice is therefore necessary.
In the Elijah transgenic animals, islet overgrowth was also suggestive of IGF-H- 
induced islet hyperplasia. However, owing to the uncertainty regarding the precise 
expression domain of the rat elastase I promoter, the source of IGF-H responsible for 
the overgrowth effect could be defined with less precision. The islet cells in which the 
IGF-H transgene is expressed in Elijah transgenic animals were not determined. There 
appeared to be no obvious difference in the proportion of a-cells between Elijah 
transgenic and control islets unlike the observations made in the Ripley study. The P- 
cell proportion also appeared to be unchanged between Elijah transgenic and control 
islets. In the absence of quantitative data, it would appear probable that IGF-H induces 
hyperplasia of the whole islet in Elijah animals carrying the transgene. Ascertaining a-, 
P- and 8-cell proportions within such islets should prove whether this is the case.
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Petrik et al. (1999) found that islet hyperplasia in E l9.5-20 transgenic mice 
widely overexpressing IGF-E was caused by an increased rate of islet cell proliferation. 
They showed immunoreactivity for PCNA in a- and p-cells from hyperplastic islets to 
be twice that in controls (transgenic, 33.4 ± 0.7 % vs. control, 20.2 ± 5.8 %; P < 0.05 
and transgenic, 24.4 ± 0.9 % vs. control, 10.1 ± 0.5 %; P  < 0.01 respectively). Petrik et 
al. (1998) had earlier demonstrated a transient increase in the number of islet cells 
expressing inducible nitric oxide synthase (iNOS) in the neonatal rat just preceding an 
increase in apoptosis. It is also known that the apoptosis characterising p-cell 
destruction in response to cytokines in type 1 diabetes involves increased intracellular 
concentration of nitric oxide and increased expression of iNOS (Corbett and McDaniel, 
1995). Petrik and colleagues (Petrik et al., 1999) found the number of islet cells in IGF- 
E-overexpressing mice containing immunoreactive iNOS to be significantly less than in 
controls. The proportion of islet cells undergoing apoptosis was also significantly less in 
transgenic animals than non-transgenic siblings. From these results, Petrik et al. (1999) 
proposed that the mechanisms underlying the observed islet hyperplasia evident in IGF- 
E transgenic animals are most probably a combination of increased cell proliferation 
coupled with enhanced survival. The percentages of a- and p-cells undergoing cell 
replication was greater in islets from transgenic animals than controls. Again, this is 
consistent with IGF-E providing a mitogenic stimulus to each of the endocrine cell 
populations. The number of islet cells undergoing apoptosis was reduced in islets from 
transgenic mice compared with controls. Although apoptotic cells proved difficult to 
identify, apoptosis during rat development has been shown to predominantly occur 
within the p-cells (Petrik et al., 1998). The IGFs are known to prevent apoptosis in a 
variety of cell types (Geier et al., 1992; Stewart and Rotwein, 1996), including isolated 
rat islets (Petrik et al., 1998), by mechanisms that include an inhibition of caspases 
(Jung et al., 1996). Although islets from IGF-E transgenic mice showed a decrease in 
the percentage of iNOS-immunoreactive cells, it could not be ascertained whether cells 
that expressed iNOS later progressed to apoptosis. Hill and colleagues (Hill et al., 2000) 
showed that in their IGF-E-overexpressing mice in which circulating IGF-E is retained 
postnatally, the wave of developmental islet cell apoptosis seen in control animals 
between PN11-16 was substantially reduced in the IGF-E transgenic animals (PN11; 
transgenic, 6 ± 1 % TUNEL-positive nuclei; control, 12 ± 1 %; P  < 0.01). Both a- and 
p-cell DNA synthesis in the resulting hyperplastic islets of transgenic animals was 
greater at PN13 and PN16 than in controls (Hill et al., 2000). Also, the proportion of a-
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to p-cells in the hyperplastic islets did not change over the course of the study. Both 
observations suggest that the additional IGF-E availability provided a mitogenic 
stimulus to both islet cell types consistent with previous results (Petrik et al., 1999).
Presented with data from these two studies (Hill et al., 2000; Petrik et al., 1999), 
it appears likely that islet hyperplasia in the Elijah and Ripley transgenic animals also 
resulted from a combination of an IGF-E-induced increase in cell proliferation coupled 
with enhanced survival. However, further work will be necessary to determine the exact 
mechanisms of the islet overgrowth. Indices of islet cell replication and apoptosis can 
be obtained from measures of PCNA immunoreactivity and TUNEL respectively. By 
examining transgenic and control animals at a range of postnatal time-points, the 
progression of islet hyperplasia can be determined with greater precision. Potentially, 
examination of pancreata from PN2wk-PN3wk animals when the developmental wave 
of islet cell apoptosis is occurring will give most insight into the mechanisms of 
endocrine overgrowth. Whether IGF-E overexpression in Elijah and Ripley transgenic 
animals suppresses this neonatal apoptotic wave and whether this contributes to islet 
hyperplasia remain to be determined.
The extent of islet hyperplasia in both the Elijah and Ripley transgenic animals 
appeared to be appreciably less than that observed in the transgenic mouse model of 
widespread IGF-E overexpression in which mean islet area in E l9.5-20 fetal pancreas 
was five-fold higher than in controls (Petrik et al., 1999). It was not clear from the 
outcome of this study whether the generation of islet hyperplasia was primarily caused 
by an increased local expression of IGF-E within the pancreas of transgenic animals or 
resulted from exposure to the increased (65 % over control) circulating levels. IGF-E 
mRNA and peptide were abundant in the islets of transgenic mouse pancreata, although 
this could be an effect of increased mean islet size, as well as a cause (Petrik et al., 
1999). Considering the results of the current study, it appears prudent to speculate that 
the more acute phenotype shown by the transgenic animals of Petrik and coworkers 
(Petrik et al., 1999) is primarily a product of the increased serum levels of IGF-E 
relative to their non-transgenic siblings. This hypothesis is supported in the Ripley 
transgenic animals by the finding that RIP-IGF-E transgenic mice exhibit only low 
levels of circulating IGF-E (Devedjian et al., 2000).
Comparing the extent of islet hyperplasia between the Elijah and Ripley 
transgenic mice raises issues regarding differences in sampling used in the two studies. 
Owing to the different nature of the Elijah study, a much smaller number of islets (n = 
92) were sampled than in the Ripley study (n = 764). Also, because of the different
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hypotheses being tested, magnification of images for morphometric analysis was much 
greater (x 200) in the Ripley study than the Elijah analysis (x 50), so that error (in real 
terms) associated with islet area measurement data from the latter analysis was greater 
than in the former study. Considering these factors, islet hyperplasia in Elijah transgenic 
animals would appear to be more extensive, both in terms of the extent of overgrowth of 
each mega-islet and also the incidence of hyperplasia within the respective islet 
samples. IGF-II expression within islets in Ripley animals bearing the transgene was 
clearly greater than in transgenic Elijah mice. If the assumption is made that islet 
overgrowth effects are relative to the amount of exogenous IGF-E, then it is impossible 
to explain the greater effects in the Elijah mice without invoking acinar-expressed IGF- 
E in these animals. This is taking the low circulating level of IGF-E (relative to 
controls) in the REMGF-E transgenic mice of Devedjian et al. (2000) into 
consideration. The more acute phenotype of Elijah transgenic animals indicates that the 
IGF-E protein is able to traverse the boundary between acini and islets to exert its 
mitogenic effects on the endocrine compartment. IGF-E availability to the islet by 
acinar tissue surrounding it on all aspects is likely to result in islet hyperplasia with 
overgrowth of different endocrine cell types, particularly if IGF-E is also expressed to 
some extent within the islet.
6.4.5.3.4. Interaction Between Hyperplasia and Disrupted Architecture o f  Islets
In all three IGF-E overexpression mouse models mentioned above (Devedjian et 
al., 2000; Hill et al., 2000; Petrik et al., 1999), disrupted islet architecture was seen to 
accompany islet hyperplasia as in the current study. Centrally-localised clusters of a- 
cells were seen within the p-cell mass of the islet core in contrast to their characteristic 
peripheral arrangement within the islet mantle. Similar changes in islet morphology are 
observed in animal models of type 2 diabetes and obesity, such as prediabetic Zucker 
Diabetic Fatty (ZDF) rats (Larsson et al., 1977; Polonsky, 1995; Tokuyama et al., 1995) 
and ob/ob (Shino et al., 1973) and db/db mice (Like and Chick, 1970), which present 
enlarged islets with disorganised intra-islet cell distribution. Devedjian et al. (2000) 
argued that the alteration in a-cell distribution evident in islets of transgenic IGF-E- 
overexpressing mice may not be a general occurrence with p-cell hyperplasia, since 
transgenic mice overexpressing growth hormone are highly hyperinsulinaemic and 
normoglycaemic (Valera et al., 1993), and show high hyperplasia of islets but normal 
a-cell distribution (J. Visa and F. Bosch, unpublished observations). Similarly,
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overexpression of IGF-I in p-cells of transgenic mice resulted in islet hyperplasia but 
normal distribution of a-cells (C. Costa and F. Bosch, unpublished observations). 
Devedjian et al. (2000) suggested from the disrupted islet architecture in their RIP-IGF- 
II transgenic mice that overexpression of IGF-E might alter the location of islet cells 
and lead to islet disorganisation. This is consistent with the finding that “starfish­
shaped” islets of Goto-Kakizaki (GK) rats show increased IGF-E expression (Hoog et 
al., 1996). The GK rat is a model of mild type 2 diabetes without obesity7. Greater 
amounts of a high-molecular-weight form of IGF-E were found in pancreatic extracts 
from PN2month and PN6month GK rats than in extracts from PN1 month GK and 
control rats (Hoog et al., 1996, 1997). More IGF-E mRNA was detected in starfish­
shaped islets of GK rats than in either GK rat islets with normal structure or islets of 
control rats (Hoog et al., 1996).
One explanation for the disorganised islet architecture in islets of IGF-E- 
overexpressing mice is that islet IGF-E expression causes changes in cell adhesion 
properties of the different endocrine cells. a-Cells were also seen to be ingressing into 
the islet body from the mantle in dumbbell islets (Chapter 5). It was speculated that 
migration of a-cells from the mantle drives islet fission and results from changes in cell 
adhesion properties of different endocrine cell types, most notably the a- and P-cells. 
By generating N-CAM knockout mice, Esni et al. (1999) showed that cadherin- 
mediated adhesion in islets is increased, resulting in aberrant a-cell localisation in the 
islet core. This disruption of normal islet architecture was attributed to increased 
cadherin-mediated adhesion between a-cells in the absence of N-CAM (Esni et al., 
1999). Hence, IGF-E expression in endocrine cells might cause differential expression 
of N-CAM and/or cadherin within the islet cells. This might possibly be in the form of a 
recapitulation of islet ontogeny preceding the loss of endogenous IGF-E at PN2wk- 
3wk. An alternative and attractive hypothesis is that IGF-E-expressing islets exhibit 
defective putative islet fission and as a result, a-cells ingressing from the islet mantle 
become isolated within the islet core and the hyperplastic islet remains as one “mega­
islet”, unable to divide into daughters. Incomplete or partial islet fission could explain 
the unusual shapes typically exhibited by hyperplastic islets (Devedjian et al., 2000; 
Hill et al., 2000; Petrik et al., 1999) and similarly account for the “starfish-shaped” 
islets in GK rats (Hoog et al., 1996).
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6.4.5.3.5, IGF-II Primarily a Mitosenic Stimulus for Existing Islets
It was found in the current study that the number of islets per pancreas section 
was not different between IGF-H transgenic animals and controls. This finding is 
concordant with results from the earlier studies (Hill et al., 2000; Petrik et al., 1999) of 
pancreatic morphology in IGF-H-overexpressing mouse models. This suggests that 
although IGF-H is likely to function as an islet cell mitogen, it may not be a significant 
factor in the generation of novel islets from the pancreatic ductal epithelium by 
neogenesis. This hypothesis is supported by the pattern of immunostaining for the 
immature endocrine cell marker Pdxl, in the pancreata of IGF-H transgenic animals 
(Petrik et al., 1999). Pdxl immunoreactivity was seen predominantly within the 
differentiated (3-cell population of existing islets, with little presence in isolated clusters 
of endocrine cells indicative of neogenesis. However, Petrik and colleagues (Petrik et 
al., 1999) found an increase in the number of isolated cells immunopositive for insulin 
per tissue section over control animals. This was taken to suggest that a limited degree 
of neogenesis was occurring. This result is consistent with a finding from the current 
study. In one pancreas from an Elijah transgenic mouse, immunoperoxidase staining 
revealed scattered glucagon-immunopositive acinar cells throughout the exocrine tissue 
of a few pancreatic lobes where they were evident both within acini and at the acinus 
periphery. Since glucagon is held to be a marker of primitive endocrine cells, it is 
speculated that these infrequent glucagon+ cells in the exocrine pancreas represent cases 
of neogenesis. Demonstrating such cells to be Pdxl-immunopositive would support this 
hypothesis. Considering the low incidence of such cells however, it would appear that 
IGF-H primarily functions as a mitogenic factor for existing endocrine cells, activating 
hyperplasia of existent islets. This is consistent with its ability to increase DNA 
synthesis within isolated islet-like cell clusters containing p-cells, from human fetal 
pancreas, but its relatively poor ability to increase the numbers of such structures 
compared with hepatocyte growth factor or FGF7 (Otonkoski et al., 1988b, 1994).
6.4.S.4. Predisposition to Type 2 Diabetes in Elijah and Ripley Transgenic Animals?
As mentioned above, islet hyperplasia and/or aberrant a-cell localisation within 
the islet core as seen in Elijah and Ripley transgenic mice is also observed in animal 
models of type 2 diabetes and obesity, such as prediabetic Zucker Diabetic Fatty (ZDF) 
rats (Larsson et al., 1977; Polonsky, 1995; Tokuyama et al., 1995) and ob/ob (Shino et
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al., 1973) and db/db mice (Like and Chick, 1970), which exhibit enlarged islets with 
disorganised islet cell distribution. Islets from RIP-IGF-II transgenic mice have been 
shown to display enhanced glucose-stimulated insulin secretion and glucose utilisation 
(Devedjian et al., 2000). Such mice exhibited hyperinsulinaemia, mild hyperglycaemia, 
and altered glucose and insulin tolerance tests consistent with insulin resistance as in the 
prediabetic state. Approximately 30 % of animals showed increased insulin resistance 
and developed overt diabetes with severe hyperglycaemia when fed a high-fat diet 
(Devedjian et al., 2000). It was inferred that an increase in circulating lipids may 
exacerbate the prediabetic phenotype in these mice. The authors proposed that islet 
hyperplasia was an early event in the RIP-IGF-II transgenic animals overexpressing 
IGF-H that led to hyperinsulinaemia as a result of which insulin resistance developed. 
The results were taken to support the hypothesis that hyperinsulinaemia may be an 
initial event in type 2 diabetes and that insulin resistance may be a consequence of the 
increased insulinaemia (Devedjian et al., 2000). Interestingly, in E19.5-20 transgenic 
mice widely overexpressing IGF-H, despite the presence of islet cell hyperplasia, 
circulating insulin concentrations and plasma glucose levels were found to be no 
different from controls (Petrik et al., 1999). This was suggested to be due to a 
downregulation of insulin secretion by IGF-H, as for islet-like cell clusters from human 
fetuses (Otonkoski et al., 1988b) and for perifused adult rat islets (Hill et al., 1997). 
Alternatively, if glucagon release was increased in transgenic animals as a result of the 
increased a-cell proportion in their hyperplastic islets, this might also suppress insulin 
release (Petrik et al., 1999).
Further work remains to be performed to determine whether the Elijah and/or 
Ripley transgenic mice display insulinaemia and insulin resistance as do the RIP-IGF-H 
mice of Devedjian et al. (2000). If so, these transgenic mice may be a suitable model in 
which to study the processes that lead to type 2 diabetes.
6.4.5.S. Presence o f “Hevatocvte-Like” Cells in Islets from Transzenic Animals
In two pancreata from Elijah and Ripley transgenic mice, H & E histochemistry 
revealed the presence of large cells which morphologically resembled hepatocytes and 
so these cells were referred to as “hepatocyte-like” cells. These cells were clearly 
distinguishable from adjacent endocrine cells by their abundant eosinophilic cytoplasm 
and were located at the islet periphery. This phenomenon was not observed frequently, 
occurring with an incidence of 0.13 % in islets of Ripley transgenic animals. However,
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the occurrence of such cells in transgenic animals of both lines at an estimated similar 
frequency would suggest that it is a real phenomenon. Similar “hepatocyte-like” cells 
within islets have been reported in a transgenic mouse model of FGF8 overexpression in 
which the mouse FGF8 transgene was driven by the rat glucagon promoter (Yamaoka et 
al., 2002). In this mouse model, the hepatocyte-like cells were localised to the periphery 
of islets as was seen in the present study, and displayed large clear nuclei with several 
small nucleoli and abundant eosinophilic cytoplasm. They were described as being 
morphologically indistinguishable from hepatocytes (Yamaoka et al., 2002). These cells 
were found to produce neither insulin nor glucagon on the immunohistochemical basis. 
It was inferred that FGF8 had stimulated the transdifferentiation (the direct 
transformation of one differentiated cell type to another) of a proportion of endocrine 
cells into hepatocyte-like cells (Yamaoka et al., 2002). This hypothesis was supported 
by the expression of the mature hepatocyte marker albumin in the FGF8 transgenic 
islets. The lack of expression of the immature hepatocyte marker a-fetoprotein by these 
islets was taken to imply that highly differentiated hepatocytes were generated in the 
islets of FGF8-overexpressing animals. An alternative explanation is that FGF8 may 
induce only albumin expression, but not a-fetoprotein expression, regardless of 
hepatocyte maturity. Parallels can be drawn between the current study and that of 
Yamaoka et al. (2002): both transgenic models involve a highly local overexpression of 
a growth factor within and/or adjacent to the pancreatic islets. However, FGF8 might 
also be made available to the pancreatic islets via the bloodstream. It was speculated 
that the level of FGF8 protein in the circulation of FGF8-overexpressing animals would 
be considerably higher than in controls although blood concentration was not measured 
(Yamaoka et al., 2002). Transgenic mice expressing interferon-y under the control of 
the same glucagon promoter exhibit a mean serum interferon-y concentration 50-fold 
greater than in control animals (Yamaoka et al., 1999). It remains to be seen whether the 
“hepatocyte-like” cells observed in the Elijah and Ripley IGF-II overexpression mouse 
models do indeed express transcription products characteristic of hepatocytes and 
resemble hepatocytes not just morphologically but also functionally. If so, it also 
remains to be proven whether such cells are actually generated by the 
transdifferentiation of endocrine cells. If so, then the observation of these cells in the 
islets of IGF-II-overexpressing animals might prove to be a very interesting finding. If 
an hepatocyte identity of such cells can be confirmed then it could be speculated that a 
high local concentration of IGF-II induces hepatocytes within the pancreas, perhaps by 
transdifferentiation of islet endocrine cells. So, one avenue of future work might involve
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the characterisation of these “hepatocyte-like” cells in islets from Elijah and Ripley 
transgenic mice. A lack of expression of endocrine markers such as insulin and 
glucagon and the exocrine marker amylase and positive immunostaining for the liver- 
specific proteins albumin, a-fetoprotein, transferrin, and/or transthyretin (prealbumin) 
would lend support to the ability of IGF-II to stimulate the induction of hepatocytes in 
the pancreatic islets.
On the basis that hepatocyte-like cells are found within the pancreatic islets, 
Yamaoka and colleagues (Yamaoka et al., 2002) suggested that such cells are most 
probably derived from endocrine precursor cells. They went on to argue that although 
hepatocyte-like cells are localised to the islet mantle where non-p-cells such as a-cells 
are usually located, this finding does not necessarily imply that such cells originated 
from non-p-cells. As mentioned above, the arrangement of islet cells has been 
considered to be dependent on adhesion molecules of each islet cell. If adhesion 
molecules such as cadherin, which has been shown to be essential for p-cell aggregation 
(Dahl et al., 1996), are not expressed in hepatocyte-like cells, they will lose contact with 
p-cells and become relegated to the islet mantle, outside the p-cell aggregate.
6.4.6. Summary
In conclusion, dramatically similar phenotypes affecting islet morphology were 
seen in two lines of transgenic mice overexpressing IGF-II in different compartments of 
the pancreas: the acini or islets. Transgenic animals displayed islet hyperplasia in 
conjunction with disorganised islet architecture as a result of IGF-II overexpression. 
Circumstantial evidence suggests that IGF-II produced in the acinar compartment is 
able to exert its mitogenic effects on the adjacent endocrine compartment and so the 
effects of IGF-H are not cell-autonomous but can be exerted over a distance. 
Furthermore, the appearance of “hepatocyte-like” cells morphologically resembling 
hepatocytes in the islets of transgenic animals of both lines permits speculation on 
possible IGF-D induction of hepatocytes, perhaps by the transdifferentiation of 
endocrine cells. Further work is needed to determine whether all endocrine populations 
are affected by the hyperplasia in both lines and to elucidate mechanisms of islet 
overgrowth. An immunocytochemical characterisation of the “hepatocyte-like” cells to 
confirm an hepatocyte identity is also an avenue of future study. Finally, investigation is 
required to determine whether transgenic animals display insulinaemia and insulin 
resistance as a result of islet hyperplasia, predisposing to type 2 diabetes.
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7. Induction of Hepatocytes in Dexamethasone-
Treated Embryonic Pancreas In Vitro
7.1. Introduction
7.1.1. Hepatic Transdifferentiation of the Pancreas
It is widely believed that the differentiated state is permanent and irreversible. 
However, in some cases, terminally differentiated cells can interconvert (Slack, 1986, 
1992), undergoing phenotypic alterations after an appropriate stimulus and in a 
permissive environment. Such alterations are associated with distinct morphological 
changes and are accompanied by the elaboration of new gene products, indicating 
activation of genes that are normally repressed in that cell type (DiBerardino et al., 
1984; Okada, 1986). The phenotypic interconversion of one differentiated cell to 
another usually arises in situations of chronic tissue damage and associated 
regeneration. Some changes may be indirect, occurring via an intervening stem cell, 
whereas others may be direct transformations, sometimes called transdifferentiations 
(Eguchi and Kodama, 1993; Okada, 1991). Many examples have been reported, some of 
which are known to predispose to cancer (Slack, 1986, 1992). However, the molecular 
and cellular mechanisms involved remain largely uncharacterised.
The appearance of hepatocytes in the pancreas has been described both in animal 
experiments and in human pathology. Hepatic foci have been reported to occur in the 
pancreas of rats or hamsters in response to various experimental treatments including 
treatment with the protein synthesis inhibitor ethionine (Scarpelli and Rao, 1981), 
copper depletion of the diet (Rao et al., 1986b; Rao and Reddy, 1995), after 
transplantation (Dabeva et al., 1997), or in transgenic mice overexpressing keratinocyte 
growth factor (KGF, also known as FGF7) in the pancreas (Krakowski et al., 1999). 
The phenomenon has also been observed spontaneously in the vervet monkey (Wolfe- 
Coote et al., 1996), and the reverse transformation has been observed in the liver of a 
human cancer patient (Wolf et al., 1990), and has recently been experimentally induced 
in Xenopus laevis tadpoles by overexpressing an activated form of the Xenopus 
homolog of Pdxl, Xlhbox8-VP16, in the liver (Horb et al., 2003). It has been pointed 
out that although such whole-organism observations cannot prove that the hepatocytes 
derive from pancreatic cells, they suggest a relatively high-frequency conversion
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between pancreatic cells and hepatocytes (Shen et al., 2000). These observations may 
reflect the intimate developmental relationship between the two tissues; the liver and 
pancreas originate from adjacent regions of the foregut endoderm (Slack, 1995; Zaret, 
2000).
7.1.2. Induction of Hepatocytes in Pancreatic Buds In Vitro
Using an in vitro system to study the transdifferentiation of pancreas to liver, 
Shen et al. (2000) showed that the pancreatic cell line AR42J-B13, yields foci of 
hepatocytes on treatment with the synthetic glucocorticoid dexamethasone. 
Immunofluorescence analysis showed that treatment with 10 nM dexamethasone for 
five days increased amylase expression in a proportion of cells. Another sub-population 
of cells progressively flattened onto the substratum and amylase expression was reduced 
in these cells after five days of treatment. After two weeks of treatment, expression of 
amylase was almost non-existent. After three weeks these cells showed strong 
expression of the liver-specific protein albumin. Such cells were shown by electron 
microscopy to exhibit typical features of hepatocytes such as extensive endoplasmic 
reticulum and structures resembling bile canaliculi. Testing the dexamethasone-treated 
cultures for the induction of eight liver-specific markers showed the markers to appear 
in sequence according to hepatocyte maturation. When more than one was stained 
simultaneously all cells expressing a later marker were also found to express the earlier 
marker. The consistent coexpression of liver proteins in the cultured cells strongly 
suggested that dexamethasone provokes the formation of hepatocytes and not just the 
ectopic expression of a few liver proteins. The changes induced by dexamethasone 
represented a coordinated program of hepatocyte differentiation rather than the 
activation of one or a few individual genes. Shen et al. (2000) demonstrated that indeed 
a proportion of the hepatocytes arose directly from differentiated exocrine-like cells, 
with no intervening cell division. Initially the cells lost the pancreatic phenotype and 
lost their expression of amylase. They then started to express hepatic genes that are 
produced in fetal liver and later they expressed larger amounts of albumin and other 
gene products characteristic of adult liver. Based on immunofluorescence detection, 
these hepatocytes were subsequently shown to demonstrate mature liver characteristics 
such as the expression of liver genes involved in phase I and II detoxification pathways, 
ammonia detoxification, and the metabolism of glucose (Tosh et al., 2002). The 
conversion of differentiated exocrine-like cells into hepatocytes was shown by Shen et
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al. (2000) to be associated with induction of the transcription factor C/EBP (CCAAT 
enhancer binding protein)p. Furthermore, Shen et al. (2000) went on to demonstrate 
dexamethasone induction of hepatocytes concomitant with C/EBPp activation in 
cultures of mouse embryonic pancreatic buds established using the system of Percival 
and Slack (1999) as described in Chapter 3. This result demonstrated that 
dexamethasone-induced conversion is not restricted to the AR42J-B13 cells, but that it 
also occurs in the normal developing pancreas (Shen et al., 2000). Moreover, it also 
demonstrates the eminent suitability of the embryonic pancreatic bud culture system for 
studying the phenomenon of dexamethasone-induced hepatic conversion of pancreas to 
liver.
7.1.3. Current Study
It has been observed (Dr. D. Tosh, unpublished observations) that following 
dexamethasone treatment of intact pancreatic bud cultures, induced hepatocytes express, 
amongst a number of liver-specific markers, one of two ammonia-detoxifying enzymes: 
glutamine synthetase (GS) or carbamoylphosphate synthetase I (ammonia; CPS I). In 
the mammalian liver the distribution of these two enzymes is mutually exclusive in that 
they are expressed in two distinct populations of hepatocytes that are zonally 
demarcated in the liver acinus/lobule. In each acinus hepatocytes extend from the 
upstream portal to the downstream central venules (Lamers et al., 1989; Rappaport, 
1973). In the adult rat, CPS I protein and mRNA is exclusively expressed in a 
contiguous large compartment (Fig. 7.1.) including the periportal (afferent) zone, 
intermediate zone and early perivenous zone with expression decreasing in a porto- 
central direction (Bartels et al., 1989; Moorman et al., 1988, 1990). Expression of GS 
protein and mRNA is also exclusive and restricted to the late perivenous (efferent) zone, 
a small compartment comprising the last downstream pericentral hepatocytes lining the 
central vein in each acinus (Bartels et al., 1989; Moorman et al., 1988, 1990). 
Therefore, expression of these enzymes exhibits a strict reciprocal relationship 
(Gebhardt, 1992). The enzyme heterogeneity in the liver has been attributed largely to 
gradients of metabolites and regulatory factors along the liver acinus (Gumucio, 1989). 
Kuo et al. (1988) attributed the highly restricted pattern of GS expression to specific 
geographically located signals such as possible variations in the composition of 
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been proposed (Shiojiri et al., 1997) that factors associated with central veins direct the 
hepatocytes lining the central vein to express GS and to suppress CPS I expression. 
Blood-borne modulatory factors such as hormones, substrates and oxygen, are supposed 
to be the major determinants for the establishment and the dynamics of a gradient type 
of protein zonation (Jungermann, 1988; Jungermann and Katz, 1989). Such blood-borne 
factors are assumed to constitute the primary determinants for CPS I expression within 
the hepatic acinus (Moorman et al., 1990).
Mirroring observations in vivo, GS and CPS I expression have also been shown 
to be complementary in dexamethasone-treated AR42J-B13 cells (Tosh et al., 2002) and 
in pancreatic bud cultures in vitro. By conducting immunofluorescence analysis on 
dexamethasone-treated intact pancreatic bud cultures, CPS I expression was 
demonstrated in cells throughout the majority of the epithelium whilst GS expression 
was restricted to cells in a much smaller compartment at the periphery of the epithelium, 
adjacent to the surrounding mesenchyme (Dr. D. Tosh, unpublished observations). This 
latter finding raised the possibility that epithelium-mesenchyme interactions might play 
a role in the induction of at least one population of hepatocytes formed during 
dexamethasone-induced hepatic transdifferentiation. Consequently, two interesting 
questions arose: (1) Does hepatic transdifferentiation of dexamethasone-treated 
pancreatic buds still occur in the absence of mesenchyme? (2) If transdifferentiation 
does occur, is the GS+ hepatocyte population induced, and if not, does induction of CPS 
I-expressing hepatocytes still occur in their absence? In order to address these questions, 
El 1.5 pancreatic epithelium was carefully dissected free of its surrounding mesenchyme 
and cultured in isolation. As a positive control, El 1.5 intact pancreatic buds were 
established and maintained in vitro in parallel with the isolated epithelial cultures. After 
inducing hepatic conversion in half of the cultures with dexamethasone treatment, 
cultures were fixed and immunofluorescence analysis performed for liver- or pancreas- 
specific protein markers to determine whether or not hepatic conversion had occurred 
and if so, which (periportal or perivenous) hepatocyte population(s) had been induced.
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7.2. Materials and Methods
The protocol employed for establishing pancreatic bud cultures and subsequent 
immunofluorescence analysis was essentially that developed by Percival and Slack 
(1999) with some minor procedural modifications.
7.2.1. Pancreatic Bud Dissection and Establishing Cultures
Pancreatic buds were obtained from either MF1 albino mice or embryos of the 
ROSA-26 gene trap mouse strain (Zambrowicz et al., 1997) following their outbreeding 
since recombinant pancreatic bud cultures (Chapter 3) were established in parallel. In 
this chapter the lacZ status of cultures is not relevant. Dorsal pancreatic buds were 
dissected and intact pancreatic bud cultures, isolated epithelial cultures, and in later 
experiments, segregated epithelium/mesenchyme co-cultures were established as in 
Chapter 2, Section 2.1.
7.2.2. Treatment of Cultures
From either day (d) 2 or 3 of the culture period, the synthetic glucocorticoid 
dexamethasone or “Dex” (Sigma D-1756) was added daily to the newly replenished 2 
ml culture medium to a final concentration of 1 pM. As a control, Dex was withheld 
from the medium. In later experiments, 100 ng/ml of recombinant Fibroblast Growth 
Factor (FGF) 1/acidic (a)FGF, FGF7/KGF, FGF8b (the latter was also added at 1 pg/ml) 
or FGF 10 (all R & D Systems: 232-FA, 251-KG, 423-F8 and 345-FG respectively) 
were added to isolated epithelial cultures from d2. FGF was added directly onto the 
culture prior to addition of fresh medium. Dex treatment was either concurrent with 
FGF incubation or was commenced 1-2 days after FGF treatment was begun.
7.2.3. Immunofluorescence Cytochemistry
Cultures were fixed as described in Section 2.2.1. Then, immediately thereafter 
or following storage (in PBSA with 0.02 % NaN3 at 4°C), cultures were subjected to 
immunofluorescence cytochemistry as in Section 2.5.2. The primary and secondary 
antisera used together with their source and working concentrations are summarised in
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Tables 2.1. and 2.2. respectively (Section 2.5.1.). The first staining cycle was typically 
completed before the second was commenced except when double-staining for CPS I 
and GS: only one incubation was conducted with both primary antibodies, each used at 
a working dilution of 1/500. One 2.5 h incubation (at room temperature) was then 
performed with the two secondary antisera. In some experiments when staining for 
neurogenin3, antigen retrieval was performed with citrate buffer or ammonium chloride 
following the permeabilisation stage and occasionally, staining intensity was enhanced 
by avidin-biotin signal amplification as in Section 2.5.2.2.
7.2.4. Scoring Immunopositive Cells and Imase Capture
During their treatment in vitro, live cultures were periodically observed using a 
Leica DMIRB inverted compound microscope; images of live specimens were collected 
from a Zeiss LSM510 confocal microscope. Immunofluorescence-stained pancreatic 
bud cultures were examined using a Leica DMRB fluorescent microscope. Images of 
stained specimens were taken with a Spot RT Color digital camera (National 
Diagnostics Inc.) and stored as uncompressed 24-bit TIFF images. Immunopositive 
cells were scored as absolute numbers or as an approximate percentage of total cells 
either directly or from merged images following adjustment of colour channels using 
the Adobe Photoshop 6.0 package.
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7.3. Results
7.3.1. Growth and Morphology of Cultures In Vitro
Once placed on to the fibronectin substrate, intact pancreatic buds adhered 
within a few hours and gradually flattened out over the first one-two days as described 
by Percival and Slack (1999) and in Chapter 3. Mesenchymal cells spread rapidly out 
of the explant to form a monolayer of cells around the epithelium and on the second or 
third day of culture, the epithelium began to branch. Over the subsequent six days in 
vitro, the epithelium became an extended branched structure radiating from the original 
centre (Fig. 7.2. (a)). The mesenchyme resolved into a periphery mainly composed of 
smooth muscle cells and an inner region dominated by fibroblastic cells with occasional 
patches of lymphoid tissue. The presence of 1 pM dexamethasone (Dex) in the culture 
medium for 6 days from 2d of culture produced a change in pancreatic bud morphology 
(Fig. 7.2. (b)). The number of epithelial branches was reduced and large, flattened cells 
became evident from day 4 of Dex exposure. Cultures also appeared very dense, 
presumably due to increased deposition of zymogen granules. These observations were 
consistent with the previously described induction of hepatic conversion (Shen et al., 
2000).
Isolated epithelia rapidly adhered to the fibronectin substrate within a few hours 
and survived in the culture system, forming an epithelial monolayer. However, epithelia 
deprived of their mesenchyme did not undergo the typical morphogenetic behaviour of 
the intact cultures, showing no branching morphogenesis even after 8 days’ 
maintenance in vitro (Fig. 7.2. (c)). Following exposure to 1 pM Dex from 2d, cultured 
epithelia showed changes in morphology. Cell aggregates or “islands” of cells began to 
appear after 4 days of Dex treatment (Fig. 7.2. (d)). By 7 days of Dex exposure, some 
cell detachment from the substrate was evident as the free ends of chains of cells 
tethered to the fibronectin substrate floated in the culture medium. Large, flattened cells 
were not visible in the Dex-treated epithelia as they had been in the Dex-treated intact 
buds, implying that hepatic conversion had not been induced in the absence of 
mesenchyme. An analysis of pancreatic and liver marker expression would confirm this 
suggestion and determine the identity of the cell islands.
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(c). (d).
Figure 7.2. Cell Aggregates are Generated by Dexamethasone Treatment of 
Isolated Pancreatic Epithelium
(a) Intact 8d pancreatic bud culture, (b) Intact 8d pancreatic bud following 
treatment with dexamethasone for 6d. (c) Isolated 8d pancreatic epithelium,
(d) Isolated 8d pancreatic epithelium after 6d of dexamethasone treatment; 
cell “islands” are shown at greater magnification in inset
Images collected on Zeiss LSM510 confocal microscope. Bar = 200 pm
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7.3.2. Immunofluorescence Analysis
7.3.2.1. Hepatic Conversion o f Intact Pancreatic Buds
Control intact pancreatic buds cultured for 9d without Dex exhibited the 
characteristic appearance of exocrine and endocrine markers: approximately 80 % of the 
epithelial cells were associated into acinus-like structures and expressed amylase, but 
insulin- and glucagon-immunopositive cells were also evident in islet-like structures 
(Fig. 7.3. (a)). Intact buds cultured without Dex failed to show expression of the liver- 
specific proteins CPS I and GS (Fig. 7.3. (b)). Whole pancreatic buds exposed to 1 pM 
Dex for 7 days from 2d of culture retained expression of amylase throughout the explant 
(Fig. 7.3. (c)). The monoclonal mouse anti-glucagon antibody (Sigma G-2654) used in 
the current study was that employed by Shen et al. (2000). Although (a-) amylase is 
commonly accepted as a marker of pancreatic acinar cells, it is also expressed in 
immature hepatocytes and in the epithelia of intrahepatic bile ducts in fetal and adult 
human liver (Terada and Nakanuma, 1991, 1995; Terada et al., 1998). No signal has, 
however, been reported (Professor J. M. W. Slack, personal communication) from 
immunofluorescence analysis with this anti-glucagon antibody, in cultured cells from 
the human hepatoma cell line, HepG2, or in Xenopus laevis liver. Therefore in practice, 
the anti-glucagon antibody used in the present study was capable of distinguishing 
between pancreatic exocrine cells and hepatocytes.
Whilst whole pancreatic buds exposed to 1 pM Dex for 7 days retained their 
expression of amylase throughout the culture, no insulin-immunopositive cells were 
evident and the number of glucagon* cells was negligible compared with control 
untreated buds. Liver proteins were induced by treatment with dexamethasone, as 
judged from high expression of the liver-specific protein transferrin or TFN (Fig. 7.3.
(e)), indicating hepatocyte induction. Expression of both CPS I and GS was also seen in 
Dex-treated whole cultures (Fig. 7.3. (d)). Between 60 % and 70 % of epithelial cells 
were CPS I-immunopositive whilst 10-20 % of epithelial cells stained for GS. No 
colocalisation of the two liver markers was observed, consistent with previous 
observations (Dr. D. Tosh, unpublished observations). This suggested the induction of 
distinct CPS I* periportal-like and GS+ perivenous-like hepatocyte populations.
The patterns of differentiation resulting from the pancreatic epithelium being 
subjected to a particular environment and/or treatment such as Dex exposure are 
summarised in Table 7.1. The data were derived from an average of four replicates for 
each experiment. The proportions of cells immunopositive for each cell marker stained
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Figure 7.3. Hepatic Conversion of Pancreatic Buds by Dexamethasone Does Not 
Occur in the Absence of Mesenchyme
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Hepatic Markers
CPS l/GS Transferrin (TFN)
(i). (i).
Immunofluorescence analysis of pancreatic and hepatic markers in 9d intact buds 
and isolated epithelium cultured without (a-b and f-g) or with (c-e and h-j) 1 pM 
dexamethasone for 7d
(a), (c) and (e) Bar = 200 pm; (b), (d) and (f)-(i) Bar = 100 pm; (j) Bar = 50 pm
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for are represented as +, ++ or +++. On this qualitative scale as used by Horb and 
Slack (2000), ++ denotes the proportion of amylase+ cells and insulin+ cells in untreated 
intact pancreatic buds; + represents the smaller proportion of glucagon-immunopositive 
cells in the control intact buds. Since no CPS I or GS staining was detected in intact 
cultures, - is used to denote an absence of CPS I4" cells and GS+ cells in the control buds. 
According to this scale, a higher or lower number o f+ ’s than the control value indicates 
a greater or lesser number of immunopositive cells relative to the control, respectively, 
whilst a - denotes the absence of cells staining for the marker concerned.
Table 7.1. Cell Differentiation Patterns of Pancreatic Epithelium Subjected to 
Different Environments and Culture Conditions
CULTURE TYPE 
& TREATMENT
RELATIVE ABUNDAN<CE OF CELL MARKER
Amylase Insulin Glucagon CPS I GS TFN
Intact Bud (Control) ++ ++ + - -
Intact Bud + Dex +++ - + ++ + ++
Isolated Epithelium - + + - -
Isolated Epithelium 
+ Dex
- + +++ - _ * -
Isolated Epithelium 
+ FGF1
- + +++ - -
Isolated Epithelium 
+ FGF1 +Dex
+ + +++ - +
Isolated Epithelium 






+ Mesenchyme + Dex
+ ++ +++ + +
* Refer to Section 7.3.2.9.
7.3.2.2. Absence o f  Hepatocytes in Dex-Treated Isolated Epithelia
Isolated pancreatic epithelia cultured for 9d in Dex-free medium showed small 
numbers (< 5) of scattered glucagon- or insulin-immunopositive cells although no 
amylase expression was seen (Fig. 7.3. (f)), indicating an absence of exocrine 
differentiation. No CPS I4" cells or GS-expressing cells were observed in these cultures
303
Chapter 7: Dexamethasone-induced Hepatocytes
(Fig. 7.3. (g)). Isolated epithelia subjected to 1 pM Dex over 2-9d of culture also 
showed no staining for the liver markers CPS I, GS (Fig. 7.3. (i)) or transferrin (Fig.
7.3. (j)), suggesting that dexamethasone-induced conversion cannot occur in the 
absence of pancreatic mesenchyme. In the Dex-exposed epithelia as in control untreated 
epithelia, small numbers of insulin-immunopositive cells were observed and amylase 
expression was absent (Fig. 7.3. (h)). However, isolated epithelia exposed to Dex for 7 
days showed markedly greater numbers of glucagon-expressing cells than epithelia 
cultured in Dex-free media. The glucagon-immunopositive cells in the Dex-treated 
epithelia were associated together in small aggregates or clusters (Fig. 7.4.), presumed 
to correspond to the cell “islands” identified initially (Fig. 7.2. (d)). The earliest 
differentiated cells to emerge during normal pancreas development are glucagon- 
expressing cells (Pictet and Rutter, 1972) and increased early differentiation of 
precursor epithelial cells would result in an excessive number of glucagon-positive cells 
(Apelqvist et al., 1999; Jensen et al., 2000b). Hence, a specific increase in the numbers 
of glucagon-expressing cells might suggest that dexamethasone promotes the expansion 
of a primitive endocrine precursor cell population. This Dex-driven increase in the 
numbers of glucagon* cells in isolated epithelial cultures was then partially quantified 
by further immunofluorescence analysis.
7.3.2.3. Dexamethasone-Stimulated Increase in the Number o f  Glucaeon+ Cells in 
Isolated Epithelia
Whilst the number of insulin-immunopositive cells was not appreciably 
increased in Dex-treated isolated epithelial cultures compared to untreated control 
epithelia (mean ± S.E. was 1.6 ± 1.04 cells and 0.5 + 0.354 cells per culture 
respectively), the 10.2 ± 2.83 glucagon-immunopositive cells counted in each Dex- 
treated isolated epithelial culture was markedly higher than the 1.0 ± 0.707 cells control 
value (Fig. 7.4. and Graph 7.1.). The small numbers of cells were attributed in part to 
some detachment from the substrate with prolonged culture duration. Although the Dex- 
induced increase in the number of glucagon+ cells was obvious, it could be argued that 
this figure is dependent upon the original volume of explanted epithelial tissue. Hence, 
the number of glucagon-immunopositive cells could be expressed as a proportion of the 
total number of epithelial cells. Expressing glucagon-labelling index as a proportion of 
DAPI-labelled cells fails to account for the presence of any mesenchyme that might 
conceivably contaminate the “isolated” epithelium. It was decided to determine the total
304
Chapter 7: Dexamethasone-induced Hepatocytes 
Amylase/Insulin/Glucagon----------------------------- -s
(a). Control - No Dex (b). 7d Dex
(c). 7d Dex (d). 7d Dex
Immunofluorescence analysis for amylase, insulin and glucagon in 9d isolated epithelia 
cultured without (a) or with (b-d) 1 pM dexamethasone for 7d. Bar = 100 pm
Figure 7.4. and Graph 7.1. Dexamethasone Increases the Number of Glucagon* 
Cells in Isolated Epithelium
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number of epithelial cells by staining for the epithelial marker pan-cytokeratin. Since 
the anti-pan-cytokeratin antibody used (Sigma C-2931) was raised in mouse as was the 
anti-glucagon antibody (Sigma G-2654) employed until this point, double 
immunofluorescence analysis for pan-cytokeratin and glucagon was attempted using 
one of two polyclonal antibodies raised in rabbit (DAKO A0565 and Abeam ab9379). 
However, the 1:1 acetone:methanol fixation of the cultured epithelium required for 
staining with the pan-cytokeratin antibody was not conducive to successful staining 
with either of the two anti-glucagon antisera. Due to time constraints, further staining 
attempts were deemed unnecessary.
Efforts were also made to characterise the glucagon+ cell population expanded 
by dexamethasone treatment by staining for neurogenin3 (ngn3) as a marker of 
endocrine cell progenitors (Apelqvist et al., 1999; Jensen et al., 2000a; Schwitzgebel et 
al., 2000). However, as reported in Chapter 3, despite repeated attempts, 
immunofluorescence cytochemistry using either of the two anti-ngn3 antibodies (mouse 
monoclonal, Transduction Laboratories N63520 and rabbit polyclonal, Abeam ab7560) 
proved to be unsuccessful, irrespective of fixation conditions, and inclusion of citrate 
buffer or ammonium chloride antigen retrieval and/or avidin-biotin signal amplification 
steps in the staining protocol.
73.2.4. Time-Course o f Dexamethasone-induced CPS 7* Periportal-Like and GSf 
Perivenous-Like Hepatocytes
To determine the time-course and zonation of dexamethasone-induced CPS I4- 
hepatocytes and GS+ hepatocytes in intact pancreatic buds, expression of the two 
markers was examined in intact buds exposed to 1 pM dexamethasone for 3-9 days 
from 2d of culture onwards (Fig. 7.5.). The numbers of both CPS 1^  cells and GS+ cells 
increased over 3-7 days of Dex treatment whereupon the abundance of cells expressing 
either of the two proteins appeared to plateau. At no time-point examined, did GS+ cells 
outnumber cells expressing CPS I. CPS I and GS expression were seen to be clearly 
distinct in all cultures examined at all time-points. Colocalisation of the two proteins 
was never encountered in any of the cells in the cultures.
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(c). 7d Dex (d). 9d Dex
Figure 7.5. Numbers of CPS I+ Hepatocytes and GS+ Hepatocytes in Intact 
Pancreatic Buds Increase with Duration of Dexamethasone Exposure
Immunofluorescence analysis for CPS I and GS in 5-1 Id intact buds cultured 
with 1 pM dexamethasone from 2d of culture for 3 (a), 5 (b), 7 (c) or 9 (d) days
Bar = 100 pm
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7.3.2.5. Can Either the CPS 7* Hepatocyte or the GS? Hepatocyte Population be 
Induced in the Absence o f  the Other?
As dexamethasone-induced conversion had been shown not to occur with a total 
depletion of mesenchyme, attempts were made to examine induction of hepatocytes by 
staining for liver-specific proteins in an environment only partially deprived of 
mesenchyme or factors from it. It was proposed that in the absence of exocrine 
differentiation, Dex-induced conversion cannot proceed if hepatocytes arise directly 
from exocrine cells (Shen et al., 2000). Therefore, an environment must be engineered 
in which only a limited amount of exocrine differentiation occurs to address the original 
aim of the study. To this end, epithelium and mesenchyme from the same dorsal 
pancreatic bud were segregated and co-cultured in the same dish at a separation of 
approximately 5 mm from one another. It has been shown that FGF can promote 
exocrine differentiation from isolated pancreatic epithelium (Horb and Slack, 2000; 
Miralles et al., 1999). On the basis of this finding, isolated epithelium was cultured in 
the presence of FGF then exposed to Dex in an attempt to yield some exocrine cells 
which might then be induced to form hepatocytes. Such an outcome would also 
indirectly support the role of FGF 10 in the development of the pancreas as Bhushan and 
coworkers (Bhushan et al., 2001) suggest. In preliminary experiments, isolated 
epithelium was cultured with FGF1 also known as acidic (a)FGF as in the study by 
Horb and Slack (2000) in which 22 h exposure to 100 ng/ml FGF1 was shown to 
promote exocrine differentiation. FGF1 is capable of stimulating all known FGF 
receptors (Omitz et al., 1996) and should therefore be able to replicate the effect of any 
of the 22 known FGFs.
7.3.2.6. Mesenchyme Stimulates Epithelial Expression o f Endocrine and Exocrine 
Markers
The co-cultures of segregated epithelium and mesenchyme displayed expression 
of amylase, insulin and glucagon when subjected to immunofluorescence analysis (Fig.
7.6. (c)-(e)). Approximately 40 % of cells expressed amylase whilst about 50 % and 10 
% of cells were immunopositive for insulin and glucagon respectively. Consequently, 
the numbers of cells expressing each of the three proteins was substantially elevated 
compared with isolated epithelium (Fig. 7.6. (b)). In comparison with intact buds (Fig.
7.6. (a)), the proportion of cells staining for amylase was reduced although the
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Intact Bud
Figure 7.6. Mesenchyme Increases Exocrine but Suppresses Endocrine Differentiation
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percentages of both insulin+ cells and glucagon+ cells were notably higher. Furthermore, 
in three of four epithelium and mesenchyme co-cultures, islet-like clusters of insulin- 
and glucagon-immunopositive cells were much larger in size than those seen in intact 
bud cultures, and were also frequently interconnected. These observations suggest that 
low levels of mesenchyme promote both exocrine and endocrine differentiation of the 
pancreatic epithelium. Moreover, the apparent decrease in exocrine expression and 
elevation in endocrine expression in the co-cultures compared with intact buds indicates 
that abundant mesenchyme stimulates exocrine expression whilst suppressing endocrine 
differentiation to some extent.
7.3.2.7. Dexamethasone Increases the Number o f Glucagon* Cells at the Expense o f  
Insulin+ Cells in Co-Cultures
Co-cultures of segregated epithelium and mesenchyme exposed to 1 pM Dex for 
3-9d showed expression of amylase, insulin and glucagon (Fig. 7.6. (f)-(h)). 
Approximately 25 % of cells stained for amylase whilst about 15 % and 60 % of cells 
proved to be immunopositive for insulin and glucagon respectively. Interestingly, in the 
co-cultures dexamethasone exposure increased the number of glucagon-immunopositive 
cells as in isolated epithelial cultures, but at the expense of the insulin-immunopositive 
cell population. When co-cultures were subjected to immunofluorescence analysis for 
the hepatic enzymes CPS I and GS, six of seven cultures showed no cells 
immunopositive for either marker. However, in one co-culture treated for 3d with Dex, 
19 cells stained for CPS I whilst a further 24 cells demonstrated GS expression (Fig.
7.6. (i)). As in Dex-treated intact cultures, no coexpression of the two enzymes was 
observed and the complementary CPS I and GS expression pattern was retained. Some 
exocrine cells were present in the co-cultures of segregated epithelium and mesenchyme 
and hepatic conversion did occur albeit infrequently in these co-cultures. To date 
though, no evidence had been generated to support the dissociation of induction of 
either the CPS I*- periportal-like or GS+ perivenous-like hepatocyte population from the 
other.
7.3.2.8. FGFl-Treated Isolated Epithelia
Isolated epithelium cultured for 3d in the presence of 100 ng/ml FGF1 showed 
no staining for amylase though demonstrated both insulin+ cells and glucagon-
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immunopositive cells (Fig. 7.7. (b)). The proportion of insulin+ cells was comparable to 
that in control untreated isolated epithelial cultures (Fig. 7.7. (a)), although numbers of 
glucagon-immunopositive cells were greater than those in control epithelia. Neither 
CPS f  cells nor GS-immunopositive cells were seen in FGF 1-exposed epithelia.
7.3.2.9. Dexamethasone Can Induce GS+ Hepatocytes in the Absence o f the CPS i* 
Hepatocyte Population
Isolated epithelium cultured for 2-6d in the presence of 100 ng/ml FGF1 or 
FGF10 and exposed to Dex for 3-7d showed similar patterns of staining for amylase, 
insulin and glucagon irrespective of the FGF employed (Fig. 7.7. (c)-(f)). Isolated 
epithelia exposed to both FGF and Dex showed similar proportions of insulin+ cells and 
cells immunopositive for glucagon as isolated epithelia exposed to FGF1 (Fig. 7.7. (b)). 
Those epithelia subjected to Dex in addition to FGF however, showed expression of 
amylase (notably Fig. 7.7. (e)) which was absent from FGF 1-treated epithelia not 
exposed to the dexamethasone. This implied the presence of exocrine cells in the Dex- 
and FGF-treated epithelia. Three of seven isolated epithelia cultured with Dex and 
FGF1 also contained cells expressing GS (Fig. 7.7. (g)-(h)) although in none of these 
cultures were CPS 1^  hepatocytes also induced. Staining for GS showed that hepatic 
conversion can be induced in FGF-treated isolated epithelia but moreover demonstrated 
conclusively that CPS 1^  hepatocytes need not be induced to initiate induction of the 
GS-expressing population and that induction of the two hepatocyte populations occurs 
independently of one another. In two of the eight negative controls for FGF treatment in 
which isolated epithelia were exposed to Dex only for 3d, some GS+ cells were also 
observed (Fig. 7.7. (i)-(j)) although again, CPS I-immunopositive cells were absent. 
This again demonstrated the dissociation of the induction of GS+ hepatocytes from that 
of the CPS I* population. The reason for such hepatic conversion being observed was 
however, unclear since no liver markers were detected in previous experiments.
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s------------------------------ Amylase/Insulin/Glucagon
Figure 7.7. FGF1 Increases the Number of Glucagon+ Cells in Isolated Epithelium
The Proportion of Amylase-Staining Cells in Dexamethasone- and FGF-Treated 
Isolated Epithelia is Greater than that in Epithelia Exposed Only to FGF (This 
Page). Dexamethasone Induces Hepatic Conversion in FGF1- or FGFIO-Treated 
Isolated Epithelia in which GS+ Hepatocytes are Induced in the Absence of CPS I+ 
Hepatocytes (Facing Page). Hepatic Conversion in Dexamethasone-Treated Isolated 
Epithelia Controls is Believed to be a Consequence of Mesenchymal Contamination
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Immunofluorescence analysis for amylase, insulin and glucagon in control epithelia 
cultured without (a) or with (b) 100 ng/ml FGF1 for 3d and in epithelia cultured 
with 1 pM dexamethasone and either 100 ng/ml FGF1 (c-e) or 100 ng/ml FGF10 (f) 
(facing page)
Immunofluorescence analysis shows staining for GS but not CPS I in epithelia 
cultured with 1 pM dexamethasone and 100 ng/ml FGF1 for 3d (g-h) or control 
epithelia cultured with only 1 pM dexamethasone for 3d (i-j) (this page)
(a) and (f)-(i) Bar = 100 pm; (b)-(e) and (j) Bar = 50 pm
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7.4. Discussion
7.4.1. Independence of GS*Hepatocyte and CPS 7* Hemtocvte Induction 
in Dexamethasone-Induced Hepatic Conversion
The original aim of this study was to address the questions: (1) Does hepatic 
transdifferentiation of dexamethasone-treated pancreatic buds still occur in the absence 
of mesenchyme? (2) If transdifferentiation does occur, is the GS+ hepatocyte population 
induced, and if not, does induction of CPS I-expressing hepatocytes still occur in their 
absence? In investigating the role of epithelial-mesenchymal interactions in 
dexamethasone-induction of CPS I+ hepatocyte and GS+ hepatocyte populations, a 
number of interesting findings were made regarding the influence of the mesenchyme 
and the effects of dexamethasone in exocrine and endocrine differentiation.
In intact pancreatic buds, the numbers of both CPS I* hepatocytes and GS+ 
hepatocytes induced by exposure to 1 pM dexamethasone increased over 3-7 days of 
Dex treatment whereupon the abundance of the cells expressing either protein attained a 
plateau. CPS I and GS expression was always clearly distinct in all cultures examined at 
all time-points. Colocalisation of the two proteins was never encountered in vitro. 
Hence, the complementary fashion of CPS I and GS expression in vitro mirrors the 
mutually exclusive complementary expression pattern of CPS I and GS within the 
mammalian liver in situ (Bartels et al., 1989; Moorman et al., 1988, 1990). The finding 
from the current study is also consistent with the complementary GS and CPS I 
expression observed in vitro in hepatocytes induced from pancreatic AR42J-B13 cells 
by treatment with dexamethasone (Tosh et al., 2002). GS was found to be expressed 
first after 3d of Dex treatment and then CPS I appeared after around 5d of 
dexamethasone exposure (Tosh et al., 2002). However, the mutual exclusivity of CPS I 
and GS expression observed in the pancreatic hepatocytes induced in vitro in this study 
(Tosh et al., 2002) and the current study is inconsistent with the coexpression of the two 
enzymes in hepatocytes in the pancreata of rats fed a copper-depleted diet (Yeldandi et 
al., 1990). The concomitant expression of GS and CPS I genes in pancreatic 
hepatocytes in vivo was attributed in part to the absence of a portal blood supply to the 
pancreas (the portal vein does not drain into the pancreas) resulting in a lack of 
hormonal or metabolic gradients and also to the possible cell matrix homogeneity in the 
pancreas (Yeldandi et al., 1990). It is clear from the present study however that such 
factors cannot solely be responsible for GS and CPS I coexpression in pancreatic
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hepatocytes in situ. In the in vitro cultures of AR42J-B13 cells and pancreatic buds it is 
unlikely that there are any local gradients existing across the cultures to mimic a portal 
blood supply. The observations from the present study and those of Tosh et al. (2002) 
that the complementary pattern of GS and CPS I expression is retained in cultured 
pancreatic hepatocytes, suggest that the normal liver zonation need not be maintained 
by continued environmental variations such as differences in the composition of 
extracellular matrix within the acinus (Kuo et al., 1988) and the presence of factors 
associated with central veins (Shiojiri et al., 1997). Instead, once established, the 
periportal and perivenous hepatocytes represent two relatively stable subtypes of 
hepatocyte (Tosh et al., 2002).
In order to answer the questions posed at the outset, isolated epithelia were 
exposed to dexamethasone but as a consequence of the lack of hepatic conversion in a 
totally mesenchyme-deficient environment, Dex-treated epithelia could not be 
employed to address these questions. In order to provoke some exocrine differentiation, 
isolated epithelia were exposed to FGF or co-cultured with mesenchyme. Co-cultures 
subjected to dexamethasone treatment however, were found to contain both CPS I* 
hepatocytes and GS-expressing hepatocytes. Three of seven isolated epithelia cultured 
with Dex and FGF1 displayed GS-immunopositive cells although in none of these 
cultures were CPS I+ hepatocytes induced. Furthermore, in two of the eight negative 
controls for FGF treatment in which isolated epithelia were exposed only to Dex, GS- 
expressing cells were again observed in the absence of CPS I-immunopositive 
hepatocytes. The hepatic conversion in these control cultures was assumed to be a 
consequence of the presence of some contaminating mesenchyme. The five cultures 
showing only GS+ cells demonstrated quite strikingly that in dexamethasone-induced 
hepatic conversion of pancreas in vitro, CPS I4- hepatocytes need not be induced for the 
GS+ hepatocyte population to be induced and that induction of the two populations 
occurs independently of one another. In none of the cultures examined were CPS I* 
hepatocytes ever induced in the absence of GS-expressing hepatocytes.
The results from the current study show that a model in which the induction of 
either GS+ perivenous hepatocytes or CPS I*" periportal hepatocytes induces the 
formation of the other hepatocyte population cannot be supported. It might be assumed 
from the evidence presented here that the inductive signal is mesenchymal in origin and 
can be mimicked by FGF. Furthermore, the induction of GS+ hepatocytes would appear 
to be initiated at a lower threshold of the inducing signal than CPS I* cell induction 
since the CPS I* hepatocytes were never found in isolation from GS+ cells. Dissociation
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of induction of the two hepatocyte populations was only observed when the 
presumptive inductive signal was suppressed to a low level.
7.4.2. Hepatic Conversion Cannot Occur in the Absence o f Exocrine 
Cells
Whole pancreatic buds exposed to 1 pM Dex for 7 days from 2d of culture 
retained a high proportion of amylase-staining cells throughout the explant. Hepatocytes 
were induced by treatment with dexamethasone, as judged from expression of the liver- 
specific proteins transferrin, CPS I and GS. In the present study cultures were not 
simultaneously stained for amylase and either transferrin, CPS I or GS so it could not be 
ascertained whether cells expressing a liver marker also expressed the exocrine product 
amylase. Shen et al. (2000) found that in dexamethasone-treated intact pancreatic bud 
cultures, albumin expression was often found in cells negative for amylase, or the two 
proteins were often coexpressed. This was in contrast to their finding that in AR42J- 
B13 cells, amylase was lost from all cells that had reached the stage of albumin 
expression. It is known that glucocorticoids can increase the expression of amylase in 
pancreatic (AR42J) cells (Logsdon et al., 1985). The persistence of amylase expression 
in cells expressing liver markers may represent a partial hepatic conversion. It is 
possible that cells coexpressing amylase and a liver protein(s) lose their amylase 
expression with prolonged culture in the presence of dexamethasone as do the AR42J- 
B13 cells.
Unlike Dex-treated intact pancreatic buds, epithelia denuded of their 
mesenchyme and similarly subjected to 1 pM Dex over 2-9d of culture showed no cells 
expressing any of the three liver markers stained for. When denuded epithelium was co­
cultured with pancreatic mesenchyme however, both CPS I+ hepatocytes and GS+ 
hepatocytes were observed. These findings suggest that dexamethasone-induced hepatic 
conversion cannot occur in the absence of pancreatic mesenchyme. Isolated epithelial 
cultures failed to stain for the exocrine marker amylase. This is consistent with the 
suggestion that mesenchyme promotes exocrine differentiation (Gittes et al., 1996; 
Miralles et al., 1998b). Shen et al. (2000) showed that in the hepatic conversion of the 
AR42J-B13 cell line, some hepatocytes arose directly from the differentiated exocrine­
like cells, with no intervening cell division. Although this does not exclude the 
generation of hepatocytes from stem cells or other types of progenitor cell, exocrine 
cells are the precursor cells for hepatocyte production for a proportion of hepatocytes.
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Whilst isolated epithelia did not express amylase, culturing the denuded epithelium with 
mesenchyme yielded amylase expression in approximately 40 % of the cultured cells. 
As mentioned above, in three of seven isolated epithelia cultured with Dex and FGF1, 
cells immunopositive for the liver marker GS were induced, suggesting that hepatic 
conversion had occurred. In such cultures, amylase+ cells were frequently detected, 
consistent with FGF-driven promotion of exocrine differentiation from isolated 
pancreatic epithelium (Horb and Slack, 2000; Miralles et al., 1999). It is also possible 
however that in the cultures exposed to both FGF1 and Dex, dexamethasone induced an 
increase in amylase expression. The findings from the experiments are consistent with 
the induction of hepatocytes only in the presence of exocrine cells.
7.4.3. Requirement of Mesenchyme for Differentiation of the Pancreatic 
Epithelium
7.4.3.I. Mesenchymal Factor(s) Promote Pancreatic Differentiation
In the present study, it was demonstrated that pancreatic epithelia deprived of 
their mesenchyme fail to undergo the typical morphogenetic behaviours of developing 
intact pancreatic buds in vitro. Isolated epithelia showed no branching morphogenesis 
throughout an 8-day culture period. For 40 years it has been known that inductive 
signals originating in the mesenchyme play an essential role in the development of the 
pancreatic epithelium. Classic studies by Golosow and Grobstein (1962) and Wessels 
and Cohen (1967) used recombined embryonic tissues to show that pancreatic buds 
could develop in vitro, but that isolated epithelium would not undergo any growth or 
morphogenesis in the absence of mesenchyme. In the study by Golosow and Grobstein 
(1962), salivary mesenchyme was shown to be even more effective than pancreatic 
mesenchyme in promoting growth and differentiation of the mouse pancreatic 
epithelium in vitro. As the effects of mesenchyme could be exerted across a Millipore 
filter, it was suggested that the mesenchyme secreted a soluble growth factor required 
by the epithelium (Golosow and Grobstein, 1962). In some circumstances, the 
mesenchyme could be substituted by a chick embryo extract, the necessary factor being 
trypsin-sensitive (Rutter et al., 1964). Although the mitogen from chick embryos was 
partially purified (Ronzio and Rutter, 1973), the identity of the “mesenchymal factor” 
remains elusive, partly because it may in fact comprise multiple substances.
In the present study, isolated pancreatic epithelia cultured for 9d in Dex-free 
medium showed small numbers of glucagon+ cells and insulin-immunopositive cells
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although no amylase-expressing cells were seen, indicating an absence of exocrine 
differentiation. However, culturing denuded epithelium in the presence of mesenchyme 
rescued exocrine development: in co-cultures of epithelium and mesenchyme 
approximately 40 % of cells expressed amylase. The proportion of amylase+ cells in 
denuded epithelium cultured with mesenchyme was however, lower than that seen in 
intact pancreatic buds which are supported by a greater amount of mesenchyme. It is 
envisaged that the epithelium in such co-cultures receives markedly fewer inductive 
signals than does that in intact buds owing to the massively greater distance of 
separation between epithelium and mesenchyme in co-cultures. In the current study it 
was also found that proportions of insulin+ cells and glucagon+ cells in co-cultures of 
epithelium and mesenchyme were much higher than in intact pancreatic buds: in co­
cultures approximately 50 % and 10 % of cells were insulin- and glucagon- 
immunopositive respectively. Furthermore, islet-like clusters of insulin+ cells and 
glucagon+ cells in denuded epithelium cultured with mesenchyme were much larger in 
size than those seen in intact bud cultures. Taken together, these results are consistent 
with work suggesting that the default state of the pancreatic epithelium is to form islets, 
and mesenchyme provides an instructive signal for differentiation of exocrine cells 
(Gittes et al., 1996; Miralles et al., 1998b). Mesenchyme acts quantitatively as a 
repressor of endocrine tissue development (Miralles et al., 1998b). It had been 
hypothesised that the pancreatic epithelium produces factors such as activins or bone 
morphogenetic proteins (BMPs) which act on epithelial cells in an autocrine manner to 
promote endocrine differentiation (Furukawa et al., 1995; Lyons et al., 1995; Ritvos et 
al., 1995). This was subsequently confirmed when exogenous application of the activin 
inhibitor follistatin (Nakamura et al., 1990) was shown to promote amylase expression 
whilst repressing insulin expression and thus mimics the effects of the mesenchyme 
(Miralles et al., 1998b).
7.4.3.2. Promotion o f Exocrine Differentiation by FGF?
One candidate for the “mesenchymal factor” mentioned above is FGF. FGF1, 
FGF7 and FGF 10 are all expressed in the pancreas during development and have been 
shown to be capable of activating epithelial cell proliferation in isolated pancreatic 
epithelium in vitro (Bhushan et al., 2001; Mason et al., 1994; Miralles et al., 1999). 
These three FGFs bind to a specific receptor, FGFR2IHb which is known to be 
expressed in the fetal pancreatic epithelium (Finch et al., 1995; Orr-Urtreger et al.,
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1993). Culturing intact pancreatic buds in the presence of a dominant negative form of 
the FGFR2b receptor has the effect of reducing cell proliferation (Miralles et al., 1999). 
It has been shown that FGF can promote exocrine differentiation from isolated 
pancreatic epithelium (Horb and Slack, 2000; Miralles et al., 1999). On account of these 
findings, isolated epithelium was cultured with FGF in an attempt to promote 
differentiation of exocrine cells which might then be induced to form hepatocytes by 
dexamethasone. It was envisaged that hepatocyte production in such circumstances 
would indirectly support the exocrine promoting effects of FGF (Horb and Slack, 2000; 
Miralles et al., 1999). However, the results of the immunofluorescence analysis were 
somewhat inconclusive. Isolated epithelia were cultured in the presence of 100 ng/ml 
FGF1 which is capable of stimulating all known FGF receptors (Omitz et al., 1996) and 
should therefore be able to replicate the effect of any of the 22 known FGFs. Denuded 
epithelia cultured for 3d under such conditions showed no cells staining for amylase 
though demonstrated both insulin+ cells and glucagon+ cells. No effect of FGF on 
exocrine differentiation was therefore observed in these cultures. Neither CPS I+ 
hepatocytes nor GS+ hepatocytes were seen in FGF 1-exposed epithelia, demonstrating 
that the FGF1 alone was not capable of inducing hepatic conversion. Consistent with 
the ability of FGF1 to mimic the effects of FGF10, isolated epithelia cultured for 2-6d 
with 100 ng/ml FGF1 or FGF10 and exposed to Dex for 3-7d showed similar patterns of 
staining for amylase, insulin and glucagon. Denuded epithelia subjected to Dex in 
addition to FGF showed expression of the exocrine pancreatic marker amylase which 
was absent from the FGF 1-treated epithelia cultured in Dex-free medium. Three of the 
seven Dex- and FGF 1-treated epithelia also displayed staining for GS indicating the 
induction of hepatic conversion. These findings would suggest that exocrine cells are 
present within the FGF- and Dex-treated isolated epithelia. However, it could not be 
determined with certainty whether amylase expression in these cultures was a 
consequence of exposure to FGF or Dex. Although the observations are consistent with 
FGF-driven promotion of exocrine differentiation it is equally if not more plausible that 
the Dex stimulated an increase in amylase expression, especially since the isolated 
epithelial cultures exposed only to FGF1 showed no amylase expression. The latter 
hypothesis is consistent with the observation that glucocorticoids can increase the 
expression of amylase in pancreatic (AR42J) cells (Logsdon et al., 1985).
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7.4.4. FGF1-Induced Expansion o f  Glucagon* Cells
It was shown in the current study that in isolated epithelia subjected to FGF1 for 
3d, whilst the proportion of insulin+ cells was comparable to that in control untreated 
epithelia, numbers of glucagon* cells were substantially greater in the FGF 1-treated 
epithelia. This finding suggests that FGF1 stimulates some endocrine differentiation. 
Although the study of Horb and Slack (2000) found no evidence for an effect of FGF 1 
treatment on insulin expression in isolated epithelia, glucagon expression was not 
examined. The earliest differentiated cells to emerge during normal pancreas 
development are glucagon-expressing cells (Pictet and Rutter, 1972) and increased early 
differentiation of precursor epithelial cells would result in an excessive number of 
glucagon-positive cells (Apelqvist et al., 1999; Jensen et al., 2000b). Hence the FGF1- 
stimulated increase in the number of glucagon-expressing cells is concordant with FGF1 
promoting the expansion of a primitive pancreatic precursor cell population. It has been 
demonstrated that FGF 10 signalling regulates the size of the Pdxl-expressing epithelial 
progenitor cell population during early pancreatic organogenesis (Bhushan et al., 2001). 
Mutant mice in which FgflO had been inactivated showed significantly fewer Pdxl* 
pancreatic cells compared to wild-type littermates. This was taken to show that although 
the specification of Pdxl+ cells occurs in the absence of FgflO, the maintenance and 
expansion of the Pdxl+ progenitor cell population is dependent upon FGF 10 signalling 
from the mesenchyme (Bhushan et al., 2001). More recently, it has been shown that 
culturing the pancreatic epithelium for 7d in the presence of FGF7 represses endocrine 
differentiation whilst an undifferentiated endocrine progenitor cell population is 
expanded (Cras-Meneur et al., 2001; Elghazi et al., 2002). Interestingly, FGFRl-IIIb 
transcripts have been shown to be enriched in pancreatic epithelia cultured with FGF7 
or epidermal growth factor (EGF) when compared with untreated epithelia, suggesting 
that FGFRl-mb represents a marker for pancreatic progenitor cells (Cras-Meneur and 
Scharfmann, 2002). The fact that FGF1 is able to stimulate all known FGF receptors 
(Omitz et al., 1996) and therefore mimic the effects of all known 22 FGFs permits 
speculation that the FGF1 used in the current study similarly promoted the expansion of 
a pancreatic precursor cell population. Further work is needed to characterise these 
glucagon-expressing cells by immunostaining for markers of endocrine progenitor cells, 
notably Isll and ngn3 (Apelqvist et al., 1999; Jensen et al., 2000a; Schwitzgebel et al., 
2000).
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7.4.5. Dexamethasone-induced Expansion o f  Glucagon+ Cells
Similarly to the above, isolated epithelia exposed to dexamethasone for 7d 
showed substantially greater numbers of glucagon+ cells than control epithelia cultured 
in Dex-ffee media. Whilst the number of insulin-immunopositive cells was not 
appreciably increased by Dex exposure, the 10.2 ± 2.83 glucagon-immunopositive cells 
counted in each Dex-treated epithelial culture was markedly higher than the 1.0 ± 0.707 
cells control value. One of the reasons for these cell numbers being quite low was the 
detachment of epithelial cells from the fibronectin substrate. Isolated epithelia initially 
attached to the substrate rapidly and formed a monolayer showing that cell adhesion of 
epithelial cells was not detrimentally affected by the absence of mesenchyme. However, 
with prolonged culture periods (> 7d), cell detachment occurred increasingly so that 
culture duration and treatment times were reduced in subsequent experiments to 
minimise cell loss from coverslips.
In addition to the increased number of glucagon* cells, such cells in the Dex- 
treated epithelia were aggregated together into islet-like cell clusters which most 
probably corresponded to the cell “islands” observed under brightfield magnification. 
Additionally, dexamethasone exposure was also seen to selectively increase the number 
of glucagon-immunopositive cells in co-cultures of epithelium and mesenchyme, but at 
the expense of the insulin-immunopositive cell population. The observed increase in the 
numbers of glucagon-expressing cells suggests that dexamethasone, like FGF1, 
promotes expansion of a primitive endocrine precursor cell population. Efforts were 
made to characterise the glucagon-expressing cells by staining for ngn3 as a marker of 
endocrine cell progenitors (Apelqvist et al., 1999; Jensen et al., 2000a; Schwitzgebel et 
al., 2000). However, despite repeated attempts, immunofluorescence cytochemistry for 
ngn3 proved to be unsuccessful. Therefore, the precise identity of this epithelial cell 
population expanded by dexamethasone treatment proves elusive until further attempts 
to characterise these cells prove fruitful. Another unresolved question is whether the 
expanded glucagon+ cell population and the few insulin-immunopositive cells account 
for all of the cells within the isolated epithelia exposed to Dex treatment. It is for 
example, conceivable that pancreatic duct cells might occur within such cultures. The 
current results also do not exclude any effects of Dex on the 5- and PP-cell populations.
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In the current study, the relationship between the induction of two hepatocyte 
populations expressing either of two hepatic enzymes during dexamethasone-induced 
hepatic conversion of the pancreas was investigated by subjecting the pancreatic 
epithelium to a mesenchyme-deficient environment in vitro. Using this approach it was 
demonstrated quite conclusively that Dex-induction of the glutamine synthetase+ 
hepatocyte and carbamoylphosphate synthetase I* hepatocyte populations is 
independent of the other by showing that the GS+ perivenous-like hepatocytes can be 
induced in the absence of the CPS I* periportal-like hepatocyte population. Moreover, it 
was demonstrated that hepatic conversion cannot occur in the absence of exocrine cells, 
consistent with the finding that some hepatocytes arise from differentiated exocrine 
cells without cell division (Shen et al., 2000). By manipulating the ratio of mesenchyme 
to epithelium it was shown that pancreatic epithelium denuded of its mesenchyme will 
form endocrine tissue whilst the mesenchyme provides an instructive signal for 
differentiation of exocrine cells as previously reported (Gittes et al., 1996; Miralles et 
al., 1998b). Furthermore, it was discovered that dexamethasone enhances the number of 
glucagon+ cells in pancreatic epithelium deprived either completely or partially of 
mesenchyme, consistent with dexamethasone-induced expansion of a primitive 
endocrine precursor cell population. Further work is needed to characterise this 
population of cells to prove an endocrine progenitor role. This finding might be 
employed to amplify pancreatic cells in vivo or in vitro to develop therapeutic 




8.1. Generation o f  IGF-II Transsettic Lines by Dr. Bill Bennett 
(Chapter 6): Methodology Written by Dr. Bill Bennett
8.1.1. Elijah: Rat Elastase I  Promoter-Igf2 Construct
Plasmid pEGH3 (Omitz et al., 1985) was a kind gift of Dr. G. H. Swift and 
contains a 213 bp promoter region (spanning positions -205 to +8 relative to start of 
transcription) of the rat elastase I gene coupled with human growth hormone (hGH). 
This promoter fragment is flanked by unique Sail and BamHI sites at the 5' and 3f ends 
respectively. A Xhol site was added to the 3' end by digestion of pEGH3 with BamHI 
and ligation of a linker containing the Xhol site which also reconstituted the BamHI site. 
The resulting plasmid was digested with Sail and Xhol to release a 223 bp fragment 
containing the elastase promoter.
p99a:5 consists of a pUC19 plasmid backbone with an insert comprising the 
coding region of the mouse Igf2 gene, corresponding to the last three exons of the gene: 
exons 4, 5 and 6, the latter including transcription termination and polyA signals 
endogenous to Igf2, as described previously (Ward et al., 1994). The Igf2 coding region 
was a ~3.5 kb Kpnl (partial digest) fragment from a cosmid containing Igf2 genomic 
sequence. There is a unique Sail site immediately upstream of the Ig£2 coding region, 
and p99a:5 was digested with Sail and the elastase promoter Sal-Xho fragment inserted. 
The resultant construct, designated pEIP-IGF2, was checked for correct orientation by 
restriction mapping and partial sequencing at each end. Bulk DNA was prepared using 
the Endofree Maxiprep kit (Qiagen) according to the manufacturer's instructions. The 
final pellet was redissolved in endotoxin-free TE and checked for purity by A280/260 
spectrophotometry and gel electrophoresis.
Construct DNA was prepared for injection by digesting 150 pg pEIP-IGF2 with 
20 U Sail and 30 U EcoRI overnight and then running the digest out on a preparative 
agarose gel. The 5.4 kb construct band was excised from the gel and purified using a 
QiaEx gel extraction kit (Qiagen) according to the manufacturer's instructions. The 
extracted construct DNA was dialysed for 3 days at 4°C into injection buffer (10 mM 
Tris.HCl, 0.1 mM EDTA, pH 7.4) with several changes of buffer. The DNA was 
quantified by spectrophotometry and gel electrophoresis and diluted to a final
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concentration of 1-2 ng/jj.1 in injection buffer, then particles removed by passing through 
endotoxin-free 0.2 pm spin filters (Costar).
8.1.2. Ripley: Rat Insulin IPromoter-l2f2 Construct
The Ripl-DipA plasmid (Palmiter et al., 1987) was obtained from Dr. D. Tosh 
and consisted of the rat insulin I gene promoter region (spanning positions -205 to +8 
relative to start of transcription) coupled with the diphtheria A toxin coding region.
The rat insulin I (RIP) promoter region was subcloned into BlueScript KS+ by 
cutting Ripl-DipA with Xbal and BamHI to release a 700 bp fragment containing the 
promoter. This was gel purified and ligated into BlueScript KS+ previously digested 
with Xbal and BamHI, to give plasmid RIP-BSKS+. In order to add a unique Xhol site 
to the 5’ end of the subcloned promoter fragment, a PCR primer was designed with 17 
bp homology to the Bluescript polylinker region immediately upstream of the insert, but 
with an additional non-homologous 9nt added on 5' to this containing a Xhol site and 3 
flanking nucleotides (to give efficient restriction). This XHOI-127 primer (5'- 
gcgcctcgagtggcggccgctctagA-3') was used in combination with a standard Bluescript 
KS sequencing primer to amplify a 735 bp fragment from plasmid RIP-BSKS+ 
containing the promoter fragment flanked by unique Xhol and Sail sites at the 5' and 3' 
ends respectively.
100 ng of plasmid RIP-BSKS+ was added to a 50 pi PCR reaction containing 75 
mM Tris.HCl, pH 9.0, 20 mM (NH4)S0 4 , 0.01 % Tween-20, 3 mM MgCh, 250 pM 
dNTPs, 2 U Taq polymerase and 150 nM of each primer. 36 reaction cycles were carried 
out, each consisting of 60 sec denaturation at 95 °C, 60 sec annealing at 60°C and 60 sec 
extension at 72°C. After final extension for 10 min at 72°C, the PCR product was 
purified away from the reaction mixture and unincorporated nucleotide using a QiaEx 
spin column (Qiagen) according to the manufacturer's instructions. The PCR product 
was then subcloned into pGEM-T to give plasmid pGEM-RIP.
An Nhel site was added to the 3' end of the Igf2 coding region by cutting the 
plasmid p99a:5 at the unique EcoRI site and ligating in a linker containing the Nhel site 
which also reconstituted the EcoRI site. This gave plasmid p99-Nhe. This plasmid was 
then linearised by digestion with Sail, which cuts directly upstream of the Igf2 coding 
region, and the ends phosphatased to prevent re-ligation. pGEM-RIP was digested with 
Xhol and Sail to release the 720 bp RIP fragment. This was gel purified and ligated into
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linearised p99-Nhe to give the final construct plasmid pRIP-IGF2. With the promoter 
inserted in the correct orientation, this contains the transgene construct flanked by 
unique Sail and Nhel sites.
pRIP-IGF2 was checked by restriction mapping and partial sequencing, then a 
bulk prep was prepared as described above using the Endofree Maxiprep kit. 
Approximately 50 fig plasmid was digested overnight with 20 U Sail and 15 U Nhel 
then the 5.9 kb transgene construct fragment was gel purified, dialysed and diluted into 
injection buffer as before.
8.1.3. Construct Microiniection
Fi (C57BL/6xCBA) females were super-ovulated at PN4-6wk by intra- 
peritoneal (i.p.) administration of 5 IU Folligon (PMSG or pregnant mare serum 
gonadotrophin; Intervet Ltd.) mid-afternoon followed by 5 IU Chorulon i.p. (hCG or 
human chorionic gonadotrophin; Intervet Ltd.) 48 h later. Females were then 
immediately paired with stud Fi (C57BL/6xCBA) males, then on the following morning 
were checked for plugs to ensure that mating had occurred and if so, were sacrificed by 
cervical dislocation, and fertilised eggs harvested from the dissected ampullae into M2 
medium. The egg clutch was treated with hyaluronidase to remove the cumulus cells, 
and embryos transferred into KSOM medium in a 37°C, 5 % CO2 incubator.
Single cell embryos with visible pro-nuclei were injected with transgene 
construct DNA using standard methods (Hogan et al., 1994). Briefly, approximately 20- 
40 picolitres of injection buffer (containing about 1000-4000 copies of the transgene 
construct) were injected directly into one of the pro-nuclei using a micro-injection 
needle drawn on a Sutter P97 needle puller and using a shaped holding pipette and 
gentle suction to hold the embryo in position in a drop of M2 medium during injection.
Successfully injected embryos were transferred back into KSOM medium and 
placed in the incubator during preparations for oviduct transfer, or in some cases 
cultured overnight to the 2-cell stage prior to surgery. Pseudopregnant MF1 female 
mice, prepared by mating 12 h previously with a vasectomised male were weighed and 
anaesthetised by i.p. administration of 0.009 ml/g bodyweight Hypnorm/Hypnovel 
mixture, comprising 0.079 mg/ml fentanyl citrate, 2.5 mg/ml fluanisone and 1.25 mg/ml 
midazolam. Following laparotomy, the oviduct was exposed, and a polished transfer 
pipette loaded with approximately 20 injected embryos in a minimal volume of M2
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medium was used to transfer embryos into the infundibulum of the pseudopregnant 
recipient.
8.1.4. Transgenic Line Derivation
Potential founders bom to the pseudopregnant host mothers were tested by PCR 
for the presence of the transgene at around PN3wk. Earclips from animals to be tested 
were boiled for 10 min in 1 ml freshly prepared 50 mM NaOH, then neutralised by the 
addition of 50 pi 1M Tris.HCl, pH 8.0. 1 pi of this was added to 24 pi reaction mix to 
give a 25 pi reaction containing 75 mM Tris.HCl, pH 9.0, 20 mM (NH4)SC>4 , 0.01 % 
Tween-20, 3 mM MgCh, 250 pM dNTPs, 1 U Taq polymerase and 150 nM of each 
primer. 36 reaction cycles were carried out, each consisting of 60 sec denaturation at 
95°C, 60 sec annealing at 60°C and 60 sec extension at 72°C. Primers were designed to 
span the junction between promoter and Igf2, so as to be unique to the transgene.
For mice injected with the EDMgf2 construct, forward primer ELAS-141 
(5 '-taactg agtgccggccttgttctg-3 ') and the reverse primer IGF2R142 (5'- 
tgagaagcaccaacatcgacttcc-3') amplify a 279 bp product.
For mice injected with the RJP-Igf2 construct, forward primer RIP-153 (5'- 
ctgaggtgaggacacagctatcag-3') and reverse primer IGF2R142 amplify a 655 bp 
product.
Positive potential founders were crossed to non-transgenic Fi (C57BL/6xCBA) 
animals and two or three litters of offspring tested for transmission. Only one founder 
for each constmct was found to transmit consistently. The line carrying the ELP-Igf2 




Table 8.1. (a). Measurements for Each Field (Partial Section) Analysed for Statistical




























11 35 1 3.678140 3.620442 98.43133 21429.90747 0.58263 6 1863.14488
Male 2 4.367803 3.638905 83.31202 342672.75652 7.84543 10 34316.86810
3 2.894609 2.868588 99.10105 2929.40255 0.10120 3 976.46752
4 3.263429 3.167421 97.05806 43746.4925 1.34051 6 7291.08208
5 2.842980 2.813476 98.96222 5155.44915 0.18134 3 1718.48305
Mean 3.4093922 3.2217664 95.37294 83186.80164 2.01022 5.6 9233.20913
2 / 33 1 3.902151 3.681844 94.35422 22353.9975 0.57286 7 3193.42821
Female 2 4.064567 3.853347 94.80338 94810.8793 2.33262 11 8346.73947
3 3.780493 3.758012 99.40534 998.91503 0.02642 2 499.45752
4 3.699910 3.659789 98.91562 1466.57189 0.03964 2 733.28595
5 3.430177 3.321815 96.84092 50342.32447 1.46763 8 6292.79056
Mean 3.7754596 3.6549614 96.86390 33994.53764 0.88783 6 3813.14034
3 / 31 1 4.385866 3.821666 87.13595 388663.9973 8.86174 13 29897.23056
Male 2 3.979068 3.923895 98.61342 6173.0704 0.15514 2 3086.5352
3 3.973527 3.926802 98.82409 4938.45633 0.12428 2 2469.22817
4 1.918774 1.909364 99.50958 0 0 0 -
5 2.380220 2.336960 98.18252 0 0 0 -
Mean 3.327491 3.1837374 96.45311 79955.10481 1.82823 3.4 11817.66464
3 / 31 1 3.779808 3.759104 99.45225 0 0 0 -
Male 2 3.836032 3.760197 98.02309 73171.4616 1.90748 5 14634.29232
3 3.736200 3.684855 98.62574 2435.5569 0.06519 1 2435.5569
4 3.353148 3.056654 91.15774 204945.942 6.11205 4 51236.4855
5 3.090613 3.028576 97.99273 3505.5558 0.11343 1 3505.5558
Mean 3.5591602 3.4578772 97.05031 56811.70326 1.63963 2.2 17952.97263
3 / 32 1 2.526211 2.508575 99.30188 6992.4052 0.27679 3 2330.80173
Female 2 2.963545 2.911373 98.23954 2300.8717 0.07764 1 2300.8717
3 2.522893 2.399461 95.10752 2813.4237 0.11152 2 1406.71185
4 2.686221 2.619144 97.50292 3296.0455 0.12270 1 3296.0455
5 2.569980 2.509226 97.63601 13341.315 0.51912 1 13341.315
Mean 2.653770 2.5895558 97.55757 5748.81222 0.22155 1.6 4535.14916
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Table 8.1. (b). Measurements for Each Field (Partial Section) Analysed for
Statistical Morphometry Study of Pancreas Sections from Age- and Sex-Matched





























1 / 35 1 2.935007 2.884485 98.27864 18081.485 0.61606 1 18081.485
Male 2 3.253608 3.214370 98.79402 7995.0615 0.24573 4 1998.76538
3 3.500546 3.413349 97.50905 45265.4416 1.29310 2 22632.7208
4 3.190314 2.983606 93.52076 59022.0358 1.85004 2 10791.6494
5 3.463268 3.426013 98.92428 0 0 0 -
Mean 3.2685486 3.1843646 97.40535 26072.80478 0.800986 1.8 13376.15515
2 / 33 1 1.638737 1.619309 98.81445 796.88728 0.04863 1 796.88728
Female 2 3.316559 3.277440 98.82049 3135.1715 0.09453 2 1795.8023
3 3.603008 3.575278 99.23037 21875.1169 0.60713 3 7291.70563
4 4.006719 3.836765 95.75828 107931.46014 2.69376 11 9811.95092
5 2.697980 2.572550 95.35097 53372.7422 1.97825 5 10674.54844
Mean 3.0526006 2.9762684 97.59491 37422.27560 1.08446 4.4 6074.17891
3 / 31 1 2.953204 2.928097 99.14984 4455.8345 0.15088 0 -
Male 2 2.643451 2.582599 97.69801 41262.2994 1.56093 5 8252.45988
3 3.349646 3.232826 96.51247 71828.3516 2.14436 5 14365.67032
4 2.144876 2.096622 97.75027 8739.5713 0.40746 4 2024.01887
5 3.106341 2.939425 94.62660 102020.2782 3.28426 7 14574.32546
Mean 2.8395036 2.7559138 97.14744 45661.267 1.50958 4.2 9804.11863
31 31 1 1.371308 1.194848 87.13199 13004.60178 0.94834 3 4334.86726
Male 2 3.857204 3.666650 95.05979 145179.3935 3.76385 8 16485.21582
3 2.814067 2.753014 97.83044 54446.481 1.93480 2 27223.2405
4 3.885761 3.720940 95.75833 102577.7238 2.63984 9 11182.14285
5 3.431711 3.413079 99.45706 0 0 0 -
Mean 3.0720102 2.9497062 95.04752 63041.64002 1.85737 4.4 14806.36661
3 / 32 1 1.879079 1.780037 94.72923 10662.5762 0.56744 2 5331.2881 1
Female 2 2.198481 2.071323 94.21610 79946.874 3.63646 5 10902.95183
3 2.272752 2.228261 98.04242 26899.6225 1.18357 5 5379.9245
4 2.211194 2.001280 90.50676 52007.1828 2.35200 4 13001.7957
5 2.501223 2.299517 91.93571 94661.229 3.78460 3 31553.743
Mean 2.2125458 2.0760836 93.88604 52835.4969 2.30481 3.8 13233.94063
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Table 8.2. Measurements for Each Section Analysed for Statistical Morphometry
Study of Pancreas Sections from Ripley Transgenic and Age- and Sex-Matched






Section Number of 
Islets/Section
Total Section Area (mm2) Mean Islet Area (pm2)
TG CTL Transgenic Control Transgenic Control
1 / 43 1 19 12 20.93247 24.01568 4772.524 11576.04
Female 2 19 26 20.4464 31.18273 7567.221 11311.78
3 22 38 25.29856 31.76815 5386.319 18976.35
4 15 34 28.06826 33.00867 10345.22 13786
5 33 31 31.28911 30.53618 11646.43 18949.95
Mean 21.6 28.2 25.20696 30.10228 7943.542 14920.02
1 / 43 1 13 14 23.06994 35.75626 6606.624 9554.675
Female 2 28 29 28.34825 43.37217 6811.023 13294.45
3 28 35 27.00852 37.94556 9977.058 15365.33
4 19 21 33.112 32.74346 12105.03 6215.452
5 26 18 31.35083 25.32661 6112.7 11227.14
Mean 22.8 23.4 28.57791 35.02881 8322.487 11131.41
1 / 46 1 62 12 22.78584 15.39916 16543.73 9062.731
Male 2 75 14 26.9128 19.78081 44551.4 30618.13
3 43 18 23.66573 22.99312 25370.39 34247.78
4 46 22 29.29795 24.01552 18497.74 48172.05
5 54 13 31.47079 22.47093 23719.75 47998.05
Mean 56 15.8 26.82662 20.93191 25736.6 34019.75
2 / 43 1 34 36 32.5697 31.4275 9068.161 9363.398
Male 2 49 32 43.73049 29.40998 14516.35 9990.518
3 52 58 43.31973 34.14004 15229.79 12565.62
4 28 22 37.31668 28.23698 10681.13 5202.081
5 8 22 27.74574 24.10819 10994.75 6013.707
Mean 34.2 34 36.93647 29.46454 12098.04 8627.065
2 / 43 1 13 25 20.53161 18.31792 16600.57 13431.27
Male 2 17 31 30.19614 19.09829 49520.66 16375.09
3 18 28 31.0707 20.68021 60153.31 16134.86
4 16 32 31.03061 23.29445 44575.04 29116.31
5 27 35 27.00943 24.47704 23671.98 15135.39
Mean 18.2 30.2 27.9677 21.17358 38904.31 18038.58
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